<SEC-DOCUMENT>0001193125-14-077579.txt : 20140228
<SEC-HEADER>0001193125-14-077579.hdr.sgml : 20140228
<ACCEPTANCE-DATETIME>20140228164742
ACCESSION NUMBER:		0001193125-14-077579
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20140421
FILED AS OF DATE:		20140228
DATE AS OF CHANGE:		20140228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SANGAMO BIOSCIENCES INC
		CENTRAL INDEX KEY:			0001001233
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				680359556
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30171
		FILM NUMBER:		14656178

	BUSINESS ADDRESS:	
		STREET 1:		501 CANAL BLVD
		STREET 2:		POINT RICHMOND TECH CNTR.
		CITY:			RICHMOND
		STATE:			CA
		ZIP:			94804
		BUSINESS PHONE:		5109706000

	MAIL ADDRESS:	
		STREET 1:		501 CANAL BLVD
		STREET 2:		POINT RICHMOND TECH CNTR.
		CITY:			RICHMOND
		STATE:			CA
		ZIP:			94804
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>d672020dpre14a.htm
<DESCRIPTION>PRELIMINARY PROXY STATEMENT
<TEXT>
<HTML><HEAD>
<TITLE>Prepared by R.R. Donnelley Financial -- Preliminary Proxy Statement</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:4px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Washington, D.C. 20549 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SCHEDULE 14A </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Securities Exchange Act of 1934 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>(Amendment No.&nbsp;&nbsp;&nbsp;&nbsp;)
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Filed by the
Registrant&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed by a
Party other than the Registrant&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Preliminary Proxy Statement </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT><B></B><B></B></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Confidential, for Use of the Commission Only&nbsp;(as permitted by Rule 14a-6(e)(2)) </B></FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Definitive Proxy Statement </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Definitive Additional Materials </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting Material Pursuant to &#167;240.14a-12 </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="6"><B>SANGAMO BIOSCIENCES, INC. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(Name of Registrant as Specified In Its
Charter) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Name of Person(s) Filing Proxy
Statement, if other than the Registrant) </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Payment of Filing Fee (Check the appropriate box): </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">No fee required. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Title of each class of securities to which the transaction applies: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Aggregate number of securities to which the transaction applies: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Per unit price or other underlying value of the transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and
state how it was determined): </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposed maximum aggregate value of the transaction: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total fee paid: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fee paid previously with preliminary materials. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amount Previously Paid: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form, Schedule or Registration Statement No.: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Filing Party: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date Filed: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SANGAMO BIOSCIENCES, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>To Be Held April&nbsp;21, 2014 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>To the Stockholders of Sangamo BioSciences, Inc.:
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">NOTICE IS HEREBY GIVEN that the Annual Meeting of Stockholders (the &#147;Annual Meeting&#148;) of Sangamo BioSciences,
Inc., a Delaware corporation (the &#147;Company,&#148; &#147;Sangamo&#148; or &#147;we&#148;), will be held on Monday, April&nbsp;21, 2014, at 9:00&nbsp;a.m. Pacific time at 501 Canal Boulevard, Richmond, California 94804, for the following
purposes, as more fully described in the Proxy Statement accompanying this Notice: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">1. To elect seven
(7)&nbsp;directors to serve on the Board of Directors for a one-year term ending at the Annual Meeting held in 2015 or until their successors are duly elected and qualified; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">2. To approve the compensation of the Company&#146;s named executive officers, as described in this Proxy Statement, on an
advisory basis; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">3. To approve an amendment to the Company&#146;s Certificate of Incorporation to increase the
number of authorized shares of common stock from 80,000,000 shares to 160,000,000 shares; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">4. To ratify the
appointment of Ernst&nbsp;&amp; Young LLP as the Company&#146;s independent registered public accounting firm for the year ending December&nbsp;31, 2014; and </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">5. To transact such other business as may properly come before the meeting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">This
Proxy Statement and related solicitation materials, including the annual report and proxy card, are being mailed on or about March
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2014 to all stockholders entitled to notice of, and to vote at, the Annual Meeting, only stockholders of record at the close of
business on March&nbsp;6, 2014 are entitled to notice of and to vote at the Annual Meeting. The stock transfer books of Sangamo will remain open between the record date and the date of the meeting. A list of stockholders entitled to vote at the
Annual Meeting will be available for inspection at the executive offices of Sangamo. All stockholders are cordially invited to attend the meeting in person. To attend the meeting you will need a form of photo identification. If your shares are held
in street name, you will also need to bring proof of your ownership of our common stock, such as your most recent brokerage statement. Whether or not you plan to attend the meeting, please vote as soon as possible. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sincerely,</FONT></TD></TR>
<TR>
<TD HEIGHT="32"></TD></TR>
<TR>
<TD VALIGN="top"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Edward O. Lanphier&nbsp;II</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>President and Chief Executive Officer</B></FONT></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Richmond, California </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">March &nbsp;&nbsp;&nbsp;&nbsp;, 2014 </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Important Notice Regarding the
Availability of Proxy Materials </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>For the Stockholder Meeting to be Held on April&nbsp;21, 2014: </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Proxy Statement, Proxy Card and Annual Report on Form 10-K for 2013 are available at: </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>www.edocumentview.com/sgmo </I></B></FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>YOUR VOTE IS VERY IMPORTANT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>REGARDLESS OF THE NUMBER OF SHARES&nbsp;YOU OWN, PLEASE
READ THE ATTACHED PROXY STATEMENT CAREFULLY, COMPLETE, SIGN AND DATE THE ENCLOSED PROXY CARD AS PROMPTLY AS POSSIBLE AND RETURN IT IN THE ENCLOSED ENVELOPE. PLEASE REFER TO THE &#147;VOTING BY MAIL, VIA THE INTERNET OR BY TELEPHONE&#148;
SECTION&nbsp;ON PAGE&nbsp;3 OF THE PROXY STATEMENT FOR ALTERNATE VOTING METHODS. </B></FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SANGAMO BIOSCIENCES, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>501 Canal Boulevard </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Richmond, California 94804 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROXY STATEMENT </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>FOR THE ANNUAL MEETING OF STOCKHOLDERS </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>To Be Held On April&nbsp;21, 2014 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>General </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The enclosed Proxy Statement (&#147;Proxy&#148;) is solicited on behalf of the Board of Directors of Sangamo BioSciences, Inc., a Delaware
corporation (the &#147;Company&#148;, &#147;Sangamo&#148; or &#147;we&#148;), for use at the Annual Meeting of Stockholders to be held on Monday, April&nbsp;21, 2014 (the &#147;Annual Meeting&#148;). The Annual Meeting will be held at 9:00&nbsp;a.m.
Pacific time at 501&nbsp;Canal Boulevard, Richmond, California 94804. This Proxy Statement and related solicitation materials for the Annual Meeting are being mailed to stockholders on or about to March &nbsp;&nbsp;&nbsp;&nbsp;, 2014. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Voting </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The specific
proposals to be considered and acted upon at the Annual Meeting are summarized in the accompanying notice of Annual Meeting (the &#147;Notice&#148;) and are described in more detail in this Proxy Statement. On March&nbsp;6, 2014, the record date for
determination of stockholders entitled to notice of and to vote at the Annual Meeting, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of Sangamo&#146;s common stock, par value $0.01, were issued and outstanding. No
shares of Sangamo&#146;s preferred stock, par value $0.01, were outstanding. Each stockholder is entitled to one vote for each share of common stock held by such stockholder on March&nbsp;6, 2014. Stockholders may not cumulate votes in the election
of directors. All votes will be tabulated by the Inspector of Election appointed for the Annual Meeting, who will separately tabulate affirmative and negative votes, abstentions and broker non-votes. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Quorum and Broker Non-Votes </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Holders of fifty percent (50%)&nbsp;of the outstanding shares of our common stock entitled to vote at the Annual Meeting on the record date must be present in person or represented by proxy at the Annual
Meeting in order to have a quorum. Abstentions and broker non-votes will be treated as shares present for the purpose of determining the presence of a quorum for the transaction of business at the Annual Meeting. If the persons present or
represented by proxy at the Annual Meeting constitute the holders of less than fifty percent (50%)&nbsp;of the outstanding shares of our common stock as of the record date, the Annual Meeting may be adjourned to a subsequent date for the purpose of
obtaining a quorum. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Broker non-votes result from shares held of record by stock brokerage firms or financial institutions
which are not voted due to the failure of the beneficial owners of those shares to provide voting instructions as to certain non-routine matters as to which such brokerage firms or financial institutions are not permitted to vote on a discretionary
basis. Two matters to be submitted to stockholder approval at the Annual Meeting, the amendment to our Certificate of Incorporation to increase the authorized number of shares of common stock (Proposal No.&nbsp;3) and ratification of the appointment
of Ernst&nbsp;&amp; Young LLP (Proposal&nbsp;No.&nbsp;4), are considered &#147;routine matters&#148; and therefore brokerage firms or other financial institutions will not be precluded from voting in the absence of voting instructions from the
beneficial owners of the share. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Votes Required for Each Proposal </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The required vote for each of the proposals expected to be acted upon at the Annual Meeting is described below: </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Proposal&nbsp;No.&nbsp;1 &#151; Election of directors.</I>&nbsp;Directors are elected by a plurality of affirmative votes of the
shares present in person or represented by proxy and entitled to vote at the Annual Meeting. Under this standard, the seven nominees receiving the highest number of affirmative votes will be elected. Withheld votes and broker non-votes will have no
effect in Proposal No.&nbsp;1. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Proposal&nbsp;No.&nbsp;2 &#151; To approve, on an advisory basis, the compensation of our
named executive officers. </I>Approval of the advisory non-binding resolution regarding the compensation of the Company&#146;s named executive officers requires the affirmative vote of a majority of the shares present in person or represented by
proxy and entitled to vote on Proposal No.&nbsp;2. As a result, abstentions will have the same effect as voting against the proposal and broker non-votes will have no effect on the vote outcome. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Proposal&nbsp;No.&nbsp;3 &#151; To approve an amendment to our Certificate of Incorporation to increase the number of authorized
shares of common stock from 80,000,000 shares to 160,000,000 shares. </I>The affirmative vote of a majority of the shares of our common stock outstanding and entitled to vote at the Annual Meeting is required to approve Proposal No.&nbsp;3. As a
result, abstentions will have the same effect as voting against the proposal. We do not expect broker non-votes in Proposal No.&nbsp;3.<I> </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Proposal&nbsp;No.&nbsp;4 &#151; Ratification of independent registered public accounting firm.</I>&nbsp;This proposal must be approved by a majority of the shares present in person or represented by
proxy and entitled to vote on the proposal. As a result, abstentions will have the same effect as voting against the proposal. We do not expect broker non-votes in Proposal No.&nbsp;4. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Recommendations of the Board of Directors </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">After careful consideration, our
Board of Directors has unanimously approved the proposals described in this Proxy Statement and their recommendations for each proposal are set forth below: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:30pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Proposal</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="border-bottom:1px solid #000000;width:147pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Recommendation of the Board of Directors</B></FONT></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">1&nbsp;&nbsp;Election of Directors</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">FOR all Nominees</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2&nbsp;&nbsp;To approve, on an advisory (non-binding) basis, the compensation of our named executive officers</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">FOR</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">3&nbsp;&nbsp;To approve an amendment to our Certificate of Incorporation to increase the authorized number of shares of common
stock from 80,000,000 shares to 160,000,000 shares</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">FOR</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">4&nbsp;&nbsp;Ratification of the appointment of Ernst&nbsp;&amp; Young LLP as our independent registered accounting firm for the
year ending December&nbsp;31, 2014.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">FOR</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Voting by Mail, via the Internet or by Telephone </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">You may vote by mailing a completed proxy card, by telephone or over the Internet. Should you receive more than one Proxy because your
shares are registered in different names and addresses, each Proxy should be signed and returned or the shares represented thereby should be voted by telephone or over the Internet to assure that all your shares will be voted. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Registered Holders </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If your shares are registered in your own name as a registered holder, you may vote by mailing a completed proxy card, via the Internet or by telephone. Instructions for voting via the Internet or by
telephone are set forth in the proxy card attached to this Proxy Statement. To vote by mailing a proxy card, sign and return the enclosed proxy card in the enclosed prepaid and addressed envelope and your shares will be voted at the Annual Meeting
in the manner you direct. In the event no directions are specified, the proxy holders will vote your shares in the manner recommended by our Board of Directors on all matters presented in this Proxy Statement and as the
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
proxy holders may determine in their discretion with respect to any other matters properly presented for a vote at the Annual Meeting. If you are a registered holder and you do not return the
proxy card, your shares will not be voted and will not be deemed present for the purpose of determining whether a quorum exists. You may revoke or change your proxy vote at any time before the Annual Meeting by sending a written notice of revocation
or submitting another proxy with a later date to the Inspector of Elections of the Company at the Company&#146;s principal executive offices before the beginning of the Annual Meeting. You may also revoke your proxy vote by attending the Annual
Meeting and voting in person. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Beneficial Owners </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If your shares are registered in the name of a bank or brokerage firm, you may be eligible to vote your shares over the Internet or by
telephone rather than by mailing a completed voting instruction card provided by the bank or brokerage firm. Please check the voting instructions card provided by your bank or brokerage firm for availability and instructions. If Internet or
telephone voting is unavailable from your bank or brokerage firm, please complete and return the enclosed voting instruction card in the self-addressed postage paid envelope provided. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Solicitation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sangamo will bear the entire cost of solicitation, including
the preparation, assembly, printing and mailing of this Proxy Statement and any additional solicitation materials furnished to the stockholders. Copies of solicitation materials will be furnished to brokerage firms, fiduciaries and custodians
holding shares in their names that are beneficially owned by others so that they may forward this solicitation material to such beneficial owners. In addition, Sangamo may reimburse such persons for their costs in forwarding the solicitation
materials to such beneficial owners. The original solicitation of proxies by mail may be supplemented by a solicitation by telephone, facsimile or other means by directors, officers, employees or agents of Sangamo. No additional compensation will be
paid to these individuals for any such services. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Deadline for Receipt of Stockholder Proposals </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposals of stockholders of Sangamo that are intended to be presented by such stockholders at Sangamo&#146;s Annual Meeting in 2015 must
be received no later than &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2015, in order that they may be included in the Proxy Statement and form of Proxy relating to that
meeting. In addition, the Proxy solicited by the Board of Directors for the Annual Meeting in 2015 will confer discretionary authority to vote on any stockholder proposal presented at that meeting, if Sangamo does not receive notice of such proposal
prior to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2015. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MATTERS TO BE CONSIDERED AT THE ANNUAL MEETING </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROPOSAL&nbsp;NO. 1: </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>ELECTION OF DIRECTORS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>General </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">At the Annual Meeting, seven (7)&nbsp;directors are to be elected to serve until the next Annual Meeting of Stockholders or until a
successor for such director is duly elected and qualified, or until the death, resignation or removal of such director. The seven director nominees receiving the highest number of affirmative votes will be elected. The nominees for election have
agreed to serve if elected, and management has no reason to believe that such nominees will be unavailable to serve. In the event the nominees are unable or decline to serve as directors at the time of the Annual Meeting, the proxies will be voted
for any nominee who may be designated by the present Board of Directors to fill the vacancy. Unless otherwise instructed, the proxy holders will vote the proxies received by them FOR the nominees named below. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Nominees for Term Ending Upon the Annual Meeting of Stockholders in 2015 </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Edward O. Lanphier&nbsp;II</I>, age&nbsp;57, the founder of Sangamo BioSciences, Inc., has served as our President, Chief Executive Officer and as a member of our Board of Directors since
Sangamo&#146;s inception in 1995. Mr.&nbsp;Lanphier has over 30 years of experience in the pharmaceutical and biotechnology industry. From June 1992 to May 1997, he held various positions at Somatix Therapy Corporation, a gene therapy company,
including Executive Vice President, Commercial Development and Chief Financial Officer. Prior to Somatix, Mr.&nbsp;Lanphier was President and Chief Executive Officer of BioGrowth, Inc., a biotechnology company that merged with Celtrix Laboratories
to form&nbsp;Celtrix Pharmaceuticals, Inc. in 1991. From 1986 to 1987, Mr.&nbsp;Lanphier served as Vice President of Corporate Development at Biotherapeutics, Inc. From 1984 to 1986 he served as Vice President of Corporate Development at Synergen
Inc. Prior to Synergen, he was employed by Eli&nbsp;Lilly and Company, a pharmaceutical company, in the strategic business planning biotechnology group. He currently serves on the board of directors of the Biotechnology Institute, the board of
directors and as a member of the Executive Committee of the Alliance for Regenerative Medicine, the board of trustees for The Buck Institute for Research on Aging and the Dean&#146;s Advisory Board of the University of Michigan School of Public
Health. Mr.&nbsp;Lanphier received a B.A. in biochemistry from Knox College. Mr.&nbsp;Lanphier brings extensive experience in executive management of biotechnology companies focused on the therapeutic development of biologics. In addition,
Mr.&nbsp;Lanphier&#146;s day to day leadership and intimate knowledge of Sangamo&#146;s business and operations provide the Board with an in-depth understanding of the Company. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Paul B. Cleveland</I>, age&nbsp;57, has served as a member of our Board of Directors since November 2008. From February 2013 to August
2013, Mr.&nbsp;Cleveland was Executive Vice President, Corporate Strategy and Chief Financial Officer of Aragon Pharmaceuticals, a private biotechnology company focused on the development of small-molecule drugs for the treatment of
hormone-dependent cancers. From April 2011 through February 2013 he served as General Partner and Chief Operating Officer of Mohr Davidow Ventures. From January 2006 through February 2011, Mr.&nbsp;Cleveland served as Executive Vice President,
Corporate Development and Chief Financial Officer of Affymax, Inc., a biopharmaceutical company. From April 2004 to December 2005, he served as a managing director at Integrated Finance, Ltd., an investment bank. From September 1996 to April 2003,
he served as a managing director at J.P. Morgan Chase and Co. (and a predecessor firm, Hambrecht&nbsp;&amp; Quist), an investment bank. From January 1993 to September 1996, he was a partner at Cooley Godward LLP, a law firm. From December 1988 to
December 1992, he was a corporate attorney at Sidley Austin LLP, a law firm, and from September 1981 to November 1988, he was a corporate attorney at Davis Polk&nbsp;&amp; Wardwell, a law firm. Mr.&nbsp;Cleveland received a J.D. from Northwestern
University School of Law and an A.B. from Washington University in St. Louis. Mr.&nbsp;Cleveland brings extensive experience in the areas of finance, investment banking and corporate and securities law to our Board. His experience as the chief
financial officer of a biotechnology company provides additional insight to the Board on the operational, financial issues and best practices of such companies. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Stephen G. Dilly, M.B.B.S., Ph.D.,</I> age 54, has served as a member of our Board of
Directors since March 2010. From January 2012 to December 2012, Dr.&nbsp;Dilly was Chief Executive Officer of PhotoThera, Inc., a medical device company. From 2006 to December 2011, Dr.&nbsp;Dilly served as President and Chief Executive Officer and
a member of the board of directors of APT Pharmaceuticals, Inc., a drug development company.&nbsp;From 2007 to 2009, he served as a member of the board of directors of Avigen, Inc., a biopharmaceutical company which merged with MediciNova, Inc. in
December 2009. From 2003 to 2006, he served as Chief Medical Officer and Senior Vice President of Development of Chiron BioPharma, a biotechnology company which was later acquired by Novartis International AG. From 1998 to 2003, he held various
management positions at Genentech, Inc., including Vice President of Development Sciences from 2002 to 2003 and Vice President of Medical Affairs from 1998 to 2001. From 1988 to 1998, Dr.&nbsp;Dilly held various management positions in drug
development with SmithKline Beecham in the U.K. During his career, Dr.&nbsp;Dilly has been closely associated with the development and launch of marketed drugs for many therapeutic areas, including Kytril, Paxil, Kredex, Requip, TNKase, Xolair,
Avastin, Raptiva, Tarceva, Lucentis and Cubicin. Dr.&nbsp;Dilly currently serves as Executive Chairman of the Allergen Research Corporation Inc. In 1982, Dr.&nbsp;Dilly received an M.B.B.S., the equivalent of an M.D. in the U.S., from the University
of London in the U.K. and a Ph.D. in cardiac physiology from University of London in 1988. Dr.&nbsp;Dilly brings medical expertise and significant drug development experience to our Board. Dr.&nbsp;Dilly&#146;s extensive experience in all stages of
drug development, from project prioritization through clinical trial design and data analysis to product launch, provides the Board with valuable insight into this process as the Company continues to advance and develop our ZFP Therapeutic pipeline.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>John W. Larson</I>, age&nbsp;78, has served as a member of our Board of Directors since January 1996. From February 2003
to December 2009, Mr.&nbsp;Larson served as a partner at the law firm of Morgan, Lewis&nbsp;&amp; Bockius LLP. From 1969 to January 2003, Mr.&nbsp;Larson served as partner at the law firm of Brobeck, Phleger&nbsp;&amp; Harrison LLP, except for the
period from July 1971 to September 1973 when he was in government service as Assistant Secretary of the United States Department of the Interior and Counselor to George P. Shultz, Chairman of the Cost of Living Council. From 1988 until March 1996,
Mr.&nbsp;Larson was Chief Executive Officer of Brobeck. Mr.&nbsp;Larson serves on the boards of directors of Needham Funds and WageWorks, Inc. and other organizations. Mr.&nbsp;Larson received a L.L.B. and a B.A., with distinction, in economics,
from Stanford University. Mr.&nbsp;Larson&#146;s extensive legal career and business background and his experience on the boards of numerous public and private companies provides the Board with substantial expertise in corporate governance,
securities law and corporate transactions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Steven J. Mento,&nbsp;Ph.D.</I>, age&nbsp;62, has served as a member of our
Board of Directors since May 2005. Since July 2005, he has been serving as President and Chief Executive Officer of Conatus Pharmaceuticals Inc., a biotechnology company engaged in the development of human therapy for liver disease. From 1997 to
2005 he was President and Chief Executive Officer of Idun Pharmaceuticals. Prior to that, from 1982 to 1992, Dr.&nbsp;Mento held various positions at American Cyanamid Company, the last one being the Director of Viral Vaccine Research and
Development at Lederle-Praxis Biologicals, a business unit of American Cyanamid Company. In January of 1992, he joined Viagene, Inc. as Vice President of Research and Development. Dr.&nbsp;Mento was responsible for directing the company&#146;s
transition from basic research through initiation of the first company sponsored Phase&nbsp;I and Phase&nbsp;II clinical trials in the emerging field of gene therapy. In October of 1995, Chiron Corporation acquired Viagene, Inc., and renamed the
company Chiron Viagene, Inc. Dr.&nbsp;Mento currently serves on the boards of BIOCOM, the BIOCOM Institute and the Biotechnology Industry Organization (BIO), as well as a member of the BIO ECS Governing Body, the BIO Health Section Governing Body,
the Donald P. Shiley BioScience Center at SDSU Scientific Advisory Board and Cal&nbsp;State San&nbsp;Marcos Advisory Council. Dr.&nbsp;Mento received a B.A., M.S., and a Ph.D. in microbiology from Rutgers University. He completed his post-doctoral
fellowship in somatic cell genetics at the University of Toronto. Dr.&nbsp;Mento&#146;s technical background and extensive operational experience in the early stages of the development of biologic drugs provide the Board with expertise in the
management and development of our novel ZFP Therapeutic platform. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Saira Ramasastry</I>, age 38, has served as a member of our Board of Directors since June
2012. Since April 2009 she has served as Managing Partner of Life Sciences Advisory, LLC, a company that she founded to provide strategic advice, business development solutions and innovative financing strategies for life science companies. From
August 1999 to March 2009, Ms.&nbsp;Ramasastry was an investment banker with Merrill Lynch&nbsp;&amp; Company, Inc. where she helped establish the biotechnology practice and was responsible for origination of mergers and acquisitions (M&amp;A),
strategic and capital markets transactions. Prior to joining Merrill Lynch she served as a financial analyst in the M&amp;A group at Wasserstein Perella&nbsp;&amp; Co., an investment banking firm, from July 1997 to September 1998.
Ms.&nbsp;Ramasastry currently serves on the boards of directors of Pain Therapeutics, Inc., Repros Therapeutics Inc. and the American Liver Foundation, on the Industry Advisory Board of the Michael J. Fox Foundation for Parkinson&#146;s Research and
as an advisor to Cure CMD. She received a B.A. in economics with honors and distinction and an M.S. in management science and engineering from Stanford University as well as an M. Phil. in management studies from the University of Cambridge in the
U.K. Ms.&nbsp;Ramasastry&#146;s extensive experience in global healthcare investment banking and strategic advisory consulting provides valuable financial, commercial assessment and business development skills to the Board and her thorough
understanding of the Company&#146;s technology and programs provides the Board with valuable insight in the development of our novel ZFP Therapeutic platform. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>William R. Ringo, </I>age 68, has served as Chairman of our Board of Directors since April 2010. From April 2008 until his retirement in April 2010, Mr.&nbsp;Ringo was Senior Vice President of Business
Development, Strategy and Innovation at Pfizer Inc. and was responsible for guiding Pfizer&#146;s overall strategic planning and business development activities. Prior to joining Pfizer, he served as an executive in residence at Warburg Pincus and
Sofinnova Ventures. From August 2004 to April 2006, Mr.&nbsp;Ringo was President and Chief Executive Officer of Abgenix, Inc., a biotechnology firm focused on developing human antibodies as agents to treat cancer and other serious diseases. At
Abgenix, he led efforts to transform the organization into a more focused product company by strengthening the senior management team and enhancing an existing partnership with Amgen, which acquired Abgenix in 2006. Mr.&nbsp;Ringo began his career
at Eli Lilly&nbsp;&amp; Company in 1973 and during his 28-year tenure he held a number of senior positions, including Product Group President for Oncology and Critical Care, President of Internal Medicine Products, President of the Infectious
Diseases Business Unit and Vice President of Sales and Marketing for U.S. Pharmaceuticals. He retired from Lilly in 2001. From 2001 to 2007, he served on various boards of directors, including Encysive Pharmaceuticals, Inc., Inspire Pharmaceuticals,
Inc. and InterMune, Inc. where he was the non-executive chairman of the board of directors after serving as interim Chief Executive Officer from June to September 2003. Mr.&nbsp;Ringo served on the board of directors of Onyx Pharmaceuticals, Inc.
from 2011 to 2013. He also serves on the board of directors of BioCrossroads, a public-private collaboration of corporate, university, government and entrepreneurial leaders that supports Indiana&#146;s life sciences research and corporate strengths
in life sciences while encouraging business development in the region. Mr.&nbsp;Ringo is a senior advisor to Barclays Healthcare Group and a strategic advisor to Sofinnova Ventures. He received a B.S. in business administration and an M.B.A. from
the University of Dayton. Mr.&nbsp;Ringo&#146;s extensive senior executive experience in both biotechnology and pharmaceutical companies provides valuable operational, commercial assessment, corporate leadership and management skills to the Board.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Board Independence </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors has determined that each of its current and nominated directors is independent under applicable listing standard of NASDAQ Stock Market LLC (&#147;NASDAQ&#148;), except for
Mr.&nbsp;Lanphier, who is the Chief Executive Officer of the Company. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Board Committees and Meetings </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors held six meetings during the year ended December&nbsp;31, 2013. The Board of Directors has an Audit Committee, a
Compensation Committee, a Nominating and Corporate Governance Committee and a </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Clinical Review Committee. Each director attended or participated in 75% or more of the aggregate of (i)&nbsp;the total number of meetings of the Board of Directors and (ii)&nbsp;the total number
of meetings held by all committees of the Board on which such director served during 2013. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Audit Committee </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee currently consists of four directors: Mr.&nbsp;Cleveland, Dr.&nbsp;Dilly, Dr.&nbsp;Mento and Ms.&nbsp;Ramasastry. Our
Board of Directors has determined that each member of the Audit Committee is independent under the applicable listing standard of NASDAQ and Securities and Exchange Commission (&#147;SEC&#148;) rules. Mr.&nbsp;Cleveland serves as the Chairman of
this committee. The Board of Directors has determined that Mr.&nbsp;Cleveland is an &#147;audit committee financial expert&#148; as defined under SEC rules and has the requisite financial sophistication in accordance with the applicable NASDAQ
listing standards. The Audit Committee held five meetings during 2013. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee assists the Board of Directors in
its oversight of the integrity of the Company&#146;s financial statements, the risk management and internal controls of the Company and the Company&#146;s compliance with legal and regulatory requirements. The Audit Committee interacts directly
with, and evaluates the performance of, the independent registered public accounting firm, including determining whether to engage or dismiss the independent registered public accounting firm and to monitor the independent registered public
accounting firm&#146;s qualifications and independence. The Audit Committee also pre-approves all audit services and permissible non-audit services provided by the independent registered public accounting firm. The Audit Committee Report is included
herein on page 45. The Audit Committee has a written charter which is available on our website at www.sangamo.com. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Compensation Committee
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee currently consists of three directors: Dr.&nbsp;Mento, Mr.&nbsp;Larson and Mr.&nbsp;Ringo, each
of whom is independent under applicable listing standard of NASDAQ and SEC rules. Dr.&nbsp;Mento serves as the Chairman of this committee. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee&#146;s responsibilities include (i)&nbsp;establishing, administering and reviewing compensation plans and programs for the Company&#146;s executive officers and other employees,
including incentive and equity-based plans and programs; (ii)&nbsp;establishing compensation arrangements for the executive officers and setting the performance goals for their incentive compensation programs; (iii)&nbsp;evaluating the performance
of executive officers and awarding incentive compensation; (iv)&nbsp;adjusting compensation arrangements as appropriate based upon performance and (v)&nbsp;reviewing and monitoring management development and succession plans and activities.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee is authorized to engage, oversee and terminate independent compensation consultants and other
professionals to assist in the design, formulation, analysis and implementation of compensation programs for the Company&#146;s executive officers and other key employees. The Compensation Committee engaged the services of Radford, an Aon Hewitt
Company, (&#147;Radford&#148;) to provide advice and recommendations regarding the Company&#146;s 2013 equity grants, and 2013 base salaries and incentive compensation levels for all employees at the level of vice president and above. In August
2012, the Compensation Committee retained the services of Radford to advise the committee on the Company&#146;s overall compensation practices, including the following: (i)&nbsp;assessment of compensation levels and mix of elements for the
Company&#146;s executive officers and vice presidents, (ii)&nbsp;executive compensation and governance trends based on peer group practices and market trends, (iii)&nbsp;development of company-wide cash and equity grant ranges based on the
Company&#146;s job classification structure, and (iv)&nbsp;adoption of a 2013 equity incentive plan as a successor to the Company&#146;s 2004 Stock Incentive Plan. In addition, the Compensation Committee retained the services of Radford in September
2013 in order to (i)&nbsp;assess compensation levels and mix of elements for the </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Company&#146;s executive officers and vice presidents, (ii)&nbsp;review the peer group companies selected in 2012 and recommend any changes to that list, and (iii)&nbsp;advise the committee on
executive compensation and governance trends based on peer group trends and market practices. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee held
seven meetings and executed one unanimous written consent in lieu of a meeting during 2013. The Compensation Committee has a written charter, which is available on our website at www.sangamo.com. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Compensation Committee Interlocks and Insider Participation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">None of our Compensation Committee members has been an officer or employee of Sangamo at any time. None of our executive officers serves on the board of directors or compensation committee of any entity
that has one or more executive officers serving as a member of our Board or our Compensation Committee. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Nominating and Corporate
Governance Committee </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Nominating and Corporate Governance Committee currently consists of three directors:
Mr.&nbsp;Larson, Mr.&nbsp;Cleveland and Mr.&nbsp;Ringo, each of whom is independent under applicable listing standard of NASDAQ. Mr.&nbsp;Larson serves as the Chairman of this committee. The Nominating and Corporate Governance Committee considers
and periodically reports on matters relating to the size, identification, selection and qualification of the Board of Directors and candidates nominated for the Board of Directors and its committees, and develops and recommends governance principles
and policies applicable to the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Nominating and Corporate Governance Committee held two meetings during 2013. The
Nominating and Corporate Governance Committee has a written charter which is available on our website at www.sangamo.com. The Nominating and Corporate Governance Committee considers properly submitted stockholder recommendations for candidates for
membership on the Board of Directors as described below under &#147;Identification and Evaluation of Nominees for Directors.&#148; In evaluating such recommendations, the Nominating and Corporate Governance Committee seeks to achieve a balance of
knowledge, experience and capability on the Board of Directors and to address the membership criteria set forth under &#147;Director Qualifications.&#148; Stockholder nominees will receive the same consideration that nominees of the Board receive.
Any stockholder recommendations proposed for consideration by the Nominating and Corporate Governance Committee must provide all information requested by the Nominating and Corporate Governance Committee relating to such recommendation, including
the candidate&#146;s name and qualifications for membership on the Board of Directors and should be addressed to Investor Relations at the following address: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Investor Relations Department </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sangamo BioSciences, Inc.
</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">501 Canal Boulevard </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Richmond, CA 94804 </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Director Qualifications </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Nominating and Corporate Governance Committee will use a variety of criteria to evaluate the qualifications and skills necessary for
members of our Board of Directors. The Nominating and Corporate Governance Committee may assess character, judgment, business acumen and scientific expertise, and familiarity with issues affecting the biotechnology and pharmaceutical industries.
Other qualifications will be determined on a case-by-case basis, depending on whether the Nominating and Corporate Governance Committee desires to fill a vacant seat or increase the size of the Board to add new directors. In addition, the Nominating
and Corporate Governance Committee may also evaluate whether a potential director nominee&#146;s skills are complementary to existing Board members&#146; skills or meet the Board&#146;s need for operations, management, commercial, financial or other
expertise. While the Nominating and Corporate Governance </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Committee does not prescribe specific diversity standards, as a matter of practice, the committee considers diversity in the context of the Board as a whole and takes into account the personal
characteristics and experiences of current and prospective directors that reflect a broad range of perspectives in the Board&#146;s decision making process. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Identification and Evaluation of Nominees for Directors </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Nominating and
Corporate Governance Committee utilizes a variety of methods for identifying and evaluating nominees for director. The Nominating and Corporate Governance Committee assesses the appropriate size of the Board of Directors, and whether any vacancies
on the Board of Directors are expected due to retirement or otherwise. In the event that vacancies are anticipated, or otherwise arise, the Nominating and Corporate Governance Committee considers various potential candidates for director. Candidates
may come to the attention of the Nominating and Corporate Governance Committee through current members of the Board of Directors, executive recruiting firms, stockholders or other persons. These candidates are evaluated at regular or special
meetings of the Nominating and Corporate Governance Committee, and may be considered at any point during the year. The Nominating and Corporate Governance Committee considers properly submitted stockholder recommendations for candidates for the
Board of Directors. In evaluating such recommendations, the Nominating and Corporate Governance Committee uses the qualifications standards discussed above and seeks to achieve a balance of knowledge, experience and capability on the Board of
Directors. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Clinical Review Committee </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Clinical Review Committee was established in September 2010 for the purpose of overseeing the ongoing and proposed human clinical trials of the Company. The Clinical Review Committee meets from time
to time and its responsibilities include monitoring patient recruitment, clinical monitoring, data analysis, clinical data distribution and the review of study protocols. The Clinical Review Committee currently consists of three directors:
Dr.&nbsp;Dilly, Mr.&nbsp;Lanphier and Ms.&nbsp;Ramasastry. Dr.&nbsp;Dilly serves as the Chairman of this committee. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Leadership Structure
of the Board </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under our bylaws, the Board is not required to appoint our Chief Executive Officer as the Chairman of the
Board, and the Board does not have a policy on whether or not the roles of Chief Executive Officer and Chairman of the Board should be separate. Currently two individuals serve these two positions. Mr.&nbsp;William Ringo serves as the Chairman of
the Board. The Chairman is responsible for chairing Board meetings and meetings of stockholders, setting the agendas for Board meetings and providing information to the Board members in advance of meetings and between meetings. In addition, our
Chief Executive Officer, Mr.&nbsp;Edward Lanphier, also serves as a director of our Board. The Board believes that Mr.&nbsp;Lanphier&#146;s membership as a director provides the Board with an in-depth understanding of our business operations because
of his extensive experiences and knowledge of the day-to-day management of all aspects of our operations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Of the seven
directors on our board, six directors, including our Chairman of the Board, are independent under applicable NASDAQ corporate governance rules. The Board believes that this establishes a strong independent board that provides effective oversight of
the Company. Moreover, in addition to feedback provided during the course of Board meetings, the independent directors conduct regular executive sessions without Mr.&nbsp;Lanphier or any other members of management. We believe that our leadership
structure of the Board is appropriate given the nature and size our businesses as it provides both effective independent oversight and expertise in the complexity and management of our operations as a life sciences company. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Oversight of Risk Management by the Board </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our Board of Directors is generally responsible for the oversight of corporate risk in its review and deliberations relating to Company activities and has determined that the Company&#146;s principal
source of risk falls into two categories, financial and product development and testing. The Audit Committee oversees management </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
of financial risks. Our Board of Directors regularly reviews information regarding the Company&#146;s cash position, liquidity and operations, as well as the risks associated with each. The Board
regularly reviews plans, results and potential risks related to our lead therapeutic development programs and other preclinical programs as well as financial and strategic risk related to our Company&#146;s operations. In addition, the Board of
Directors established the Clinical Review Committee in September 2010, which is responsible for, among other things, monitoring and reviewing risks associated with conducting clinical trials for our human therapeutic programs. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, the Nominating and Corporate Governance Committee monitors the effectiveness of our corporate governance guidelines and
policies and manages risks associated with the independence of the Board of Directors and potential conflicts of interest. Our Compensation Committee oversees risk management as it relates to our compensation plans, policies and practices for all
employees, including executives, particularly whether our compensation programs may create incentives for our employees to take excessive or inappropriate risks which could have a material adverse effect on the Company. While each committee is
responsible for evaluating certain risks and overseeing the management of such risks, the entire Board of Directors is regularly informed through committee reports about such risks. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Annual Meeting Attendance </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Although we do not have a formal policy
regarding attendance by members of the Board of Directors at our annual meetings of stockholders, directors are encouraged to attend annual meetings of our stockholders. Six directors attended the 2013 Annual Meeting of Stockholders. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Communications with the Board of Directors </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Although we do not have a formal policy regarding communications with the Board of Directors, stockholders may communicate with the Board of Directors, including the non-management directors, by sending a
letter to the Sangamo Board of Directors, c/o&nbsp;Investor Relations, 501 Canal Boulevard, Richmond, California&nbsp;94804. Stockholders who would like their submission directed to a particular member of the Board of Directors may so specify.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Code of Ethics </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors has adopted a Code of Business Conduct and Ethics, which is applicable to all employees and directors of the Company. A copy of our Code of Business Conduct and Ethics is available
on our website at www.sangamo.com in the Investor&nbsp;&amp; Media Section under Corporate Governance. In the event that we make any amendments to or grant any waivers of, a provision of the Code of Ethics that applies to the principal executive
officer, principal financial officer, or principal accounting officer that requires disclosure under applicable SEC rules, we intend to disclose such amendment or waiver and the reasons therefore, on our website at www.sangamo.com, in the
Investor&nbsp;&amp; Media section. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Director Compensation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth certain information regarding the compensation of each non-employee director for service as a member of the Board of Directors during 2013. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="54%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Fees&nbsp;Earned&nbsp;or<BR>Paid in Cash<BR>($)&nbsp;(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock&nbsp;Awards<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option&nbsp;Awards<BR>($)&nbsp;(2)&nbsp;(3) (4)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Paul B. Cleveland.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">49,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">54,662</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">103,662</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen G. Dilly, M.B.B.S., PhD.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">52,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">54,662</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">107,162</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John W. Larson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">42,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">54,662</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">97,162</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Steven J. Mento, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">47,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">54,662</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">102,162</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Saira Ramasastry.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">45,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">54,662</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">99,662</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">William R. Ringo</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">84,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">54,662</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">138,662</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consists of the annual retainer fee for service as a member of the Board of Directors or any Board committee. For further information concerning such fees, see the
section below entitled &#147;Director Annual Retainer and Meeting Fees.&#148; </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the Automatic Grant Program in effect under the Company&#146;s 2013 Stock Incentive Plan, Mr.&nbsp;Cleveland, Dr.&nbsp;Dilly, Mr.&nbsp;Larson,
Dr.&nbsp;Mento, Ms.&nbsp;Ramasastry and Mr.&nbsp;Ringo each received an option to purchase 10,000&nbsp;shares of common stock with an exercise price per share of $7.77 at the 2013 Annual Meeting, and each such option had an aggregate grant date fair
value of $54,662 without adjustment for estimated forfeitures. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of December&nbsp;31, 2013 the following non-employee directors held options to purchase the following number of shares of the Company&#146;s common stock:
Mr.&nbsp;Cleveland, 20,000 shares; Dr.&nbsp;Dilly, 80,000 shares; Mr.&nbsp;Larson, 100,000 shares; Dr.&nbsp;Mento, 75,556 shares; Ms.&nbsp;Ramasastry, 60,000 shares and Mr.&nbsp;Ringo, 80,000 shares. </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts represent the aggregate grant date fair value of the awards in accordance with FASB Accounting Standards Codification Topic 718, or ASC 718, <I>Compensation
&#151; Stock Compensation</I>. The assumptions used in the calculation of such grant date fair values are described in Note 3 to our consolidated financial statements included in our Annual Report on Form 10-K for the year ended December&nbsp;31,
2013. </FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Director Annual Retainer and Meeting Fees </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Each non-employee Board member receives an annual cash retainer of $30,000, subject to pro-ration for directors who either join or leave the Board during the year. To the extent that the Board meets more
than ten times in any year, each member of the Board will receive, for each meeting in excess of ten, a per meeting fee of $1,000 if attended in person and $500 if attended by video or telephone conference. The Chairman of the Board receives an
additional annual cash retainer of $45,000. In addition, the non-employee Board members serving as the Chairman of the Audit Committee, the Chairman of the Clinical Review Committee, the Chairman of the Compensation Committee and the Chairman of the
Nominating and Corporate Governance Committee receive an additional annual cash retainer of $15,000, $15,000, $10,000 and $7,500, respectively. Each non-employee Board member serving as a member of the Audit Committee, the Clinical Review Committee,
the Compensation Committee and the Nominating and Corporate Governance Committee, other than the Chairman, receives an additional annual cash retainer of $7,500, $7,500, $5,000 and $4,000, respectively. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Automatic Grant Program under the Company&#146;s 2013 Stock Incentive Plan (the &#147;2013 Plan&#148;) provides the Compensation
Committee with the ability to implement a program whereby directors are given the option to elect to convert their cash board retainer fees into RSU grants. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>2013 Stock Incentive Plan </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the Automatic Grant Program in effect
under 2013 Plan, each new non-employee Board member receives, at the time of his or her initial election or appointment to the Board, an option to purchase 50,000&nbsp;shares of common stock, provided such person has not previously been employed by
the Company. In addition, on the date of each annual stockholders meeting, each continuing non-employee Board member who served as a director for the previous six months receives an option to purchase 10,000&nbsp;shares of common stock. Each option
granted under the Automatic Grant Program will have an exercise price per share equal to the fair market value per share of the Company&#146;s common stock on the grant date and will have a maximum term of 10&nbsp;years, subject to earlier
termination following the optionee&#146;s cessation of Board service. Each option is immediately exercisable for all the option shares, but any shares purchased under the option will be subject to repurchase by the Company, at the exercise price
paid per share, upon the optionee&#146;s cessation of Board service prior to vesting in those shares. The shares subject to each automatic option grant will vest in successive equal monthly installments upon completion of each month of Board service
over a designated period. For the initial grant, the designated vesting period is three years, and for the annual grant the designated vesting period is one year. However, the </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">11 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
shares subject to each automatic option grant will immediately vest upon (i)&nbsp;the optionee&#146;s death or permanent disability while serving as a Board member, (ii)&nbsp;an acquisition of
the Company by merger or asset sale, (iii)&nbsp;the successful completion of a tender offer for more than 50% of the Company&#146;s outstanding voting stock or (iv)&nbsp;a change in the majority of the Board effected through one or more proxy
contests for Board membership. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Automatic Grant Program provide the Compensation Committees with discretion to grant, in
lieu of the 50,000 share initial option grant and/or 10,000 share annual option grant that would otherwise be awarded under such program, a number of shares of restricted stock or restricted stock units (RSUs) to the non-employee directors with a
fair market value substantially equal to the grant date fair value of the option that would otherwise be awarded. In addition, the Automatic Grant Program provides the Compensation Committee with the ability to implement a program whereby directors
are given the option to elect to convert their cash board retainer fees into RSU grants. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the Automatic Grant
Program under the 2013 Plan, on the date of the 2013 Annual Meeting Mr.&nbsp;Cleveland, Dr Dilly, Mr.&nbsp;Larson, Dr.&nbsp;Mento, Ms.&nbsp;Ramasastry and Mr.&nbsp;Ringo each received an option to purchase 10,000&nbsp;shares of common stock each
with an exercise price per share of $7.77. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Recommendation of the Board of Directors </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Board of Directors recommends that the stockholders vote&nbsp;FOR the election of the nominees listed above. Unless otherwise
instructed, the proxy holders named in each proxy will vote the shares represented thereby FOR the election of the nominees named above. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROPOSAL NO. 2: </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ADVISORY VOTE ON EXECUTIVE COMPENSATION </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>General </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to Section&nbsp;14A(a)(1) of the Securities Exchange Act
of 1934, as amended (the &#147;Exchange Act&#148;), the Company&#146;s stockholders are entitled to vote at the 2014 Annual Meeting to approve the compensation of the Company&#146;s named executive officers as disclosed in this Proxy Statement in
accordance with the standards established under Item&nbsp;402 of Regulation S-K under the Exchange Act. This proposal is commonly referred to as &#147;say-on-pay.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The stockholder vote on executive compensation is an advisory vote only, and it is not binding on the Company, the Company&#146;s Board of Directors or the Compensation Committee of the Board. Although
the vote is non-binding, the Company&#146;s Board of Directors and the Compensation Committee of the Board value the opinions of the stockholders and will consider the outcome of the vote when making future compensation decisions affecting the
Company&#146;s executive officers. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We encourage stockholders to read closely the &#147;Executive Compensation&#148; section
of this Proxy Statement, beginning with the Compensation Discussion and Analysis (&#147;CD&amp;A&#148;) on page 23, which describes in detail our executive compensation programs, policies and practices with respect to the compensation of our named
executive officers in the fiscal year ended December&nbsp;31, 2013. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company&#146;s overarching compensation goal is to
reward our executive officers in a manner that supports a strong pay-for-performance philosophy, in order to create a positive relationship between the compensation program and the Company&#146;s operational performance and stockholder return, while
maintaining an overall level of compensation that the Company believes is fair, reasonable and responsible. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We design our
executive compensation program to implement our core objectives of attracting and retaining superior executive talent, motivating and rewarding executives whose knowledge, skills and performance are critical to our business, ensuring executive
compensation is aligned with our corporate strategies and business objectives and aligning executives&#146; incentives with the creation of shareholder value. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee established the 2013 compensation program and the associated Company goals in accordance with the foregoing goals and philosophy. The Company&#146;s resulting business success
in the 2013 year is summarized under the heading &#147;2013 Business Highlights&#148; in the CD&amp;A. We believe that the accomplishments are reflected in the increase in the Company&#146;s market capitalization during 2013. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Resolution </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board is
asking the Company&#146;s stockholders to indicate their support for the compensation of the Company&#146;s named executive officers, as described in this Proxy Statement, by casting a non-binding advisory vote &#147;FOR&#148; the following
resolution: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#147;Resolved that the Company&#146;s stockholders hereby approve the compensation paid to the Company&#146;s
executive officers named in the Summary Compensation Table of this Proxy Statement, as that compensation is disclosed pursuant to Item&nbsp;402 of Regulation S-K, including the Compensation Discussion and Analysis, the various compensation tables
and the accompanying narrative discussion included in this Proxy Statement.&#148; </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The vote on this resolution is not
intended to address any specific element of compensation; rather the vote relates to the overall compensation of the Company&#146;s named executive officers, and the philosophy, policies and practices described in this Proxy Statement in accordance
with the compensation disclosure rules of the Securities and Exchange Commission. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors believes our executive compensation program uses appropriate
structures and sound pay practices that are effective in achieving our core objectives. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Recommendation of the Board of Directors
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Board of Directors recommends an advisory vote FOR the resolution to approve the compensation of the named
executive officers as disclosed in this Proxy Statement in accordance with the standards established under Item&nbsp;402 of Regulation S-K under the Exchange Act. Unless otherwise instructed, the proxy holders named in each proxy will vote the
shares represented thereby FOR the approval of such resolution. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">14 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROPOSAL NO. 3: </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>AMENDMENT OF CERTIFICATE OF INCORPORATION TO </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Introduction </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Board of Directors has unanimously determined that it is in the best interests of the company and its stockholders to amend our
Amended and Restated Certificate of Incorporation (the &#147;Certificate of Incorporation&#148;) to increase the number of authorized shares of our common stock from 80,000,000 shares to 160,000,000 shares, which will result in an increase of the
total number of authorized shares of our capital stock from 85,000,000 shares to 165,000,000 shares. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Currently our
Certificate of Incorporation authorizes an aggregate of 85,000,000 shares of capital stock, consisted of 80,000,000 shares of authorized common stock and 5,000,000 shares of authorized preferred stock. No shares of preferred stock are issued and
outstanding and we are not proposing to increase the number of authorized preferred stock. As of February&nbsp;10, 2014, we had 62,793,810 shares of common stock issued and outstanding and 8,963,071 shares subject to outstanding stock options and
restricted stock units. As of February&nbsp;10, 2014, we had 2,885,119 shares of common stock reserved for future issuance under our 2013 Stock Incentive Plan (the &#147;2013 Plan&#148;) and 1,527,763 shares reserved for issuance under our 2010
Employee Stock Purchase Plan (the &#147;Purchase Plan&#148;). Accordingly, approximately 95% of our authorized shares of common stock have been issued or reserved for issuance, which leaves relatively few shares available to us, i.e., 3,830,237
shares, for future issuances for corporate purposes. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">No other changes to the Certificate of Incorporation have been approved
or are being proposed by our Board of Directors. To effectuate the increase of number of authorized shares of our common stock, Article IV, paragraph (a)&nbsp;of the Certificate of Incorporation is proposed to be amended as set forth below in its
entirety: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;A. <U>Classes of Stock</U>. The total number of shares of stock which the Corporation shall have authority to
issue is one hundred and sixty five million (165,000,000), consisting of five million (5,000,000)&nbsp;shares of Preferred Stock, par value $0.01 per share (the &#147;Preferred Stock&#148;), and one hundred and sixty million
(160,000,000)&nbsp;shares of common stock, par value $0.01 per share (the &#147;Common Stock&#148;).&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>A copy of
the amendment proposed by the Company to the Article IV of the Certificate of Incorporation is attached to this Proxy Statement as <U>Appendix A</U>. For a description of the material terms and provisions of our common stock and each other class of
our securities which qualifies or limits our common stock, please see the description of our capital stock in our Registration Statement on Form 8-A dated March&nbsp;31, 2000.<B> </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Reasons for the Proposed Amendment </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Given the small number of authorized
shares currently available under our Certificate of Incorporation, we believe that an increase in the number of authorized shares of our common stock is critical to ensure that a sufficient number of shares is available for future issuances if and
when our Board of Directors deems it to be in our and our stockholders&#146; best interests. While we have no current plans to issue any shares that will be authorized if the increase is approved, we may use any of the increased shares at the time
and in the manner approved by the Board of Directors, which may include raising capital through equity financing, executing strategic transactions or establishing collaborative relationships, acquiring businesses or assets and issuance of equity
awards to employees. In addition, historically we have relied significantly on equity financing to fund our business operations and plan to do so in the future, therefore the increase of our authorized shares will provide us with the ability and
flexibility to access capital when needed and available. We believe that if we do not obtain stockholder approval to increase the number of authorized shares of our common stock, our planned operations will be materially and adversely impacted.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">15 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Effects of Stockholder Approval of Increased Authorized Shares </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the proposed amendment is approved and adopted, the additional authorized shares of common stock may be issued from time to time by
actions of our Board of Directors without further stockholder approval, except as required by law, regulatory authorities or NASDAQ corporate governance listing rules. The increase in authorized shares of common stock will not alter our current
number of issued shares of common stock. The relative rights and limitations of the shares of common stock will remain unchanged under this amendment. The additional share of common stock to be authorized by stockholder approval under this Proposal
No.&nbsp;3 would have the rights identical to the currently outstanding shares of our common stock. Our stockholders will not realize any dilution in their percentage of ownership of us or their voting rights as a result of the increase. However,
issuances of significant numbers of additional shares of common stock in the future may dilute stockholders&#146; percentage ownership, and if such shares are issued at prices below what current stockholders paid for their shares, may dilute the
value of current stockholders&#146; shares. Under our Certificate of Incorporation, stockholders do not have preemptive rights to purchase additional securities that may be issued by us. This means that current stockholders do not have a prior right
to purchase any new issuances of shares in order to maintain their proportionate ownership interests in the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
additional shares of common stock that would become available for issuance may also be used to oppose a hostile takeover attempt or to delay or prevent changes in control of the company. For example, without further stockholder approval, the Board
of Directors could strategically sell shares of common stock in a private transaction to purchasers who would oppose a takeover or favor the current Board of Directors. However, this proposal to increase authorized shares is prompted by business and
financial considerations and not by the threat of any hostile takeover attempt, and we are not aware of any such attempts directed at us. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Votes Required </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
affirmative vote of a majority of the shares of our common stock outstanding and entitled to vote at the Annual Meeting is required to approve the amendment to our Certificate of Incorporation to effect the proposed increase in our authorized common
stock. The amendment to the Certificate of Incorporation will be effective immediately upon acceptance of filing by the Secretary of State of Delaware following stockholder approval of this proposal. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Recommendation of the Board of Directors </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>The Board of Directors recommends that the stockholders vote FOR approval of the amendment to our Certificate of Incorporation to increase the number of authorized shares of our common stock from
80,000,000 shares to 160,000,000 shares, and proxies solicited by the Board of Directors will be voted in favor thereof, unless a stockholder has indicated otherwise on the proxy. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">16 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROPOSAL&nbsp;NO. 4: </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors has appointed Ernst&nbsp;&amp; Young LLP, independent registered public accounting firm for Sangamo during 2013,
to serve in the same capacity for the year ending December&nbsp;31, 2014, and is asking the stockholders to ratify this appointment. The decision of the Board of Directors to appoint Ernst&nbsp;&amp; Young LLP was based on the recommendation of the
Audit Committee. The affirmative vote of a majority of our shares of common stock present or represented by proxy and entitled to vote is required to ratify the appointment of Ernst&nbsp;&amp; Young LLP. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the event the stockholders fail to ratify the appointment, the Board of Directors will reconsider its selection. Even if the selection
is ratified, the Board of Directors in its discretion may direct the appointment of a different independent registered public accounting firm at any time during the year if the Board of Directors believes that such a change would be in the best
interests of Sangamo and its stockholders. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A representative of Ernst&nbsp;&amp; Young LLP is expected to be present at the
Annual Meeting, will have the opportunity to make a statement if he or she desires to do so, and will be available to respond to appropriate questions. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Principal Accounting Fees and Services </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table presents fees
for professional audit services rendered by Ernst&nbsp;&amp; Young LLP for the audit of the Company&#146;s annual financial statements for 2013 and 2012, and fees billed for other services rendered by Ernst&nbsp;&amp; Young LLP during 2013 and 2012:
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="74%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit Fees and expenses (1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">718,938</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">554,614</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit &#151; related Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Tax Fees (2)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">45,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All Other Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">763,938</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">589,614</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes fees and expenses for the audit of our annual financial statements included in our Forms 10-K and the related audit of internal controls, review of interim
financial statements included on Forms 10-Q, consultations regarding accounting and auditing matters, fees in connection with our underwritten public offering completed in September 2013, fees in connection with the filing of the Company&#146;s
registration statements on Form S-3 and Form S-8 and services normally provided in connection with statutory and regulatory filings. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes fees billed for professional services for tax compliance, tax advice and tax planning. </FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Policy on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Under its charter, the Audit Committee must pre-approve all engagements of the independent registered public accounting firm for the performance of all audit and non-audit services that are not prohibited
and the fees for such services. The Audit Committee has delegated to its Chairman the authority to evaluate and approve service engagements on behalf of the full committee in the event a need arises for specific pre-approval between committee
meetings. If the Chairman approves any such engagements, he will report that approval to the full Audit Committee not later than the next committee meeting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee has determined that the rendering of other professional services for tax compliance and tax advice by Ernst&nbsp;&amp; Young LLP is compatible with maintaining their independence. The
Audit Committee </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">17 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
has established a policy governing our use of Ernst&nbsp;&amp; Young LLP for non-audit services. Under the policy, management may use Ernst&nbsp;&amp; Young LLP for non-audit services that are
permitted under SEC rules and regulations, provided that management obtains the Audit Committee&#146;s approval before such services are rendered. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Recommendation of the Board of Directors </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Board of Directors
recommends that the stockholders vote&nbsp;FOR the ratification of the appointment of Ernst&nbsp;&amp; Young LLP to serve as Sangamo&#146;s independent registered public accounting firm for the year ending December&nbsp;31, 2014. Unless otherwise
instructed, the proxy holders named in each proxy will vote the shares represented thereby FOR the ratification of the appointment of Ernst&nbsp;&amp; Young LLP in this proposal. </B></FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>OTHER MATTERS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Sangamo knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters properly come before the Annual Meeting, it is the intention of the persons named in
the enclosed form of Proxy to vote the shares they represent as the Board of Directors may recommend. Discretionary authority with respect to such other matters is granted by the execution of the enclosed Proxy. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANAGEMENT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Executive
Officers </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth information regarding our named executive officers as of February&nbsp;28, 2014:
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="30%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="64%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Age</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="border-bottom:1px solid #000000;width:27pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Position</B></FONT></P></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward&nbsp;O.&nbsp;Lanphier&nbsp;II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">57</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">President, Chief Executive Officer and Director</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H. Ward Wolff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geoffrey Nichol, M.B., Ch.B.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">59</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Executive Vice President, Research and Development</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dale&nbsp;G.&nbsp;Ando,&nbsp;M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">60</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vice President, Therapeutic Development and Chief Medical Officer</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Philip&nbsp;D.&nbsp;Gregory,&nbsp;D.&nbsp;Phil</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President, Research and Chief Scientific Officer</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Edward O. Lanphier&nbsp;II</I>, the founder of Sangamo BioSciences, Inc., has served as our President,
Chief Executive Officer and as a member of our Board of Directors since Sangamo&#146;s inception in 1995. Mr.&nbsp;Lanphier has over thirty years of experience in the pharmaceutical and biotechnology industry. From June 1992 to May 1997, he held
various positions at Somatix Therapy Corporation, a gene therapy company, including Executive Vice President, Commercial Development and Chief Financial Officer. Prior to Somatix, Mr.&nbsp;Lanphier was President and Chief Executive Officer of
BioGrowth, Inc., a biotechnology company that merged with Celtrix Laboratories to form&nbsp;Celtrix Pharmaceuticals, Inc. in 1991. From 1986 to 1987, Mr.&nbsp;Lanphier served as Vice President of Corporate Development at Biotherapeutics, Inc. From
1984 to 1986 he served as Vice President of Corporate Development at Synergen, Inc. Prior to Synergen, he was employed by Eli Lilly and Company, a pharmaceutical company, in the strategic business planning biotechnology group. He currently serves on
the board of directors of the Biotechnology Institute, the board of directors and as a member of the Executive Committee of the Alliance for Regenerative Medicine, the board of trustees for The Buck Institute for Research on Aging and the
Dean&#146;s Advisory Board of the University of Michigan School of Public Health. Mr.&nbsp;Lanphier received a B.A. in biochemistry from Knox College. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>H.&nbsp;Ward Wolff </I>has served as our Executive Vice President and Chief Financial Officer since December 2007. Prior to his appointment as Executive Vice President and Chief Financial Officer,
Mr.&nbsp;Wolff served as a </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">18 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
member of the Company&#146;s Board of Directors and Chairman of the Audit Committee from June 2006 through December 2007. Prior to joining the Company, Mr.&nbsp;Wolff served as Senior Vice
President, Finance and Chief Financial Officer of Nuvelo, Inc. (now ARCA biopharma, Inc.) from July 2006 to August 2007 and Chief Financial Officer and Senior Vice President, Finance, of Abgenix, Inc. from September 2004 to April 2006. From July
2002 to December 2003, Mr.&nbsp;Wolff served as Chief Financial Officer of QuantumShift. From 1998 to January 2002, he was Senior Vice President and Chief Financial Officer of DoubleTwist, Inc. From 1992 to 1998, he was Senior Vice President of
Finance and Administration and Chief Financial Officer of Premenos Technology Corporation. From 1985 to 1992, Mr.&nbsp;Wolff was an Executive Director of Russell Reynolds Associates, Inc. From 1974 to 1985, Mr.&nbsp;Wolff held numerous positions
with Price Waterhouse &amp;&nbsp;Co., as a certified public accountant, including Senior Audit Manager. Mr.&nbsp;Wolff currently serves on the board of directors of Portola Pharmaceuticals, Inc. Mr.&nbsp;Wolff received a B.A. in economics from the
University of California at Berkeley and an M.B.A. from Harvard Business School. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Geoffrey M. Nichol,
M.B., Ch.B.,</I> has served as our Executive Vice President, Research and Development since July 2011. Dr.&nbsp;Nichol has over twenty years of experience in the pharmaceutical and biotechnology industries and has made contributions in all stages of
the drug development process from program initiation, through all phases of clinical evaluation to product approval. He has been closely associated with the development of over 15 new drug candidates and the approval and/or launch of several
marketed drugs, including Augmentin BID, Foradil<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> and Yervoy&#153;. Dr.&nbsp;Nichol has particular expertise in
development of platform technologies. From 2002 to 2010, he served as Senior Vice President of Product Development at Medarex, Inc., where he was responsible for all aspects of the clinical development of therapeutic products based on a fully-human
monoclonal antibody platform. From 1996 to 2002, he held various senior management positions at Novartis Pharmaceuticals, including Vice President, U.S. Medical Affairs and Vice President and Global Head, Project Management, and in the seven years
prior held management positions in drug development with SmithKline Beecham Pharmaceuticals. Most recently, Dr.&nbsp;Nichol has been Chief Medical Officer of Ikaria, Inc., a biotherapeutics company. Dr.&nbsp;Nichol earned his B.Med.Sc., M.B., Ch.B.,
or the equivalent of an M.D. in the U.S., from Otago University Medical School in New Zealand and received an M.B.A. from Warwick University in the United Kingdom. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Dale G. Ando,&nbsp;M.D., </I>has served as our Vice President, Therapeutic Development and Chief Medical Officer since August 2004. Dr.&nbsp;Ando has held senior positions in therapeutic product
development in several biotechnology companies. From 1997 until he joined Sangamo in 2004, he was Vice President, Clinical Research at Cell Genesys, Inc. While at Cell Genesys, Dr.&nbsp;Ando directed the development of Phase&nbsp;I-III GVAX
programs, oncolytic virus programs and Phase&nbsp;I/II trials of chimaeric T-cell receptor products in HIV and cancer. From 1992 to 1997, Dr.&nbsp;Ando served as director of clinical gene therapy at Chiron Corporation. From 1997 to 2001
Dr.&nbsp;Ando served as a member of the Recombinant DNA Advisory Committee (RAC) and the Adenoviral Safety Committee for the National Institutes of Health (NIH). Dr.&nbsp;Ando began his career as a faculty member at the UCLA Medical School in the
Division of Rheumatology. He received his M.D. and internal medicine training at the University of Michigan and a B.S. in chemistry from Stanford University. Dr.&nbsp;Ando is board certified in internal medicine and is a subspecialist in
rheumatology. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Philip D. Gregory, D. Phil., </I>has served as our Chief Scientific Officer since July 2009 and Senior Vice
President, Research since January 2014. He joined Sangamo in December 2000 as a Scientist, became a Team Leader in October 2001, Senior Director, Research in July 2003 and Vice President, Research in October 2005. Prior to joining the Company,
Dr.&nbsp;Gregory was at the University of Munich, Germany, where he studied the role of chromatin structure in gene regulation and published extensively in this field. He has authored over 85 articles, reviews and book chapters in the field of gene
editing and gene regulation and is an inventor on 27 of Sangamo&#146;s patent families, which includes 13 issued US patents, 24 pending US patent applications, 18 issued foreign patents and 116 pending foreign patent applications. He has served as a
member of the Scientific Advisory Board of the Keystone Symposia since December 2009. Dr.&nbsp;Gregory received a D. Phil. in biochemistry from the University of Oxford and a B.Sc. in microbiology from the University of Sheffield. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">19 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth certain information known to Sangamo with respect to the beneficial ownership of common stock as of
February&nbsp;10, 2014, by (i)&nbsp;all persons who are beneficial owners of five percent (5%)&nbsp;or more of our common stock based on 62,793,810&nbsp;shares outstanding as of February&nbsp;10, 2014, (ii)&nbsp;each director and each nominee for
director, (iii)&nbsp;the executive officers named in the Summary Compensation Table of the Executive Compensation of this Proxy Statement and (iv)&nbsp;all current directors and named executive officers as a group. Unless otherwise indicated, the
principal address of each of the stockholders below is c/o&nbsp;Sangamo BioSciences, Inc., 501&nbsp;Canal Boulevard, Richmond, CA 94804. Except as otherwise indicated or to the extent authority may be shared by both spouses under applicable law, and
subject to applicable community property laws, we believe the persons named in the table have sole voting and investment power with respect to all shares of common stock held by them. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="80%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:134pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and Address of Beneficial Owner</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Shares<BR>Beneficially<BR>Owned</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percentage<BR>of Shares<BR>Beneficially<BR>Owned&nbsp;(19)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">RA Capital Management, LLC (1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,227,272</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">20 Park Plaza, Suite 1200</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Boston, MA 02116</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Goldman Sachs Group, Inc. (2)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,466,891</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">200 West Street</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">New York, NY 10282</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">BlackRock, Inc. (3)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,416,980</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">40 East 52</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"> nd</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> Street</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:3.00em; text-indent:-1.00em"><FONT
STYLE="font-family:Times New Roman" SIZE="2">New York, NY 10022</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">FMR LLC (4)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,305,600</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.9</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">245 Summer Street</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Boston, MA 02210</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Adage Capital Advisors, L.L.C. (5)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,550,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">200 Clarendon Street, 52nd floor</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Boston, MA 02116</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Wasatch Advisors, Inc. (6)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,214,232</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">505 Wakara Way,</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Salt Lake City, UT 84108</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward O. Lanphier II (7)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,378,386</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Paul B. Cleveland (8)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,667</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen G. Dilly, M.B.B.S., Ph.D. (9)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">80,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John W. Larson (10)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">318,160</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Steven J. Mento,&nbsp;Ph.D. (11)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">95,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Saira Ramasastry (12)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">60,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">William R. Ringo (13)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">80,800</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H. Ward Wolff (14)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,019,346</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geoffrey M. Nichol, M.B., Ch.B. (15)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">263,638</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dale G. Ando,&nbsp;M.D. (16)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">598,014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Philip D. Gregory, D. Phil. (17)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">428,846</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All current directors and named executive officers as a group (11 persons) (18)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,334,357</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Less than one percent. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">According to a Schedule&nbsp;13G/A filed on February&nbsp;14, 2014, RA Capital Management, LLC is the beneficial owner of an aggregate of 5,227,272
shares of common stock. Mr.&nbsp;Peter Kolchinsky (the &#147;Manager&#148;) is the manager of RA Capital Management, LLC, which is the investment adviser and sole general partner of RA Capital Healthcare Fund, L.P. (&#147;Fund&#148;). Each of RA
Capital Management, LLC and Manager has shared </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">20 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
power to dispose or to direct the disposition of 5,227,272 shares of common stock and shared power to vote or to direct to vote of 5,227,272 shares of common stock, and the Fund has shared power
to dispose or to direct the disposition of 4,043,002 shares and shared power to vote or to direct to vote of 4,043,002 shares of common stock. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">According to a Schedule 13G filed on February&nbsp;13, 2014, each of The Goldman Sachs Group, Inc. and Goldman, Sachs&nbsp;&amp; Co. has shared power to vote or direct
to vote of 4,466,891 shares of common stock and shared power to dispose and direct the disposition of 4,466,891 shares of common stock. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">According to a Schedule&nbsp;13G/A filed on January&nbsp;30, 2014, BlackRock, Inc. is the beneficial owner of 4,416,980 shares of common stock. BlackRock, Inc. has sole
power to dispose or to direct the disposition of 4,416,980 shares of common stock and sole power to vote or to direct to vote of 4,416,980 shares of common stock. </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">According to a Schedule 13G filed on February&nbsp;14, 2014, Fidelity SelectCo (&#147;SelectCo&#148;) is the beneficial owner of 4,305,600 shares of common stock. Each
of Edward C. Johnson 3d and FMR LLC, through its control of SelectCo, has sole power to dispose of 4,305,600 shares of common stock. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">According to a Schedule&nbsp;13G filed on February&nbsp;12, 2014, Adage Capital Advisors, L.L.C. (&#147;ACA&#148;) is the managing member of Adage Capital Partners GP.
L.L.C. (&#147;ACPGP&#148;), which is the general partner of Adage Capital Partners, L.P., which directly holds 3,550,000 shares of common stock. Each of ACA and ACPGP has shared power to vote or direct to vote 3,550,000 shares of common stock and
shared power to dispose or to direct the disposition of 3,550,000 shares of common stock. Mr.&nbsp;Robert Atchinson and Mr.&nbsp;Phillip Gross, as managing members of ACA, may be deemed the beneficial owners of 3,550,000 shares of common stock.
</FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">According to a Schedule 13G filed on February&nbsp;13, 2014, Wasatch Advisors, Inc. is the beneficial owner of 3,214,232 shares of common stock and has sole power to
vote or to direct to vote such shares, and the sole power to dispose or direct the disposition of such shares. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 1,683,332 shares of common stock subject to options exercisable within 60&nbsp;days after February&nbsp;10, 2014. Also includes 100,000&nbsp;shares held in a
trust for the benefit of Mr.&nbsp;Lanphier&#146;s children and 1,595,054&nbsp;shares held in family trust. Excludes Restricted Stock Units (&#147;RSUs&#148;) covering an additional 295,000 shares of common stock that may vest and become issuable
more than 60 days after February&nbsp;10, 2014. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consists of 11,667 shares issuable upon the exercise of stock options, of which 9,167&nbsp;shares fully vest within 60 days of February&nbsp;10, 2014. The remaining
2,500 shares do not vest within 60 days of February&nbsp;10, 2014 and would be subject to repurchase upon cessation of service to Board if exercised prior to vesting. </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consists of 80,000 shares issuable upon the exercise of stock options, of which 77,500 shares fully vest within 60 days of February&nbsp;10, 2014. The remaining 2,500
shares do not vest within 60 days of February&nbsp;10, 2014 and would be subject to repurchase upon cessation of service to Board if exercised prior to vesting. </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(10)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 100,000 shares issuable upon the exercise of stock options, of which 97,500&nbsp;shares fully vest within 60 days of February&nbsp;10, 2014. The remaining
2,500 shares do not vest within 60 days of February&nbsp;10, 2014 and would be subject to repurchase upon cessation of service to Board if exercised prior to vesting. Also includes 11,260&nbsp;shares of common stock held in Mr.&nbsp;Larson&#146;s
individual retirement account (IRA). </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(11)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 75,556 shares issuable upon the exercise of stock options, of which 73,056&nbsp;shares fully vest within 60 days of February&nbsp;10, 2014. The remaining 2,500
shares do not vest within 60 days of February&nbsp;10, 2014 and would be subject to repurchase upon cessation of service to Board if exercised prior to vesting. Also includes 19,944&nbsp;shares held in a trust. </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(12)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consists of 60,000 shares issuable upon the exercise of stock options, of which 36,667&nbsp;shares fully vest within 60 days of February&nbsp;10, 2014. The remaining
23,333 shares do not vest within 60 days of February&nbsp;10, 2014 and would be subject to repurchase upon cessation of service to Board if exercised prior to vesting. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">21 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(13)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 80,000 shares issuable upon the exercise of stock options, of which 77,500&nbsp;shares fully vest within 60 days of February&nbsp;10, 2014. The remaining 2,500
shares do not vest within 60 days of February&nbsp;10, 2014 and would be subject to repurchase upon cessation of service to Board if exercised prior to vesting. </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(14)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 906,999 shares of common stock subject to options exercisable within 60&nbsp;days after February&nbsp;10, 2014. In addition to the shares reported as
beneficially owned by Mr.&nbsp;Wolff in the table above, he also holds RSUs covering an additional 115,000 shares of common stock that may vest and become issuable more than 60 days after February&nbsp;10, 2014. </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(15)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 242,915 shares of common stock subject to options exercisable within 60&nbsp;days after February&nbsp;10, 2014. Excludes RSUs covering an additional 121,666
shares of common stock that may vest and become issuable more than 60 days after February&nbsp;10, 2014. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(16)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 580,665&nbsp;shares of common stock subject to options exercisable within 60&nbsp;days after February&nbsp;10, 2014. Excludes RSUs covering an additional
79,666 shares of common stock that may vest and become issuable more than 60 days after February&nbsp;10, 2014. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(17)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 414,498&nbsp;shares of common stock subject to options exercisable within 60&nbsp;days after February&nbsp;10, 2014. Excludes RSUs covering an additional
94,999 shares of common stock that may vest and become issuable more than 60 days after February&nbsp;10, 2014. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(18)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 4,235,629 shares issuable upon the exercise of stock option, of which 4,199,799 shares are fully vested within 60 days of February&nbsp;10, 2014. The remaining
35,833 shares do not vest within 60 days of February&nbsp;10, 2014 and would be subject to repurchase upon cessation of service to the Board if exercised prior to vesting. Excludes RSUs covering an additional 706,331 shares of common stock that may
vest and become issuable more than 60 days after February&nbsp;10, 2014. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(19)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Shares of common stock issuable upon the exercise of options currently exercisable or exercisable within 60&nbsp;days after February&nbsp;10, 2014, are deemed
outstanding for purposes of computing the percentage ownership of the person holding such options, but are not deemed outstanding for computing the percentage ownership of any other person. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">22 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>COMPENSATION DISCUSSION AND ANALYSIS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">It is our intent in this Compensation Discussion and Analysis (&#147;CD&amp;A&#148;) to inform our stockholders of the policies and
objectives underlying the compensation programs for our executive officers. Accordingly, we will address and analyze the key elements of the compensation provided to our chief executive officer, our principal financial and accounting officer and the
senior research and clinical development executive officers named in the Summary Compensation Table which follows this discussion. We refer to these officers as our named executive officers. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Executive Summary of Compensation Principles and Decisions </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Company&#146;s overarching compensation goal is to reward our executive officers in a manner that supports a strong pay-for-performance philosophy in order to create a positive relationship between its compensation program and the Company&#146;s
operational performance and stockholder return, while maintaining an overall level of compensation that the Company believes is fair, reasonable and responsible. The Company believes its compensation objective is accomplished through the following
principles and processes that are followed in establishing executive compensation and by the following decisions made with respect to the 2013 compensation package for our named executive officers: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pharmaceutical research, development and commercialization require sustained and focused effort over many years, and involve a high degree of risk.
Consequently, the Compensation Committee believes the Company&#146;s compensation program must balance incentives that create rewards for the realization of our long-term strategic objectives with compensation that rewards employees for the
achievement of annual goals that further the attainment of the Company&#146;s long-term objectives. The Compensation Committee strives to create a positive relationship between its compensation program and the Company&#146;s operational performance
and stockholder return. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In order to assure that the compensation programs for the executive officers remain competitive with peer companies, accomplish the Company&#146;s
pay-for-performance objectives, and create rewards for the realization of our long-term strategic objectives, the Compensation Committee works with an independent consultant to obtain the advice and market data needed to ensure that the compensation
programs achieve these goals. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based on advice from our independent compensation consultant, Radford, an Aon Hewitt Company (&#147;Radford&#148;), Mr.&nbsp;Lanphier&#146;s and
Dr.&nbsp;Gregory&#146;s base salary for the 2013 year was increased in order to reward each executive&#146;s performance and to bring his base salary level to between approximately the 50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> and 75</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile of the market data derived from the comparator group. The base salary increases for the other executive
officers were more modest and positioned the base salaries of those executive officers at or above the 75</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"> percentile of the market data derived from the comparator group. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company&#146;s 2013 cash incentive program provided our executive officers with a direct financial incentive in the form of a cash bonus award tied
to the Company&#146;s achievement of aggressive pre-established clinical, research and development, business and corporate development, and financial objectives for the 2013 year, as well as individual performance objectives as provided in their
plans for Dale Ando, our Vice President, Therapeutic Development and Chief Medical Officer and Philip Gregory, our Senior Vice President, Research and Chief Scientific Officer. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As a result of the Company&#146;s exceptional performance in 2013, as highlighted below under the heading &#147;2013 Business
Highlights,&#148; and in the case of Drs. Ando and Gregory, their individual performance, each named executive officer was awarded in excess of 100% of his target bonus for 2013. </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Like most other biotechnology companies that have not yet commercialized any pharmaceutical products, the Company has been heavily dependent on the
capital markets for its cash requirements, and has historically used equity compensation as a significant component of the compensation package for the Company&#146;s executive officers. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">23 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">At the 2013 Annual Meeting, our stockholders approved the Company&#146;s 2013 Stock
Incentive Plan (the &#147;2013 Plan&#148;) as the successor to the Company&#146;s 2004 Stock Incentive Plan that would otherwise have expired in March 2014. Consistent with evolving corporate governance practices and in order to address stockholder
concerns regarding dilution, the Compensation Committee sought approval of a share reserve under the 2013 Plan that is intended to meet the Company&#146;s equity compensation needs for two to three years. The Compensation Committee is committed to
using equity incentive awards prudently and within reasonable limits. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2013 the Compensation Committee determined that it was appropriate to provide executives with an equity package that included both restricted stock
units (&#147;RSUs&#148;) and stock option awards. Based on the Company&#146;s increased stock price during 2013, the Compensation Committee reduced the number of shares subject to the equity grants made in 2013 as compared to the equity grants made
in 2012, and focused on the Company&#146;s burn rate and the percent of the Company&#146;s outstanding equity subject to each award. The percentage of the Company&#146;s equity granted pursuant to the 2013 equity awards placed the executive officers
between the 50th and the 75th percentile of the comparator group on equity awards, which was consistent with the Company&#146;s policy. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company has entered into employment agreements with its President and Chief Executive Officer, Edward O. Lanphier, its Executive Vice President,
Research and Development, Dr.&nbsp;Geoffrey Nichol and its Executive Vice President and Chief Financial Officer, H. Ward Wolff. These agreements provide financial protection against the potential loss of employment in designated circumstances, which
the Compensation Committee believes will allow the executives to focus attention on the best interests of the stockholders, without undue concern as to the executive&#146;s own financial situation. None of our employment agreements contain a tax
gross-up. The Compensation Committee has been advised by its independent compensation consultant that the benefits provided under these agreements are consistent with both peer company and broader market practices, and are fair and reasonable.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company does not offer a defined benefit pension plan, deferred compensation plan or supplemental executive retirement plan. Instead, the Company
relies on equity compensation in order to attract and retain key employees, align the interests of our executive officers with those of our stockholders and to provide our executive officers and other employees with the opportunity to accumulate
retirement income. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company does not offer any significant perquisites to the executive officers. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2013 Business Highlights </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As discussed in this CD&amp;A, the Compensation Committee strives to create a positive relationship between its compensation program and
the Company&#146;s operational performance and stockholder return. The Compensation Committee established the 2013 compensation program and the associated Company goals in accordance with this philosophy and recognized the following key financial
and operational achievements during the 2013 year: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company completed the treatment and treatment interruption (&#147;TI&#148;) phase for its SB-728-T clinical trials in HIV/AIDS (SB-728-1101 and
SB-728-902, Cohort 5). At medical meetings in 2013, the Company presented data from these trials. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company presented preclinical proof of concept data from In Vivo Protein Replacement Platform (&#147;IVPRP&#148;) and Sangamo&#146;s DNA-binding
technology (&#147;ZFP&#148;) therapeutic program for treatment of hemoglobinopathies at the Annual Meeting of the American Society of Hematology. New preclinical data were presented demonstrating therapeutic levels of gene modification in non-human
primates from Sangamo&#146;s IVPRP. In addition, preclinical and clinical manufacturing data were presented from Sangamo&#146;s ZFP Therapeutic program for the treatment and potential cure of both sickle cell disease (&#147;SCD&#148;) and
beta-thalassemia. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">24 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company was awarded a $6.4 million Strategic Partnership Award from the California Institute of Regenerative Medicine (&#147;CIRM&#148;) to develop
ZFP Therapeutics for the treatment of beta-thalassemia. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">As a result of actions taken and the foregoing significant milestones achieved during the 2013 year, on January&nbsp;8, 2014, the Company entered into
a Global Research, Development and Commercialization Collaboration and License Agreement with a wholly-owned subsidiary of Biogen Idec Inc. (&#147;Biogen&#148;), pursuant to which Sangamo and Biogen will collaborate to discover, develop, seek
regulatory approval for and commercialize therapeutics based on ZFP for hemoglobinopathies, including SCD and beta-thalassemia. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company concluded the year with $131.8 million in cash, cash equivalents, investments and interest receivable. In September 2013, the Company
completed an underwritten public offering of its common stock resulting in net proceeds of $69.5 million. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company acquired Ceregene, Inc., a privately held biotechnology company focused on the development of adeno-associated virus (&#147;AAV&#148;) gene
therapies. The acquired assets include all of Ceregene&#146;s therapeutic programs, including CERE-110, an AAV vector expressing nerve growth factor (&#147;NGF&#148;) for the treatment of Alzheimer&#146;s disease that is currently in a Phase 2
clinical trial, certain intellectual property rights relating to the manufacturing of AAV, and certain toxicology and safety data from Ceregene&#146;s human clinical trials. In addition to the products and technologies acquired through the Ceregene
acquisition, the Company advanced its intellectual property portfolio. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company believes that the increase in the Company&#146;s market capitalization during 2013 was the result of the Company&#146;s achievement of the
foregoing performance milestones. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Overview of the Company&#146;s Executive Compensation Program </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Corporate Governance and the Role of the Compensation Committee </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee assists the Board of Directors in fulfilling its fiduciary responsibilities with respect to the oversight of the Company&#146;s affairs in the areas of compensation plans,
policies and programs of the Company, especially those regarding executive compensation and employee benefits. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Compensation Committee&#146;s responsibilities include (i)&nbsp;establishing, administering and reviewing compensation plans and programs for the Company&#146;s executive officers and other employees, including incentive and equity-based plans and
programs; (ii)&nbsp;establishing compensation arrangements for the executive officers and setting the performance goals for their incentive compensation programs; (iii)&nbsp;evaluating the performance of executive officers and awarding incentive
compensation; (iv)&nbsp;adjusting compensation arrangements as appropriate based upon performance; and (v)&nbsp;reviewing and monitoring management development and succession plans and activities. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">During 2013, Dr.&nbsp;Mento served as Chairman of the Compensation Committee, and Messrs. Larson and Ringo served as members of the
Compensation Committee. The Company&#146;s Board of Directors has determined that all of the Compensation Committee members who served during the 2013 year are &#147;independent&#148; directors under the NASDAQ definition of independence.
Dr.&nbsp;Mento and Messrs. Larson and Ringo have extensive experience in executive management and the biotechnology industry, including experience with compensation practices and policies. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Objectives of the Company&#146;s Compensation Program </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company is
developing a new class of human therapeutics and is committed to building a sustainable business focused on the research, development and commercialization of engineered DNA-binding proteins for the development of novel therapeutic strategies for
unmet medical needs. To achieve this strategic objective, the Company has emphasized the recruitment of executives with significant industry or scientific experience. This is a very competitive industry and our success depends upon our ability to
attract and retain qualified executives through competitive compensation packages. The Compensation Committee administers the compensation programs for our executive officers with this competitive environment in mind. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">25 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pharmaceutical research, development and commercialization require sustained and focused
effort over many years, and involves a high degree of risk, particularly in the early stages of clinical development. As a consequence, the Compensation Committee believes the Company&#146;s compensation program must balance long-term incentives
that create rewards for the realization of our long-term strategic objectives with near term compensation that rewards employees for the achievement of annual goals that further the attainment of the Company&#146;s long-term objectives and align the
interests of our employees with those of our stockholders. The Company believes that compensation should not be based primarily on the near-term performance of our stock, which has been and continues to be highly volatile. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">To this end, the objectives of the Company&#146;s compensation program are to: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Enable the Company to attract and retain highly qualified executives with extensive industry or scientific experience by providing a competitive
compensation package that includes long-term incentives that provide significant retentive value; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Reward executives for the Company&#146;s success in meeting its annual clinical development and other research and operational goals;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Reward executives for their individual performance and achievement of their personal goals and those of the functional organizations that they manage;
and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Align the interests of our executives with those of our stockholders. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Executive Compensation Determination Procedures and Policies </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Compensation Committee reviews executive compensation annually. As part of this process, the Chief Executive Officer makes recommendations to the Compensation Committee with respect to the compensation levels for individual executives other than
himself based on the performance evaluation conducted by the executive&#146;s manager. The Compensation Committee reviews this information and adjusts or approves the recommendations as appropriate. In addition, for each named executive officer, the
Compensation Committee considers the Company&#146;s performance against annual and longer term objectives, market data regarding executive compensation at comparable companies and realized and realizable values under previous equity awards.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the case of the Chief Executive Officer, the Compensation Committee evaluates his performance against the Company&#146;s
annual goals and longer term objectives pre-established by the Board of Directors, together with market data regarding executive compensation at comparable companies and realized and realizable values under previous equity awards. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In August 2012, the Compensation Committee retained the services of Radford to advise the committee on the Company&#146;s overall
compensation practices, including the following: (i)&nbsp;assessment of compensation levels and mix of elements for the Company&#146;s executive officers and vice presidents, (ii)&nbsp;executive compensation and governance trends based on peer group
practices and market trends, (iii)&nbsp;development of company-wide cash and equity grant ranges based on the Company&#146;s job classification structure, and (iv)&nbsp;adoption of an equity incentive plan as a successor to the Company&#146;s 2004
Stock Incentive Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In September 2013, the Compensation Committee again retained the services of Radford in order to
(i)&nbsp;assess compensation levels and mix of elements for the Company&#146;s executive officers and vice presidents, (ii)&nbsp;review the peer group companies selected in 2012 and recommend any changes to that list, and (iii)&nbsp;advise the
committee on executive compensation and governance trends based on peer group trends and market practices. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation
Committee determined that Radford was independent using certain defined criteria including (i)&nbsp;fees paid by Sangamo to Radford as a percentage of Radford&#146;s total revenue; (ii)&nbsp;other services provided to Sangamo by Radford;
(iii)&nbsp;Radford&#146;s business or personal relationships with Compensation Committee members and executive officers; (iv)&nbsp;shares of Sangamo common stock owned by Radford; and (v)&nbsp;other potential conflicts of interest. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">26 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Comparative Analysis </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Because the biotechnology industry is a dynamic industry, the comparator group used by the Compensation Committee to measure the competitive positioning of our compensation packages is periodically
updated to ensure that companies continue to meet the established criteria. Accordingly, the peer companies for purposes of measuring the competitive positioning of the 2012 equity awards and the 2013 compensation package for the named executive
officers were selected in October 2012, based on an analysis performed by Radford. Peer companies were selected at that time primarily using the following criteria: publicly-held pre-commercial U.S. biotechnology companies, companies with 50 &#150;
500 employees, companies with market capitalization values between $125 million and $600 million and a preference for companies located in northern California. Specifically, the selected comparable companies were as follows: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Affymax, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">ISIS&nbsp;Pharmaceuticals,&nbsp;Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Alnylam Pharmaceuticals, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">MannKind Corporation</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amicus Therapeutics</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">MAP&nbsp;Pharmaceuticals,&nbsp;Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Celldex Therapeutics, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Neurocrine&nbsp;Biosciences,&nbsp;Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dendreon Corporation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Osiris Therapeutics, Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dyax Corp.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rigel Pharmaceuticals, Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dynavax Technologies Corporation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vical, Incorporated</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exelixis, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">XenoPort, Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geron Corporation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">XOMA Corporation</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Immunomedics, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2013, Sangamo&#146;s market capitalization increased significantly. Accordingly, in September 2013,
based on the recommendation of Radford, the criteria primarily used to select the peer group were modified to adjust the market capitalization range of comparator companies from between $125 million and $600 million, to between $300 million and $1.2
billion. Based on this change, the Compensation Committee selected the following comparable companies for purposes of measuring the competitive positioning of the equity awards granted in December 2013: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="65%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Alnylam Pharmaceuticals, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Infinity&nbsp;Pharmaceuticals,&nbsp;Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Anacor Pharmaceuticals, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">MannKind Corporation</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Celldex Therapeutics, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Neurocrine&nbsp;Biosciences,&nbsp;Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cytokinetics, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Osiris Therapeutics, Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dyax Corp.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rigel&nbsp;Pharmaceuticals,&nbsp;Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dynavax Technologies Corporation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sarepta Therapeutics, Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exelixis, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Synta Pharmaceuticals Corp.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geron Corporation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">XenoPort, Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Idenix Pharmaceuticals Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">XOMA Corporation</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Immunomedics, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Key Elements of the Company&#146;s Executive Compensation Program </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following are the key elements of the Company&#146;s executive compensation program: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Base Salary </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash Incentive Bonus </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Equity Compensation </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Base Salary </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Base salary
is intended to enable the Company to attract and retain skilled and experienced executives and to provide a level of economic security for executives from year to year. For each executive position, the
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">27 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">
Compensation Committee generally targets base compensation in the range of the 50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> to 75</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">percentile of the market data derived by Radford from the comparator group. The Committee considers this positioning
appropriate given each of our executive&#146;s tenure and responsibilities with the Company, as well as the high cost of living in the San Francisco Bay Area. However, the actual base salary for an executive officer may be below or above the range
based on individual performance, experience, skills and the importance of the executive&#146;s position to the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT
STYLE="font-family:Times New Roman" SIZE="2">In accordance with our practice, in December 2012, the Company conducted annual performance reviews for the 2012 year for all of its employees, including named executive officers. Based on these reviews,
Company performance for the 2012 year, advice from Radford and competitive data from the peer group, the Compensation Committee approved increases to annual base salaries for each of the Company&#146;s named executive officers, effective
January&nbsp;1, 2013. Mr.&nbsp;Lanphier&#146;s and Dr.&nbsp;Gregory&#146;s base salary was increased by approximately 11.5%, and 10%, respectively, in order to reward each executive&#146;s performance, reflect the importance of that officer&#146;s
position and to bring his base salary level to between approximately the 50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"> and 75</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
percentile of the market data derived from the peer group. The base salary increases for the other executive officers were more modest and positioned the base salaries of those executive officers at or above the 75</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile of the market data derived from the peer group.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The 2013 and 2012 base salaries were as follows: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="71%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013<BR>Base&nbsp;Salary</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012<BR>Base&nbsp;Salary</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percent<BR>Increase</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward O. Lanphier II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">640,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">574,225</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11.50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H. Ward Wolff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">400,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">390,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.56</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geoffrey M. Nichol, M.B., Ch.B.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">453,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">440,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.07</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dale G. Ando, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">437,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">427,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Philip D. Gregory, D. Phil.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">385,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">350,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Cash Incentive Bonus for 2013 </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Incentive Compensation Plan Terms and Conditions </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation
Committee has adopted the Sangamo BioSciences, Inc. Incentive Compensation Plan (the &#147;Incentive Plan&#148;) as a performance-based cash bonus program for the Company&#146;s executive officers. The Compensation Committee has discretion under the
Incentive Plan to implement one or more performance periods under the plan, each of a duration determined by the Compensation Committee. The Incentive Plan includes a list of criteria upon which performance objectives established under the Incentive
Plan will be based, including both individual and Company performance objectives. For each Company and individual objective, the Compensation Committee may set differing levels of attainment. The Compensation Committee will then establish dollar
levels for the bonus to which each participant may become entitled for that performance period based on the level at which the performance objectives are actually attained. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">A participant will not become entitled to a bonus under the Incentive Plan for a particular performance period unless the participant remains employed by the Company through the date bonuses are paid to
each participant following completion of that performance period. However, should a change in control transaction be consummated prior to the completion of a performance period, then the performance period will terminate upon the consummation of
that change in control and each participant in the Incentive Plan will receive a bonus in the dollar amount previously set by the Compensation Committee at target level attainment of each performance objective; however, such bonus will be pro-rated
to reflect each participant&#146;s actual period of service from the start date of the performance period through the effective date of the change in control. The pro-rated bonus paid pursuant to the terms of the Incentive Plan will reduce the
amount of any severance payable to the participant based on the participant&#146;s target bonus pursuant to the terms of any employment agreement. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">28 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>2013 Objectives and Achievement </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The cash incentive program for the 2013 year under the Incentive Plan was designed to advance our pay-for-performance policy by focusing
the attention of our executive officers on the attainment of key Company short-term objectives that further the attainment of the Company&#146;s long-term objectives. The program provided each of our executive officers with a direct financial
incentive in the form of a cash bonus award tied to our achievement of aggressive pre-established clinical, research and development, business and corporate development, and financial goals for the 2013 year. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Given the uncertainties involved in pharmaceutical development, the Compensation Committee&#146;s milestones for certain clinical and
research objectives have typically focused on the achievement of a specific milestone, rather than a successful outcome. The Compensation Committee believes that this focus is appropriate for the cash incentive program because the executive officers
are already incentivized to produce successful outcomes pursuant to outstanding equity awards, as described under the heading &#147;Equity Compensation&#148; below. The Compensation Committee also believes that this strategy protects against the
potential of short-term incentives to encourage excessive risk taking. However, in order to advance our pay-for-performance strategy, and align our cash incentive program with the interests of our stockholders, in 2013 the Compensation Committee
structured the incentive program so that certain objectives were either (i)&nbsp;dependent upon a successful outcome, or (ii)&nbsp;resulted in an increased payout based on a successful outcome. For example, the weighting of the clinical objectives
was 15% for execution, but 20% for positive proof of principle from one study. The Compensation Committee determined the relative weight of each goal under the cash incentive program based on its importance to the Company&#146;s success. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee has historically determined the size of potential cash bonuses by reference to target bonus amounts, based on
market data from the peer group for each executive position. The specified percentages are intended to help ensure that the Company&#146;s total cash compensation is competitive when compared to the peer companies identified by Radford. It is also
designed to ensure that a portion of each executive&#146;s cash compensation is contingent on goal achievement, thereby increasing the performance-based component of each executive&#146;s total compensation. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">For the performance period under the Incentive Plan coincident with the 2013 calendar year, the target cash bonus
for our executive officers was as follows: Mr.&nbsp;Lanphier, 60% of base salary; Dr.&nbsp;Nichol, 45% of base salary; Mr.&nbsp;Wolff, 40% of base salary, and Drs. Ando and Gregory, 35% of base salary. With the exception of Mr.&nbsp;Wolff, the
target percentage of base salary for each executive officer was increased from the percentage established in the 2012 year, in order to set the target cash bonus for the 2013 year at approximately the 50</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile of the peer group. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For Messrs. Lanphier and Wolff and Dr.&nbsp;Nichol, 100% of the target bonus was based on pre-established corporate performance
objectives; for Drs. Ando and Gregory, 80% of the target bonus was based on corporate performance objectives and 20% of the target bonus was based on individual performance objectives. The Company was required to achieve a minimum of 70% of the
corporate performance objectives for any bonuses to become payable. There was an opportunity for achievement of the corporate performance objective at a level above 100% in the event of exceptional performance. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the actual level of achievement for any category of objectives was deemed to be below the target level for that category of
objectives, the dollar amount of the portion of the executive officer&#146;s bonus allocated to that category of objectives was calculated on a proportional basis between $0 and his target bonus amount. If performance exceeded the target level for
that category of objectives, the dollar amount of the portion of the bonus allocated to that category of objectives was increased at the discretion of the Compensation Committee above the target bonus amount for that category of objectives to
reflect the extent to which the results exceeded the target. At the time the objectives were set, we believed that the objectives, though aggressive, were achievable at the established target levels, but substantial uncertainty nevertheless existed
as to the actual achievement of the objectives at the established level. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">29 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The principal individual performance objective for Dr.&nbsp;Ando was to achieve the
development component of the Company&#146;s performance objectives. In addition, Dr.&nbsp;Ando&#146;s individual performance objectives related to implementation of organizational enhancements in the Company&#146;s development group and expanding
technical expertise and implementing organizational enhancements in the research and manufacturing groups. The principal individual performance objective for Dr.&nbsp;Gregory was to achieve the research component of the Company&#146;s performance
objectives. In addition, Dr.&nbsp;Gregory&#146;s individual performance objectives related to implementation of organizational enhancements in the Company&#146;s research group and support of the Company&#146;s business development group. The
maximum achievement for Drs. Ando and Gregory&#146;s individual performance objectives was 125% of target. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The performance
objectives, weighting and achievement under the program for 2013 are summarized as follows: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="58%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="18%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:152pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Corporate Performance Objectives For 2013</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:35pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Weighting</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:44pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Achievement</B></FONT></P></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Clinical Objectives:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">15%&nbsp;for&nbsp;execution&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">20% for positive proof of principle</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">20%</FONT><BR>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">(100%&nbsp;of&nbsp;category)</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:4.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;Advance clinical trials of SB-728-T program: relates to achievement of certain objectives in the
Company&#146;s ongoing clinical trials.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Development Objectives:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">25%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">25%</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">(100% of
category)</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;Achieve all development deliverables in agreement with
Shire.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:4.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;Advance pre-clinical pipline of ZFP Therapeutics.</FONT></P></TD>

<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Business/Corporate Development Objectives:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="3" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">20%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="3" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">20%+10%</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">(150% of
category)</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:4.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;Complete at least one ZFP Therapeutic corporate partnership</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:4.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;Evaluate, license or acquire additional technologies or synergistic products.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Research Objectives:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="4" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">25%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="4" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">25% + 5% bonus</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">(120% of
category)</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:4.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;Advance prioritized ZFP Therapeutic research programs.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:4.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;Secure new grant funding to support preclinical programs</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:4.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;Achieve all deliverables in agreements with partner Dow AgroSciences and Shire</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Finance and Organizational Objectives:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10%+10%</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">(200% of
category)</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;Conclude 2013 with more than $57.5 million in cash and cash
equivalents, excluding cash from new corporate partnerships or financing activities.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:4.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;Other organizational objectives</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">100%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">125%</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee determined that the Company&#146;s performance for the 2013 year resulted in
total achievement of 125% of the weighted objectives (see table above for specific objective achievement). The Compensation Committee determined that the level of achievement of the Business/Corporate Development Objectives, the Research Objectives
and the Finance and Organizational Objectives exceeded 100%, based on the results achieved by the Company in executing those objectives, as described above under the heading &#147;2013 Business Highlights&#148;. In addition, the Compensation
Committee determined that Dr.&nbsp;Ando met his individual performance goals at 110% (or 22% of the 20% for that category) and that Dr.&nbsp;Gregory met his individual performance goals at 125% (or 25% of the 20% for that category). </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">30 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee retains the discretion each year to grant supplemental bonuses
under the Incentive Plan to named executive officers that are above or below the established target based on the above criteria and its subjective assessment of each named executive officer&#146;s performance. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The table below sets forth the target and actual cash incentive program awards for our named executive officers based on the
Company&#146;s performance in the 2013 year, and for Drs. Ando and Gregory, achievement of individual performance objectives: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target<BR>Award</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Actual<BR>Award</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward O. Lanphier II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">384,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">480,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H. Ward Wolff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">160,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">200,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geoffrey M. Nichol, M.B., Ch.B.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">204,075</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">255,094</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dale G. Ando, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">153,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">186,812</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Philip D. Gregory, D. Phil.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">134,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">168,438</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Equity Compensation </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Company has historically granted stock options to its executives, and to all of its employees, to provide long-term incentives that align the interests of its work force with the achievement of the
Company&#146;s long-term vision to develop and commercialize pharmaceutical products and with the interests of the Company&#146;s stockholders. Given the time periods involved in pharmaceutical development, the Company believes that these long-term
incentives are critical to the Company&#146;s success. The exercise price for options granted by the Company is equal to the closing price of the Company&#146;s stock on the option grant date. Accordingly, stock options produce realizable value to
the holder only if the Company&#146;s stock price increases over the period of time that the award remains outstanding. Option grants are typically subject to a four year vesting schedule with 25% of the grant vesting on the first anniversary of the
grant and then monthly thereafter for the next three years. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In December 2011 the Compensation Committee awarded RSUs to its
executives in lieu of annual stock option grants. The committee made that change for a number of reasons, including reducing the dilutive effect of the incentive equity awards made to management, making the Company&#146;s equity compensation
practices competitive with the Company&#146;s peer group and providing additional retention incentive. Each RSU entitles the recipient to one share of our common stock at a designated issue date following the vesting of that unit, without the
payment of an exercise price or other cash consideration for the issued share. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2011, the Compensation Committee weighted
more heavily the retention incentive provided to the executive officers by an award of RSUs based on the Company&#146;s stock price at such time and the value that could be realized by each executive officer pursuant to his equity awards, many of
which had no intrinsic value at such time. However, in 2012 and 2013, based on the advice of Radford and its review of peer group data, the Compensation Committee awarded equity packages that utilize both RSU awards and stock options. The
Compensation Committee believes that this approach enables the committee to balance the positive and negative attributes of each type of equity award. For example, stock options are generally considered to have a stronger pay-for-performance
component since the awards result in realizable value to the executive only if the company&#146;s stock price increases over time. For this reason, higher numbers of option shares are generally awarded by companies, increasing stockholder dilution,
but also providing a greater return to the executive when the company&#146;s stock price increases. RSUs retain value when the company&#146;s stock price decreases, and accordingly are considered to have a stronger retention value, particularly in
volatile markets. Because RSUs </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">31 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
retain value when the stock price decreases, companies generally award smaller numbers of RSUs than they would stock options, thereby resulting in less stockholder dilution. Consistent with the
awards made in 2012, the equity awards in 2013 were granted with a 2:1 award ratio of stock options to RSUs. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based on the
Company&#146;s significantly increased stock price during 2013, the Compensation Committee reduced the number of shares subject to the equity grants made in 2013 as compared to the equity grants made in 2012 and focused on the Company&#146;s burn
rate and the percent of the Company&#146;s outstanding equity subject to each award. The percentage of the Company&#146;s equity granted pursuant to the 2013 equity awards placed the executive officers between the 50th and the 75th percentile of the
comparator group on equity awards, which was consistent with the Company&#146;s policy. In addition, Dr.&nbsp;Gregory&#146;s equity awards reflect his promotion to Senior Vice President of Research and Chief Scientific Officer. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following equity awards were granted to our named executive officers by the Compensation Committee effective December&nbsp;12, 2013:
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="65%"></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of&nbsp;Option<BR>Shares at an<BR>Exercise&nbsp;Price&nbsp;Per<BR>Share of
$12.12</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of<BR>Restricted&nbsp;Stock<BR>Units</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward O. Lanphier II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H. Ward Wolff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geoffrey M. Nichol, M.B., Ch.B.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dale G. Ando, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">46,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">23,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Philip D. Gregory, D. Phil.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The stock options awarded in December 2013 are subject to a four year vesting schedule with 25% of the
grant vesting on the first anniversary of the grant and then monthly thereafter for the next three years. The RSUs awarded in December 2013 vest and the underlying shares of common stock will become issuable in three successive equal annual
installments measured from the grant date. The equity awards granted to Messrs. Lanphier and Wolff and Dr.&nbsp;Nichol are subject to accelerated vesting in whole or in part in the event the officer&#146;s employment terminates under certain
circumstances or upon certain changes in control or ownership of the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">At the 2013 Annual Meeting, our stockholders
approved the 2013 Plan as the successor to the Company&#146;s 2004 Stock Incentive Plan that would otherwise have expired in March 2014. Consistent with evolving corporate governance practices and in order to address stockholder concerns regarding
dilution, the Compensation Committee sought approval of a share reserve under the 2013 Plan that is intended to meet the Company&#146;s equity compensation needs for two to three years. At the time the 2013 Plan was approved, our historic three-year
average gross burn rate, representing annual equity award grants as a percentage of total shares outstanding, was 3.51%, calculated in accordance with the methodology used by a leading proxy advisory firm. This is below the 6.70% gross burn rate
limit that such proxy advisory firm applies to the Pharmaceutical and Biotechnology GICS industry group of the Russell 3000 for 2013 that the Company is measured against. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Because our executive officers have generally retained their equity awards for significant time periods, thereby aligning the interests of our executive officers with the interests of our stockholders, we
have not adopted a policy requiring our executive officers to hold their equity awards for any designated period of time. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Equity awards are granted to all employees, including executives, when they are hired, and employees are eligible for additional equity
awards in connection with annual performance reviews in December of each year. New hire equity awards are generally pre-authorized and become effective on the employee&#146;s start date, with the exercise price of any stock option grants set at the
closing price of the Company&#146;s stock on that date. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">32 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Employment Agreements </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Company has entered into an employment agreement with Messrs. Lanphier and Wolff and with Dr.&nbsp;Nichol. These agreements provide financial protection against the potential loss of employment in
designated circumstances, which the Compensation Committee believes will allow the executives to focus attention on the best interests of the stockholders, without undue concern as to the executive&#146;s own financial situation. None of our
employment agreements contain a tax gross-up. The Compensation Committee has been advised that the benefits provided under these agreements are consistent with both peer company and broader market practices, and are fair and reasonable. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A summary of the material terms of the employment agreements with Messrs. Lanphier and Wolff and with Dr.&nbsp;Nichol, together with a
quantification of the benefits available under those agreements, may be found in the section of the Proxy Statement entitled &#147;Employment Contracts and Change in Control Arrangements.&#148; </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Other Elements of Executive Compensation Program </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The remaining elements of the Company&#146;s executive compensation program, like its broader employee compensation programs, are intended to make the Company&#146;s overall compensation program
competitive with those of its peer companies, keeping in mind the constraints imposed by the Company&#146;s reliance on the capital markets as the primary source of its cash needs. With the exception of the employment agreements between the Company
and the Company&#146;s President and Chief Executive Officer, Executive Vice President and Chief Financial Officer and Executive Vice President, Research and Development, all of the remaining elements of the Company&#146;s executive compensation
program (401(k)&nbsp;Plan, Medical, Dental, and Vision Plans, Life and Disability Insurance, and Employee Stock Purchase Plan) are available to all Company employees. Under the terms of the Company&#146;s Employee Stock Purchase Plan and the
Internal Revenue Code, as a beneficial owner of more than 5% of the Company&#146;s outstanding common stock, Mr.&nbsp;Lanphier is not eligible to participate in that plan. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Allocations between Base Salary, Cash Incentive Bonus and Equity Compensation for Executives and Risk-Taking </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">As discussed above, the development and commercialization of pharmaceutical products involves a high degree of risk, particularly in the early stages of clinical development. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Recently, the Company has sought to align equity and cash components with industry peers in order to offer compensation packages that
enable us to attract and retain talented employees, including those in the Company&#146;s executive ranks. The Compensation Committee continues to evaluate the relative importance of equity and cash components of total compensation. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company does not believe that the performance-based nature of the executive compensation program encourages excessive risk-taking by
its executive officers that would threaten the economic viability of the Company. Some clinical milestones under the cash incentive program each year are generally focused on the achievement of a specific milestone, rather than a successful outcome.
The Compensation Committee believes that this strategy protects against the potential of near-term incentives to encourage excessive risk taking. In addition, long-term equity awards tied to the value of the Company&#146;s common stock represent a
significant component of an executive officer&#146;s total direct compensation, as evidenced by the compensation breakdown contained in the Summary Compensation Table that follows. Those awards promote a commonality of interest between the executive
officers and the Company&#146;s stockholders in sustaining and increasing stockholder value. Because the equity awards are typically made on an annual basis to the executive officers, those officers always have unvested awards outstanding that could
decrease significantly in value if the Company&#146;s business is not managed to achieve its long-term goals. Accordingly, the overall compensation structure is not overly-weighted toward near-term incentives, and the Company has taken what it
believes are reasonable steps to protect against the potential of disproportionately large near-term incentives that might encourage excessive risk taking. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">33 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Internal Revenue Code Section&nbsp;162(m) </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Section 162(m) of the Internal Revenue Code disallows a tax deduction to publicly held companies for compensation paid to certain of their
executive officers, to the extent that compensation exceeds $1.0 million per covered officer in any year. The limitation applies only to compensation that is not considered to be performance-based. The stock options granted to our executive officers
have been structured with the objective of qualifying those awards as performance-based compensation. The RSUs awarded to our named executive officers will not qualify as performance-based compensation. In addition, the bonuses provided to our named
executive officers under the Incentive Plan and any other cash incentive programs will not qualify as performance-based compensation for purposes of Section 162(m). However, we believe that in establishing the cash and equity incentive compensation
programs for our executive officers, the potential deductibility of the compensation payable under those programs should be only one of a number of relevant factors taken into consideration, and not the sole governing factor. For that reason, we may
deem it appropriate to provide one or more executive officers with the opportunity to earn incentive compensation, whether through cash bonus programs tied to our financial performance or through RSUs tied to the executive officer&#146;s continued
service, which may, together with base salary, exceed in the aggregate the amount deductible by reason of Section 162(m) or other provisions of the Internal Revenue Code. We believe it is important to maintain cash and equity incentive compensation
at the levels needed to attract and retain the executive officers essential to our success, even if all or part of that compensation may not be deductible by reason of the Section 162(m) limitation. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Non-performance-based compensation paid to our executive officers for 2013 exceeded the $1.0 million limit per covered officer. However,
we generated a net loss for the year ended December 31, 2013 and we expect to incur net losses for the foreseeable future. In addition, as of December 31, 2013, the Company had net operating loss carryforwards for federal income tax purposes of
approximately $209 million that will begin to expire in 2018. These loss carryforwards defer the impact of any deductions that the Company might lose under Section 162(m) for one or more of those carryforward years. Accordingly, although tax
deductions for some amounts that we paid to our named executive officers as compensation for 2013 were limited by section 162(m), that limitation did not result in the current payment by us of increased federal income taxes due to our net loss
position as well as our net operating loss carryforwards. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Advisory Vote on Executive Compensation </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are conducting an advisory vote on executive compensation at our 2014 Annual Meeting (Proposal&nbsp;No.&nbsp;2). While this vote is not
binding on the Company, our Board of Directors or our Compensation Committee, we believe that it is important for our stockholders to have an opportunity to vote on this proposal as a means to express their views regarding our executive compensation
philosophy, our compensation policies and programs, and our decisions regarding executive compensation, all as disclosed in this CD&amp;A and our Proxy Statement generally. Our Board of Directors and our Compensation Committee value the opinions of
our stockholders and, to the extent there is any significant vote against the compensation of our named executive officers as disclosed in the Proxy Statement , we will consider our stockholders&#146; concerns and the Compensation Committee will
evaluate whether any actions are necessary to address those concerns. In addition to our advisory vote on executive compensation, we are committed to ongoing engagement with our stockholders on executive compensation and corporate governance issues.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">At the 2011 Annual Meeting we conducted our first advisory vote on executive compensation. At such meeting, approximately 80%
of the votes cast on the advisory vote on executive compensation proposal (Proposal No. 2) were in favor of our named executive officer compensation as disclosed in our proxy statement, and as a result our named executive officer compensation was
approved. The Board of Directors and Compensation Committee reviewed these final vote results in the context of our overall compensation philosophy and programs, and based on the level of support, determined that no significant changes to our
compensation policies and programs were necessary. Nevertheless, as discussed in this CD&amp;A, the Compensation Committee does make modifications periodically to our executive compensation programs to more closely align our executive compensation
with the interests of our stockholders. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">34 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The award of RSUs to our executive officers, in addition to stock options, as part of the
equity package is one such modification that has occurred following the first advisory vote on executive compensation at our 2011 Annual Meeting. This approach enabled the Compensation Committee to balance the positive and negative attributes of
each type of equity award. For example, stock options are generally considered to have a stronger pay-for-performance component since the awards result in realizable value to the executive only if the Company&#146;s stock price increases over time.
For this reason, higher numbers of option shares are generally awarded by companies, increasing stockholder dilution, but also providing a greater return to the executive when the company&#146;s stock price increases. RSUs retain value when the
company&#146;s stock price decreases, and accordingly are considered to have a stronger retention value, particularly in volatile markets. Because our stock price has been, and will likely continue to be volatile, the Compensation Committee believes
that RSUs are a valuable addition to the compensation package for the Company&#146;s executive officers. In addition, the Compensation Committee has awarded RSUs with a 2:1 award ratio of stock options to RSUs, and accordingly the award of RSUs
results in less dilution than stock option grants on our outstanding shares. This, and other periodic modifications, is intended to build upon our strong compensation governance framework and pay-for-performance philosophy. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have determined that our stockholders should vote on a say-on-pay proposal every three years, consistent with the preference expressed
by our stockholders at the 2011 Annual Meeting </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">35 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Summary Compensation Table </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table provides certain summary information concerning the compensation earned, for services rendered in all capacities to
the Company and its subsidiaries for the years ended December&nbsp;31, 2013, 2012 and 2011 by the Company&#146;s President and Chief Executive Officer, the Company&#146;s Executive Vice President and Chief Financial Officer, and each of the
Company&#146;s three other most highly compensated executive officers whose total compensation for the 2013 year was in excess of $100,000 and who were serving as executive officers at the end of that year. No other executive officers who would have
otherwise been includable in such table on the basis of total compensation for the 2013 year have been excluded by reason of their termination of employment or change in executive status during that year. The listed individuals shall be hereinafter
referred to as the &#147;named executive officers.&#148; </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:97pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and Principal Position</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Salary<BR>($) (1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Bonus<BR>($) </B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock<BR>Awards<BR>($) (2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Awards<BR>($) (3)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Non-Equity<BR>Incentive Plan<BR>Compensation<BR>($) (4)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:9pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(b)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(e)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(f)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(g)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(h)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward O. Lanphier II,</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2013</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">640,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">909,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,283,310</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">480,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,312,310</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and Chief<BR>Executive Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2012</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">574,225</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">973,800</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">946,500</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">290,701</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,785,226</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2011</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">557,500</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">382,500</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">210,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,150,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H. Ward Wolff,</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2013</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">400,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">424,200</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">598,878</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">200,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,623,078</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Executive Vice President<BR>and Chief Financial Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2012</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">390,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">243,450</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">340,740</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">157,950</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,132,140</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2011</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">375,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">191,250</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">112,500</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">678,750</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geoffrey M. Nichol, M.B., Ch.B.,</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2013</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">453,500</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">424,200</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">598,878</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">255,094</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,731,672</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Executive Vice President,<BR>Research and Development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2012</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">440,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">297,550</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">416,460</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">178,200</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,332,210</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">202,289</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">191,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,229,610</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">63,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,836,899</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dale G. Ando, MD,</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2013</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">437,500</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">278,760</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">393,548</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">186,812</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,296,620</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vice President,</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2012</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">427,500</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">189,350</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">265,020</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">128,250</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,010,120</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Therapeutic Development<BR>and Chief Medical Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2011</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">415,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">127,500</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">93,375</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">635,875</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Philip D. Gregory, D. Phil.,</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2013</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">385,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">424,200</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">598,878</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">168,438</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,576,516</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President, Research<BR>and Chief Scientific Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2012</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">350,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">216,400</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">302,880</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">108,150</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">977,430</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2011</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">315,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">127,500</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">70,875</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">513,375</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts in column (c)&nbsp;include amounts deferred under the Company&#146;s 401(k) Plan, a qualified deferred compensation plan under section 401(k) of the
Internal Revenue Code. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts in column (e)&nbsp;reflect the aggregate grant date fair value of the RSUs awarded to the named executive for the applicable year, calculated in accordance
with FASB Accounting Standards Codification Topic 718, or ASC 718, <I>Compensation &#151; Stock Compensation</I>, without taking into account any estimated forfeitures. The assumptions used in the calculation of the grant date fair value of each RSU
award are included in Note 4 of the Notes to Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December&nbsp;31, 2013, filed with the Securities and Exchange Commission on February&nbsp;24, 2014.
</FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts in column (f)&nbsp;represent the aggregate grant date fair value of the stock option grants for each indicated year in accordance with ASC 718. The
assumptions used in the calculation of the grant date fair values of each option grant are included in Note 4 of the Notes to Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December&nbsp;31, 2013, filed with
the Securities and Exchange Commission on February&nbsp;24, 2014. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts in column (g)&nbsp;reflect the cash awards made to the named executive officers under the Company&#146;s non-equity incentive plan that was in effect for
the indicated year. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Nichol received a $150,000 sign-on bonus which he was required to repay to the Company in the event his employment was terminated by the Company for cause or
in the event he voluntarily terminated his employment other than for good reason at any time prior to June&nbsp;17, 2013. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">36 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Grants of Plan-Based Awards </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table provides certain summary information concerning each grant of an award made to a named executive officer in the 2013
year under a compensation plan. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:18pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant<BR>Date</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Potential&nbsp;Payouts&nbsp;Under&nbsp;Non-<BR>Equity<BR>Incentive Plan Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All&nbsp;Other<BR>Stock&nbsp;Awards:<BR>Number of<BR>Shares of<BR>Stock or Units<BR>(#)
(6)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All
Other<BR>Option<BR>Awards:<BR>Number&nbsp;of<BR>Securities<BR>Under-<BR>lying<BR>Options<BR>(#) (3)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exercise or Base<BR>Price&nbsp;of&nbsp;Option&nbsp;or<BR>Stock Awards<BR>($/Sh)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant<BR>Date<BR>Fair<BR>Value<BR>($)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Threshold<BR>($) (1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target<BR>($) (2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Maximum<BR>($) (1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Edward O.&nbsp;Lanphier&nbsp;II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">268,800</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">384,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">909,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">150,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,283,310</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">H. Ward Wolff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">112,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">160,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">35,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">424,200</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">598,878</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Geoffrey M. Nichol, M.B., Ch. B.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">142,852</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">204,075</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">35,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">424,200</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">598,878</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Dale G. Ando, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">85,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">153,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">23,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">278,760</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">46,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">393,548</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Philip D. Gregory, D. Phil.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">75,460</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">134,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">35,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">424,200</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">598,878</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">The Company was required to achieve a minimum of 70% of the corporate performance objectives for any bonuses to become payable. If the applicable performance goals were
attained at a level between threshold and target, the potential bonus would be in a dollar amount interpolated on a straight line basis between the threshold and the indicated target bonus amount. If performance goal attainment were above the target
level, then the potential bonus would be increased above the indicated target bonus amount to reflect the extent to which the target goals were exceeded as deemed appropriate by the Compensation Committee. For Drs. Ando and Gregory, 20% of the
target bonus payable was conditioned on the achievement of individual performance objectives. The maximum achievement for Drs. Ando and Gregory&#146;s individual performance objectives was 125% target, or $38,281 and $26,951, respectively.
</FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Reflects the potential payouts under the Company&#146;s non-equity incentive plan based on the Company&#146;s attainment of certain research and development,
operational and financial goals at target level. Also reflected for Drs. Ando and Gregory is the achievement of certain individual goals at target level. For more information regarding the non-equity incentive plan, please see the section entitled
&#147;Cash Incentive Bonus for 2013&#148; in the Company&#146;s Compensation Discussion and Analysis. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">The reported option was granted under the Company&#146;s 2013 Stock Incentive Plan and will vest and become exercisable in accordance with the following schedule:
twenty-five percent of the option shares will vest and become exercisable on the one year anniversary of the option grant date and the remaining option shares will vest and become exercisable in thirty-six equal monthly installments over the
thirty-six month period measured from the first anniversary of the option grant date, provided the optionee continues to provide services to the Company through each applicable vesting date. </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">The reported stock option and RSU awards granted to Mr.&nbsp;Lanphier will immediately vest in whole or in part on an accelerated basis upon a change in control of the
Company or upon the termination of his employment with the Company under certain circumstances, as described in the section below entitled &#147;Employment Contracts and Change in Control Agreements.&#148; </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">The reported stock option and RSU awards granted to Mr.&nbsp;Wolff and Dr.&nbsp;Nichol will immediately vest on an accelerated basis upon the termination of their
employment with the Company in connection with a change in control of the Company, as described under the heading &#147;Employment Contracts and Change in Control Agreements.&#148; </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents an RSU award granted under the Company&#146;s 2013 Stock Incentive Plan. The units are structured to vest in three successive equal annual installments over
the 3-year period measured from the grant date, provided the executive officer continues to provide services to the Company through each applicable vesting date. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">37 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Outstanding Equity Awards at Year-End </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table provides certain summary information concerning outstanding equity awards held by the named executive officers as of
December&nbsp;31, 2013. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options (#)<BR>Exercisable</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options (#)<BR>Unexercisable<BR>(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Exercise<BR>Price<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Expiration<BR>Date</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number<BR>of<BR>Shares<BR>or units<BR>of stock<BR>that<BR>have&nbsp;not<BR>vested<BR>(#)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Market<BR>Value of<BR>shares<BR>or<BR>units of<BR>stock<BR>that<BR>have
not<BR>vested<BR>($)&nbsp;(7)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:9pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(b)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(e)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(f)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(g)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ROWSPAN="6"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Edward O. Lanphier II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)(2)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,041,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">150,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/11/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">120,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)(2)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,666,800</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">62,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">187,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/05/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6)(2)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,389,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">225,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.70</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/08/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">300,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/07/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">350,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3.45</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/10/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">250,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">13.98</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">200,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.82</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/13/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">150,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4.11</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/20/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.39</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4/22/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" ROWSPAN="10"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">H. Ward Wolff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">35,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">486,150</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/11/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">416,700</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">22,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">67,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/05/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6)(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">694,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">112,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">37,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.70</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/08/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">200,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/07/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">212,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3.45</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/10/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">300,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">14.27</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/03/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.28</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">06/07/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.73</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">06/07/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ROWSPAN="6"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Geoffrey M. Nichol, M.B., Ch.B.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">35,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">486,150</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/11/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">36,666</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">509,291</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">27,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">82,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/05/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6)(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">694,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">181,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">118,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.94</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">07/11/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" ROWSPAN="9"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Dale G. Ando, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">23,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">319,470</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">46,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/11/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">23,333</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">324,095</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">17,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">52,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/05/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">33,333</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">462,995</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.70</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/08/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/07/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">179,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3.45</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/10/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">13.98</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.82</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/13/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4.11</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/20/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ROWSPAN="11"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Philip D. Gregory, D. Phil.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">35,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">486,150</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/11/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">26,666</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">370,391</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">20,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">60,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/05/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">33,333</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">462,995</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.70</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/08/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/07/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">78,709</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3.45</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/10/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">90,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">13.98</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.82</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/13/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">15,791</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4.11</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">38 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Each of the options reported above as being wholly or partially unexercisable for the underlying shares of the Company&#146;s common stock will vest and become
exercisable for the total number of shares subject to that option at the time of grant as follows: twenty-five percent of the total number of option shares on the one year anniversary of the option grant date and the balance of the option shares in
thirty-six successive equal monthly installments over the thirty-six month period measured from the first anniversary of the option grant date, provided the optionee continues in the Company&#146;s service through each applicable vesting date.
Accordingly, the vesting schedule for the unexercisable options reported for each named executive officer is determined by applying such vesting schedule to the total number of shares for which each such option was granted. The table below indicates
the total number of shares for which each such reported option was granted and the number of shares for which that option has been exercised prior to January&nbsp;1, 2014. Each option listed below corresponds to the option in the above table that
has an expiration date ten (10)&nbsp;years later than the grant date of the option listed below: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="62%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option&nbsp;Grant<BR>Date</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total<BR>Number&nbsp;of<BR>Option<BR>Shares on<BR>Grant&nbsp;Date</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number<BR>of Option<BR>Shares<BR>Exercised<BR>Before<BR>January&nbsp;1,<BR>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Edward O. Lanphier II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/08/10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">300,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/06/12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">250,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">150,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">H. Ward Wolff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/08/10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">150,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/06/12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">90,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Geoffrey M. Nichol, M.B., Ch.B.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">07/11/11</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">300,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/06/12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">110,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Dale G. Ando, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/08/10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/06/12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">46,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Philip D. Gregory, D. Phil.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/08/10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/06/12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">80,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Each of these awards will vest on an accelerated basis upon a change in control of the Company, as described under the heading &#147;Employment Contracts and Change in
Control Agreements.&#148; </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Each of these awards will vest on an accelerated basis upon termination of employment with the Company under certain circumstances in connection with a change in
control of the Company, as described under the heading &#147;Employment Contracts and Change in Control Agreements.&#148; </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents an RSU award granted on December&nbsp;12, 2013. The units are structured to vest in three successive equal annual installments over the 3-year period
measured from the grant date, provided the executive officer continues to provide services to the Company through each applicable vesting date. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents an RSU award granted on December&nbsp;6, 2012. The units are structured to vest in three successive equal annual installments over the 3-year period measured
from the grant date, provided the executive officer continues to provide services to the Company through each applicable vesting date. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents an RSU award granted on December&nbsp;8, 2011. The units awarded in December 2011 are structured to vest in two installments over the executive
officer&#146;s period of continued service: one-third of the shares vest on the second anniversary of the award date, and the remaining two-thirds of the shares vest on the third anniversary of the award date. </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Based on the $13.89 closing price of the Company&#146;s common stock on December&nbsp;31, 2013. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">39 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Option Exercises and Stock Vested </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth for each of the named executive officers the number of shares of the Company&#146;s common stock acquired
and the value realized upon the vesting of RSU awards and on each exercise of stock options during the year ended December&nbsp;31, 2013; no other named executive officer exercised any stock options or held any RSUs that vested during the 2013 year.
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="40%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of<BR>Shares&nbsp;Acquired<BR>on Exercise (#)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value&nbsp;Realized<BR>on&nbsp;Exercise&nbsp;($)&nbsp;(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of<BR>Shares&nbsp;vested<BR>(#)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Market&nbsp;Value&nbsp;of<BR>shares&nbsp;or&nbsp;units&nbsp;of<BR>stock&nbsp;that&nbsp;have<BR>vested&nbsp;
($) (2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:9pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(b)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(e)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward O. Lanphier II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">311,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">110,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,333,200</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H. Ward Wolff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">88,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">626,980</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">484,800</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geoffrey M. Nichol, M.B., Ch.B.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">43,334</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">525,208</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dale G. Ando, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">161,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,065,146</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">28,334</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">343,408</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Philip D. Gregory, D. Phil</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">123,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">716,136</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30,001</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">363,612</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Value realized is determined by multiplying (i)&nbsp;the amount by which the market price of the common stock on the date of exercise exceeded the exercise price by
(ii)&nbsp;the number of shares for which the options were exercised. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Value realized is determined by multiplying the number of shares of common stock vested on the date of vesting by the market price of the common stock on such date.
</FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Pension Benefits </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Company does not sponsor a tax-qualified defined benefit retirement plan or a supplemental executive retirement plan. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Nonqualified Deferred Compensation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company does not sponsor a
nonqualified deferred compensation plan. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Risk Assessment of Compensation Policies and Practices </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company&#146;s compensation programs throughout the organization are designed to maintain an appropriate balance between long-term and
near-term incentives by utilizing a combination of compensation components, including base salary, annual cash incentive awards, and long-term equity awards. Although not all employees in the organization may have compensation comprised of all three
of those components, the compensation programs are generally structured so that any near-term cash incentives are not likely to constitute the predominant element of an employee&#146;s total compensation. For this reason, the Company does not
believe that its near-term incentive compensation programs are reasonably likely to encourage excessive risk-taking by the participants in those programs. For a discussion of the primary components of the compensation for the Company&#146;s
executive officers and the Company&#146;s risk assessment of the compensation programs for its executive officers, please see the section above entitled &#147;Executive Compensation and Related Information &#151; Compensation Discussion and
Analysis&#148; including the section &#147;Allocations between Base Salary, Cash Incentive Bonus and Equity Compensation for Executives and Risk Taking.&#148; </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">40 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Equity Compensation Plan Information </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table provides information as of December&nbsp;31, 2013 with respect to the shares of the Company&#146;s common stock that
may be issued under the Company&#146;s existing equity compensation plans. There are no outstanding options that the Company has assumed in connection with its acquisition of other companies, and there are currently no assumed plans under which the
Company can grant options. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Column (A)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Column (B)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Column (C)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:49pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Plan Category</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities&nbsp;to&nbsp;be<BR>Issued Upon<BR>Exercise
of<BR>Outstanding&nbsp;Options,<BR>Restricted&nbsp;Stock&nbsp;Units<BR>and Other Rights</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Weighted&nbsp;Average<BR>Exercise Price of<BR>Outstanding&nbsp;Options</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of&nbsp;Securities<BR>Remaining&nbsp;Available&nbsp;for<BR>Future Issuance
Under<BR>Equity&nbsp;Compensation<BR>Plans<BR>(Excluding Securities<BR>Reflected in Column A)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Equity Compensation Plans Approved by Stockholders&nbsp;(1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,469,521</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,457,353</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)(6)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Equity Compensation Plans Not Approved by Stockholders</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,469,521</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,457,353</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consists of the 2013 Stock Incentive Plan (the &#147;2013 Plan&#148;) and the 2010 Employee Stock Purchase Plan (the &#147;Purchase Plan&#148;).
</FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 1,063,750 shares subject to RSUs that will entitle the holder to one share of common stock for each unit that vests over the holder&#146;s period of continued
service with the Company. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Excludes purchase rights accruing under the Purchase Plan with a stockholder-approved reserve of 2,100,000&nbsp;shares. Under the Purchase Plan, each eligible employee
may purchase up to 2,000&nbsp;shares of common stock at semi-annual intervals on the last U.S.&nbsp;business day of April and October each year at a purchase price per share equal to 85% of the lower of (i)&nbsp;the closing selling price per share
of common stock on the employee&#146;s entry date into the two-year offering period in which that semi-annual purchase date occurs or (ii)&nbsp;the closing selling price per share on the semi-annual purchase date. </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The calculation does not take into account the 1,063,657 shares of common stock subject to outstanding RSUs. Such shares will be issued at the time the RSUs vest,
without any cash consideration payable for those shares. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consists of shares available for future issuance under the Purchase Plan and the 2013 Plan. As of December&nbsp;31, 2013, 1,527,763 shares of common stock were
available for issuance under the Purchase Plan, and 2,929,590 shares of common stock were available for issuance under the 2013 Plan. The 2,929,590 shares available for issuance under the 2013 Plan may be issued upon the exercise of stock options or
stock appreciation rights granted under discretionary grant and automatic option grant programs, or those shares may be issued under the stock issuance program as stock bonuses or pursuant to restricted stock awards or RSUs which vest upon the
attainment of prescribed performance milestones or the completion of designated service periods. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The total number of shares of common stock reserved for issuance under the 2013 Plan is 4,457,353. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">41 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Employment Contracts and Change in Control Arrangements </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Chief Executive Officer Employment Agreement </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In June 2011, the Company entered into an amended and restated employment agreement with Edward&nbsp;O.&nbsp;Lanphier II, our President and Chief Executive Officer. Pursuant to the terms of the agreement,
Mr.&nbsp;Lanphier will receive an annual base salary and a potential cash bonus, each in an amount or at a rate determined annually by the Compensation Committee. In the event (a)&nbsp;Mr.&nbsp;Lanphier terminates his employment due to a material
reduction of his duties, responsibilities or authority, a material reduction in his base salary (except pursuant to certain pay reductions uniformly applied to the Company&#146;s management) or a relocation of his principal place of employment to a
location more than 40 miles from his home and from the Company&#146;s headquarters, (b)&nbsp;Mr.&nbsp;Lanphier is terminated by the Company without cause, or (c)&nbsp;Mr.&nbsp;Lanphier&#146;s employment agreement is not assumed or otherwise
continued in effect by the acquiring entity following a change in control of the Company, he will be entitled to receive the following severance benefits, provided he timely executes a general release of claims against the Company, which becomes
effective and enforceable: (i)&nbsp;a lump sum cash payment in an amount equal to the sum of (a)&nbsp;two times his annual base salary at the rate in effect on his termination date, (b)&nbsp;a prorated portion of Mr.&nbsp;Lanphier&#146;s target
bonus for the year of termination based upon the time elapsed between December&nbsp;31 of the preceding year and his termination date, and (c)&nbsp;his target bonus for the year in which such termination occurs; (ii)&nbsp;reimbursement of his health
care coverage costs under COBRA for a period of twelve months; (iii)&nbsp;an additional twenty-four months of service vesting credit for each of his stock options outstanding at the time of his termination, and all of his vested options will remain
exercisable for up to a three-year period measured from his termination date; and (iv)&nbsp;the Company will provide him with certain information technology services for up to a twenty-four month period. Upon a change in control of the Company all
of Mr.&nbsp;Lanphier&#146;s outstanding stock options will vest in full, and such options will remain exercisable for all the option shares for up to a three-year period measured from the date of the change of control or (if later), his termination
date. Mr.&nbsp;Lanphier&#146;s severance benefits will be subject to reduction to the extent doing so would put him in a better after-tax position after taking into account any excise tax he may incur under Internal Revenue Code Section&nbsp;4999 in
connection with any change in control of the Company or his subsequent termination of employment. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Executive Vice President Employment
Agreements </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In November 2007, the Company entered into an employment agreement with H. Ward Wolff, our Executive Vice
President and Chief Financial Officer, which was amended and restated in December 2008 and December 2011 in order to implement technical changes. Pursuant to the terms of the agreement, Mr.&nbsp;Wolff&#146;s annual base salary is set at a minimum of
$375,000, subject to adjustment by the Compensation Committee from time to time, and he is eligible to receive a bonus of up to 40% of his base salary each calendar year. However, the bonus will be payable only upon the achievement of specific
performance criteria to be established by the Compensation Committee. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In July 2011, the Company entered into an employment
agreement with Dr.&nbsp;Geoffrey&nbsp;M. Nichol, our Executive Vice President, Research and Development. Pursuant to the terms of the Employment Agreement, Dr.&nbsp;Nichol&#146;s annual base salary is set at a minimum of $425,000, subject to
adjustment by the Compensation Committee from time to time, and he is eligible to receive a bonus of up to 40% of his base salary for his performance each calendar year. The bonus will be based upon the achievement of specific performance criteria
to be established by the Compensation Committee. In addition, Dr.&nbsp;Nichol received a sign-on bonus in the amount of $150,000, which he was required to repay to the Company in the event his employment had been terminated by the Company for cause
or in the event he had voluntarily terminated his employment other than for good reason prior to June&nbsp;17, 2013. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant
to the terms of the employment agreements with Mr.&nbsp;Wolff and Dr.&nbsp;Nichol, if the Company terminates Mr.&nbsp;Wolff&#146;s or Dr.&nbsp;Nichol&#146;s employment without cause, or Mr.&nbsp;Wolff or Dr.&nbsp;Nichol terminates his employment for
good reason, within 12 months following a change in control and Mr.&nbsp;Wolff or Dr.&nbsp;Nichol executes a general release of all claims in favor of the Company, then Mr.&nbsp;Wolff or Dr.&nbsp;Nichol will receive the
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">42 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
following severance benefits: (i)&nbsp;a severance payment equal to his annual base salary in effect on his termination date plus his target bonus for the year in which such termination occurs,
(ii)&nbsp;for Mr.&nbsp;Wolff, reimbursement of his health care coverage costs under COBRA for up to twelve months, and for Dr.&nbsp;Nichol, a lump-sum cash payment in the amount of $25,000, (iii)&nbsp;accelerated vesting of all of his outstanding
equity awards and (iv)&nbsp;for Mr.&nbsp;Wolff, a one-year period measured from his termination date to exercise any outstanding options for all the option shares, but in no event will any such option remain exercisable following the expiration of
the maximum option term. If the Company terminates Mr.&nbsp;Wolff&#146;s or Dr.&nbsp;Nichol&#146;s employment without cause, or Mr.&nbsp;Wolff or Dr.&nbsp;Nichol terminates his employment for good reason, in the absence of a change in control or
more than 12 months after a change in control and Mr.&nbsp;Wolff or Dr.&nbsp;Nichol executes a general release of all claims in favor of the Company, then Mr.&nbsp;Wolff or Dr.&nbsp;Nichol will receive (i)&nbsp;salary continuation payments for a
twelve month period following his termination date at his rate of base salary in effect on his termination date and (ii)&nbsp;for Mr.&nbsp;Wolff, reimbursement of his health care coverage costs under COBRA for up to twelve months, and for
Dr.&nbsp;Nichol, a lump-sum cash payment in the amount of $25,000. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>2013 Plan </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee of the Board of Directors, as the administrator of the 2013 Plan, has the authority to provide that any
outstanding options held by the Chief Executive Officer or any other executive officer or any other unvested equity award made to such individual under the 2013 Plan will vest on an accelerated basis in connection with certain changes in control of
the Company or the subsequent termination of the officer&#146;s employment following the change in control event. In addition, all outstanding options and RSUs under the Company&#146;s 2013 Plan will immediately vest upon a change in control, to the
extent not assumed or continued in effect by the successor entity or replaced with a incentive compensation program which preserves the intrinsic value of the award at that time and provides for the subsequent vesting and concurrent payout of that
value in accordance with the pre-existing vesting schedules for those awards. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">RSUs awarded to Mr.&nbsp;Lanphier on
December&nbsp;8, 2011, December&nbsp;6, 2012 and December&nbsp;12, 2013, provide that in the event (a)&nbsp;Mr.&nbsp;Lanphier terminates his employment due to a material reduction of his duties, responsibilities or authority, a material reduction in
his base salary (except pursuant to certain pay reductions uniformly applied to the Company&#146;s management) or a relocation of his principal place of employment to a location more than 40 miles from his home and from the Company&#146;s
headquarters, or (b)&nbsp;Mr.&nbsp;Lanphier is terminated by the Company without cause Mr.&nbsp;Lanphier will receive an additional 24 months of service vesting credit under each outstanding RSU award, and the RSUs that vest as a result will become
issuable at such time. In addition, upon a change in control of the Company all of Mr.&nbsp;Lanphier&#146;s outstanding RSUs under his December&nbsp;8, 2011, December&nbsp;6, 2012 and December&nbsp;12, 2013 award will vest in full, and will become
issuable at such time. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In connection with Mr.&nbsp;Wolff&#146;s appointment as Executive Vice President and Chief Financial
Officer, the Company amended the existing stock options for 60,000 shares that he received in connection with his service as a non-employee Board member so that those options will remain outstanding and continue to vest during his continued service
as an employee of the Company or as a consultant. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Incentive Compensation Plan </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company&#146;s Incentive Compensation Plan (the &#147;Incentive Plan&#148;) is a performance-based cash bonus program for the
Company&#146;s executive officers. Pursuant to the terms of the Incentive Plan, should a change in control transaction be consummated prior to the completion of a performance period that has been implemented under the Incentive Plan, then the
performance period will terminate upon the consummation of that change in control and each participant in the Incentive Plan will receive a bonus in the dollar amount previously set by the Compensation Committee at target level attainment of each
performance objective; however such bonus will be pro-rated to reflect each participant&#146;s actual period of service from the start date of the performance period through the effective date of the change in control. Any pro-rated bonus paid
pursuant to the terms of the Incentive Plan will reduce the amount of any severance payable to the participant based on the participant&#146;s target bonus pursuant to the terms of any employment agreement. The 2013 bonus program adopted for the
2013 </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">43 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
year under the Incentive Plan is summarized in detail under the heading &#147;Cash Incentive Bonus for 2013&#148; in the Compensation Discussion and Analysis section of this Proxy Statement.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Quantification of Benefits </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The charts below quantify the potential payments our executive officers would receive under various scenarios. The value attributed to the accelerated vesting of equity awards represents the intrinsic
value of each stock option or RSU award vesting on an accelerated basis in connection with the identified triggering event, which is assumed to occur on December&nbsp;31, 2013. The intrinsic value is calculated by multiplying (i)&nbsp;the aggregate
number of shares which vest on an accelerated basis by (ii)&nbsp;the amount by which the $13.89 closing selling price per share of the Company&#146;s common stock on December&nbsp;31, 2013 exceeds the exercise price or other issue price (if any)
payable per vested share. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Quantification of Benefits Upon Termination in the Absence of a Change in Control </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The chart below quantifies the compensation Mr.&nbsp;Lanphier, Mr.&nbsp;Wolff and Dr.&nbsp;Nichol would have each received had their
employment terminated in the absence of a change in control of the Company but under circumstances entitling them to severance benefits under their employment agreements: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="43%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Salary<BR>Continuation</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Pro Rated<BR>Bonus</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Other&nbsp;Lump-<BR>Sum Cash<BR>Payment</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>COBRA</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Accelerated<BR>Vesting of<BR>Equity<BR>Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Information<BR>Technology<BR>Services</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward O. Lanphier II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,280,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">768,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">33,881</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,272,050</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,400</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H. Ward Wolff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">400,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26,972</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geoffrey M. Nichol, M.B.,Ch.B.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">453,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Quantification of Benefits Upon a Change in Control </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The chart below quantifies the compensation Mr.&nbsp;Lanphier would have received pursuant to his employment agreement upon a change in
control of the Company in which his outstanding equity awards and his employment agreement are assumed or otherwise continued in effect. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="79%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Accelerated&nbsp;Equity</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward O. Lanphier II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,282,050</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The chart below quantifies the value of the accelerated equity the named executive officers are entitled
to receive upon a change in control of the Company in which their outstanding equity awards are not assumed or otherwise continued in effect. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="79%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Accelerated&nbsp;Equity</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward O. Lanphier II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,282,050</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H. Ward Wolff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,008,330</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geoffrey M. Nichol, M.B.,Ch.B.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,131,641</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dale G. Ando, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,252,841</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Philip D. Gregory, D. Phil.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,124,494</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The chart below quantifies the cash award each named executive officer would have received under the
Incentive Plan for the 2013 year in connection with a change in control of the Company on the assumed date: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="77%"></TD>
<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Incentive&nbsp;Plan&nbsp;Award</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward O. Lanphier II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">384,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H. Ward Wolff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">160,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geoffrey M. Nichol, M.B., Ch.B.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">204,075</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dale G. Ando, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">153,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Philip D. Gregory, D. Phil.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">134,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">44 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Quantification of Benefits Upon Termination in Connection With a Change in Control </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The chart below quantifies the payments Mr.&nbsp;Lanphier, Mr.&nbsp;Wolff and Dr.&nbsp;Nichol would each have received had their
employment terminated in connection with a change in control under circumstances entitling them to severance benefits under their employment agreements. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="43%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Salary<BR>Continuation</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Pro Rated<BR>Bonus (1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Other&nbsp;Lump-<BR>Sum Cash<BR>Payment</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Accelerated<BR>Vesting of<BR>Equity<BR>Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>COBRA</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Information<BR>Technology<BR>Services</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward O. Lanphier II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,280,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">384,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,282,050</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">33,881</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,400</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H. Ward Wolff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">400,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,008,330</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26,972</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geoffrey M. Nichol, M.B.,Ch.B.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">453,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,131,641</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The pro-rated bonus paid pursuant to the terms of the Incentive Plan (as quantified in the chart above) will reduce the amount of any severance payable based on the
participant&#146;s target bonus pursuant to the terms of any employment agreement. The amounts reflected in the chart reflect the payments as reduced. </FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Board Compensation Committee Report on Executive Compensation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis contained in this Proxy Statement with management, and based on such review and such discussions, the Compensation Committee recommended to the Board of
Directors that the Compensation Discussion and Analysis, as contained herein, be included in this Proxy Statement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Submitted by the Compensation </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Committee of the Board of
Directors </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Mento </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Larson </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Ringo </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Board Audit Committee Report </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>The information contained in this report shall not be deemed to be &#147;soliciting material&#148; or to be &#147;filed&#148; with the
Securities and Exchange Commission, nor shall such information be incorporated by reference into any future filings with the Securities and Exchange Commission, or subject to the liabilities of Section&nbsp;18 of the Securities Exchange Act of 1934,
as amended, except to the extent that the Company specifically incorporates it by reference into a document filed under the Securities Act of 1933, as amended, or Securities Exchange Act of 1934, as amended. </I></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following is the report of the Audit Committee with respect to the Company&#146;s audited financial statements for the year ended
December&nbsp;31, 2013, included in the Annual Report on Form&nbsp;10-K for that year. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee has reviewed and
discussed the audited financial statements for the year ended December&nbsp;31, 2013 with the management of the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Audit Committee has discussed with Sangamo&#146;s independent registered public accounting firm, Ernst&nbsp;&amp; Young LLP, the matters required to be discussed by Public Company Accounting Oversight Board (PCAOB) Auditing Standard No.&nbsp;16,
<I>Communications with Audit Committees,&#148;</I> or any successor standard. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee has received the written
disclosures and the letter from Ernst&nbsp;&amp; Young LLP required by applicable requirements of the Public Company Accounting Oversight Board regarding Ernst&nbsp;&amp; Young LLP&#146;s communications with the Audit Committee concerning
independence, and has discussed with Ernst&nbsp;&amp; Young LLP its independence from Sangamo. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">45 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based on the review and discussions referred to above in this report, the Audit Committee
recommended to Sangamo&#146;s Board of Directors that the audited financial statements be included in Sangamo&#146;s Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2013 for filing with the Securities and Exchange Commission.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Submitted by the Audit </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Committee of the Board of Directors </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Cleveland </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Dilly </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Mento </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ms.&nbsp;Ramasastry </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition to the
indemnification provisions contained in Sangamo&#146;s Restated Certificate of Incorporation and Bylaws, Sangamo has entered into separate indemnification agreements with each of its directors and officers containing provisions which may require
Sangamo, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as officers or directors. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>POLICIES AND PROCEDURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consistent with the requirement under NASDAQ
listing rules, the Audit Committee of the Board of Directors is responsible for reviewing and approving all related party transactions as defined under SEC rules and regulations. While we do not have a formal written policy or procedure for the
review, approval or ratification of related party transactions, the Audit Committee must review the material facts of any such transaction and approve that transaction. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">To identify related party transactions, each year we submit and require our directors and officers to complete director and officer questionnaires identifying transactions with the Company in which the
director or officer or their family members have a conflict of interest. The Company reviews the questionnaire for potential related party transactions. In addition, at meetings of the Audit Committee, management may recommend related party
transactions to the committee, including the material terms of the proposed transactions, for its consideration. In making its decision to approve or ratify a related party transaction, the Audit Committee will consider all relevant facts and
circumstances available to the committee, including factors such as the aggregate value of the transaction, whether the terms of the related party transaction are no less favorable than terms generally available in an arms&#146; length transaction
and the benefit of such transaction to us. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SECTION&nbsp;16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The members of the Board of Directors, the executive officers of the Company and persons who beneficially own more than ten percent of
the outstanding common stock are subject to the reporting requirements of Section&nbsp;16 of the Securities Exchange Act of 1934, as amended, which require them to file reports with respect to their beneficial ownership of the common stock and their
transactions in such common stock. Based upon (i)&nbsp;the copies of Section&nbsp;16 reports which the Company received from such persons for their 2013 year transactions in the common stock and their common stock holdings, and (ii)&nbsp;written
representation that no other reports were required, the Company believes that all reporting requirements under Section&nbsp;16 for such year were met in a timely manner by its directors, executive officers and greater than ten percent beneficial
owners, except that Edward O. Lanphier II. filed one late Form 4 covering one reportable transaction. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">46 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Company&#146;s Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31,
2013 has been provided concurrently with the Notice of Annual Meeting and Proxy Statement to all stockholders entitled to notice of and to vote at the Annual Meeting. The Annual Report on Form&nbsp;10-K is not incorporated into this Proxy Statement
and is not considered proxy soliciting material. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">THE BOARD OF DIRECTORS OF </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">SANGAMO BIOSCIENCES, INC. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Dated: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2014 </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">47 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Appendix A </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>CERTIFICATE OF AMENDMENT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>OF </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SEVENTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SANGAMO BIOSCIENCES, INC. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Sangamo BioSciences, Inc., a Delaware corporation (the &#147;Corporation&#148;), hereby certifies as follows: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">1. That the Corporation&#146;s Board of Directors has duly adopted the following resolution to amend the Corporation&#146;s Seventh Amended and Restated Certificate of Incorporation, as amended:
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">RESOLVED, that the Seventh Amended and Restated Certificate of Incorporation of the Corporation, as amended shall be amended
as follows: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Article IV, Paragraph A, shall be amended and restated as follows: </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A. Classes of Stock. The total number of shares of stock which the Corporation shall have authority to issue is one hundred sixty-five
million (165,000,000), consisting of five million (5,000,000) shares of Preferred Stock, par value $0.01 per share (the &#147;Preferred Stock&#148;), and one hundred sixty million (160,000,000) shares of Common Stock, par value $0.01 per share (the
&#147;Common Stock&#148;). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Corporation has caused this Certificate of Amendment of the Seventh Amended and Restated
Certificate of Incorporation to be signed by the Corporation&#146;s President, its authorized officer, on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2014. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SANGAMO BIOSCIENCES, INC.</B> </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR>
<TD VALIGN="top"></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Name: Edward O. Lanphier III</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Title: &nbsp;&nbsp;President, Chief Executive Officer and Director</FONT></TD></TR>
</TABLE></DIV>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD></TR>


<TR>
<TD VALIGN="bottom" COLSPAN="3" ROWSPAN="6">


<IMG SRC="g672020pc_pg001a.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3">


<IMG SRC="g672020pc_pg001b.jpg" ALT="LOGO">
</TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Electronic Voting Instructions</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Available 24 hours a day, 7 days a
week!</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1">Instead of mailing your proxy, you may choose one of
the voting methods outlined below to vote your proxy.</FONT></P></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="1">VALIDATION DETAILS ARE LOCATED BELOW IN THE TITLE BAR.</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Proxies submitted by the Internet or telephone must be received by 1:00 a.m., Central Time, on April 21, 2014.</B></FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="middle" ROWSPAN="4">


<IMG SRC="g672020pc_pg001c.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Vote by Internet</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;&#149;&nbsp;&nbsp;Go to <B>www.envisionreports.com/SGMO</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;&#149;&nbsp;&nbsp;Or scan the QR code with your
smartphone</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;&#149;&nbsp;&nbsp;Follow the steps outlined on the
secure website</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Vote by telephone</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;&#149;&nbsp;&nbsp;Call toll free 1-800-652-VOTE (8683)&nbsp;within the USA,</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;US territories&nbsp;&amp; Canada on a touch tone</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT
STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;telephone</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;&#149;&nbsp;&nbsp;Follow the instructions provided by the recorded message</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Using a <B><U>black ink</U></B> pen, mark your votes with an <B>X</B> as shown in this example. Please do not write outside the designated areas.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="7"></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="6"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT><FONT STYLE="font-family:Times New Roman" SIZE="7"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g672020pc_pg001d.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="98%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>


<TR>
<TD VALIGN="top" COLSPAN="5" STYLE="BORDER-BOTTOM:1px dashed #000000">
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B></B><FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#113;</FONT><B></B><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IF YOU HAVE NOT VOTED VIA THE
INTERNET <U>OR</U> TELEPHONE, FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#113;</FONT><B></B><B></B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:1px" align="left"><FONT SIZE="1">&nbsp;</FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000" BGCOLOR="#000000"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#ffffff">A</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Proposals &#151; The Board of Directors recommends a vote <U>FOR</U> all the nominees listed and <U>FOR</U> Proposals 2, 3 and 4.</B></FONT></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="11%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR>
<TD VALIGN="bottom" COLSPAN="23"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">1.&nbsp;&nbsp;&nbsp;To elect seven directors to serve on the Board of Directors for a one-year term ending at the
Annual Meeting held in 2015 or until their successors are duly elected and qualified:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="5">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="5">&#43;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="5">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;Nominees:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Withhold</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Withhold</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Withhold</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="white-space:nowrap">01&nbsp;-&nbsp;Edward&nbsp;O.&nbsp;Lanphier&nbsp;II</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="white-space:nowrap">02&nbsp;-&nbsp;Paul&nbsp;B.&nbsp;Cleveland</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">03 - Stephen G. Dilly,</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT
STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;M.B.B.S., Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD COLSPAN="3" VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="1">04 - John W. Larson</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="white-space:nowrap">05&nbsp;-&nbsp;Steven&nbsp;J.&nbsp;Mento,&nbsp;Ph.D.</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">06 - Saira Ramasastry</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="white-space:nowrap">07&nbsp;-&nbsp;William</FONT> R. Ringo</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD></TR>

<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Against</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Abstain</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Against</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Abstain</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="7"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">2.&nbsp;&nbsp;&nbsp;Say on Pay - An advisory vote on the approval of executive compensation.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="4"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-left:1.00em; text-indent:-1.00em;"><FONT STYLE="font-family:Times New Roman" SIZE="1">3.&nbsp;&nbsp;&nbsp;To&nbsp;approve an amendment to our Certificate of Incorporation to increase the number of
authorized shares of common stock from 80,000,000 to 160,000,000 shares.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="4"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD></TR>
<TR>
<TD COLSPAN="7" VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="5" VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD></TR>
<TR>
<TD COLSPAN="7" VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-left:1.00em; text-indent:-1.00em;"><FONT STYLE="font-family:Times New Roman" SIZE="1">4.&nbsp;&nbsp;&nbsp;To&nbsp;ratify the appointment of Ernst &amp; Young LLP as our independent registered public
accounting firm for the year ending December&nbsp;31,&nbsp;2014.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="4"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000" BGCOLOR="#000000"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#ffffff">B</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Non-Voting Items</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Change of Address</B> &#151; Please print new address below.</FONT></P>
<P STYLE="font-size:2px;margin-top:0px;margin-bottom:1px"><FONT SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Meeting Attendance&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR>
<TD COLSPAN="23" VALIGN="bottom" STYLE="BORDER:1px solid #000000; padding-left:8px"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="9"><FONT STYLE="font-family:Times New Roman" SIZE="1">Mark box to the right if you plan to attend the Annual&nbsp;Meeting.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="5"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="5"><FONT STYLE="FONT-FAMILY:WINGDINGS"></FONT>&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="5"><FONT STYLE="FONT-FAMILY:WINGDINGS"></FONT>&nbsp;&nbsp;</FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="18%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="75%"></TD></TR>


<TR>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000" BGCOLOR="#000000"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#ffffff">C</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="9"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Authorized Signatures &#151; This section must be completed for your vote to be counted. &#151; Date and Sign Below</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">NOTE: PLEASE SIGN EXACTLY AS NAME APPEARS HEREON. JOINT OWNERS SHOULD EACH SIGN. WHEN SIGNING AS ATTORNEY, EXECUTOR,
ADMINISTRATOR, TRUSTEE OR GUARDIAN, GIVE FULL NAME AND TITLE AS SUCH. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Date (mm/dd/yyyy) &#151; Please print date below.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Signature 1 &#151; Please keep signature within the box.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Signature&nbsp;2&nbsp;&#151;&nbsp;Please&nbsp;keep&nbsp;signature&nbsp;within&nbsp;the&nbsp;box.</FONT></TD></TR>
<TR>
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="6">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g672020pc_pg001e.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="font-size:120px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:120px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD></TR>


<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B></B><FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#113;</FONT><B></B><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IF YOU HAVE NOT VOTED VIA THE INTERNET <U>OR</U> TELEPHONE,
FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#113;</FONT><B></B><B></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-size:1px">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px dashed #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD></TR>

<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="5" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="4"><B>Proxy &#151; Sangamo BioSciences, Inc.</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:1px"><FONT SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>PROXY SOLICITED BY THE BOARD OF
DIRECTORS</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>FOR THE ANNUAL MEETING OF STOCKHOLDERS, APRIL 21, 2014</B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The undersigned hereby appoints Edward O. Lanphier II and H. Ward Wolff and each of
them, as proxies of the undersigned, with full power of substitution, to vote all shares of Sangamo BioSciences, Inc. Common Stock which the undersigned is entitled to vote on all matters which may properly come before the 2014 Annual Meeting of
Stockholders of Sangamo BioSciences, Inc., to be held at 501 Canal Boulevard, Richmond, California 94804 on April 21, 2014 at 9.00 a.m. PDT or at any postponement or adjournment thereof.</FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE SHARES REPRESENTED BY THIS PROXY CARD WILL BE VOTED AS SPECIFIED ON THE
REVERSE SIDE, BUT IF NO SPECIFICATION IS MADE THEY WILL BE VOTED FOR ALL NOMINEES, FOR PROPOSALS 2, 3 AND 4 AND AT THE DISCRETION OF THE PROXY ON ANY OTHER MATTER THAT MAY PROPERLY COME BEFORE THE MEETING.</B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(SEE PROXY STATEMENT FOR DISCUSSION OF ITEMS)</B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ACCOMPANYING
ENVELOPE.</B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CONTINUED AND TO BE SIGNED ON REVERSE
SIDE</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g672020pc_pg001a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g672020pc_pg001a.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`]`%W`P$1``(1`0,1`?_$`.X``0`!`P4!`0``````
M```````)`0<(`@0%!@H#"P$!``$$`P$```````````````$"!`4&`P<("1``
M``8"`0(#`P8(!@T%"@\``0(#!`4&``<($1(A$PDQ%!5!(B,6%PI187$R))76
M:8&1L4(8F*'!T3,E528G5]=8&9E#T]0U-O#A4E,T5J8W*3EUA<751H:VQD=W
ME[<H.-@1``$#`P,"`P4$`@P+!0<%``$``@,1!`4A$@8Q$T$B!U%A,A0(<2,5
M%H%"D:%28I)3TR14E)87\-%RTC-#D]0F5ABQX7,TU8*BXD1D)565-G;65__:
M``P#`0`"$0,1`#\`]_&$3")A$PB81,(F$3")A$PBX:?L,!5(A[8+1.P];@8Q
M(7$C-S\DQAXB/0`0`5GLE(K-V;1$!'H)E#E#Q]N$49OJ!>KYQ#].?7>MMC[=
MD;I>XC<99P-5GTU74K[%6YQ`H-5W::5M;2#:HL$U$WI3)F4>BHLF14R1%`24
M[8)`ZHHUV?W@?9^Y_3IY5<_>,_!.VOZQQSV%7*9'L]DWEN=O<H18B1MAWA"-
MK<.UD"1FLC/&J;ULBX4.LJJ<"J%\DXY!=Y:A%;+TBO7%Y9<XR\M.1?)ZK<>]
M.\,N(6LG%MOLM08*Z.K>]GG,5*6%BPBY.PW>29JM(ZN0+QPXZ-SJ++>2B3L%
M7J$-<36J*+>S^O=ZYW,&P["W7Z?_`!?EH;BWKZ6D$4FL%IB#VDY+$1AO>@3N
MUILY_?)BT?#3IJ/FM;23!J)O**3S"]1H<XGIT4K-ST@/7]YF>HQZAU!X\[,H
MNJ]?ZX'1>R7MF@*7`RQ7LOL6H,PD&UJD92QOI*:@$06:G9C&(J)I)F4-Y@&.
M!1+4UQ)H45L[#][(W+Q^Y);NT;R-X=:ZN,;J';NP]9.9W1>RIN-6,E2[7*UY
M"2*M:V=GCY=5R@P!0Q">Y@=3O(7M[!Z-Y!UZ(IZ>-/KG\#^0G')#D[9;7<.-
MFN#7F'UF:2Y"U"6I$7)7J:C_`(@TBZC9$$9&"M\8=,!`'[186_<`E/V&`2A6
M#454*4C6&WM5;KK#:Z:@V/2=G5-WY?DV&B6:(L\5WJ$*J5!9W#NW:;9T4A@$
MR*@D5)[#%#V8!!Z(KCY*)A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")
MA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$6V=.VC)$SAZZ;LVY?`Z[I9-N
MB'4!Z`954Q"!_'A%YQ_6R]>U'TRI6N:2U%IB3VGOC85++<8&W6Q-_":/K4&]
M=2,6V>&L39)16\6%!XP.H:,C1,"!0)[THD54G6EQH/>B\-?*KDCZE//V*U;O
MKE_LS:$AQRW3NQOIJC2,8JYH6B`L8S#=O;:_3*A#ND&\E\!CU%RK+N3NR@HF
M8HF`P"`<1)/52O3?]Z;I%2XU>G5Z>W%?5<:A$ZRIFUV<-`QZ"11_P?KG3EHB
MXU<RW0QA<OE9M1PN8!^E54,8>N5OT`"*4+TQM14V,^[G4.I54C%\UV#PMVI=
M9]1--)8K^[7ZJVRT651V!0,"KKZP/E"&`W4Q1*!?YH!E311JA>2G@+/OHC[M
M]ZN+"`%1&:)M'C[#659N<4UOJM9+'6(.235.0?,4;J197B1RCX>6<W7PZYQC
MX2I7L=^[?2-93]&CBR[AR,FQ(U/<8V@S1)))0U@9;BV`::<R`D*!EGA^PIA.
M?J84P('7M``SD9\*A>?[[M-J]I.\JO57YXOF2!876"^U*14%4R`F1K,6RW6N
M[S+E@4A2@04H6#]W-VAT`%_QAE#12I\0I4-5PU5]:?0%V5S!68)R>R-Z>JU)
MR-VL:J"*TN>!2T_=I2'B0E#%%ZV8.;I=)198I#E(HJX3$W4Q2=(_5KXU1>E#
MURMFZXV#]W$XU6S5U0KC#7VQY#B4I6(^+BF"4756*R:+IP2*001!%@Z!XT41
M.8@`<3&4`_43&ZU.^`(OAZ8'I\TA/[O%L_97&B^[.U%R4Y+ZEN&YK'LZ@7.1
MBYA#96@+7?'VO:I!,$A-'0%8?$KA(^0001!5XB_6.H<W5,I):/+]JA<)Z`OJ
M*^HS:>/.\.3O-';]1VMP`T'$7)G9MAW%N]G.3D!:Z3&1CYTR@HRFL%G-MKX-
MG9"&^)MT%1Z]S<ZOS\!QZGHB]#O"/U<>`7J$&4C.,^^X"P7-NU!\ZUG:6SZB
M[,18B0#B^)2K0E'3;V/(40ZN&Z:R(=0^=E0(/1%)1DHF$3")A$PB81,(F$3"
M)A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"+'7EAR>U
M7PUX];2Y*;GF/A&O]5UIU8)3RC)C(2[L!(WAZ[#('$/>IFP2JJ31L3V=ZO<;
MH0IC!!-!5%^>KRB3]>KUNJU-<HZUH_<+;AP\7DI/4>F:7?*_KZHN:C'F5%G)
M-JG(6RNV/<$\JV`3*R3Y%9LJN)R,"$3#H/&=SM?!2NS<+GD[RK]!;U/.,6XX
M21M^P.!%LKVV-)FO[>1>WS32$M*).+I6896;$TY6THAS1+(BY8_1D1]_52.3
MM*4I0U:6^Q%>'?FEXO>'W3;AYMO6+/S9[BC9Z_LB?-&H`*C)XPN$E7MERKHR
M?SDW#%9Z198PAU'M$1\>F"?+^E%='UC=N(<^_0"]/OF1#KA)3>L=ITBH;822
M4,Z<0UH)1[=JFUK2IRAW-E)&W,HYT4IO^2DD1Z_.`<EVK045TONN7/R(ONB-
MR>EKLN:1:VR*KVPKAQQ^)+D(%FHER9OSW:BQXG+W+RM.L,DJ]20[_",=D!,O
M1(_0PCIXH5&QZ*VMWNVN/'KO>G\J@92;L^B[E:*M$B3N6"XZ5MUUK4"=!`>A
MN].>?,BCT`1+U#\`9`'4>**:?[H=O)#8_"GDGQGD7:J4GJG;CNQQB)S"91G3
M-U5AM()J)MSF#M*G<8V9$0_-[^O4>N2P^"%<G]W7TML#6>F/6$XR;*H]FIUO
MKG)'844HM/P;^+:3K6W5FXA%/HAT[;(MY-F+<$U`4144(*:Q#`/:8!&:5J#T
M4*(7TW*$IR=^[M^J+Q/18"\V%Q@VZ3?-?8E#]*9*0%?JDR_4(B8HG$ZD?JZQ
MM@*'01.<0_"`P`=A!ZJ5<'B6ZD^<OW6WE=H!LHI*7_A#=Y*W5AB<YW+P\'59
M-':M+8-DRB8Z1$*V_=-TQ#YO1,2Y'Q-]X12?_=+^2L%N;@MNGB%,/T5I[2=T
MD9B'8KKE,J\U/NN,6<,5FS4XB=1M'66/D@<&+\T@O4@'H)PZRS4$(L"ONM%H
MB[';?4Y]/6Y*IGK6Q(%[:X^$?D!=L99W]8M1W3L:J=2@HA',V"IN@=>[H/7J
M`#D,UJ/!%$5P5]+2P\D+%SJTII'8-OUSZBG`J_O[?H5FRGS5N'V!0:':YNKS
MM?9SK,6=BI>P@=JPBL1+-W7NW>X!-REY2AE"0&UK3J$7J:^[_>N/=N5DZ_X'
M<WUSQ7+:@,YAO1KK-L$:Y+;<CZ6L>/MM2NL-V-&\9N>B+MS`]3122))M2'6!
M(BR#COK:ZNAZJ%ZP<K1,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(
MF$3")A$PB81,(F$3")A$PB81,(O,9][+HNR;IZ6AG=+92DA4*9O37UIVXA$I
MK*JLZ,2.LL,6;?IH@(FB(J=EVOG";YI#JIG'\WJ%#^GZ4"Y/[O1ZM/&[DAQ-
MTOQ*LMOKFN.4.B:/%4!_KJ<>MH@NQ*_743-HJ\ZY6<"@TG&+Z/(3WMJB8SEH
MXZ]Q1*8HX812GBI7?:!Z:6V*!SK]:&V(TR$9\9/4`XXU=&DR;"5CE5'&TG]"
MN=8V!&O*TD(/6+U:Q3*\B*YB`17WLIBB)C&Z3MZT\5"B(^["ST5R-X4^HGZ8
M&T$SRD-#25O6AXAV8ODMJIMIA*URP)`0QOHA9WB.%4G0.T#&REFH(\%*PH]'
M"D6G<W%?UB_1/V(99Y=("H779VI(YV8#*,]R:.M9*E,'8-U?GD4L%PK53<_1
M_P#("H;H(&'(;J"U%%UQ1T5>IGB?9^>G$N2FJCS)],?=T+:MLU^(\Y5];M)3
M0_&ZSM..CR")U)2D2"<A`6!B!#)2,,CWF#O*?*17J/!%(!]WLY)&NGKDR5Z-
M%1E09<Q:MOGZR56+5\ROHS<[5E]G2#6,*;P&,E+A65'3=(>H)%=`G["AE3=7
M5190_=W95?B_ZYO-;B:#E1E7K(PY`4IK']PD05>Z(W*X-5?H1_G$@+([`OR@
M'3Y,-T=1%^@.+!F(/0*V0(,B42OCIHIIJ.NY(4.KA0I0,L8J0]H"81$`#IG*
MH7A@]".$8ZK]:;U>.$DLB"^OMAL=Z&=P)NONKN)K.Z'?PUN=/IY8$6INZED^
MHA^:/3.-OQ$>"E=`^[30@Z\Y>>KGP<LQ/,@STJS,W$*[#]'</*S;;107H+-3
MAV`8U??)%'J'4"DZ8;XM**);T$^2CKA#ZM>K:VM+>XZ\V;L"\\0=@%6=%:QZ
MT1-W"0K5"D7JJIBH))PNPZ]"K"J<0[$/-#J`&'(;HZB*_P#]W\VH%6]>A0T>
MN'P?;ZG*:I'*4W1)T@]F4K)#&^:/:?REHXQR?(/41#(9\2+.VF6O^B%][KND
M7&IC'5CD3=DJ[+L$#"V;.B;PU6BVB@,0GT9TR;!@VSHI1#Q4*'RCE1T?IXHK
M.?>6M$2WI\>I9H7U#./B"E0>[8>M-OJ##D!BV+O334A'DO0I%;=A2M]BTE^R
M+(E'_P`I</W:A^HJ#D/&M4"]\_'C<$)R!T1J#=U<535AMJZYJ5Y9"E_>T_K#
M"M)!PW+^'W1TL=(?DZDSD!J*J%>7)1,(F$3")A$PB81,(F$3")A$PB81,(F$
M3")A$PB81,(F$3")A$PB81,(F$3")A$PB818T<OMW\:>/7'G9&RN7=BJ5=T"
MSA58:]_7.-4GHB>93Q31I*NG66[*3>VA_/"L**3!NV756ZB/;VE,8L&E->B+
MP#;5])OAIZ@5:VERJ]!W<TX^L^G)DUFNW#6\H677VP:<X.9Q(QTUHJT3OPJP
M0Q')$1-&-G*ZR`J%\H))!02(9Q[015JE3&?=FO5NW]R7L&R.!W+B<F[ML_4E
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M80'KY+.KS2*'7_P4>H^S)%`^B+//A%6I"8^]@\H6$$Y>Q)4-E\WW;V3B0;^_
M1#:16;1QI5E[XV>L2/F$M+I.4//060\],O>FH3N*,?K_`*45]_1UM7./8?KD
M<F^/&U_4"Y'[)USQ'D]ER\W"S$Y!R-?V^UC;(RKD##V&'7AE8BO1J9IY-9S\
M,1;KG,AY:1T`-W%J!=NI[$4?VO\`C_S.YI^NQZD,;P`Y`L>->S*[?]V2<_MM
MY(R+!@G2H2\5.BR-7!S$5>X.EE[%9(I!4A`:=HE8G-WE[0`U.NX[>J*]'W=9
MM=:?ZB/JA;&V==D[U8=-\=-EGVMM`':CAC<+>TNLQ\3LI9!VTC%79IAS&*KD
M$Z+<YRAU$A1\,EIZGQ1>4Y9W/V0TWL]%E,(Q\W=I*96LC1%\@RCK#=)6>N,:
MQ+.-@338S;ANFX<-R%6*X,5JHHF`^68P4(I>_0#CY5OZP_"95RS?MBOW]\EF
MJKINX0"1BEJ3)`24;*+E+[ZP<'Z=JQ#'(I\@CE3*UT12F\Z3*V?[V=H5C`G,
M9Y&;LX8-G1TBE.=N:%?K34L82E$![6T6<3GZ^(%\?$,?K_I197??-K_64J?P
M?UR9P@I9V\OO#8#QJ`E%RRK*<)3HE!T<O01!O(OFK@@>P#"V-TZ],JD\$"]+
M?HZU>?I?I<\%JS9V[AK.1O':A^_-W93D<(^^,COVR:A3@!RB5DZ3Z=?DZ94S
MX5"DIRI$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$
MPB81,(F$3")A%$9ZX7!RX^H#Z=NWM(:T."FU(-Y!;8UA%*+E1;62Y4`[MRWJ
M[E0X"4HV"*?.VS<1$"@\41$P@7J(4N%0B@@^Z2<;]1TM'DIO!3<KUSR@<MT=
M)[>XMS4(%4LFA6M9LPR2QI^-?JFE;*YF9:/)Y$DF1-JBF!T>T#CXPP$54K#W
MCA:ZOJ;UCO76YSZY<MVVG.+&DN2CD]FB`26@GNY-F/:A7H."9/&YS-5'$[M2
MJ31P%,Q@,HF)PZ@8.L"FXGP"*4G[I#QZ<4+@YM[E7:D$T9_E1N6PV!D^<$,5
MR%(H9W$$Q<>8?Q%E)R8NW11#P-X#^##!XH5@#Z%;9'D]Z_WJ.\N'!Q7K>NS[
MZ=1<NJ`"V2<SFQH35-:-YXCY:8+TJG2*@#UZ>64>GAUPS5Q/@BV_W8Z-<[T]
M5[U)^4Q@,I&IL;`JV>=O<11]MC;EHF@0*KUZ"?X5$$4$/;VB`_*&&_$2BZ#Z
M;5;2Y+_>FN56X8UI[]5-.;#Y"[$>NDP'W9$\/38_3D2N<Y.A"&):I8HE^013
M'\>0W5]45X_0+08;B]7/U</4'DSA]0==/MR>Y3)R]Z1DMG;5MMO>G;+C\P5&
MM+H+18W0?!-R7Y#!DLU))ZHN/^[%RSO9/+_U;>=LV/E03MK8&ZLTX$112/9+
MI,;`3,#A3VBG7ZPB(^/YOY<1^*%;+[N]>$M?:"]:'U4+04J3YV\N<O6Y=X'5
M-628,=A[K>,$U3]>\TK.;$@T.G7Q,4H#U'(;XN\46(GICB[TCZ%7K+\Y)CWA
MM<]]O[!JJH3B@^6HN)VJ<1($16'YY^MIL[DP@`C\Y/\`'ANC2[P*+&:3X96*
M/]"C@="4RN`YW-SU]2UG]1Q!'S9![&MM=[`TUKEBJ/BJG'1\N$B[-_-!)P8X
M^``.`/*/95%,'QDXXT[5WWGK2_'77J+<U/X9<"Z)4"KMTB%[WU3T-KJ'6DGI
M4P$/B<Q*2JBK@X_.,X.;J(CE3:;B`H5IN"IJKRF^\J\YN:-SEH>'T;PZD=L[
M"G[A87B;.O0+2CU)EIVO+O))8P-FXQ4JH^DRCW!\UD<P`/0<I;JZI4K#ZV#?
M_O)_K5%/38Z=1XHZ[=0;!W-/&C@C*D\5=>3ZKQ)Q(@<?*8VK?5D4=+-V)C><
M1*46#Q*UZBKN=KT1?I.P,'%UB"AJW!LTH^$K\5'PD.P0Z@BRBXMHDPCVB0#U
M$$V[1`A"_B#.50N7PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,
M(F$3")A$PB81,(F$3")A$PB81><?U=/1-L7)"S3'-+T^-ARO&'GU'UV0BI^6
MIEA6H]>Y$UU9F=NZJMV?L0*SC;8\:AY32773.BHIV%=]O0KI&EP)&B+S`NH9
M]Q/^[C\U--7JC6C1W*:T<]X'6FZ:WL.,D("YWKX'#U*]UZ+BUY,`5M<+&14;
M[UYS55TB<ZB[GS#%<E.>D^5M/%2O8AP?D:UQU]"#2-GJP-BP]#X&)6]NX:]A
M4G,B;7#V;<OCG(`=ZCB5<&.<WM$<J_5_0H7GS^[?02^H?1Y]4CFL]4[;1<H#
M:I6DL8`][\_4VCY^Y(G*X'H?J\M6S%#&Z#XG*41\0\*6:-)4J[WW4:+C-1^G
M=SWY0._+)+K;*N#Y617$.I8?4>IF+Y)(RA@\2&EU')^@_P`X?9XY+.B%8)>B
M;L4.-?IR>L=ZLMI,NA=;D:VT36$PH<I57=SM3V:GVT:@N;YRIY#8EXKY?FB(
MAY7R^'2!\)=[46>7IIZL?\+?NRG*WD.JF9IL'DAKC<VUWTFHF))(T'9VR6GZ
M'YBQR]YB.JHR0?IB'\]\8P#U'K@:,3Q5E?2$C"<8/NRW/_DH506=FV?`\@99
MD\+U356)7ZF%%J*I5`#O-T=O5A+TZ_B\1R!\!16\UK"K<;?N?^QY=ND#-_R+
MV&\?.G'3L7782F\JS0S#W@)1,5:LZL\KYP]HI'$/8..C$\5\>5-$-QU^Z%\=
MJJF4&DINJX:CO4VD0!2.NOM"]2=T?^:/0#'.9$J'MZ]2``>P,$5CHB]._"+@
M_K.T\1_2,M=F*=8_$O5E2W'1:[[J@M%O+]LG24K!_&WYSG`Q%X$FQ7SQMVE'
M].\M3J`IAE8`H%"\W'!OD%$2_J6_>"?4R,\6<5C0>HM@U^@3:8D$#B$]982I
M%07$0*F12.J,<<1*(]"F`>@]0RD'S%P\%*AB]+[A_P"I?ZC.O=K<>./C=QKW
MC/R,V;7]E<L^0$_"O(BLV"1B7,M*DJ+^ZB*;Z]Q3.2L[AV-6BBJB[>%1.],1
ML0^0T$U)Z%%^CAZ<_IQ<>O3.T*QTGHJ*6>2$DLWG-G[1G46XW?:]S]W!!>Q6
M1TB!BMF3<HBE'1J1A;1K7HF3O.*JRO(`!T4+/_)1,(F$3")A$PB81,(F$3")
MA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"+$#F=P2XN
M\_M7)ZDY1ZPC-AUN.>N)>L2(N'L/:Z3/N&AV1Y^G6F(<,YN`DA0,!5!06!-P
M0H$6(H0.W((!ZHHPN1'IQ\M^/_I.S/`3TW=HP^Q7"25NJ3=3E:^3>VAOHZV#
M(*N]9T"UUV(80,5*P#9V+2)<RD6]("`@4YBG`%2J:410/\')'<OIZ^CGZL?"
MCGEH_;'',:[KV\VO5=MEJL[L=1NCS=]-9ZG85B"M]3<2L0[<DN49$"*BBJ0)
MLY%1PMY::"F4`$--5*[IZ$-KB)#[O?ZDL+!V&'"<K,OR*-*$+,QR0QA)K7$;
M+1R[I0[CRVB#Z/=!Y1CB!%#=2E$1`0"!\!^U/%1*7.RO:W]U@XTUNHN3FC-B
M\_YIELOW(P]J,G`U5]9XF*E^P>B;A:5KD8J4I^AA$J?0.HAU&FW3VHO3=Z@^
M\./&MONT\-18#9E#\^\\-N.&N]95R(L<0\F;-.KQ^MUW<=&Q+)RJ].[:-(YX
MJ^ZIE]V.DH57L/\`-RHZ,HBC'UI?*T]^YU;2C(688)/ZXWM>M)Y`CE$JP6Q7
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M<(J=/`0_#U_LX1<5-P4)98MY"6.&BI^%D$3(/X>;CVDM%OD#?G(O(]\DNT<I
M#\I3D,`X11V;&](KT^]B:XWEJU/CW7-<5?DDE6$-TAJ!U(ZT>WE*G2#N4KZ<
MFI6W+5J0K%X]4,/EHD\XH@13O(4I0(L:M6?=]_3VU3H'?W%R/C-QVW0W(A_6
MIZT:\ONT7UDC*C=:BJJO`["UHL>-:NJ9=V2JA1]^1.<RI4B$4*<@=HQM`%$6
M`-1^Z(\`8:]P\_;=R<F=@T2#D@?L]7SEW0:PJK<J_O)8AU)MFYW8Q;A4`*Y3
M03;F<)B8HF+W=0IV"ON12'W_`-`#TX[KK#:>DX.D;'U)I_<6R-?;7N>LM0[-
MFJE2CW;6T4:*@9.)@7"4NSB2NB&!=\FD`%=.BE6'H<I1"J@I3P1<S2/01],J
MG<=4>*[_`$E*[$TPUV\IO5K7-E7JSV99ILY>K-J8\L35X1['G;&>UYH1%5$A
M2HG'J?M[C"(J"E/!%GSHCACQ2XQT;[-M"<?]7:QHYI=*?5KU=JL>5HYG4$"M
M4)EXH^3>NWLJBV("9'"JAU2D#H!@#%!2G@BR8(0I"E(0I2D*4I2E*4"E*4H=
M"E*4.@%*4`Z``>S)1:N@?Q^W\?M_NX15PB81,(F$3")A$PB81,(F$3")A$PB
M81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$4>G/ODAOW19^,-)
MXVP>I);9O)+?[734>]W4%M4I%?9C0KG=W<JY0I3^.FW#LR=2\A$I5.SO6#N\
M/$()H0/:BMQW^M5X]/\`=I_JKDH'\?\`E2.1Y_<B=_K6?NT_U9R4_:?'G]R*
MGF>M7^[3_5?)/Q_]*?;TQY_<BU=_K5?NU/U7R4_:G'G]R*GF>M7X?^[4_'_@
MODGX?^E.//[D5>_UJOW:GZKY*?M3CS^Y$[_6J_=J?JODI^U.//[D3O\`6J_=
MJ?JODI^U.//[D5._UK/W:?ZLY*?M/CS^Y$[_`%JOW:GZKY)_M3CS^Y%7O]:K
M]VI^J^2G[4X\_N14[_6L_=I_JSDI^T^//[D5>_UJOW:GZKY*?M3CS^Y$[_6J
M_=J?JODI^U.//[D3O]:K]VI^J^2G[4X\_N1._P!:K]VI^J^2G[4X\_N1._UJ
MOW:GZKY*?M3CS^Y%3O\`6K_=I_JODH/_`-Z`QY_<B=_K5_NU/R#%\D_[5I''
MG]R)W^M9^[3_`%9R4_:?'G]R*GF>M7X?^[4\?P1?)/I_9M(?)CS^Y%7O]:S]
MVG^K.2G[3X\_N14\SUK/W:?3_P""^2?M_!_VI]O7'G]R+5W^M5^[4_5?)3]J
M<>?W(J=_K6?NT_U9R4_:?'G]R)W^M7^[4'_XKY)]?_M1TQY_<BL;R#Y)>K-Q
M2H4;N+;,#P"LNO&>R=34VTQ5#9[^:6X\;LK9%9U^=U!+SUF4B2OH\]C*L4%R
M&(8"#U#()<-3T4J<3V>`96H3")A$PBMUM+:NO]*TB7V-M"S-*E3((\>E)S;Q
M!^[(DXEI%I#Q;5!E%M'\G(/9*4?(MT$&Z*JRJRI2E*(B&<]G:760N!;6K"^4
MUH*@=!4FI(```)))6T<-X7R?U`Y#!Q3AUH^^Y!<AYCB:6-JV*-TLCG/D<R-C
M(XV.>][WM:UK220`K5:IYA<<=V_7,-;[+:S"NO8)"SW)M*5^X4]Y`UQP1Z=*
M>=,;I7J\\5AS!&N`]Y2(HB!T3E$P&`0R]N\+E+#MF[BV]UVUM'-<"[30%I.N
MHT-.JW/FOH3ZK^GIQ_YLQ#X&96Y-O:NCGM;IDTX+`86OM)YVB7[QGW;BUU'`
M@4-5UW5W.WBCN>YP>OM;[8;S]LLZ4BM68YS4+_76]C3BF+B3?C`S%HJD+!S0
MHQK11P!6SE4RB!!.0#%#KG+><>S%A`ZZNH2V%M-QW,=MJ:"H:XD:FFHZK+<R
M^F[UJX!@+GD_+,(ZVPEFY@N'MNK*=T!D>V-G>BM[F6:*LCFL)DC:&O(:XAVB
MV,[Z@'$.M7J1US-[C9,[5$6Y.ARR85._NH*+MZDJA!_`9"XLJFXIS-XE-."-
M%!4?E(DY,"1S%/X9,7&\W-;BZC@K"YFX>=E2VA-=N[=T%>G17&-^F/USR_&X
MN5X_`R286>Q-Y$?F;)LTEL(S-WF6KKEMT]IB:9&[8271C>T%NJ[#M[FIQET7
M;?J+L_9J<%;BPS>PKP<=4KY;W;&%>&.5I)28TNKV)&*;.O+,*8N3I"<I1,4!
M`.N<=E@LOD(?F+2$F'<14N8VI'4#<X5I[JK%\'^GWU>]2<&>2<.PYN<'\P8!
M-)<V=JU\K:%T<?S=Q`Z1S:C=VP[:2`:'1;Z^<P^-NM:;KK8%OVE&-*GMMD,E
MK>2BX>T6A>WQY&#636?1$/58*:FE&C5D^1.N<[<A4/-*502F$"Y3;83*W4\M
MM%"3-":/!+6[34BA+B!X&FNJMN->A/JSR[/Y7C&"PTTF;PDG;OHY);>W;;/+
MW1ADLMQ-%$'.>QP8`\E^TEFX"JW]<Y9<>+5JQYNJ$V?#+:RC;`:J2=F>L)Z'
M^%64LJA!&@Y6&FHF/L$9)A+.4T?*7:)G[C@/3M\<B3#9.*\%@^)WS9;N#00:
MMI6H()!%-:@JVRWHGZIX3F3/3W(X>=O,);7YF.W:^&7N0&,S=V.6*1\,D?;:
MY^YDCA0>W17Z:RT:]=/V+.18.GL4HDC)LVKQNX=1RSA,%VZ3]ND<ZK-5=$>\
MA5`*)B^(>'CF-+7-8'.%&D:'P/V'Q76DUE>V\$5Q/#+';S`F-[F%K9`TT<6.
M(HX`Z$M)H=#JN2R%;IA$PB81,(F$3"**SU$^OV_>E/X=?_YY-_\`]@MSY2?B
M"+MGJIW_`&'3^,$?5=2V*VU'8>ZMT:7TM"VJD?$$['6(R^7Z'86RR,WT<BLM
M%DA:J1VLHY'M*F4/$?'*D7FUI?+'GC9YIC69W8/)6"H,;S.B^;5^NRIK0G(2
MND=@Z(E.4&LN)E<=>X`Y2UO5M:ZOG?CT80.P'DG%-#=%%1(/$"\]%*O9`1'J
MG::XPH\MKQMW;^MZCL'7U.@-QOG6SK;O^V,XO=VP4W-CY+UK6SQDK%:25T1K
MF12%%@Q2.Z(H)N\O:ET"JCO$Z*%R,]<>15ZN+KCWP:VWR;W/QCW!R.T\PU)?
M-C[LO\!8;K]B^F]X[AY<P='Y$2+=2V0^I;:]AJ/$DD%1!J>POW:#;N`ZH8`K
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M=5-L:44;H(EZ#VXZ`4U119/.:O.JFZ=XF;AIB^^;8;T^>->^MD<PM27!A.KW
M[D,U2WG<.*%.J^PP.S`LWM*D,M:.KHMVB83G;+*%ZD<$$91=3<;A]26D.RQ4
M?L??E\INY$^.OIQIOO>;">=U1R9E*_&;$M?)1*1.W$R#*=DY!S67ST`!),Z9
M1$X=H=.*IV]5*R%JG.6]Q[/7J$QLS?-IGM,<N.:7)GF#1HAO:EK?1-/:C'96
MI>,7&"4!9B"2_P!ME]E*)\%B4C*$D5G*CGP2*<^5;Q[U%%9,O+_F;K_5?*NJ
M<E+GR7TGLC=G(GA+;&MAV7&S<&WT)3MQO"J;NKNF7,&UDQA]+T:3UP^B&JH"
M9<4'8G7`#K"(SN'0Z%%+YZG?(:9V;Z?C5QPNVK:F]GY(W6G:XUCM_4IYMM-0
M<62P_%;]9(:419$>QBD?3:O*D!P<A"]_L$1$.IQH*HH"[7R[YI;48/\`;%MW
M-N+C_4>0[O@KJRD5:\6O8FO:3J;6PT/8.UM@6RW6&H1RT]4KAM^IQ58D9>3:
M![TW4LZ;'J44A*%%1T)-5*O9==Q3SC<6@]31O*N/KNJ8K04_M2P24UR\Y91>
MN-I;+VILF*BJLE1-QL(P=A6Y6IU)D[`(J2,1FR,J`D*'4!RHT%""462/*FF;
M%J&WN?EBU;N3F,T:<<N*W&RBZNK3#>>T92IR',3DS)6_6,#:(R/7!1.=BZ'`
M2-2>.$/I4`>KJ/%P*J8PEC2M*FJ*RM+WCZAI=P5NC-+9O'8&LN7?(R<LFCIE
M9U/M7.KJMP;:/V&Q-8V!^HW3.UKG)2+A&LHEYO85XY753*(B<<J`'6IHH62O
MIR[[M&TN6W'LK#:?)3<%WV!H.][9YBRTILV6'4VK=I..YG)Z$NW'>QQC5EJ5
M?6-QFFL74UX@_FO4&#HQ^Y,RQC!IY2BL!N3E9SI:;OVWR&T_9-PVBA<==V\L
M.4-FT>V2L1*_MGC)H22:\3JWIZLQQF9$P5MEIU_+7)DBF!C.%SJ."@/FE,-/
MZU"2I7:.+]4YS<D=BO[/,67=-^H>DM6:5"2BYWD+MO3$L\V9L5[>M\6T&4)6
M2-8J^OHRGV>L0@HR/5%`&_NH="^8`2`#J"5"LDQY9;N9Z\I>]M.\B>3VU^3T
MWQMWK<_4#H4Y]=$]5Z*V'>X5A2]5:P@]7O(Y&"UM?M7[]N*$76&L24[EQ#PT
M@Y<B9(_<-)(Z@FJE=#O$GZ@FN-<[_P!,CNGD?JK:00G'/7KRIMMR[)WA:Y>0
M49,]Z[+Y64+9<NU794B(LM$K$G6E8&.,`HNEP2<%[P(&5-K74J%>C6?,WF[?
MGW(C8QT.4:^QN8<+Q8U5QTT+48N5D9/C1JR2UT^V-O#<M=K,BW:Q+#9T+HZ=
M@)Y5TLH7MM]I9,S@(-E"%J)`%2B[WJ1WMWD/#>EM7MH;:YK4RU5S77)MERT,
MUV1L&AV*QUGB@5]$Q)=GL(LJ#%78-WO*:0/'8&*Y>)I*$(8Z9P$*0[=IJ"BL
ME";\V=,ZXF$^67)3F1K!U+<<;3R`X2T?5<WL"$V3OS;NWMO;AC:/#-)Z%8B^
MM=ETY4Z;1(Z*JL@9-FF>RK/'!!*8QBQTT))*E=FFM^>I\?8)XVS6G:[N(Y3[
M2XY^GRX^I?QA@RX]\BM&UFA6C?&ZH%9HV!G$U3<$LVL\(Y=H@#45V?4#B4Q,
MGKIYE"FS]9%,$>"LND45#%2WGQ/3()SB=0P$Y):L*43G/U,<P].HB/B(Y+_A
M12K=?G=.@_ERI%7")A$PBP(]1I]'Q7'F!EI=VR81$5R4XCR<K(2)B)QL;',.
M36JW3R1DEE"F1;L&2"0J+*'^80A1$W@`YL/%@YV3<UH)>ZUN`!XDF"2@'O)T
M7I7Z4+>ZO/5*ZLL>R26^FXER:....IDDD?@,BUL;`-2]Q(#0-2=!J5CA<[QK
MW8O(KF))ZRLU6NL2U]-1",=/:8\8R[)O)&MN\7!8QPO%`HD60517(H"(F%04
MSE'IT$,RUO;W-KC;".[8]DIRU?."#3;#KKX>]=L<?XYRCBGI5P.UY?9WF/OG
M^KCI&MNF/B>8Q;8@=QHDH[8""TNIMW-.M05TW7NR=5W)WZ1%;I%TI%EL\`X5
M5L<+6I*+?S42FRXFWM@Y5EF;'JZ8)LI`X(*BL!`*N8"CU,.<US:WD#,W+/'(
MV%_PEP(!_G+#H3UTZ4\%G^4\2YG@H?7/+<BQ^1M,-<L`@EGCD9#*7<DLWM$;
MW^5Y>T;V[2:L!(T5G;SL;5K+AYR\UV_N%+;[*=\[+^+"FKR,:G='!77-RO/6
MP(0Z@A*+B\9=5DA(4P&2'O#YOCE];VUT[.V5VQCS:C'L!=0[-+4CKTT/M^Q;
MUQKBO,KCUYX+RFUL,@[B$?IO9;[IK)#:M+>)3,=67_1MVN\KJD4<-IUT652F
MQ=7:^YG<P4]EW"F4Y2:X\:3&#+<I&,BE)06]<LZ"YXT904S.RMECE(H5(3=I
MS``AUS#"UN[K!6(M62/<+F6NT$TU;[.GZ5TNSBO,N4>@7!'<1L,A?MM^49;O
M&UCDD[=9[<CN=NNW<`2TNI4`D&BL3I2UTNBPWH_6'8$Y`56LI\<M\-59>V+-
M8V((Y?5C4JC%J+N2*1LDX>$2,9$IA*8Y2")?`,R.1@FN'YN.U:Y\QNX:!NI(
M!EKH.H]OL79/J#A.0<DO_77%\7MKJ]RYY7AG"*V#I)=K+C)![ML=7%K"0'TJ
M`2`?!<O!ZSL/)KC5SHK.BW-1L,I8N;5YLM+=O),K6GSQ*Q?8&>%-.;9$51!H
MZ+&F2!9+O*!A\!SCDNX\1E,?+D`]K66#0X`>8;F$:CVZ]"K+)<OQ?I%ZM^G&
M7]2&7MK96GI[9V]VUL>ZZ@-Q9S0U,3R#N;W`[8ZAHKT\-K#O5WMGU&9>UZWJ
M$)M-"R:X>P=,B[P>6KTC:4=4/30T*\L)D/+8,I`Z#(%G!4^B(N%.I>J?3+'.
MQ8[Y/%QP2O=9['ASBRC@WN"I#?&GFI]@77GK[BO3B#A/I188/+7UQPQ]I?,F
MNY+3MSLMSDF":5L%:O=&#,6L+JO#&:^:JEFS3EXH3")A$PB81,(F$4>G/KCA
MO[>:O%Z\<;9G44=LKC9R":;G9QV['=P84FQ,0H5TI#R)7>TB"L,VV>%);?/1
M,#<4^Y$.X>G@-)!-*(K>"/K2=?\`JOTTQ\1Z=UYY*^`#[?'[(OEQY_<BKW>M
M+\L7Z:8^'RWKDM[!Z=0_]4/3Q$,>?W(G?ZT@^/PSTT_P=?KUR6Z]?P>.HL>?
MW(ODF7UH4BID2A_303(DF"21$[MR5(5-(H%`J9"AJ$`(F4I0`"AT`/#(J[_"
MJ+4/^^A[1ZQ7IH"4W7J'UXY*"!NH^(B'V1>(B;Q'%74KI1%J$WK1CV_X+]-,
M1#Q#K>>2WR=0$2_YHNH#T')\WA1%3N]:4>@C&>FEU`WA_ESR6\/#Q#QU%X8\
M_N1.OK2=P'^$^FEW=.@C]>>2W=T]O:!@U#U[>N1YNFG[:*H&]:0#=0BO32#N
M\1Z7KDMU$0#I[?LB\?#I_`&2-WNHB=WK2%#_`*L]-,/$?_IUR5`/$?\`\HO$
M>OY,5-:>/^'N1?/L]9TIU#A"^F<!UC)G5.%WY)]ZJB(%!(ZA@U%U.9("`!1'
MQ+T#I[,5=[$7U-_OHCAT-$^FB;V_G7GDJ(=!#Q#H.HA#QR*GVM1:0_WT10`I
M8KTT2E+^:4MXY*@4H>P0``U%T`.G7)\_N1:3?[Z$X"!XGTT#@;Q,4UXY*B!O
M`/;W:A'J'S0^3\&//[D5!3]:$0*`P_IGB4GYI1NW)00+^#H`ZB\!Z?DQY_<B
M^G7UI>O_`%7Z:7MZ_P#;GDM[?#Q_]47M`/EQY_<BKU]:7Y(STU`\.G3Z]<E>
MGXNG^:+PQY_<BT$)ZT*9E#)P_IH$%8_FK"2\<E2&55[")^8J(:AZG/Y:92]1
M\>A0#V!TQY_<BU@/K2![(OTTPZ!T_P"W/);P#Y`#IJ(/`,>;W(J]WK2_XL]-
M0/\`Z]<E?[>HL>?W(OF4OK0$%02P_IH`*J@*+"6\<E"BJJ!")^:ITU#U.H!$
MBE`1ZCT*`?)CS>Y%J_\`;1]0-\*]-(3@`@!OKSR6`0*(]1`!#40B`")0\/EZ
M8\WN1/\`VTO7N^%>FEW``@`_7GDKUZ"(=0Z_9&(@!NT.OY`_!CS^Y%3N]:/Q
M'X9Z:8]?`?\`+GDJ'7IU]H_9$/<'7KX?CQY_<BTG+ZT)SI'/$>F@<Z!A,D<U
MWY*F,DH8ADS'3$=1CY9C)*"41#H/:80]@^+S^Y%K`_K2?XL]-/\`%_EUR6'Q
M]HB'^:+Q\!_AP-WNHBL9R&XY>K%RMH,=IS:S[@!5=?O=DZEN5GFZ-:>0,G;$
M8S6NR*SL!5K!LIW5S")6?R!ZZ"!//72(7S!$39!W^"E3?]0_`/B/X/#^'\N5
MJ%7N#\OY/R]/Y<(M/>'X_P"Q_=PBUX1<#8*W7K;#OZ[:X&%L]>E$P0DX*Q1;
M&:AI)N!R*`@^C))!RQ>)>8F4W:HF8.X`'VAE4<LL#Q+$YS)1T<#0C["*%7V+
MRN5PE_'E<+<W%GE(7;HYH)'Q2L-*59)&YKV&A(JTC0KJ]-U'JG7*,HVUYK+7
MM#;SA2$FV],I=<JR,N5(ATDRRB4)&L22!4TE#%*"P'`"F$`\!SFFO+VY(-S-
M))M.FYSC3[*DK-9_G'-.520S<HS&4R4MO7M.NKJ>X,1)!)C,TCRRI`)VTU`7
M'5716DJ).FM%'T[JRG64Q'29K%5=>U&NSIDWO=[XF:7B(AI("1WWCYH>9T4Z
MCW=>N5S9#(7$?:GGF?%['/<X:=-"2/VE=YKU']0^28T8;D6>S5_B`6GL7-[<
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M`13(!4P[0Z!E$5W=V\AF@ED9,>KFN()/M)!!Z^]6V'YIS'CV1FR^`RV3L<M<
M5[L]O=3PS2[CN=W)(WM>_<XEQW.-2:G5<W5:;4:)"-JU1ZK6Z;769UE6D!5(
M.,KD(V4<*"JN=O%0[5FQ0.NH(F.)2`)C#U'J.<<\TUS)WIWN?,3U<2XG[2=5
MC\UGL[R7(/RW([V[R&5D`#IKF:2>5P`H`Z25SWD`:`$F@T"Y)I$13!W(OV,9
M'LGTPJBO+/&C)LV=2B[=(&[=>1<HHE6>K((?,(94QA*3P#H&4%\CF@/-0T4%
M2:"OL'@K.>^O;F&*VN9I9+:`$1L<YSFQM<=Q:QI)#`7:D-`!.IU74K!M?5U2
MDCPUJV50:U,(II+*Q-@N-=AI)))P0%$55&,E(MG)$UDA`Q#"4`,4>H>&7$=G
M=S,[D,4CF>T-<1^R`LYB^%<RS=H+_#8G)W=@XD"2&UGEC)!H0'QQN:2#H0#H
M>JX?[?=%?Z:M2_\`ZCT[_P"><Y?PW(_T>;^`[_$LA_=IZC_\OYO^HW7\DN?K
M>S=;W-ZK&T_8-(MDB@W%XNPK5K@IUZBT*H1(SI5K%OW2Z;8JJA2B<2@4#&`.
MO40SAFM+J!N^>*1C.E7-('[)"Q67XCRS`6[;O.XO(V5JYX8'SVTT+"X@D-#I
M&-:7$`F@-:`FFB[WG`M>3")A$PB81:1^3QZ=/'IA#3Q6!&YK?M9?DPQH=7F-
MWM*;%ZZU;8WB&HJQKJ8BVLM:]A;(AY1W>G]R:J2;2,=1-4;@D5D?J1%!R<"]
M_:.;#8P6?X2;B80=]TLC:R%X-&LC(V;?&KC6OM%*+TOP#!<*C](I.2YB'CK\
M_-E<C`TY.XOHI'1VUE82QMLV6KA&Z1LER\N,HH7/A!.VJM$GRFV_![,L&NK;
M/0Z:=DY3V"`TQ,-X5@@$_J^IR;^)NNN'_5/RCVFJ.68NBN`#WE>-Z*=PF`<O
MOPBQEM&W,#7;F68,HJ=)'`%CQ^]<#2G0.\%O#_1C@F2X?:\JP=K.76G#()LK
M$97GLY"YC9+:7[-:_+W+7=LL_P!&R?RTH5P$1O[>>L=;U>_3NS5]HNMI\<]J
M;23AK57:M&-]>VRG*596)L+52KQ44\6H+<EE,E()/#*B`)(&34(8RO=R/QN/
MNKIUNR'M"&ZCCJUSCO:[<"WS$C>=NA'M-1T63OO3+TWY?RR\XQCL.W#0X;E>
M.QQEMY[B1U];70N!+"X7$DC1>N-N'0NB#>LH<UP#*<QN/9F]-&16P*8SW%;-
MER4IKG7&Q(*S)5>C+WZM/[/L=2H3T36HMC$QM<D8^PM$1-$I/"'\ET"I"*>6
M4A2TV-ICK^2*Y=`R)C97L+:NV.VLW@N))<"/UJ=1167`N(>G'J/>8SD$^!L<
M1:0Y6^L9K<W%X+*X9!8BYADGD?+)/')`XTN71$;X]CG,WEQ.PA]M<B+7J^:^
M!V;9#QLSY`2=+(Q7C-;USE2I3*Y4WK^TU^/J,A'!4U[-"69-L]!L8/B+FM^\
MJ@N412,29;'&17;7/9$";8/ZO=;ASG`-)<#NVEM1^Y#]HIU5S>\(]+,-S*`Y
M*SQ,<TG&([K>)+^?C@NY[EK+>=]RQ_S(MYK<R1=S_01W_:88R`\.Y2/V_MO8
M-TU9&5_8&\K56E-/:]L$_/:GUMK>']ZMC_:&Q:?97>SX2V$=.*HNFE3`;/&<
M8J*3=PT>^2'0$\H-C96T,SY(H(YN^]H;)(\T:(XW-V%M`[XJM+A4@BOBK&YX
M'P?C/'\U>93&<=LLL,[>P00Y*_OY=MLS'V-U;MQ\UJ6MN03==R*6X:'/9+;]
MPUW+I>Q.5N^ZV7DA48^WQ*=NB>1"+?4KWZNPZAXO1M<=5]392:K95J9O**UU
M`5VX.EBG6*L\)U-\T.EQ;8;&RFTG>P]EUJ>YJ=92#L^S=H:#31;%Q3T5]-,L
M[B6=N["8X2?BI.39WY0)<Q.V<6!#@[=&)SL?VV$-VQ.H-2KCP^S]U.W7)2Y/
M++NQC'4,O*`E1?.J?K4=)L2:\<6>+J1F#XC0+A)R,(>+3,)7(F3</&RQ51,0
M0#+1]I8`6MNUD&Z3L;@'/[IW["[]Z`:G[`=-0M3O^'>GL4'$<!;VG'I+O)'C
MWS+&W-_^+/-Z+>2YWM+OE8XY1(X591S(Y&%E'"J^6N=W[GVPE9]76G8!M>[7
MUSQW9679"]-AJ\HNTV`TLCP\9=:^A-Q\BT6I^Q:R@1RU2.F9,B)A*':H`CE5
MSC[*S++N&+N6<MUMCW$ZL+15CJ$'<QVA]ZKY7Z<^G_"76?,<+BQE>$Y;E3H+
M`7<L]'63H&]RTG=$]CA=6-PXQR.!#BX`FK319G<9PMCC2&N9^[WN:V'8KE4:
MQ=)"=G(^"C7""]GKD/)KQ31K78V,8$C63I904>J9E`*<0,<P`'3`9?LMR$L=
MO&V**-[F``DU#7$`DDDU]NJ\_>KWX'#ZB9;%\>QMOB\1C[ZXM(X8GS2-+;>>
M6,2.=.^1YD>T-W:ANFC1JK+6'<.PX[C9NG82$V@G:JEMW957KTH,:Q,BT@:]
MO1U2HEL9H=$6KHS>O)`@*ARF.<P=YA$_CF0CLK4Y:"V#:PO@8XBIU<Z$./\`
M[VO_`'+L+%<#XK=>K?'^+S6SCA;W!6%Q-'W'U=-/AVW<K@^NYNZ<[PT$``[0
M-NBLPQY1;9C-NRNMK;/Q*+2V<K&%8TY)(0[!,9?6L2>GL]BZUD5!1!%2TU\9
MWXBV<!^E.(XS@_7HUS(/P]FZR%U"TDLLRZ05/ED.XL>/WIIM(Z;J#Q6_W'HW
MPB]X+#RW"6TSI['A;[C*,=(_[J_E%T^QOV"M1;S=GL2,_P!&R<1-I]\KG<*+
MAM?8,0UN.R)C>#\9VG1,PG]>ZQKJ#UP\>2JRC@SVA.:HT0GG+/R0**`/?:U4
M(8>I^HY8YZWL[9Y@M!``UY'D<\R"G[K=Y?MIXK4/J$P/">+W[\!Q.WX[%\M?
MR1'Y.XOIKYC8QMV7C;ESH6NK4/[7^L#@/+19^=>@?*/_`'AZ#_%FO+S*J]?Y
M>G]CKA$[OQ&_B'^+\N$5<(J=0_L]/X<(JX14Z^W\0=?Y?[F$3J'A^/V814-T
M$!#^7V818*\N[CMVMS%/+0;';86H1</.6:^'U1%4NT[+AO<CD3@[1*TJXIF^
MLFL&3DAR2:<>JW=`(CW&.'83,]A(+.9CS<,:Z=S@UG<+VL->K0YOPR4^$D$+
MT=Z&8#@^5L;X\EM+&XSDT\-O9C)275M82[A66WBN[4CL9![:&`S-?&?`-\SE
MT+^E\\+R=TY0T[Q$2VN+!3:#6[(,949)%C9-@[DJ\I;Z5<&%@59N$8!@R^K+
M!@2,6>%44&XMA.0YTR#EV<(W\)GN#&YMXV1[FU<*M9$X-<TM\:[G'=33M&AU
M6R_W%P.]'L]R1^.G@Y7;7][/!W+F,O@LL7<1VUW:OA#VF9[Q<33&X;$0W\,E
M#7-:YP6TK^R-P#IX_)"3WNT\S8>JM@71AIIQ6ZT=O6W\4U&3@HV@&311G7<K
M16_<TEB/3N@?.!+YP)G`!R9+6R-[^%,M3]W,QO=W.JX'0E_ZM']6TI0=*A7&
M3XGP,\\'I-9\:>68K-65H_*B>X#IV2.[<S[T$F%L=VZDMLZ(1]E@/;+VDA6M
M=\F=UV[3D=?E9_8%`LMGWAI[6$IJNK4FJ3.U-:P,K&L'[Q)2-E&[EC+VW9"$
MB60%?J+-LP$B;0"J)+B:];B<?!?&U#(Y8V6\KQ(YSA'(X$CJ#HUE-OM)J3U"
MW"#TA]/<'SR7C,=MC,IB;/CN4R$>2N+NYBQU_-&][&D/C+7QVU@8S!LIW9)@
MY\Y+7Q4W4CRRV]K"6T17MF6*6AUD;5-3FQHZWT9@WN=KT]==FR6K]+FM05J,
M<P%%MR:90EI,2':I"@U,!A$14#../#6%U'<26K0[[MHC+7G:V1D8DEV[C5[?
MU6]34KCMO1'@O,;+DF5XC:PSQNLH8;&2VO'FTMLI:8^/(946W?D;/>6I)-M`
M'"1V^04T#%D)4[7M*VV.V;4=[M;5&NUS<MNU,RU"_@JTI69.&@5SQD<P3?G;
MHV4=E33HQ7B"Q7BB7B5,$#("8HXV>&TAB99MMS)*Z!LAD!=N!(J33X0P#0BE
M??5=6YK"\,P6'L>%0<=?>Y6ZP%KDGY-DLXN(Y9@))'%@<;?Y")M8GM,37?$\
MR"0`C8<*][[&W\=]-;`?253<5C7U!19ZVFH.+C)RX(69B9\MOYRNT(;_`"9N
M4S%OHZ#:-C)IMTHUPJN43N$NRK/XZTQU(K4-D#Y'$R`DAA::=D?OF@ASR>I(
M`Z%7/U!^FO$_3(1V'%HXKV&[REX77\4TDD-JZW>&##-:X_\`F+6*2*>[ED!=
M(ZXB9&0V)^Z0?-<7F%,(F$5!'I_"/3"*N$3"*G4.G7Y/^[^3"*N$5.H?V.O\
M&$7G^Y_\58W:7)6RW-7BVIM%:0@*FW6N!-&7R\^_&CX)DS(W&QP&R*U'.#1Z
M:()=@-2&2`O883"'7-_X_?Q18YC);AC'-+@`9&-H"XGX2QQ`)->IZU7TW^F3
MUFN.'^D=I@!S(8=D5U<D6IR]G:;`^9[RX036%Q(W>3NKW"'$[@`#185_T#XG
M_8:7_JO;7_US9G/Q2W_I<?\`MHOY)>@/^I"Z_P#]$;_:#&?^E*0[TUN-,?I[
M=]HL[?C>;42[K6TG"DLJFF;KKP79'4_7':L.6:L=^M;)R#@S`JHMR-R*&\D#
M=X`02FUWDM]%/8MCBN&R$R-):)&.Z!P!VM8TZ5.M:"O35>6_JU]6[GG7IU9X
M=_+!G(F9:.4VXRMI>[2V"=HE[,%E;.;M#RWN%Y:-Y&TEP(G(S1E\[$PB81,(
MF$5!^3\/CT_BPBLG>N/NH=FVMC>+?6'$C:XR-80;>;CK5;JZY^%1$D^F(Z.>
M$K,_$-Y!LRDI1PJ0C@BG:98X>PP@-[;9*^M(C;P/I":FA:UPJ0`3Y@2"0!J*
M=%O_`!OU0YUQ#"R<=P-XR+"S2OF=$^WMIQW)8V1/>TW$$KF.?'&QI+"VH8T]
M0"N3?:/U-)N89W(T2!=NZ[?)+:$$Z<(*'<Q5^F"N4Y:T,EQ6\U&1DDG:A5^@
M^6H4X@8H@/3*6Y"]C#@V1PW1ACO86#HT^X>"L[;U$YO9Q7$%ID[F."ZQL>/E
M:T@-DLHMICMW"E"R,M:65\S2`05UNA<9]#:O"?+3=?0\8E8H1S5IE)_(3-B1
M5K4@NJX?5I!"S2DNC%P$@LN)EF38J+980+WD-V$[:[C+9*ZVB65QVOW"E!YO
MW7E`JX>!/3V]5F.2^KWJ7S!UL[/Y2>:2TN6W,18R*`BX8`UEPXV\<1DF8!1D
MTA?(SS;7#<ZORK?%[1-3AYR!A]?L_AEA>P3Z73DI:P3KIV:KN2/*TT+(3<L_
MD&\9`.$RG:,TE2-43=3`3N,81KER^2F>V1TIWL#J4#0!N^(T``)=XN.JJRWK
M'ZD9J_M\E?923YNUCF9$8XX(6M%PTLN';(HV,=),TD22N:9'"@W4``WMRXX:
M3OI[`I9:*P<O[+/1%LEY".D9J"ESV:"BW4'%V)I)04G&OXN83AGBK15PV.D=
MTU-Y*XJI@!<I@RM_;[1%(=C6EH!`<-I()!!!J*@&AK0ZBA5O@?5?U#XTVU9B
M<E(RUM+:6VB9)'%-$+>:1LTD#HYHWLDB,K1*UD@<(Y!W(MC]5PTCQ3X_RJ]5
M56H8,W-*KT95JX>$M5QKBS*NQ$H\F8Z-<FKUBC#RR"4L_<.3'>>\**KKJF.8
MQCGZU-S&3#7@25$CBYVYK75+@`3J#30`:4T`&BOK;UI]3K2.]8S)&2+(74EQ
M.);>UG#IY(V1/>WO02"(F)D<8$6P-8Q@:`&MIV:0X^:8E7[R5DM=U]Y(OVMG
M9/7RZ;DSI=I='<>_M2(K^]=Y"3CR);J+]!`3&2#Q#J/6AF3OV,#&2O#&EI`T
M_5!#?V`3^RL3:^J/J!96S+*SRES':1OMWL8TMVAUJU[+<@;:5A;(]K/9N/N7
M"(<8]%HV2RVI"F"66NOUL4LY"VNXFAIP;RU>LK:JZK0V(U:,:<0DEP6,1H7H
M=43E[3_."O\`%LCVF0ND\L>W;Y6U&T@M\VVNA`IK^TLA)ZP^I$F+M,/)D*V6
M/^5%N?EK42P_)N8ZU#;CL=_[DL9M!D.C0TU;HN\M-0ZT8V20N#.EPC6SRU%C
M]9R<X@@=*0?T.*576CJT]6*H7WE@Q.Y/Y7?U4(!A`#=/#+=U[=NB$!D<8FR&
M0`]`\]2/M_86O3<ZY=<8F+`SY"X?AX<D_(1PD@L9>2`"2X8*>5[PT;J4::`D
M5U7$2NM94&5=AZ!?)'7=9K,$RKT9`0D5&R+-)A%H)LHY,BTB)URE9LT"(E+W
M#\TH=1ZY4R[9N<^YC$LKW;B22#KJ>GM^Q7MERZS-S=W_`"C&0Y7+WET^>2::
M21CR^0ETA(CH*O<2XFG4Z:+@&_&71[63M\J-+36>["7D'5S2<6&T*P\_(2\T
MWLDH^4KB\ZK7F3U_/-B.U%&S9%050$0'H)@'D.6OZ1M$E!&!M-&U`:-H&ZE3
M0&FI64E]8/466SL;%N0+;?%M8VU+8+<2P,BB=!&P3B$3N8R%QC#9)'#;X5`I
MVA_I34K]W#/I"BP+E]7]AFVK`NW"2AG,7L9=B>*5M<>L9;S$)5>.4,@?M'L4
M2,)1*("(#Q#(7E'-$C@'Q=MP]K*UVGW`Z_;JL-;>H?-[:"XM;;)7+;>ZQ0QL
MS01MDL`_N"W>*4,8>-XKY@X`@U`71J_QDUIKE"05U$C)ZPF7[0(TDG'S]EGF
M;!@=X1VHRCJY9I^2K[%)10@`7R&Z8IE#M((%\,N),M=W+@V](E8#6A#14^TE
MH#O$]2MBRGK!R_E<D3><.AS%C')W#&^"WA>]^W:'R3V\+)WD`Z[WN#CJ[75=
M@'6FQA(T(&\+*'D>;YQ_JY`"9V!U"G)YG4/F>64!*'3V@/CE/S5K7_R[:?Y1
M6-'+N*[WN/';.CJ4'?F\M!0T^WK[E]#:VV(95\<-VV4I'0*`W3"NP'1B)G)%
MB"D(E$5/+2**?SO:4>OMR/FK7;_Y=M?\HJEO+>+!D;3QVT+F4W'OS>?RD:^R
MI\VB^'V;[#`$"FWG8P%MWBX$:]7P,X`ROF%\WK_>@*3Y@"'M#)^9MOZ.W7]\
MY<GYNXN[>6\;M//HW[Z?RZ>'MUU7U'6^PSB]$-W602N@-[L`5Z``&0&=)K!Y
M7S?I.B)12#N_FFZ^W(-U:Z'Y=M1^^*H/+>+#MC\NVE64W??S>>C2TU]E2=VG
MB*=%I^S?8?<R+]N-D[FP=7!?J]`?IP`Y,KU4#I]&`)&!+YOR!U]N#=VO7Y=M
M*_NC^PI'+.+4D)XY:$/^'[^;R>4#3VZ^;7VH.M]A@9Z`[PL@F==?=2A7H`#,
MR@Y(J(I%Z=5@!$!3\?D'K[<@W5J3I`W3]\?L3\V\6`C/Y=M*1_%]_-Y_*1K[
M-?-IXBBJ&M=B`+'KNZRB#40]Y`:]`A[[T=*+CY@AXI]43`E\W^:7K[<?-V@!
MK`W^$?9_W54?FWBWWG_#MIY_A^_F\GE#=/;K5VOMIT7S^SG8(@YZ;SL?Z28`
M;?Y/5\?=A!;S1(E_XX>SY@@/CT_'E?S5I_1V_P`(JO\`-O%ALKQNT\@\WW\_
MFTIK[*G5?4-;[#*:/.;=EE,5J9,72?U=@>D@!'9ESE6$`ZI>8@;RA[?84.OM
MR@W=M0_<,!_RCHN(\MXL62M_+UH#("&GOS595NT$>W:?-K^G1;O9NA]3;F5@
MW6QJHA87];%PG$R:$G-04FW1>>6$C&K2%<DHIX[B)$$@!PR744:J?SD^OCE%
MKD;RRW-MGED;J$B@(/L-'`BH\"!7WKAX?ZE<WX!'<0\5OGVMM=[3)&Z.&:-S
MF5[<@9/'(QLK*^25@;(WP<`N5/J'618.5KWU0B&\%.6FN7.2CD?/;-EK54CU
M8U7F$P273,T=09Z3%>Z@B*9$@8)`!>@"`P+V][HF$CN\UA8#U.UV[</>#N=6
MM>I5D.=<P=D8,K\_._)6UG/:QR&CG"VN1<_,1&K3N;-\W<]S?4N[SZG5=-9<
M9-"QUBM%J;Z^B2S%L:3\?-JK/Y=PR(VMKD'MH2B(ES)*1-:/9'711Z>/1:G<
MF`.\1Z!G*<OD7QMB,KMK"TC05\FC:FE3M'2I-%GY_6#U,NL79X67*3?A]D^%
M\0#(VO+K9NRW,LC8Q)<"!OEB$SY`P?"`NT&TCJE2?0LYJ3$_'6YJ6=*1*9V5
M45M=^]!2'*A"N017=5E)XJ1LJH4RA4U#$$1*/3.(9"^[9B[CNV=^FG^L^/[-
MU!7]E89OJ'S5N,=AAD9_PQWS8+/+0"^V_-M%6U:VX+&F1H(:7`.`!U7+R^L*
M!-?7H\U68U_]I<,Q@+V=V*YPL4+&LG<?'QSTPK`"39DU?K`EY7EB0ZISAT.8
M3#2R]NF",1O([+BYE/U234D?;3]JA5C8<PY1C_PUF/O)HOPB=\]F&T^XED<U
M\CV::N>YC-V_=N#6M-6BBZ87C=I(M[;[+"A1YK>V!`Z$@=_-*L2/$(L(5"9+
M`J21J^-B3B2@B$D+47_:`#YO<`&#F&4R'RWRPE(@/@`.E:D5INH3^K6GN6P'
MU:]1/RT[B!R<HP+ZAS`R(/V.D[IA[PC$_8,GF['<[-=-E"0M^]TG4FJ4`YHR
M"6O[+4Z@&OJQ:(9J#M_#T;WZ,D%*N5)ZN9!]&>\Q*)D@<`J=N8#BD8GF*]]#
M+^<[FW![D3Y-[FG0%]"-WVZGIU\1H*6UOZAYR9]U#R-SLGB+Z_\`GKBWE=M9
M+>;)&"XJQM62;97AVS:)!M#P[8S;M1UKL42LP#=]F`6_?[P;ZNP'Z7U6\P/,
M#V)]B0=GS?D\?;G(+JU%3\NW7]\=%<#E_%`YY/'+0AU-H[\WE\M-/;KYM?'1
M4-K38HF>F#>%E*5P)_=R_5V`,#(#+D5`"#TZJ=B1!3#N^0W7VY5\U:?T=O\`
M"*AO+^*AL8/'+,N92I[\WGH"#7[3KIXA:QUKL7]"_P`]]E_1^GO`_5V!_3>C
MDZWT@=/H^J)@3^;_`#0Z^W*?FK37^;M_A'_#WI^;N+?>?\.V?G^'[^;R>6FG
MMU\VOCIT5/LTV)^F_P">^R?I/_DP_5R!_0?T@JWT?A])]$`I_.^0>OMQ\U:T
M'W#:_P"44_-W%?N_^';/R?%]_-Y_+37V:^;3Q3[-=B]60_;=9>C;M]X#ZO0`
M>^]'1UQ\P0#Z/JB8$OF_S2]?;D_-VNO\W;_"*C\W<6I)3CMG5_P_?S>3RANG
MMUJ[7Q-%0-:;%Z/.N[[*(N.GN_\`D[`]6?1;S/HP]BG<E\SYWR>/MR#=6OA`
MW^$5/YNXK6/_`(=M/(?-]_-Y_+37V4/FT\57[-MB]67^>ZR]&X%\_P#R<@`]
M\$'!U1%7P^C$R1@3^;\@=?;CYJU_B&]?W13\W<4^\_X=L_/T^_F\GEII[=?-
MKXK2&M-C`1V4=X641<>5Y*AJ[`=6G8H)S>6`>!_,(/;X^P`ZY5\U:?T=O\(H
M>7<4+HS^7+/:VNX=^;S::5]E#KHN^Q=<GV-2=0#VY2,I-KLI)JA;EV#%%^U<
M/$E4VKQ-BC^AG4C5%`.0IO`XE`#9:/FC,_>#`(Z@[:FGO%?>M9N\IC+C-LR4
M%A%#CFR,<;8/>6.:T@N87GS`/`()&H!T7G<]2O9MBK7*^UQ$==>-D(U;UNFF
M(PV/RVY1ZHMB9G%>8+'.^I&K+Q`4^.04,IU042;^:X2[55#"<PYV+QB%KL6Q
MW;F<XEVK8K=P^(C1TL3W'2M3X&H'1?4WZ2N)8O+>BEC?76/Y9<RNN[L%]AQK
MCV1MS2=X&R[R-G/=2$`4>US]L;JL8`T`+`;[:;=_I-X8_P#$`YT_ZT,S_:'\
M7<?["T_W=>F?R%@?_P`/SS^QO#__`$U2>^E'L2=MG(*WQLE<./<^W3U5*O"M
M-5\HN2&Z+&DJC9:PD59S5=P7&QUUG%`1<05?()$=I*"FF4WEJG#-6Y7$&X]K
MMDS1W6BKHH&#H\TW11L=7I05H=3^J%X\^M3BV.PWIA97=I8\GM93FHF[LAQ[
M`XJ`@P7!H+G%VD$[I/*-L3W&-S=[R-S&T]"F=?+Y?)A$PB81,(J#[/X0_E#"
M*,WT]K&PC8KF$I8["V9IN?4,Y!P$.I.2Z:)5G:XU,(Z$C3R+@H'76[#^0U2'
MJ(`/87VYM/)HBY]D(FDTQD)-!X#=4F@Z>TG])7KKZHL1<W5[P1F(M7O<STMP
MLTHAB)HUOS.^:0,;H!IOD=H--Q4A"UWIK=-^JXMU802C)9"`E%%IZ*2)&SKL
MY$VL*_,H[*#.7<G5(5-LIVK',8``HB(9K8MYS0!CR2*C0ZCQ(]H'M7EQG'L_
M,^-D5C>.?-`9HP(9"9(6@ETK*-\T;0"3(VK``:G10!<H9.31K'J^F1E)-$S'
MD#P638BC(.TA8IN)?2H.$V0I+E,S3<`J;S`3[04[A`0'J.=DX<,$N$T_^6NZ
MZ#723W:T]]?VE].?1RTLWY?T+;-!"YLG&.8%]6,.\B/*[2^K?,10;2ZI;30Z
M*?1.XU*.8/2R-IKC$U9CXE>R`]G(QL:OHR#9%1@M.`LY(,4D^(J4R)E^P%0,
M`EZ@.=;N@G+AL8XASB&T:=:'6FFM/&B^9C\#F[JYC=:V5U(V[ED%OLAD<)BQ
MQ#Q#1I[A800X,J6T-:46!-#GVL?ZE?*Q_*SB+&MQG%3CY++.Y&4(V@8]J2Q[
M(7=RBBSE=./9(>[D`RBXB4O87J8W0,V2YC<_BEF&-)D-Y,*`:D[64'2IZ]/V
MEZ7Y+C)KKZ2.%6ME;&3+3<US48:R/=,]W8L0V,!K3(X[C1K-34Z"I549U!'U
M2;.]6FD4JTVX#46=4<JR94H)%N7<^T55IE18ZP1Y$`8)`8S@1[02+U$W:&<?
M:/Y4:`#W#D7-I36O;9I[:UKI[4?C9'_1M:01V[CEW^IEY"&B.LQ=^%8\"("F
M\G>:!@UW&E*K,[9-IKKK7EW91UBAG4C):OMEABFC&78K/G\)\%=)EG(]!!P=
M=U%@LL0H.D@,EW'*'=U$,PMK#-\S&Y[';!,UIJ#0&HT)\#[ET!Q/#Y6#E&/N
M+FUN&6T.8MH)'/B>&,F[K3V7DMHV2@)[;J.H#I0%1`\2Y205MWI!^\R3U5-[
MP+W0]D/.>+J$=KHM>/PE<O?,.(.%D2KG^D/U$O<;Q]N;CF(V"+,AH%6W\8'V
M?>Z?M=?\:]U^MME:LP?KIV8HP^/U*Q;&4:*M:79GRLH-`:#04!H-%-5];ZG)
MLH_X;::[(?69C*+UL6,W&N_K`C'-U%'ZT$+=RI\538)AW+&;^8"0!U-TS2!#
M*V0[V.&PC=4'2ITK[*^%5\^OP+-V=Q+\W9W47R<D8GWPR-[!>X!@FW-';+SH
MT/IN.@JL%O3.L;%/B'K9&<GFJ<M.[-Y$1\,G+2J99&:<L][[47,SC4W:_O,B
MNVCF9U!32`QB(I";H!2B(9[E,1_&)1$T[&Q0DZ=/NV=?94GQ]J]&_5YBKB3U
MSRTN-MGFRM\/@WRF*,[(FOP^.;OD+06QATC@-SJ`O<!6I"X3F[9&,IL7T^W-
M;L+619'YO5J&D%X*52=LU'#*J75M)13U2/<'1,NS>(B19!01,FJ02F*`@(95
M@HBRSR(D:0?DB144ZN;0Z^%#^E9+Z>,1<6?%/5"++VKXK@>GD\L8FB+7`/N;
M5T<C`\`@/::M>-'--02"M_SWL;"1C^*!Z[8&[PK3GYQC@9<\'+IN`;O4=CQ`
M2$)*#'N#@FNF18H+M5N@@4P=Y/$,JXU&Z-]YW6$5QTY%1U\AH14=/>/9HK7Z
M:,5=6MUS9F5MG1F3TQY!-&)H]NYIL)3'+'O;J"0=DC00:&AT7#^IY8V+C0%0
M)`6!NN\B.6G&6&F2PLLF9U&/%-HUY9Q$RON*XK,G"C-R0QVZW:84E"B)>TP=
M:^(Q.;D7]UA#'64Y%1H1VSJ*CIIU'[-5D/H\Q%Q%ZG7YREJ]MO/P?/RQ=V(A
MLC!CYPV6/>VCVAS2`]M1N!H:C21)S=J8R+,&>6ZLM"5UTT8V`SJ?BD"P3R0[
M18-)@RKL@1CI]YA?)37[#J]P=H#US6A;W#MH:QY+P2VC3J!UIIK3QHO*\/'\
M_<&W;!8WCW7;'/@VPR.[S65WNBHT]QK*'<65#::T7T>7&I1WQOXA::XP^K*3
M-:R"\FXQK]7D)(!-'+3@KNB?"4GX%$43./+!4`^;UR&P3OVEC'G?7;0$[J==
MNFM/&BH@P6<NOEOE;.ZD^<<]MOMBD=WS'\8AHT]TLJ-X9N+:ZT4$7+J5?EW%
MZK@LY5^5!MP*U6[CQ;2+E-!LJM]83"[8>2J";=90O0?,3Z&,'3QSL3"L:;'#
M!P%3D9`=/LZKZ1^A]E;?D/T5[\$9E=ZEY%CPYC27`=CROJ*D#IM=4#V*8;0M
MJK[;1^GV<E9(="3C]$ZWLLNV?S#).08P9:;$`O8)-%PY!RWB@52/WNU0!'N*
M;J?J`YH^1AE.0G<UCBPW#V@@&A.XZ#W^[JO"7J7ALI+ZBYZ>TM)W6<O);^WB
M<R)Q8^;YJ2D$9:W:Z2A%(VU=0BC:46)MCGVJWJAZM?-YQ)6M+<(KC,@Y0E2C
M`K-0V;YI9?S4W`QRJ(-?G`XZB`)^(&Z9F8HG?E*5CF_>_B#12GFKV^G2OZ%W
M9BL9-']'&9MY;=S<JSU$M8MICI,'?A]#%0MW@[M-FGF\*K;[-L#:5]2_A8[@
MYQ&1KDKQSY.2"3B*E2.X.22(YU\+9\0[1=1@](F!S=BH"<``1Z#E5I$6\3OP
M]M)6W4`H10CXZCI7]"YN'XJ:R^D3U!@R%LZ'*P\KX^PMDC+9HR6WNYA:YH>P
MDTJTT]X4A[.XU*1^!C'VJN/BVA)XO6A9SD8Z^L2$>!#/UH$4'2@2Z3(JQ!6,
MW\P$@,'<(=0S5S!.W=O8\%A\U01MKT!]GZ>J\KSX'.6IN1<V5W'\FYK;C=#(
MWL%]0P35:.T7$$-#]I<0:=%Y[N.<K*GKGI2>9*R:HO\`ECRJ1>F6?NUCO$48
M;9AD4'8G5,9P@B)`["GZE+T#H&=DY1C1<9BHZ6<%-![8_8`OJ+ZJV5FW+>M9
MCAB:(^$\=<RC&C:72V&YS0!1I-34C4^U>A!&YU%P1FJWM5:63D)MU66"B4[%
M*)OK&P%V#VOLCD=&*ZFV8L%P5:$ZN$_)/W%#L-TZV,$XT+'T#=QT.C3T=TZ&
MHUZ:KY=R8#.Q.D9)97;7Q6S;AX,,@+('[=DSZM\L+M[-LA\AW-HX[A7`?@78
MF<>QY9*V*>;,B.>>?(B`B3S<HDV(L\6N1THV%CC/UR@JX7[1*@V3$3FZ"!2_
M)FQ\BB)-F(FEW_V^%QIK^KJ3UH/M7ICZE<1/<W'"&8FV?(YOIK@YY!%$7%K!
M:@R2R!C=&BM7R.T'B0OCZD=D9.=#U4("?:KO(CEKQ1A9HL-*IJN8QZIOK71W
M,1)^XN#*LG2C)T4QT%NPXI*`(EZ&#KQ<=A+;UPD::.M9B*@Z_=NU'N_:57TG
M8BXA]2+Y^4MGM@FX1R.:'NQ$-D8,/>[9&;Q1[0]IH]NFX$`U!6"W(V5E$:KZ
MKAD9.03,RY4<1T&0IO7)19(+U[0QET6HE4`6Z2YE3]Q2"`&[AZ^W-BQ<;#/B
M00-;2?\`:,E/V%Z2]*+&T?FO17?%$6R\+Y,YU6-.YS9\Q1SJCS$4%*]*!3S/
M+?4HLLT,C:JY'!6$&3BRB_FXQK]7F\@0QF*\Z+ARG\(1?$1,*)W'EE5`HB41
MZ#G7W8F>X!L;BUY.V@/F(]FFOZ%\TX,#G;QUO\K97<IO'/;;[(9'=]S"`\0[
M6GNEA(#@RI;45I58A^H59(W^A;RWC(N?9!8XG0]NE'#&.E4"S<8T?13T(V15
M:MG`2#)N\.U4!!80*504S=@CVCTS?&H2<[9.E8[LNN6C4:$[A4>PD>Q=Y_2Y
MBKP?4%P>[O+63\*FY+;1M>^,F&1S)&]R,.<TL<Y@<W>W4MJ*@5"R8TT)E-0:
MI4.H90ZFM:,<QSF,)SJ&J\48QSF'J8QS&'J(B/7KF+O]+Z8#KWG_`*?,5U%S
M]H;SK-M:`&C+WE`-`!\Q)H*=!]BN=EJM33")A$PB81,(F$3")A$PBA)YM<==
MD[%W_.VFM:>BKA%.H2MMTIQP?C,5=RLSAVJ"J!PV;;H>VC[L=,2!YR`)]"_1
MB).@YO6#R-G;X]D5Q-LD#CI2;VD_J-+?&O7QU7T)^GGU4XCQ7TQML/F,[/8W
MT=Q<.,+?Q^C0^5S@?YA:RVPW`U.UY=KYZ.JL31X>;I^3CQ`?PJ<*?]8.9S\7
MQW]*/\&Y_DUW;_?IZ?\`_-%S^QRS_<EG-P!T+?\`5^V[)/VS5,91F+JB/HQ"
M79CQY,JY<K34*Y!B/V3V>;L)4U"-A/\`3)%:B)`[C=_8`ZYR/(6EU:!EO+O?
MW`:4F'0.%?O&@>/VZFGBO./U->I/%^8\'M,;@\U-D)V9)DAB=^-T`$4H+S^)
M6\4%02`-KC(`30;=Q4P6:8O"Z81,(F$3"*@^T/R_VAPBBV/Z?EK4KDE"'V)!
M"J]]18>;2;@(I^!$JUYB:@44Q0$#C,@!!#WG^\YMPY)$)1)VW:8OY7J/B_=_
M9[NJ]D-^I[#MRL.1&*N=D?I5^4BWN,UGH1\Y_P"%K_H_C6VNOI[VFU0/(.'1
MV+`M3[IY@4/DO'K+13]0D+#T^5KTBO5W@%,(KR+PL*)"+I_1%[PZ^S*H.310
MOMG&)Q^7L7P=0*EX<-P]PKTZKDP'U18?#Y+B]\_%7+V\?X)>8!X$C`99;J.9
M@N&FGEC:902T^8T-%RFW.!%LV3%<W(UEL."BS\J]E<>;S`*N8EZN6H-=+/:&
MZDH^4!/H+]><+4%`0.E\U(5B]WYHY18\D@M'6#C$\_)Q3L=0CS&4/H1[`W=K
M7K16O!_J9PO$K[T\N[C%W,S.%8C-V<P;(P&Z=EF7C6/CK\`A^::7!WQ;#3JO
MKN/@59]G*\XSL]@0D4'+*H:5K4$#B,?K_5!?5<%`Q+UU)@D8OOR4J>',=(J/
M02`<.[V9%CR.*T_#]T3G?)22N=J/-W"XBGLI5<?!/J6P_$&>G3)\7<S?DB^R
MT\VV1@^9&1FFE8V.OP&,2@.+NI!HN1V3P:M%YE.5K]O?(-BER'X=U;C+$(KQ
M;Y0U;F:]$W".7L\B=(0%W&.C64ABHI_2E!(WX0SCM>016\=FPQN+K6]=.34:
MAQ:=H]XV^*M.(_49AN-V/"K6;&7$LG%>>7&?E(D8._%/):O%NROPR-^7(+CY
M3N!]JWM@X1V69M=WL*=ZAD4;7P`:<-V[8\<^%1K86Q[N(W54Y1[31`A:T_T<
MOTWT1OPAE#,]"R%D1C<0W(_,^&K?+Y?MT^Q6^,^H;$6&%QV+?CKATEEZFNY0
M7;V4=`[Y3^:@?QO\V/G/D\P6^J_"RQ0%RU59U+O$.$==\(YCBFZ:DCWI59&<
MDW<&X);$#F^C3BT@B1`4#]51$P?CR),[$^*:/8ZLM\)_"@`KY?MU^Q6^8^H'
M%9/`9K#MQT[)<IZAQ<C:[>RC(8VRM-L?$R'N"CQY="MGJ3A)9-;O>&;IY>86
M2#B]QGV/H>;3;1KY(;5)WACKIHVGXP5!#W-@Q-2%#'25^D,"Y>GL'%WG8[GY
MVD9!NKIDHZ:!I<:'W^;PT5QS?ZAL1RR#G\4&-N(OSCRZQS$.Y[#\O':/O7.A
MDI\3WB[:`YN@V&O4+C-)\%;+JEMP:1?7R$EC<2JKNNO3IFT<_1"W*[3A',2Q
M<10*CU9I1)U@.J"WB<`^;D7><BN!>L:QP%TZ(BM#38:FOV^"NO4'ZCL1S23U
M&?;XVYA'-[W$S0[GL/RS<=,V1[9*?$9`VC=N@/54UGP5L]#B.'<:ZOL'('XR
M;RWKMB941C'R1+0PVXEMU-A$1@*"`M'<.&R4?-.K\P_NQ^WVESDNL_%</O7]
MMW\Z@BC`J/*8^WJ?;7:>GM57+OJ0P_([[GEW;XVYB'+^.8?&Q`O8?EW8TXPR
M2R4^)LHL';0W4=QM>A7#53T_[778/1\2KL.!<J:GYO[%Y7/U4XN0*27@;M/7
M68;U)H!NID)5BG:4R'7/]$8R1NG@(95+R&"22X<V-U)K)D`Z:%H:-Q]QVJ^S
M?U.8;*Y'D5ZS%W+6YOT\L>.,!D9]W-:0VD3KEU-#&\V[B&#S`.%?%;I#@1:D
M(0L4&PH(3E]0R(YIF5"*?"4:Y&V&K3:E'`IA$0F%4Z^<@.?[R!E`'Y!RL\DB
M[F_MNV_AAM>HKN(<-_V"O3JN*7ZE\++DG7QQ=S0^ELO%`.XS2>2"XA%Y_P"$
M#,'&/XB&D>*VE]X`6JW0>]XEKL."8J;=YL:UY5,5UHI^JG#0=%2UVFYJ3HA3
M"*\F_&DJ=BY/HB^>7K^:.56W)88'V[C$\B&PDMSJ-2_?YA[`-W3W*XXW]3F$
MPF1XW>SXJZD9@_3R_P"./#96`RS79O2VY:?U8V?-C<P^8[#3J%L=J^GI:]AQ
MW-5BTV-`QIN5&TM-;!A#N(N15+4VNL4(=%[&R8)FZO5Y48TPIG1Z%)W!W>S)
ML^2P6S[!SXG.%G#*PZCS=RNH]E*KGX9]4>$XO<^GUQ-BKJ4<,PV5LIMLC!\R
M[(.E+'QU^`1]P;@[4TT79]T\$[/M,>>0L;]"1/\`2_J>D:Y7_>HQ^L-,6U0V
MD$7[F6!(X>_IRXNP%($>@D[?G9PV'(HK,XW?&YWR,DKG:CS"0@@#V4HL1Z?_
M`%(XCAG]VGS.,N)QP2]R\\^V1@^:&2<PL;%4>0QAOF+NM=%LMH\"K7L"?Y9S
M#38<'&I\C.,-`T'#(.(I\L>LRM-:/6SFQR)B>#QB]%V`D23^>4`\<JL^1P6L
M=E$8G'Y6[?,:$>8.(H!["**XX=]2V%XQC.$V$^+N9I.*\QO<U*1(P"XCNG,<
MV!G[E[-NKG:&NBY1[P9LCN=O\N%]A2DN7I\,N%Z"(QC[O96%JUDVYKNL(&`J
MD0<7X"#<O18`*/X<I;R&(1Q1F,UCR1NCJ-02/)]NG7IJK*#ZC<1#C<98G&W!
M?8>J+^5N/<9YH'.C<+0>R7R:O/D.BTQ/!>SQM@UQ,&OT(JWI'!>6XD.6Q8MZ
M4[^?DDQ3)<45!'Z*)2Z^+<WTHY+^11&.5@C=63(BYZC1H/P_;[^BF^^HW#W>
M+RU@,9<"3(^H\7)6N[C*,AC-3:N'C(?!X\JV^G."-HUC8N&TT\OT%)H\8>.>
MS-(32"$6]14M,G?"5\K:>C3JF$&;%@,,;O25^>;O#I\N1?<BBNHKZ-D;A\W=
M,E%2/*&5T/OUZA<W//J2P_+\5SW'P8RXA?S#E=AEXBZ1A%O'9F8NAD`^-[^Z
M*.;H*&JT:6X'6?5K3@(W?7^#EC<.JEN*MSYFT8^1"YJ[.8U]HS<Q'G&$S!.+
M&%,*@+=1."@=OLR<AR.&\.2(C</GI(G-U'E[9.A]M=WA[%/J!]2F(YG/ZFRV
MV,N(!SV]Q<\(=(QWRHQ[YW/;+3XS)W1M+=!0UZKC-7<`+9K^*X<1[O8D#(GX
MQ[DW%M";5;Q+U$MJ9;-86MHRB8LJ@]6+B+-8B"J=7YIP2'I[0RN]Y)#<OOGM
MC<!=P11BI!V["VI/M!V_MJ\YC]3F$Y-><]N8,5<Q,Y?@,7CX@Z1A^7?CWVSG
M22$?$V3L':&ZC<*]%O:EP*M%;@M,Q"M^@G*NK^<VT^6KU9*-D"DE8+8"NU3M
M*BV*<?H):/\`M"1\Q8_T)O=C]OYP9PRY^%[YG"-U);%D&M/*6EA+OL.T^_56
MN;^I7#Y;(Y^];C+EC<SZ<X_C3`7L)CFLACMUTZG6)_R3MK!YAO;7H5NE^"5G
M6@7L0%]@RG=>H0;F>5;X:_`A*Z:V/;']2CD#YQIGR70)^?\`WCN#K[,G\P1=
MP/[;J#'?+=1\6T-W?9I]JXX_J2PS,E'?C&7.UGI=^52-[*]_Y9D'S?\`X56[
MMGQT*VMKX%6FQ0>]XE&_0+8^WN;.J^53!16,D#DAX+7TQK"1=U-T!1ZK2L@G
M052IK$^A*9<@F\`-E$6=AC?`_MN^ZLWPG7JYP<-WV>;[5R87ZE<-B[_C5Y)C
M+E[,%Z>Y'CCP)&5EEO8K^-MRWV1L^<:7-/F(8::T6ZVCP2M.P8CF1&-+]"1Q
M^3NX=*[-A%5XMZH2JM-61>N8]_&292!U>.9<])5,D=+YI`7+W>(#E5GR%EL^
MR>Z-Q^5@D8:$:E^XU'V;O'V+BX;]2.&XQ?\``KR;&7,HX?@LM82@2,'S#\C)
M?.9)'7X6QB[:'!VIV&G4)O/@G9]M-^=Z+"_PL2/+VEZ<JT"+J-?+A3EM8QT\
MQ>.I4$3?IJ<H,P4R0(^)`(/=\F+'/P6AL"8W$6;Y'.U'F[E*4]E*)Z<?4CA^
M#R>FTEUC+BX/!K_*7$VV1C?FAD'PO8V.OP&/M$.WZ&HIXK?;=X.V;9-AY?S3
M&]0D83DMQ?UWH*'2<QKU92LRU+"[%<V"2$@B1W'O?K4F*:27TA?*-U]H918Y
MZ.S%D"QQ^5NGRG7J'%IH/>*']I6O!OJ)Q'$L;P2QN,;<3'B/,+[,REKV#YB.
M[-IMACK\#V?+.W.=Y3N%/%9Z46NJU&D4ZJ.'*;Q>LU2O5U=VD0Q$72D)$-(U
M1PD0X`)$USMA,`#X@`AUS7[F03W$DP%`YY=[Z$UH5YJY)E(\[R+(9J%ACCO+
MV><-.I:)97/#21H2T.I]J[?G&L,F$3")A$PB81,(F$3")A%Y9?5-V%3J_P`P
MKA&3>Y.,E/>I5>C'&!V=Q2LNU+<V26K4<H15W<V-=DV;]LY`W>@0BGZ.D8$Q
M`#%'.U.*PW+L1&8HKE[27?!+M:?.X=`\4Z4((J2*]"OLE]&W&.09/T)Q]WCL
M#RZ^MW7EW2:PY%!C[5Q;<2`AMJ^>-S"WHYQ;YW`O!H5'9]K.MO\`:,X2_P!0
M^Y_L=FQ_+9'^C7W^W/\`*+U+^2>6?\J^H7]L+7_>E*_Z/M[JEFY(7*/@=L\=
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M&Q3N%:I6DS138CL?GD5*/<L40.;Q$<WO`2QC'M#K:64@NU;`QX^(_K.U/^`\
M%]!/IZRMC:>F=M#<<:RN3D^8G/?@P-A?QNK([07,Y[CBWX2TZ-(VC0+$WZG6
M3_:QU!_75W)_S&9GO0_T.X_JT2[P_'L1_P`DY[^RF*_QK.3@-!2T7MJQKO\`
M=E#V0F:BODRPM8Y!W_;#]J89J&,$BM`VI,K!FV3*'EBZ)]*0R@$#P.;-?Y'*
MQUDW;;R1?>#5T+(QT=IN;J3[O']"\X?4QDK&\X1:,MN/9+%/&28>[<82RQK'
M#M2^036QWO<:U$9\I#2XZ@*7O-+7AI,(F$3")A$PB81,(F$5.X.O;U#NZ=>G
M7QZ?AZ?@PE/'P5<(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")
MA$PB81,(F$3")A$PB81,(F$3")A%YB_4YEK^TY<6Y&OS?+MI&EK5)%-MJ3A1
MKC==(2.>ML!5^&W^R2["5D71U.IG*)RB1JL)DRCT*`9V;QAEN<3&93;AU7?%
M<.C/Q'JT1O`_9%10^*^OOT@V/&I_1"QDRD'!WW?S5W5V2Y7?8J[(^8?3N64$
M4D<;0-&.:09&4>14J/[X_MO_`,YO4%_X:&FOV@S8NU:?QEI_7'_R*]/?AO!O
MZ-Z8_P!O<G_NZE*]).2O#SD/<4K+,\IGS$NIY<Z3;=7$'7^@JF+D+-5P*JSM
M]5DY"0D)M(@G!)@<")*HG54'J9$.FK<N9`,<.T;<GNM^"X?*>C_U7,8*>TZT
MT%?,O&OUOV?'+?TML7XB#AK+@YJ(%V*Y->9FYV]BYT=:W$;&,B.A=,*N:X1L
M%`\KT5![`_('\F=<KY7*N$3")A$PBH(=>GXOR?W!PB@UW?=MA15OYC:\C+S=
M&@[>V'$2]*>M)Z52&ALM&436%BVLTKCI)7K764W%2L`B=%(2)JJR;DX`)SG'
M.P,?;VKX+&Z=&PNAB(<"T><ROD;&37XMI#R#[&@:47T6].^/\6O,%P+E-WCL
M>_\``L5+%=L?#&?G'Y>\R,&-?.TM^_?%+'>N:Y^YS6V\3?A:U<MHQU<R[_US
M9)QPYJE=MV[-UQ;+9RNUK_:%MAN8LSI*/U)8]<S*25#IHR34OF1SA%=<QC-0
M3;@5P<Q1IR`A&-EA8&OECMXB8^VQO;KKW&R#SN_?`CQUT5IZD0X!WIEEL1CF
M1WV5L>/8J1V/&-LK=MBV3:9,E!?1$WEUL<:3L<Q@`D+I=T301?)'<MN3YG&N
MQF-W'2[VW$XJ#8!EH=352<Z%>-<6L\A$EL1YXEO>[(5:UH'8Q0-1\PR0.!-\
MW,:;&`X$P$Q_.MC-QMH>X1N#:5I3:&5DH7`^-%UR_@.#?]/XXZV7'_W@QV)Y
M'V.U*,B8>_\`*OA,O8$)MFV`DO\`M?,=P;1)VMNJMS>]CUO6G*.UWR9O:%M=
ML+U(198V.V?;JIM;7ON=*6.UIUDT1+L5Z=>-'RB[9!=*P1Q6SX@NT%@.MWG4
M-<PVLMUB8[=D>QKHJU+&.C?Y_B;**.;**D%CJC0C30+:>-\3RW+_`$<L>-6&
M-=8P28UDAD?C[:YQU]NNP'74&8B<+JTR\0<]CK*<OA(BD86QT:T6+->MUQE7
MK=1FG.UZE?XG=-)Y4P#"VVIDXFKI3I"OW*^VNCH#6+-86CS7T6_@6,2$:NJ1
M8@2($5;ICT`,D+>P?*^=O:?;NMWV[BUNC'!S6-<=S0=Y#BX$>S0E=D#C?I[=
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M:)&(F,@BV366]W%<P`?KTQIABNKRQO;>`ML7RFOE&WXP/,=6U/6A)`K3HNM[
MKC]IRKF/!><\9X]+#P.\R[W2.;9[X&@WL;=ER]K'0;W&KNPY[F,W]MI+:+*#
MA2E64J5+_`G^IGKU<M;<2H:JY!7;?S8OFPY1;KSK^[)I.JW(.%P7[4$`,FL4
MG<)S&#PP^=[IN&F03;?-3N0MB\?U0W0BE-?#]*Z<^H23+OY#`W(Q9N.W:9Q'
M^(X2TPITEU$++0EL[`-M7OHYA(`:`5FSF$7GQ,(F$3")A$PB81,(F$3")A$P
MB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB@TYSU?5LIR$GW=IW;1J1
M,G@JRFK7YW1V];U(()DB6I6[A6PT1VE7'!'2?0Q2)E\Q(H@4_P`X!SL#CDMZ
MS&M[5O*^.KM6S0L'Q'P>*C_#P*^B_P!..8YE9^EUM!A^.Y+)8X7-P1-#E\/9
ML<3*ZH$%XTSMVG0N)HXU+="%B!]1]%?[3>K/ZKG*7_IV9KYO(?T6;^L0?XEW
MI^8/47_E#-?VAX[_`)BST]/2NZWB-PV9>G[@IFP),]!?)+Q%<TWN?7CQJS&;
MA#&?*S.Q'*T.Z0(L4I#-T@]X,8X&#YI#9KW)I;I]DP30/B9W!JZ6)^M':49K
M^GI^TO-/U297EM[P.SASN"R&,LQE&%LL^4Q5\USNS-Y!%8M$K214A[ONP&D'
M5P4RV:,O!281,(F$3"+2/YQ?X?Y,@T\46*+SDUJIOLF8H$G3KLT2C-@-]82^
MRGE-:#K1'8$W5(&S-:XZLH/U7J;N6BY*/;E54:%;J.CI(&4[NT,S(P]Z;1MP
MV2,[HNX(P_S[`XMKMI30AVE:@5-%W1;^D/-)N)0<GL[_`!SY)L8[(16#;IWS
MYLH;F:W=.VWV!A;')',\M;*7MC#Y0VE5PD?RRUPZH[B^N]4;:@*@DK#/JA(3
MU(@&"5]G[#,?"X"/HJ86587-@EGI@.@+KW$G8<#&4+UZ9R/PUVVY^6[T+KG4
M.`>X[&@5<7';\(&AI59&X]$^60\B;QJ#-X2YSKA*RZ9#=S/-G##%W)Y+P_+C
M;!$RH?V^\:@@,-%RQ^5.H&$#[Y9*_<:@[1A;9;'=-LM*58V=G*4VYT6J+08P
MZ1G*;NVS=NV/"DB2ME%DY`[PATU@Z&[>,8:^?+2-S'@EC0]KZM(<U[@:^#6M
M8_=6E*:A6;?1?GESD^SB;JPOX'7%M;-N[>[#X'QW5I>7(F[I#2RVBM;&[-R9
M`QT(B<UT>HKPO])W2);'3C["H%QUM>KW?6^E89+9&OFT=,C-R<*E9X=HZF&S
MB48?5V;9*$!!=-THB#H/(5!-4.W.08G(=E_RTC)+:./NG8^HH#M-!0'<T^%*
MTU&BR']S_J&<5?MXME+#+\<QN,.6E-A>NDB[+)C;RO;$YL;^_$\'>PQM=V_O
M&;F&J[D?DCI=>8U4U=`]^+[4MMUH-(,[KP"X1EZ2:3:S24BX,)AAHU[*Q18]
MJJ<W8Y?.FR(`!E0Z<`Q60;',6D;(F,>\[O!]-OVD`[C[`''P6O-])?4%EAFI
MH.W\AA;*TO;S;.:.CNQ&Z(QC_6O;%(9I&@59#',\U#"NH5CEEK*0EG[61U=M
M77AH&ZPVM'DQ=:+#P<<QMLS#-9!M#`^8S\B<A6M<(V774*7R4FHI_.'IVAS3
M8>\:T;9H9`Z,R`->22T$@FA:.IJ/:2L]F/1+F%K8Q3VN9PN5%UCY;]L5I>2S
M2/MHI7,=*6/@CKNG,C&-)WNDWZ"M3UB9Y?\`'5BVM6P[;0;C#Q,)3+A;X.]3
MNN&@H[*J-';JJ6=?7KPCIU)SIF$:FJX!JLFV769%%5,AB9RQX/)N<VUAD87&
M1K2P/^!S_AWBE!4Z5UH=%F+#T+]5;B:RXO@\G83WUS?VUK-9PW[MUA<W;@+<
M7K2UL<.^0M9W&ND8V4ACG!RR!I&P--'<VEO20A8R.@J13=CS<Y%Q;:+K[NGW
M%C/2-<FTI!!-$CQO\-@72IQ$H>2GTZ_G"`8V>VO@&&YW%SI'L#2:D.;M#A3P
MZ@>]=8\CXMSYL5E-R/YB:[NLC=6$4,DCI)VW5J^&.>(L<3L/<FC:*'S&M.BM
M[*\OM>LG45$Q5.VI;[--/HEDPJ53J;5]85?C%'1V(V=G;/IJ,:)-$*LN198Y
MU@%,YNSH(Y<MP=R07ODB9$T$ESG4:*/V>`/ZVG3WK:++T)Y3<037U]?8:PP]
MO'(Y]S<W+FP#M7AL7-W,BD<7&X!:T!AW`;M%<C8^]J/J37T'LC8B<[6H:<EZ
MC!DC'<5Y]@CI&WR3-@BC*1S-RX3;$@4G*CN54*JHFS8M'"PB8B0];2UQ]Q>7
M3K2UVND:UQJ#Y2&`FH/OI1OM)`\5J7$_37D?.>4W/$N+.MKR_MH+F8R,DVP/
MCM6.>3'(]K2[O$-BMP6M,LLL48`+PNN27*74D79MO4Y:0EUK1I)UKYO=81")
M5.],GM!C&/*:^@_,422F(Z04E2-CK$.4J+LBB9^@EZCS-PU])#!<-#>Q<"38
M:Z?=UW;O$$4K[Q0A9:S]&>;WF(P6>9%`W#\B9>NM)72@-!Q[Y&73)J`F)[!&
M9`T@E\9:]M:K8H\M-1.48=PW<6!5-_'3TS,_X%.0U&B:O;FM&GG]Z(=P4]>3
MCK$](F8I@.J=$IUB%,D0Q@K.$OVEPHVH+0/-\9<TO`9^ZJT5^W2M5<R>B/.8
M9)XI6VK7Q2PQ1?>U%Y+<6K[R%EF0VDY?`PD$4:'%L;B'N`63@>P/R!_)F*74
M*KA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A%YH?4
MMIEUF>6%L?PVMN:EDCS5NED3E=,<@XB@T!8R==8$43C*N\=$79.T3]Q71S%#
MSERF.'@(#G9/&I6-Q48,EJ""[1\=7?$>I/4^P^`H.H*^MWTD9W`6'HK8V]_E
M>`6ERVZNZQY3"R7MZ*SOH9+AK2'M(H8P*[6$-.H6!'V;;)_T,>I1_6W@O^EY
ML/S$7\=9?[,?XUZ6_-/$O'D'I+7_`/C<W^:I//2AJ5O@>0EO>3^ON7M59J:K
MF$"2.^MZ16RZ<JX&RU=0C1C`LG"CAO8#I)F.BZ[1*F@58@B`J!FK<LDC?CF[
M9+9SNZW2-@:ZFU^M0=![0>M6^PKQ_P#6KG,'D?2VQ@QF3X/>3C-1.+,/B)+&
MYH+>Y!<Z9PHZ$$@.CK5SC&X5VFGH9SKY?+M,(F$3")A$PBP!E-";NFKSLNK*
MFUXPTML7?U2W=)6HDU-N;_[E4:YK,K*ILJP,"$.@\<W#6[=11V>0\LK`Y^A3
M*B!0V)F1Q\=M#,.X;^*V=$&[1L)<Z2KB[=7X9#0`=:+TO8^I?IWCN.XG-1_B
MLOJ%BN,7.)CMS#"VRWW4]_ON7W'>,I8VUOI&MC$&XS`5(8-RM5K_`(H;8J>J
M+1KO[)]&`]=P<4PDG,YL?9%PKVU&\=..'LC`RL3*QA?L[6F62YE$)2,356CW
M8@)$A(4N7MSF;*:\9<&:XV!Q.C(VF,D4!!!\X'BUU`1XK=N3^MG"<WS6RY2<
MYR/Y=ES(^-L-C86L^.=)$UC)HY(W_P`^$+FAK[>X<UL\0HYX<2M_%<.-PK1=
M=D'%DK4#,5!A9YG7=6DK-:;Y$T"7;[<T!M;7=`<VR78DL5EI*#_4,@1^Z6!1
MVS^,`1L5P1NF8:79VR#W-8U[F/VA[@UK"\&*:-[PT&C74D;0"@.W6E2K6\]>
M>!QWEU;16EW<6%]);Q7UQ';VUG)>Q'&9K'7MZ+:)Y@@NRS)P&&-A;%+\KNE,
M3I7`<M&<3=J["MLM9]R.H&/K5DMMDL"VNV=ZLE^;4]S)UZ*:MK!4)69@XD(:
M1&VQA9%%D@'NS5,I.BG>91,.)V9M+:$166\S-8UN\L:S=0G1P#C4;3M)ZDU\
M*%6E[ZV\*XMA(<1P)ES+E;2QMX&WSK."R==-CGD<Z&ZCBFD[K/EI#`^5YWR.
M+O+M#7'H\#P4WHZHR*%UW2FGLG7U4%GK&8I[M5C5[%>&FT5ML-[1LF/D:\XD
M?)E++6JVJ[38*)J=Z#OH)BG*`W,O(L<)ZP0?S25_W@=U:PQB/:P@TT:Y]*^T
M=*+8LE]2/IQ#R,R\?X^3Q+*7V[(1730^X@LW8\8YUO8/9.UE8X)[]L;IFN%'
MPU`+21D#=.,ENNK.\L'DK!-FEYY"0>T'B:3A\9=G4":RBZ'/1J"@LP*:>*ND
MN=MX`@8G8)CE$1`,=!EH8#&YH<3':F/4#5W<+QX_#T]_L75^`]8,'QZXQUU:
MPW+I\=Q>;'M):RC[KY^2[AD(W_Z$@L$GZX.X!IT)M?9N,/('8]/@M<7)YK.,
M@-15JVQ.O9V'D9IT^OTQ/UU_3X60L\8M"()U:*B*W**F=H(J.SN'I0*7JB/>
M%W%E\9;3/NK<2E\[VEX(`#`UP<0TU\Q+A05I0>];AB/6'TPXGGKGE>`CR\N3
MSEW;2WL,K(FLLXH9V74S+>02DW$DD\;1&]S8FLB-3]X-J[S`<5[I2FO,>'BK
M#%2M,W+1G5=TG`%!PC)T-G(06PG<C3I%9=--D:!97>]NU8GRSB#6.6(V$"E;
MD$;:3-0W#K%[VD3P2[I7>#R#&`X?OMC`'>UWFUJ5KN3]9^/<AGX%?WMK-#R'
M`9)L^6G\KH[QS)K)L=TP`EW>?:6<;;D.`[D['35)E-.HI\3U-R7.H[&O#)K]
M0'TQ5;@^IKN2ME5M3%:%T;'ZW2:KFA#Q#UJ[9V1H=;R@=%24;"'>`C\S.<YA
MEE!)9VY=\R&N:'#:YM#*7^-:@M-.G59T^MK>`\>O^*\<ED_,\<%Q:LNFQVUS
M;/$N7??EX$HE8YKX'AN[MEP?7:0/,KX[WXTK[S=Z_J3FXS]*U14*O?&KYO4)
M1-"URD[8ZI]F\.S%W-1<ZV5@6]#L<^DZ.KU=&<K-S$-U`QRXW'946#)9@QKK
MU[VTW#RAK7=PF@(UWM81X4!\%USZ;>KD7IS;Y3.16-KD.;7][9N8;F,FVCA@
MN?GY7[8I(7"9UY!9NC:W[L,;('"FUIQAE.%&\+#`1DY)WJDMMNM+WJU>PV!N
M,TM%WG6-4JU(@KE69T1CDW02,S+5(TI''$ATV3M8X@(>:?IF6Y^PBD,;62&R
M[<E!I5LCG/<UPUZ`.VGV@#V+N*S^H7T[Q>1EQMGCLB_@K\;D6P0.$0DL\A<7
M%W-:7$/G+=D45R+><5!EC:T:[&UNQ=]`R54J_-.4A82,E)ODTNUB:ZU@4'R\
M@#ZP5="AM7$\55,&[!NVDGP.G"J/1$B)#K*"`@8V6<&29/+81R.<([0$NKT\
MKMYI[=!0?L+2..^IMIFLQZ?660N)H<;P]KI9W3%C6;(+AUXYL-#N>YT;.VQK
M_,7$1L%"`L]FB`MFS9N911<R""*(K*CU55%),""JI^$Y^G4?QCFNN=N)/O7F
MF:3O3/EVANYQ-!T%36@]P\%N<I7&F$3")A$PB81,(F$3")A$PB81,(F$3")A
M$PB81,(F$3")A$PB81,(H,^=%,U7-<A9]_:V6[%IE6"K*:RE(XQ\,-GU\44H
MAL1`J%MW54Y:^.E_+*'F)+K&10.`D1`$P`,[`X]-=QX]HA[&SS?'/<QGXC^K
M$X,Z]/;XKZ+?3EG^98_TNM;;#/X\VP%Q<$"\Y!RK'S;NZ[=6VQ5S'9L%?A<Q
M@<\4<\EY)6'_`-FVB_\`%W)O^I#Z;G["YG/FK_\`^D_K5]_GKOC\W^I7\=Q#
M^UO._P#?%GIZ>=0UM`;ALKVG-=OH2*M"?-US[`X[<2=20_NAIN$.8K:P:&K,
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MMPUM<0_(Q8F6`6HE$W<-R\S"=L.T1`_>"BM_,;6Y$51OK2CJ;NLL[*;OK6G[
M(2U/*5K1&Y:Y=VBZ-X.R-H1C'4AG7'<%-1[D$V0R4<]<(.PZE5,4>S+N*RQD
MIEN!;M:RW=(W;N?M?M95NXEQ.X'KM+01X+9;'A7I7FI,OR%O'K2UM..W>4@^
M7;=Y`VM\VWM'30.F>^[?.V:%[2Z;L3Q,?%U8#YEF+INV;3DF&_=?O;-'7NYZ
MCO;BGU"]V:(81;>;3EJ/6;=")7:/IK>#C%92`<V(4GH1R+#WAH"`@5-4YE#8
M&_@LFOM;IK'1P31ASF--:4>6NV%U2`=NE2:&O4:+H?GN#X99W7&>3VUG+C./
M9S&MNKFSMY7R.A,=Y<6LIM'W1FD$<S8-T7??-LD[@JYC0P=TXP7"UW_C_J2Y
M7R4:S=TL%*B9*SRK"-0AV4A-+(_I[MG%MNJ$>V67*(D2*)NPH@'4?:/#EH(;
M?*30V[2V!LA#036C?#4ZG[5@?6/`X3C'JAG./\:ADM\!:Y"1EO$]YE>R('R-
M?([5[@.KC2IKH%?S,>NM$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$
MPB81,(F$3")A$PB81,(F$3")A$PB81,(O+QZH5$@YOEY<9%_J?0EI<+5FCA\
M:O7,"9U!97!4:S'(E(]H[61:-F"3<$_+15*4?>$B@H(]3#G9_&'3_A,;8G2!
MH+ND)>/B=H'!CJ^W4BAT7V'^COD63L?0VPM+3,\ELXVW=V>U:<8BR=NTFX>3
MLNW1O+RZNY[2?(ZK`*!1[AJZKA_^`_%0?R^H=81_^6NF;!NN?W4_]6/\FO4'
MYNS?_,G,O[$Q?R*E3](FEPU>Y%W%_':QTA3U3ZDFFRDOKCE5+[OGE2*6BIJ^
MX+U-Z^>-V46L9'S%'W0IDU$TTPZ@J/35>7/D_#FB5TI^^:0#"6#X7U\Q:W4>
M`UK4GP"\9?7)GK_)^E5C;W>7Y#?,&<A<(K[CL>)A%+>Y&]MRUC"^05HV'4.:
MY[S0L"]'F==+Y2IA$PB81,(J#_=\/P_BPBQUL].XX+$LFJ[4SI'G2HRV]+-5
M)-^FG)K(^^':2VQ7J)W)'R;%)9(S51UU*D5(HH_F?-S)P765:YMY#W-*0M<!
M4=`0P:4J:UIU/5=I8?/^K#'VG,\))D=L/;P]O<QL)C:=@=%8L(;LWD$2-C^(
MN/<^+58R05?]-U35NP%(6PZO=:\3?5!.\SH760<JQ;EG(BXHC<9E>4/*1+="
M3^=')MCII&5\2@8WCF4DEY.+J/>)1<`.VC:-13SZ4H:CXJZKN#)93ZLAS'%M
MR%IF6<I,=T;.$VC&B1KH]MX[M",1R%T>D[I`YP;H2`LJ-/O./M.U&I/ZAF*:
MQU$Q-.3\E9HN:(\AP=-A,I8IB=G7CIPNK((F;?I2CI452`F!1Z%*4`P]\W)S
MWPCOFO-X:`-(UI^J`!T&NE!1=,\\@]4,_P`Y&,YY;W\G.91#"RWDBVR[7`""
M*&%C0T,(=]VV-NTU)%223V[3\AJZ0U[7BZ8D("0US'-U(FO&K3H'<2U1C5U&
MJS!$_><Z2C-PF8ATSB!R&`0$`'.&];>-NG?/!PN3J[=U->A_3^VL#SFUYE;<
MHNG<^BNHN52N$D_S#=LKC(`X/(H`0]I#@1H0:A70RV6HIA$PB81,(F$3")A$
MPB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB810@<X
M+]J&!Y`ST=;Y#;#:<3@JT==.I<U=1Z2A026AVJC<4:';;M"3;!<R(AYBYVY2
M.3?2$$Q3`.;[Q^&\DQ[70B#LU=JZVDE/Q'JYK2.O37_L7T/^G7C?.LGZ86UU
M@8L*['.N9P#<\3R>6EJ)7`UO;6UEA>*UHT/)C'E(J%B1]JO'C_'._?\`B8\?
MO]9>9KY7(G4BV_J,W^8N\?R7ZJ?Q'&?[!9K_`'%9U>GW=M5V/;UF94A_LYU*
MIT-ZY<)W3E]J[?T:+(LW#$.9O4J5;Y^3C7H+*$Z/E$BHIE$4Q,!E2@.O<E@O
M([)CIQ#L[@^"WDA-:.I5SF@=*Z?XEYN^J#CW,\1P:TN.1QX=EF[)L:TVO&<A
MA9-_9E-'7-W:PQR,H#]R'%SC1X!#"1,9FDKP@F$3")A$PBH/R>SVA[?[7X\@
MTIKT11/;BTYR)L^S-E[QAJU&O6#U];]-Q-*&,3^T:5TY+:FEJ@5VRLZEN+74
M:TYVU(%G@8*QX.O=T^_S0-]'FY6%]BXK2+'/>6N`;*7U.P2"0.U;MKN[8V5K
M0=*>(]K\$YYZ5X?A^(].;^\GCN8XK7*27?</R,>4CR45T6OMQ;&9UPW&L-GW
MFS=O>[;L(\RZ1-4_:]G;:QV`ST1M.'0TE5]*U*?B9%A24;I?5ZM?4)V7+5XA
MI<W;=_!U-FF=TBH\>,C*.#]J*8AU/G/%<V,/=@-Q"1</E<T@NV,W-(&XEE07
M'2@!TZK8L=GN%8:;,<7GY)AIY>0WF5N898WW9M;(7%DZ&(W$KK5I9+<N(C<V
M**4-8*O<#1JRFJD=;(;6O*?:DCH><FU-F79W?Z;Q[FTJF-@LJD52Z=78]6R,
MDY:4J\;*VN?KWO#@HNG)DF:"2I^Y<3(EQ$[X'7=G:,N0WLQACYF[J-JYSCMJ
M`XAK74Z#4D=-5TSFKO"9'EO#.%VG);:W;B,>VRNLW$;GL0"2ZNIWB!YCCN)(
M[:&;8PB.,.E>^-H$8$ANMQ1A7\9K-U*6&)MD5=K?;[1<+Z:WP$;5G;^WSTFJ
M\EG,17XN?LS>+K*:AP1CB'>+.!:I$%8YU!,8;3-2-?=B.,L,$<;6,VN+J-:*
M"KBUM7'J30"ITT6D>M-_;7?+F6>+GLIN/V-C;VUF+6=]RUEM#&&1MEGDAMW2
M7!'FG(B8SN.<(VM9M`R=S$KJ-,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$
MPB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"+S/^I=KV4G^65ME&T+Q=>).*
MY2B$<;-XKRFTKB8&]=8I&^(7%LDJB_0*<HE;I!T\A#M3'Q+G9G&I7#%1T[NA
M=TFV`>9QT;44]_OU\5];_I(Y+:XWT3L;66XYC&\75V=MAR*/'VHK</\`@M7$
M%A/Z[C\;R7>*P(^R68_\V^#7]12>_P"C9L&_]]<?UC_XEZ:'-L<-/F_4/^U\
M7^<I/O2@HDE6N0EOD7<1QN8I'U5+-06U'QKDM/643JV6KJE2<V=XDFF[AA*B
M(K,_$5%024#^]CFJ\MD)QS16;65OQ2[VZ-?U;4Z^P^%3[5X[^M;D=KEO2^RM
M8)^5RN&:B=3)9YF3MZ""Y%6V[22V45HV7HUN]O5Z]#.=>KY=)A$PB81,(J#_
M``=/EZY!H="BPHV+RR/1]UVS6;:$@I"$K>I;-82S*TV1&7<;<@ZO);#:Z[-#
M%4\\K)[KF,-)"[`GS>O:&9ZTPOS-@RZ<YPD?.UNVF@C)#-]?\L[:+T#Q7T29
MR'T^LN7RW%S%D+O-V\!B$-8FXV:XCL77W=I3>R^D$';KKU5H'?+7D!`1E4B;
M%4]/*77:\/K>P:PDXEU<@IS-I=+*E`3,5<VCM89X\G7D%BNBK,SE0<D'L``,
M&7K<)CI2^2-\WR\#GMD!V[B6MJ"WPHXZ:ZCJM\@]#O3'*7U[>8J^SS>/X2>_
MAR$<K;7YI[K2W,T4MJYH[(CF(,9;*"^,^8D@K);7VU]I6NK;?@7M1J*^[M2V
M)S45(N)F7[2@V>0?UZ(LM6GF3^1(M+14,\8SI".T%A4=)JM%@*/ST\Q5S96<
M,T$K7O\`D)F;JD`O;YBUPH-":M-*::CWKJ'E'".&83,X+)6]]?-].\Y:MNNY
M)"QUY;L9/+!<0O8PB.25KX28WMI&YLD9(\KUV+CAMQ_NK7(V^42@@?,K;<ZB
MN^K!I`L!-#4+)(0'QV(:S0?&8^.E@8^<D@[^G(4WSNH=!SBREDVPNNPTN(+&
MNHZE1N:'4--"16E1HL7ZL<'MO3[E8P=FZY-O)8VER&7&SO1?-0,F[,KHONI'
MQ;]KGQ>0D:>(5_\`,>NM$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$
MPB81,(F$3")A$PB81,(F$3")A$PB81,(O/\`\_\`DAQJUSR5LE4V0PT2ZMC*
M`J;AZ>]<A>6.O;("#V#9N6)'=6U)J^TTUJC[JJ3RCI.S++)]#JE*<1#.PN/6
M-_-C&2123,B<74#8K9P/F(J#+(UW6HU&A&FE%]-_IC])_5KE7I)9YOB<O)68
M62YN6L%GA.-WL!+)G->6W&2R%O=..\$/:Z(-:ZK6$M`*PL_IF\,/\3<6/ZW/
M/W_4;F;_``K)_P`=/_L++^67H'^X7U^_I',O[,\+_P#5U(=Z:O('C[M+=UIK
MVJF.EFEA;:XDI9T.N][<F]F39HEO/U]HX]X@=TZXI];:QWO+M$3N6[@[PB@D
M(!!(<Y@USD]C>PV+7SOE?&)`/-';L`)#J:PR/=4@&E=/V`O+7U;>F/J?PWT\
ML\KS*7D$F+?EHXV_/8CC]A$)'0SN;MFQ5]=3N?1KZ1O8V(M#B7;FM!G%S15\
M[$PB81,(F$3"+$.V\,-/7(;5*RR,B6]VR]R=[>;-;)PY+XQ7E*TI1U*]&SAX
MHZ[>KI4)8\05F/<7W8XF$14'NS,Q9Z_A+&L(^69&&!FNR@.[<16F[?YJ^U=X
M83Z@>=\?^2M+)T/Y;LL9'9ML'&3Y-[8YQ>"=\(D`=<&\:+DRBA[@`'E%%U$.
M$<,M`&;RVZ-IS5IC$*;'T>\/OJ:20U[#4&<)8(.*KD8SJ[:(425DDP%ZJ\2<
MK.2@!`,0@=N<PS\K9/N[>)L1+M[!NH\O%"7$N)T'2E*>\K-_]0V1BR?=LL!A
MK?#3/NI+NT9\ULO9;V$P323R.N'2@B,TB;$Z-C"2XM<XU5Y:UQ^B:]KV]4PM
MZV`^L&R95W9;=M)64C&6P'EH<,(F-9SK)Y%1#&&CAA6$$R09MDV?NI$6P%4(
MJ)U14L)\FZ6YCF,48CA;M;'0E@;4D@@DDUJ:FM=>HH*:#EO4^]RO*,;GW8W&
M1XO$PM@ML<(Y'V3+=KY9'0O;)*^63NOFE?+(Z7N%[R6.9M8&=KU#JEAJ:`DX
MQ*=EK7.62QS%PMMIG"L4)"?LDXX%P_>F91C9G',&Y?FIHHI)_,2(4#&.;J<>
M*]OGWLC7%H8QC`UK1T:T:`:ZGWGVK#\[YK<\WRD-XZV@LL=:6D5K;6T)>60P
M0MVL9ND<Y[W'5SG..KB:!HH!=K+1:4F$3")A$PB81,(F$3")A$PB81,(F$3"
M)A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A%YSO47K6RY'E):'=;W=
M9:3$J5RGE0K\7IW1MP:-%"0+%-=4D[>-@URQ./>E`%0Q56P%2,<2IF$@`.=D
M\:=;_A3#)$TN!=KW'@GS$]&QN`]G76E5]5/I5RO$;7T;LH<MQ^TO[X7=U6:3
M)Y:V<\=YY`,-I8SPMV@AH+9*N`JX!U5@P%-W1T__`++W7\O]'CC!T_C';XYG
M?YO_`!#/]I+_`"2]'?CO`/\`E&P__6\__P"E*2CTNJ]L**WQ;'-KW!8;_&CK
M"212AI;5.F:.W1=GL=<.G(EE]?WJT3:ZJ*1#I@@HBFV-YHF,?N*0!UGE9@_#
MVB.,-?W1J'O=X.THYC1KIXU%--%Y)^L;)<7O/3:RCPN"M<9<_C$9,L>1REVX
MM$$]6=N]L[>(`FCB\/,@(`#:%Q4]X>P/R!_)G7Z^::KA$PB81,(M)NGAU#P\
M?'Q\/XOPY!%?MHI'L4.^\+=LP^[=J;@C:=:3:P85^\<5B6YC,.O(39.]82]G
M3F6NO48@9)P\2WBX;PR<RFX[`3$2@7L\<W?'P6HQ\-BY[#=E[+C:0/XP-IOK
M2G:\VVG@O=_IS@^)1^GF%X)=7]G^<I;JSY'\L^)M2YF0B@[3KPR=MK3B!)=.
MM7,W;M:UT6/SMKILM8J2-`C6B.G$Z]Q_0Y.HQ]<LS>B.[6G?T#"K8HPT0G\5
MLI&!E`E%DVZQ_<`[5C"7M`<DTWG<>;D_SS=-V*EN[;L_5-=&U^$'QZ+LV"7G
MKLQ?/Y-*]W/77.:/'R^XMW7;;8V3M()!(>W;[]IMV.>P=XUC%:E9ZZ8F9^NZ
MBY'S''*JO[)1TMCN2<=:T5):&C@:/JY3F5H>4YA9$6R:%,A;<ZD7K=H*:2#E
MTV=D2Z$5*<=<OV127MI'DWAL_:^_=U-0YY:';>KRT-;6I(!:3THO-7J!8XW*
M\ZXG8^K%Y':<C=BF_CDY(ED+F3W3K=MU)`7$W<MJV"%\M7/9&^!SZN86BXG`
M=.<:\=8R-L,)?(*2A[YM&*.ALMW[]<7J32^SQ4I.7>]3>]+/`'J!P^:(!\WY
MO0<MN1;#E'.C=&YKHXS]V*-%6-T`6J_4P<9+ZJ376)N,;<V<^,QT@-@W9:M+
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M"_\`3;R3_P#*\J_MO;_YRD6],SDS6]R;RM=8AZIJV#=L]:R<R9W1>*$YHV3.
MBWL->:&0>6R11(V?,S&?%-[B`]RIR@H'4$AZ:MRC'R6MBV0NN2WNM%))NX-0
M[4-(&NAU'3]*\J_5YZ19;@7IQ9YB_O<U<PR9>.(-O.1PY>,%T$[@YMJP[FOH
MPCO=&@EAU>%.KFB+YQIA$PB81,(M)NO3PZ^WY,(L<KAR2H=+V7/:IDXR;7E8
M#4<]N)[(,V316"-'P*KQP]K"3D[DASW%:.9*/TVHD#N:_2B8`ZYD[?%74]HV
M]8YH:Z81`5-:F@#NGP@FE?;I1=K8'TFY-G^(VO-;.6W9976<AQ;&.>X3!\P:
MUEP6AII:A[A"Z2NDGDI566+S/@FU<(67T'L.#G[$SI,U1=?NEM<++[%A]A3I
M:]&2<5+,;8YJ+!5K)F+[\VDGC5VW3,"ADQ(/=E\<#(Z3[NXC=$TN:]]'T8Y@
MW$$%NXZ="T$$Z5JNP?\`I^R4^5+K#DV+N<9:27<5Y>M%\!8RV4)GDCDB?;-N
M7AT8/9D@BDB>X%K7;M%>.(Y'U@VJMI;#G:M9*6[TB%@8["U_,$AOK'"2E>@&
M=C0B62\=).JY*)S<-),U&#IL[.S5]X*7S"B10"6#\7,;V&UB>R07&TL>*[2'
M$MJ:@.%"#4$5TZ+0+_TGS`YIAN+8Z]M+^#D79?97L1E[$T<\SX'2/;)&V>,P
MRQRB:.2(2MV$["',+KE:IOA]ETN+N0UEY4TI4SE1K%O9JI6!4[0BYB-WQ).D
MSEC@%D7Z8`H4$W1E"`;HH4I@$H6MY;&TN#;[P_:!4T<-?91P:=/LH>H*U/FO
M&6\/Y#-@!>1WKX`T.D9#<P`.(JYACNX8)@6'RDF,--*M)%"KEY;K4TPB81,(
MF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$P
MB81,(O.)ZD#153E+9E`Y(\B-;%^K5/Z537?+:3U'5V?2#:![RUI371UY29N7
MW]\66^(J"NH(G[2=W:'9W%ZG%QTM;:05=YGVPE<?,?UC*WIT&@Z4UHOJY])[
MP/1JSKQ/BV6I=W0^9O>-1Y.X=]\\T==.R]H7-9\+&]ANQH#:NI58'^X#_MF\
MO_\`B!3G_P#E_-BW#^@V/]29_+KTGO9_R!P7^Q<7_P#8%)CZ6+4Z6^+@H/('
M?&U0^S&3*-?V?RBD=V03/K8J[_A1I6'FF]>IL9)(2^61X#Q02)JG3\HW?W$U
M3E^[\/96VMX291YHX!$=`[2HD?4&M:4UH-=%Y#^LR1KO3:R:.,<;PO\`]XB^
M_P`?QZ/$RNI!/]VZX9E+TOC-=QB,0JYK7;QMVNGZSKI?,Q,(F$3")A%I-[/Q
M#[1_!A%'ML/A9/7:=O&QT]ER+#9MFV!.3<84[VQK:\84J5U>]TTG6WE&+-DA
MGDHG3)%5R9_Y8+#)"!PZ$#MS9+7/16S8[4Q`VC(@#H-Y>']S=OININ%*5IM_
M:]0\6^H+&\=QF-XD_$1R\/L\7%#)Y(!?/NX\@S*F=MYV3*V,W4;8Q#N+>Q5I
MJ[5=6>\2=\ST/6I:P734GUWU=':[@M6QD96;>C4/AU)LJ-@DWUP4<VIS-/Y2
MQ)(@V*#15JBU3`1`ISCW!RC-X^-SVPLF[,Q>9"7-W5<V@#:-H`.NM:^Y9FW]
M;_33&7UY8XK'YS\NYF6^FR,DD]J;GN7<!AC9:AMNV%D<!)>>ZV1TCO%HT5_H
M#1-Z2UUNE"TSVO9K:V[9I>R3:[BCJRVK&+AK`05>@JLK3+#*RSF:K*$=`%!Z
M+AT+APJ[7.F9(`1*ECI<C:_-0&%LK;*W;0>>DAU+B[>T`--2:4%!0==:]9Y3
MU*XX_E?'I,+;92WX7QZW%O"T7@BR+PZ::>:X%W!'&V*X+YB8MD>QC8HVN:_[
MPO[IQVU++:DJ=A9SRU;2F+A=[+>I&#I$<O#4>M.;&],Z-#UB,<K++)-T?`RZ
MPB473DQU>PG=VA;Y*\9>2L+`[:R-K`7&KG;1U<?^SV"@\%K_`*J<WL>;YJUG
MQC;LV%ACH+-DUW();NX;`S;W;B1H`+CT8T5[<8:S<[;59!9CUUBF$3")A$PB
M81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"
M)A%!CSFW/R8IO(>P0.L]9<L[+4VL'5UFLOJ?CKJ/8M*<N'4,U</BL+3;0/-N
M7#=R<Q'":G0B*P&(3YH`.;W@K3%RX]C[EUKWB7:/F>QP\Q`T#@.FHI[E]&?I
MRX#Z1YWTMM,GR_+\)M<W)<W`=%D<YD[&[:ULKFM[EO;$1-:6@%A;J]I#G:DK
M#_\`I(\U_P#0ESZ_J><?_P#FLS'R&#_=V7]8?_GKO,^D_P!/=?\`]P>F?]J,
MS_G+/3T\]M\AKWN2RQ&V-<<G:G7D-?2$@SE-S:&U;JZKGE49V"119LYVF`26
M=S2S5RJ=-L<!0,DFJ8W0Q"]=?Y%;8V*R:^V=;&42-T9*Z1U"'5-"2`!05\=1
M3Q7FOZI.#^EO&^!VE]PG*\/O<H[)QL='BLSD,A<=LPS$N=#=5C;$'-:'2"CP
MXL`J'&DS6:8O`Z81,(F$3")A%%1N3E%<*[R'V''0=@M+#7T%0[EIUJ5.M.CT
M1EN5OJ>9W3%W12[G;C$)S3--LC`_#S*]XN3@';W>&;=88B";&1F1K#=.D;*?
M-YS%W!$6;>M-=]?8O:'`?1W`Y/TLQ=WD;6REY/<9*URKJW#1>/Q1R46*EM!:
M`]TQ/+G7O?#:=L'6BME+7'9=8::VI$;O_9\U'[?K&DK#=)V2ML:]M]!D['?&
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M$PB81,(F$3")A$PB81:/X_Q=/P]1Z^SYO7*?U?\`$BUY4BTF^7^#I^=^'\7R
MX1:L(F$3")A$PBTCU\/[?7IUZEZ>S"*QDW_1Z^I-C^L'V:?4'ZZO_K5\2^#?
M`?M!^+!\1^+^=]%]9_BW3S/,^G]G7YO3,E'^*?,,[7=^9[8V]:[*:?\`LT_0
MNQ<=_>E^8K3\+_%_S-^',^6[?=[WR7;^[[5-?E^U7;M\G7Q6/T)_N[_LOV!\
M#^P+[,/BL%]H_N/PCW/XG[R'U3^/=G^%.[WO_JKK\SOZ^[>/7,@[\S_-1=WY
MGYK8[96O3];;73I\7C[5VCD?^JC\WXO\2_,_YN[,WR&_N[^WM_G/9_U?P_\`
MF?';3NZ45_Z-_1V^Q9Y]0?LO^P;X/8?BWP3X%]GWPGRG?UN^.]G^#?S?/^)^
M]_2=W?Y_SN[,9/\`BOSX^:[WXE5NVN[?73;3Q]FVGZ%UAR/^]3^\!GYF_&?[
MR^_!VN]WOG>[5ORW9_UE:[>QVM/A[>E%V'2_V2?9[#_8C]6?L\\Z0^&_57M^
M'^_>_./C'O7=^E_%_B7F>]^\_I7G]WF_/ZYPWOSWS!^?W_,Z5W5K2FG7P]E-
M*=%B^?\`YX_-$_\`>)\Y^:J,[GS->YLV#M;?U>UV]O:[?W>RFSRT5ULMEIB8
M1,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")
*A$PB81,(F$7_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g672020pc_pg001b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g672020pc_pg001b.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`D@$=`P$1``(1`0,1`?_$`/@``0`!!`,!`0``````
M```````'`04&"`($"0,*`0$``04!`0$`````````````!0$"`P0&!P@)$```
M!@$#`00&!`<*!P<5`0`!`@,$!08'`!$($B$Q$Q1!(C(5%@GP46%Q@9&AP2,7
M&+'10B0V-[<X>+AB@C,T-28HX?'R0R>G2%)RDL)SM"5%575VME=WAVB(J!DI
M.8D1``$#`P($`P,&!@L+!P@+``$"`P0`$042!B$Q$P=!(A11,@CP87&!(Q61
MP4(SM!:AL5)#LR0T=+5VMM'Q<I*R4W-4-387X6+$=59F-Z)CPV15)L88@D2$
M)46&)U=W*#C_V@`,`P$``A$#$0`_`/T<?,9Y(YQQ'REQM2,;9$EZI5YKBWF&
M[2,.P3:&;N;579UDUB)E0%T%#BZ9-U1(4-^G;T:[7;F,A2X)>DMA;@E)3_\`
M1('"]?H=\*O:;MSOCLWE=Q;MQ;$W,,;RQD5#B]6M,=]E2G&@00`E1%SXU$_(
M+E=R)JD]E]M7LI3L8A7\91<U#HH(,>EE)K\2[!>EG:0G;F-UJV]FF^'<1V5+
ML'J]FI&)AL<Y$;6MI.M2U@GCR]0$#\">`KMNV793M9FL7@GLIAH[STO,.-.J
M)5YVQN5F&$D`VX1E*9'_`#3[:B;C[S-Y06S,U!KE@R_8).&DZ?\`+ND)%@NC
M'@D\>9;RK5(/(JQP*V`2'M,4]607$HAL101+L(`.MF;A,6U%><0RD:52K>T=
M-I:D_4"`?IKN>Y_8+L[A-@Y3*XO!16IS,[>[:%@K\B<;C9+L$<5<?3NH0M%_
M%/&X-J[W)[F3R<I+#+"]9R]8(H\%FUC6XCRR$=_$X17G!G[&AX],3-3"*`T:
MJQT<._:*+0O;U"81I!PF+?0VI;21JCZB?:?3,+O_`(RE&_A>M7M#V%[0[@?P
MK>7P45[U&WER'-16=;HVEA9^L^;GZN0^_8<-3AX6``SKC1RUY'7')V5(6SY6
MG9:+@LL\N(**:+H1_A-(FA8=0L-/9)B#8#>%!S)A72^LW8;<.S6'(87&M14N
M-M)"RB.;\>&M:4J_"+W-<YW<[(]J,#M##9+#X6,Q+DX7;3SBDE=U.3,F6)2K
M%1'VS0T*/LY5'`<S.3_Q]QQB1R_8C,+AG&HUJQ-O!C0))PCW#4I8WL<N`-0_
M0.IA`JYMMA`X`("&MA[!XL-O*0RD%+#BOK"K"U_9_P`G*NJ5V"[/#;>ZIHP<
M7U4+;LI]@W62V\C*-LH<'FL"EHE`^;G5ZXN\Q.3-VXC6>^VG+E@E[>TX\X>M
MK2<<H1PNV]AL',7*^/I>3)T-2D.N^I<(TCS]0"'A(%';J$1TR6#Q3&6;CH9`
M:,AQ*A[0(K:P/\<E7S$UH]X^Q':';_?"'MK#8**Q@E[IRD9;22O2IAC:^-FM
MM\57LB4\Z^FQOJ61RL*A++'.KEK`_K+]U9JLS,(?AWEC(49X2$:`MKC7^1RE
M1B9U(1:B`.FM:V9AON7PP`=M]QUL(V_BEE`Z*?,^$GZ"P%6_QN/TUZ%LSX<>
MR&23B#,V]$67]]8Z$OS.>:*]@A)<:/F]U4B[I\;FWLK<AORDY`GQTC+FRA-C
M)'Y-5BEF=BBQZOA=YBE"<<P_:WV%LM+'%<1]H3^G;4:,3C!)T]$!`AE?TJ"[
M7_!7@CG9KM>-U&`,/'](-GR)6FZ[>H1D2REWWO>#8T6Y6\+UIJ]YU<M$K+-L
MB9ILWE6_(OY==.;I`A&@"5>RYB(E@R-'`/E=_!M4P(+N`'?U@]7I`=2J=OXC
M3P93^9F*^MM8"/\`%'+Z:]ZC?#CV25B(T@[?B=5>U]\2B;KXO8W)=&"X?-[T
M=KRH/LYWK=MWR?Y`)TGBW(DR=,@^NL5>%[6Y\O']4TO&\Z<.XS8G<AY;I*+:
MAV![&AT@`"BN8?:V$(D8G&F1,3T4Z6RC3SX7B.K/_E@*^KV5\_1^SO;!6X=Y
M1%8>.8V.?B",+K^R#FT,I/6$\>.J8PT^;_E(`Y7%:)8]YV\NI>1Q*C(9OL[E
M.>G.8+67!5"-$'J./9:0;U`JH`T+L6%22*5(`V``#MWU)O8#$M]0AE-@IL`>
MP*M\OVZ^B]T?#?V/AQLTY%V]#1Z>/ME35BNZ3-;0J3;S?OI)U'F:W1S/RJY"
MUR<.WA,GS;%N7#.,K'X";=AT#-3'$K+-\E7VYFXF*J^MT$S?&`!V!5``#8-P
MU'0L-C762IUH%77='U)D-H'X$DCZZ\#[>]E^UV6QG6R.&CNN_?\`/8O==^DU
MN3&PVV_>Y(C/.LCQTK/C:M<N/G-CE/:[]BF,G\QV.283O'OA!:Y=JNE'BF^G
M\E<G:+3;O)*]+4H@XGJM*.&2PAL`IJ[@`"`#K>FX/%-,/+2RG4'9`'M&B.ZI
M/U:DA5N0(X5ZOW0^'OLSA-M9J7C<!$:DQMS[LC-+25W0S`P$R5$;'F]UF2VV
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MBN+XJYK8NV?"QJ*F_,WE`:Q\5F9\PV$S>\9YP55[23P(\A9F!LU)R!)3\:[Z
M6P`*$F\BVZA]MA`R91*(:W7L)BPF04LH!0R^H>/%)&G\%=L]V"[.IQ.\GD8&
M('<?MO,2(YNL]-YB7";9<3YN!;2XL#P(4;WIQ!YF<G\A<9KM=+AF"PS=ECN,
M3RYLI9RA'@X;6M+EM?J(6:3!-L4HN`J44@QZ1`2`DD'9OVZRYG`XF-EFV6&$
MAI4S3;E=!CH7I/T*)/MJWOKV![.[8[NX[`8+!16,0[N]$1;22O2J.=M0IA:-
MU<O4N+=N+$J4?#A6"9HYQ<KZW8[6TA<T61BV8\8>2]V:)(H1H$1L],S`M`5J
M6*`M1V<14,4$$Q[@(7M`1$1U8U@<4M"2&4\7$)\?RFD*/[))^NNBV'\._97*
M8F"]/V_$==<W?@8BR2LDQY6+2^^W[UP''25JMXGAPX5MQ1^4G(*2PU'V%_DV
M:<S*V<.,E:._.@P\4\%<Z(M)VB-$I6X%\&8?%!50=NH#>R(:CG<1CA-Z89'3
M,9Y5OG2H`'ZA]5>)[C[,]L8F_7,3&P\=..&W=P/Z`5VZT68&X[GO<VD>5/A;
MG6C,ESQY=(KWA-+-]E*6+E/E@HLQ*G'%%)/-..D)C)Y2]#0.D+=*F%9R'U]A
M=@U/*V]B4I0I+*"5&9P/_FG0E(^I/`>SF*^BXGPU]CG&,:XO;L/^,,]P"NY7
M_P#A,\M8\GS<XS7E1X^)N16^=OY09^CZC@&099,F&[RTGY(%L#@C=B)I3X/Y
M@XCH-9\<!;](!$4V=>,$^D`ZDES";<VPZ@F,3C5OR4EI)".CI^;5&=6?PJ`/
MT@5\UX+L_P!LI&=W-%D8>.N/"&"+*2I?V?JML9.9(TV/'JRF6GC?\I"0.%ZV
MA^5GFO*F;,?9\E<JW.0N<C5N261:=7W<@FV(>-K4.Y2)'12(-DDB"@W*8=MP
MWU!;HA1H4EE$5`0E3(4?G)->-_&5V\V9V[W1MJ%LN`U`B3=J0I3R4$D+?=22
MMPW)XJ\;5ZD:YBOCFFE*:4II2FE*:4II2FE*:4II2FE*:4II2OSI?-A_KH8C
M_L8Y\_)8HW7HVTO]EG^>I_R17ZH_!5_X!9O^O^'_`(!=0ERD_E%GK_W.0G]Q
MZSZE<:!Z-G_2+_24UZ)V=_V1MG_KUW^UT>H.XM@'[0.-NSNH'RIMOL_Y:Z7W
M:VLG_)'O\*9_`N5Z+WBX]L,Q?_VEW%_HF77>YDB/NG-X;]G[1,7V?_Z,\GM,
M6!I9'AZ8?H<:M/L/_*MNGQ_59?\`8?;]23Q``!S%FW<-_P#EPYS?T"-]:N6_
MD*?\"-_")KE.^/\`N-M_^KVT/Z9544'_`)S^)?\`:+H_]W^:UNO`%#U_]7=_
MRZ[57^Y^]?ZJS/Z9:K(>&7]1>W?V5L#_`-_7->K,W_MUO^=._HC51O?W_P#T
M=!_KEF/[&XFM<LWB(_K=W'?_`&!LX_WLE-;;'$MW_P!:3^CBO5.WO`8(>'_$
MK$_V;%>@+7^:9K_:_IW]";?4,`/5I_F2OX6OF1[_`'V5_465_2QKS_D_Y96+
M^UE\J/\`H)2U/-@%K_[//_A$U],QB?N&+_4KN-_2YKT5>_S<\-1]/N;(W;Z?
M_P"D6!=<\WQD3@>5T?H3M?+<7_>K?W\Y@_V$S->:F+?],80_])N>OY)V5V_%
MJ=D^^[]+7[0KZSWG_(MP_P`VV?\`P+=>@W(3^4BW]GS#X_\`V/9M_?U#8[BR
M;_Y]W]*:KYB[7`?='_YGRG]KL36IO%C^<K"?]E?Y=']\''6I+)?R>0?'KROT
M=VO;.\/^Z&X?ZY[X_LQ.J1>:@![KY6=@?SPWP?PCSCR#N/WCK#C/Y/&/CT$?
MHK=<MV!_E>RAX?<$+^R,*I.XO?UK,E_VILZ_EXC.A_=UIY+_`&6?]"U_#(KC
MN\7_`(+XH^/ZFX?^TJ:A5M_*WA5_:7XW?T<90UOR/S<O_02/VTUZ"]_L??X\
M/U3SWZ=CZKP-_J?Y#_L>R']^/)VLVX/]N-?SW_HJ*K\2?_CMBOZ]H_LCCZC3
MD(`?%5W[/^AOR_\`Z>%OW]6Q_P`TD^/7;_@45UG;(`87'$<_U[VU_0R:WEQO
M_5_B!]/[1G#SM_\`ALXU$/\`\MO_`.J2/\L5\X[N)_XEO_U3W1^G)KS=EO\`
M/<D?^>?DW?T4-M=.Y^99^G(?PXKZTA`>EQ/^@[H?TD:]-;Y_(/C#_P!TY;_W
M\<&:Y>/_`"B5]$;]$=KY"VW_`+R[P_P=M?V.S%;C_)<_FNY/_P!KC+'_`'XA
MKG=Y?RJ/_H!^W7@WQ_@#>.S[?]B<?_DFO9K7'5\"TTI32E-*4TI32E-*4TI3
M2E-*4TI32E-*5Y[<I>!,+R=S!4\MR62YFH.JMA^\8C)"Q\`PDD'C6[R"#]::
M,]=/$#HN6!D.DJ($,50-A$Q?3T&)SZL9&].AL+'6#E]1'(``6`/LYW^D>SZ>
M[-_$O/[/;&F[(C8EB<S+SL3)EU;RVRE45!0&M*4$67>Y5<%/*QX6PS)WRU:_
MDF1O+]?+E@B1NU19U-5)O6HMR6/29X5E,-E?)BJ])XZIVDD+\2&Z2@J0$]^D
M=];<?=*V&4LAE-D*)OJ/BX'/9\U@:Z':'Q;9+:43'148.,^,=-7)!,AQ)659
M9O*:#9!T@*;Z-QQTG5S%JPG&7RI*WC6^5N\H9JL<LK7(/B[")QZ]4B6Q'I.,
MURA;@P7663D5#$&W*PP(+%*7^*E4,8@G$`#623NYQ]AQI3"1U"\?>O;JH4CA
MP\-5_GL.7&I_>'QJ9?=>VI>W7-OQ&$2Y&X'2M,EQ6G[_`(KL58`+8OZ8.ZT7
M/VA2`H)XFNSESY5=;RPUNK5UF>Q0WQE?V]]6,A58EYY%=#D'DK/H1J(*2"/C
M)"]R0I&@H(@8$FA%=A,<Q`1]VNL(0D,INAH(OJ/^:;:OR_\`-W^LCYZQ;'^-
M#+;*<Q[C.WXC_H,688O(<3K!PL##:^"#8Z8*7[#AJ=4BX"0JLAQ+\LN`Q3;K
MI;&^7[#-*W"ZYLN*C%S6(IHDP4S/14Z0[CTUDGJAUTZ^D3S")S`!ES^H8"AV
MZQRMTN26`R64@`-CWC^]J"AX>-N/LJ,WK\7N3WG@H&%>P46.F%C\3&"TON**
MQBIAEI604#27R="@."!Q!)K&/_Q25OXEQ78_UTV(QL89"A;\@V-58D"RZT+0
MW=()&+*ED0%JDX1="X,H4#F`0Z0+_"#*K=SBDK264@+;4GWC^4;^SC;PY5,*
M^-3*G$YC%*V_$"<OBWH:E"2Y]FEZ6F67`-'F*2G0!<?NK^![^(/E95W$F$I?
M##7,EBFVDMC*CXU-/.*M%-'+=O2LZ7+-R4HFS3D%TS+/W=P/'&2,<2IHH%4`
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MQQ5WZP,/2`;=NM3]:%]4/!E/Y@M@:B/RM5^7[%>;K^*S(KS/WQ]RQM9PCN-T
M]=RVER491=OIOJ23H">1'&]Z@IQ\G6JKR[^5'.UG*9]E'B[DTZ/P=#G`CCC+
M1_@J.B@/[T`WAVU+^,+J]@M3`!2%.&^^XG>CH&CH)_-OI][EUB%'P_)M]=SQ
M'"WI#?QX9EN$W"&VX92WAMPP`?5.W*<_+]6MS\W:\8^1"?WP$DE)M:?U_EWP
M2U?P_`#E.>*GB1G8635R%=C1/.>_^1%%Y!'4=)^;Z6HM7M()&%`@F`R#@RH[
M'*!1TD[G6EQ]SHI^WT^)X:65L_7<+U?2/97F37Q3Y%O)YW)_<L8KSCC"U)Z[
MEF>CA)F$`3Y?-J1+,@WM9:`CW236N=9^375*T\I+LF>[4Z&G2&<GZ1!ID,F$
M@;-CQR[=D5$)-04!@!<_HQ+OXXAZP%[@W5[S<65$L)NHI_*/`I\.7$>%>J9C
MX]LSEF,@RK;4-!GMXA!/JG3H^ZD)0D@=,`A[3=5_<\"KG4]W_P"6_`7J04D%
MLL3\:8U!J5%\)&N1C@`1JF%;GAI*2$3O"F\9ZTN)WYD_9(J@"8")3"8-2-NA
M;""D,I(ZBE>\?RG$.VY>!3;Z[UYMMCXL<GMN+Z9&$BN@9.3,XON#C)RL3*EO
M@GDA44,A7,I65D72`8NQG\I&L8VLE-L*&;;)*'J&,N/N-4FBE1B6B;YO@3+=
M=RNRE%%"RBYT%K(YKQ62J10,#=)8RA3',`!K/(W@X\A;1939Q3BO>Y%QM;?L
M'+7>_(V`L*['=WQP9G=>)R&+7MZ(RF?E\U/*A)<5H.9QK^.6V!TP#T$OEU*C
M;6I"4E*02:OV9/E75S,#3*#9QF>RP/ZSK;-VQ<[6J1+T8A6:S5/9F.Q0!=\F
M#E)!W.F8`<_2)DD@4$.H1*%D;=KL=#;?120VVE/,^#26[\O8F_TFU1FP_C.R
MFQWL,ZS@(DG[G@,QDZI+B>J&<2SB@LV0=)4ED/6%P%**.0!K)L:?+2KV-\HV
M/)K?+=@EG%AR==LDGB'%9BVR#9>Z8J5Q:M$E<IOE%%$8]JL+PBG2!CJ`!!*!
M=S:P2=SNR(_0Z20"A">9_)4%^SQ*>7A>HG=WQ<Y3=FS8NT','%8;C8B)`#HD
M.**A$R(R(<TE``*U)Z13>P22H$FPK#4OE15I*5PY*?KJLAQQ#D;'60FZ1JI$
M@$TOCVOV6`0C5C%D0%DE*$L8J**%`XIBD!2E'JW#.[N]QP.I+"1U&W$FRC^^
M6OX<;<QRJ><^-7+N1<]$.WX@&<Q4Z$HB2Y]D)KS#RG`-'F+?0`2#:^JY/"QY
M80^5'6,*XFL&*F6:++/-I_$2^*%)AS5(IBX:MELU63,HS:;1*2<)*.P>6,S#
MPA.!!22!3<#&Z0RS]XNS9B9:F$I4E_J6U$_O0;M>PL+"_+YOGIW#^-;+]P=Z
MQ=Z2-O1(ST;.#)!I,EQ84H8EC%]$K+:2$Z6`\%6OJ44<A<XW??E!5:]2<U)J
MYRM$<>8Q%EG$YTDZA#N`;M\J7=2[.9DICR2?6O#K*>7(B(=*I``PF*.X#:WO
M!Y`2.@G@M*O>(]U`0/#YKW]M2FV_CJS.WH<>(C;D-WT^<QN1OZIT:E8^&(@:
M(#9L'0-95>Z22`"+&IIKORYX&OT-K1B96GG2+3(.)+^61/7(TBRB^**XI7F\
M:+<KP2`A-D4\510!ZD3!L4!#MUK+W.MR1UPRFQ:<1:Y_?#>_+P]GC7GV5^*S
M)93<:]Q+PD9"UXO)PM`><(`R3X>+E]-]3-M*4VLH<3:M>G?R9ZFZ5L2OZ^;2
M0;`\XBNS?ZF0XBU_9.JJ56C"`/O4OB?&:2?CKB(!Y10>DGB%U('>[J@E)839
M)?/O?Y]P.$<N0]WYQQ%CQKU)KX^<TTB*V-M0R(J-RI_E;OF_6.29+A_-&WI2
M="+7ZJ1=6@UL=._+P@9R$QM"&RG.MB8X/E46ZY:[&'-*_K1SE2<VN`7(9X`-
M_=#RF%CD^G<545S*&V,4"C'M[F<0XZX&4GJ=/Q/#IM*:'AQOJO\`,1:O*,=\
M4V2QV1R^13AHRU9;[MN"^Y]E]WXB7B18A/FZJ91?5>VE2`@72HD2[PYXDQG$
M2LY+K49>).\IY'RM:<I+O).(9PZD4YM"I%5(9!-DX<$=-F?0`%5,)3GW[0#4
M=F,JK+.MN*0$:$:>!O>N'[\=\)??++XC+R\<UCE8K"Q\>$MNJ=#@C@CJDK2D
MI*K\4BX'MK<3417A--*4TI32E-*4TI32E-*4TI32E-*4TI32E4V#ZOQ]O[OW
M:4IL'?I2G2'U:6\*4Z0^K2G.FP?3]_2E4Z0^K\H^C3QO3PMX578._P!/T_>T
MM3YJ;!]/W]*4Z0[]NW5+`\Z4V#ZM+#GXTH``&JTIL&EJ>%J;!]6E*;!I2FP?
M01V_%W:>-Z4$`'\>_P"$-4(O2FP?3?5?"WA2G2'TWT/&E-@^@CI;A:E-@TI3
M8-4MQO2J`4`[@^GT'2U#QYU78/Q:6%*KJM*:4II2FE*:4II2FE*:4II2FE*:
M4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2
MFE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:
M4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2
MFE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:
M4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*H!@'Z
M?E^[2GA<<J;A^+O^SN[_`,>E*;AI3YZ;]NW;ISI3</P_5Z?WM*7%-P_/^#Z_
MNTI3</I^/5*4Z@T!O2J=6^_8/9JM/VJJ!@'Z?5I3YZ;_`'Z4H(@'Y?R=X?7I
M2F_W]^W9V_N=VE*=0=OV#L/WZ6I3</IMI2J"8`[1W_%]8[!^/5;4''E03``@
M';N.^WX/OU2E5$0#2E!,`;]_9^]OV?;I2J=79OL(A]FW[_9I2J]0;;_=^7[-
M*53J#[0^\/H&E*Y;Z4JG4'TV_?U2_+YZ50#`(;_;M]?[F^JTJO4'=OZ=O3W_
M`%:4IN'T]/\`O;Z4X53J#Z>C[_2&E*J`[AN'[WY!TI5=*4TI32E-*4TI32E-
M*5J;FOFA@WC]D6#Q7D:4L+*VV''\_DR,;Q=9E9AF>JUE\$?*N%7S%%5%)V1R
M.Q4!'K,&PAWAO*PL-.R+76C@%O7HO<#S6!MQ^D?(&O:NW_8'N+W.VK)WEM1F
M*YA8N39@.%R0VTH2'T:VTA"R"4E/-7(&_LK'KWSVX[8X=VAE9YBTHN:A`C99
MLK2GS;TB<86A%R2)T#MVQRN5OA<WB>&3<WC?HO;[-9V=OY)]I+K:4:%&P\P_
M=:/\K]CC4KMSX9^Z>ZF(<G$,0E-3I/IVM4II!+GK#`\P4H:1ZBXN>&CS^[QK
M':-\QWC%D*U0U-K<W;EIN=B<,S4<D[I4ZS0,QSU/1U;QV99==N4J"CN4E$2N
M2FV\H03&4V`IMKWMM96.A;CB4!*-=_,/WM)4JWML$GZ?K%2>XOA0[P;7PTC/
M96/!3CXK^5:64RV5$*P[#C\VP"O,$MMJZ=OSAL$\Q5+M\R#C!C].=5L<W;T2
M5VQM*M)^6I,ZZZ)9[ENZX4031\)N/CHFOE`DD>HNX>7(FM["I!$WMK*.(2I*
M4>9.KWART(<O_BN)/S7(/(TV_P#"?W?W*J,G%QX*C*BJD-ZI;*?LTXV)EB3=
M7E/HYK"K'\LJ;]Y"K7RE\_N.>0)RTUVN3%J6DZ?.Y6KLT1U3IMFBE)X8K[*S
MWE-NLNW*1RDVB7R9FQR;E='$2)[F#;5KNWLDR@.+2C00W;S#]\-D?A//V>-:
M&X/AD[K[8QT/*Y1B$F+/CXY]G3*942WE7E1XFH)/E*G$$.`\6QQ5858S?,BX
MP%EJ+##-V[S^1I]"MUD@TF>!->4<UEQ;D4W*@M@!HD,,V.<3F[`.'2/;J]6V
M<HG5J2CR`D^8<@;']FI#_P"5#O#Z'(Y#T\'TV+C%^1_&V;I;$@1B4C5YB'5`
M6'$CB*[F/_F(\:,FT&0R35IFUKU:.I%0R$Z<NZ7.-'7PU=\E6'$T"LDS5;@L
MLZ5N-7=)J(E`3I-RE6'U#E'5C^V\HPZAEQ*.HM92/,.:6TNF_L\J@>/CPYBL
M.Y_A8[N;1W*UM+,1X2<P]D9,)*4RF5)Z\2`QDG@5!5@D19#:DJ/!2R6QYDD5
MB-H^:3Q*IZ]E;S4_=4CU3&$MEV7\&A6%8B=-ALB#B]\Z1.5MT+/B6L.@&X#X
MAD/TH!T=NLJ=K9<H"PE%BO2/,.>CJ6M_@\?IX<ZG</\`!KWNSC<1S'QL>4S<
MPWC&KS&0?5.P?O!"2"K@@QN.L^4+\GO<*E+]N;`!J\2T>][/[H-=4L?@I\)S
M'C_$:]>+9TT/+"W\3RHQ)P,*VWA@?U-^K6(;?R1<Z02C7T]?O#W;Z>?T^'.N
M+_\`EQ[G#*'$%B'ZX8\S;>I:MT`_Z?5>]M74X:>>GCRJ*!^:=Q'*\=,AL%V\
M=E>,,X[7#X"L(%+9,\UY2SX\1ZQ;``MW<4D)G*G<U/L4^PB&^<[5S&G4$(M9
MP^\.39`7^`D?,>/L-NT'P9]\`RB1Z7'])>/RDT?QQGBQAWQ'FFVKWD.$!L?O
M@NI/`&TMO.<N`6$=0)1Q*V8&F2FCQY5C%J<R<ZZ#',%3P:X%ZF#<3,3%OUT8
MI`"FPBV,=</T9#"&JG;N2U.`!%VC97F'"[2GOK\B#R\>'.U<7'^'/N;)EY.$
MTS#Z^)6E$@&2T`DJQDG+ITF_G_B<5Y7EO9P);]Y0J)HOYIO$>9-6RL;!=CFM
M9\H)Q('H%C)UGP^\5970%S"U$K86SA(P(`80%Q_`UL?JOE[E)2BX4![PYGE_
M?KLYOP:][X`EJD1<>!"^[^H/6,</O-(7%T^;CJ21KM[GC4EVOGEQZIDC(QL[
M+VA%W&5J%MCPK:H33HA(>P8ZG<I1ITSHMS%4<'J5><J'3#UR+@5(?7,`:Q-;
M=R;S?40E&C4I/O#FE8;/_E$#Z./*N1POPV=T<_%9FXUB$67I;T9.J4TDEUB<
MSCG!8G@!)?0`H\"BZQY036%T[YF/%>\S$!"5^>N"SZRU/$-TC"N*/.MTE(/-
M]\AL<4)954[<2HKN[//-R."&[6R(F4/ZI#"%[NVLJRE2EI2-!4#YAS0E2U#Z
MDH4?P#F170YWX1>\VWH,G(Y&-`3&B3<G%<M+9)#N)ANSI@`U<0EAE901[ZK)
M3Q(JY9(^8UQCQ4C<W%OF[>W)0YYY6[#Y&DS\AX,HQR9,XC73;`U:G\VC\90+
MA,#DW**`%6]@P#JC&V\I(0A;:4$+0%#S#D4!S_)4#^Q6IM3X4N[V]'(#6#CP
M5JR45+[.N6RB[:X#63!5J4-)]*\A1!XA9*/>!J\47G[QSR-;YRD5F8M2T_7[
M?:*/)HNZA-LVR<]3:<>]S:2;I9N"2K=*O)B=-4/554]0NYA#5CVW\C'1U7$H
MT:4GWAR40D?LD?1]5:.Y/AB[K;5P4?<668A)QLF#'EH*932E%F5*$-HE*3<*
M+Q`4GFE/F/`&L>#YDW%PTM0X0)RW^?R/<*G1ZPF-'GB)KS]TBY67@TW:AFP%
M:-U&4,N*JAO52$H`;;?5ZMLY-*5*4E%DI4H^8<`CG\O'E4HKX3.\28.1G^G@
MF-BX,F6_:6S=+,5QMMXI&KS*"G4:4CBJ_EKL8Y^8YQBRECV3R?4INVN:G#T,
MN1GCAW2YQF["L'R1-XJ\PDQ6;@NL]"X0#E,4``5/``JNW08!U<_MC*Q9"8CJ
M4!]3FBVH>]H#EK^S20;\O"L>ZOA0[P;.W.QM+.1X*,U(R1@I2F4TM/J/0,Y'
M25@V"/2O(5K/EUDHOJ!JS63YG?%&JN9AG,3]R36@Z#?\DR`)42P+`2K8UN"M
M'M*Z9B-OTSIO/)B5)$NYUDMCE]40W#;&558A".)`'F',I"Q^%)'[(\#6_BO@
M^[U9AIA^%&QY;D9.'!03,9%Y$Z*)D=)\W!)9(*E'@E7E/$&I$8\Z>/TA7&UJ
M;2UG&'=W>EX^04/49E-<;'?HCWY74C-S-P6*T6CPW56$.A$WJF$!UA.`R(<Z
M9"-?34OWA[J38_L^'X*Y63\-W<^)E5X9UF'ZYO'2YQ'J6K="$[T7SJO8J"_=
M3S4.(J)U_FH\16SB505G[L"L/)X)B7X?`-B$I'O(N!"QXR*F(M0!4CV+'J=&
M+_FBGJ*;&[-;:MIYA(!*4<>I;S#]Z4$+_`HCZN/*NU:^#'OBZTRZF+CM+[68
M=1_'6.*<&]Z><397`I<X-C]\3YD^7C4O/><6`V$/2YMU*V4(^_+W%M7C%JDP
M=192BY7K.%[`#I(K?J9E1O-N9))"<`\5N<RY=TR&$-1.`R*UN-@)U-A)/F'Y
M3:G1]/D23\QX<S7#1OAT[FRIV0QS3,/U&,3%4_>2U8>LQTC*L:3?S7AQG5*M
M[K@2V?,H"HGB?FF<29J3@HIC/74[RQVW(-)C"GH%B334GL8-UW-K265%KT((
M-TFYO!5,($7'L+N.M@[6RR024HL`#[PY*Y5VTSX->]\&))F2(V/#$2'"E.6F
ML$]'(*"8Q`U7)45#4D<4<SPJ3+%SRX]U<T627E[2D:9J-+NK$&]0F7`&@;]2
MK-?JXJ<4VX^$Y6KE1>G52'UT52E3,`&.4-8&MNY-V^A*+)6M!\P]Y"DH/CX%
M0X^//PKD<7\-?=',I>5!8AD,3I<1=Y32?MH4N/"?`NKBD/R60E0X*22H<$FH
M[J7S0>)]S?UJ+@I^YJN[9CJBY1ARKT:>0(I4\BY3B,.5IPNH9OT-WB]WFT$E
M43;&2;B98?T93"&96U<LELNE*-"5E)\WB&RZ1_BI)_8YD5U&:^#SO7@8LR9D
M(T`,0<K+Q[MI;)/J86.=RCX2-7%*8C*U)4."E@-CS*`.0Y'^8SQCQ5^L(+=-
M6]O^K!].1]K!C29Z0\!S7+<:D2167EFQ@?D).E$I#)[@=/\`2!ZO;JQG;F4D
M-H<;2C2X`4^8#@4ZAX\.']RHS:WPI=W]YIQ9PD>"L9AME<;7+91J3(C"6WKU
M*\A+)N0JUE>4\:O-,Y]<=+[?WF-*[,6A>U,+N7'KA!U49IJT+9#41SD<$0?*
MH`B+7X8:'4\7<">+LG[0AJQW`9%IE4A:4]()N?,.5PGA[>*@/[QJ-W!\,O=7
M;6V4;NRC$,89S'F:E29+2E%CUB8-]`-]776$Z>>GS<@:QU/YD?%U5SCMH6<M
M_C90OF/<;50#4B>*5Q9\G+VMO5&[PQFP>3:+K4QZ"RQ_4;@4IC[`8!UE7MC+
M-ZR4HLVA:U>8<$M@%1^H$6]O(<:F%_"7WC:9RCRH\$-X?&S9\FTMDZ8^/3'5
M)*;*\Z@)36A(XK)(3Q!K?D`V#;\VVN>^FOFBJZ4II2FE*:4II2FE*:4K\Z'S
M5>WG+B#;T\,,U_\`K:UUZ-M/_92A[9@_R4U^J?P7\/AWSA_[_8K]&-0YR^[;
M'G[;8?\`D=6WVV[OV/4>T=2.-_D#/MUG](->@]C2/N?;/_7O_P`3FH/XG;?M
M%XVV[OU<_*R_I@I^M[*_R)_Z9G\"Y7H/>SAVLS'_`%KW#_HN57QY7[^0RV([
M=F<JKOMZ/_V2\I>_2!^:;_F__0XU5[,?G\)_5V1_83;M3!Q4_G:Y!;?^USYB
M`_A_4O6-M:F2_DK8/[F'_EUQ/>;_`')VQ[/N39']*OU#KCLR5P_[OYYHO[_Y
M@)[M^[6^[[LFW^87_""NX1_NEOGV_<#G]-,UE7"O;]C2TCW_`.R9QIWW[OZ]
M.9]@_#K#F`3DV1X^J=_0VJB._P#<]^H-O^VV?_LABJUIY#!M(9Z]'^P!DKO^
MWFDH/I^_6]&_--?SS_HHKUKM@/XKMK_^3(/]E*]#2]N$D![_`/:GB^[M[?U,
M(?EU"H-IW'_4O_25\N7OW`5_4IS^E37G$L`_$EG'<.G]KOY6>WH#^953O[==
M`/S8O_J\[_+37U6F_P!U1/ZD=P_Z5%>DME$/@KAWV[?ZN63IV#O$?F7\=OK^
M[7/-_G9W^&G]!>KY2PY'ZQ[\_G3']@LW7G'CC?Q<&[=PO_F#AZ.T/BN3_/J9
M=_.K^9;7^37U1NSEN'V:-F?H[=;Z\B_Y97?NV_4/BD1'_P"B7*^VHO'D>B'^
MG>_2FZ^:NU?#;^.O_P!H\E_:S&UJ=Q?W#)6'!'8`_9L^6=L/HV_:[QIM^[J0
MRGYF0?#K2_T=ZO;N[Q`VGG[_`/:S?O\`9J?4B\YO]$\G_K',5B[.SN_;TR=K
M7Q1_B\?V>G'Z*W7)?#M_*]G\_P#8+']CL?4E\1/ZS&7.\?\`:9Y"!O\`?Q=7
MV`?O#6KEOY"#X=%G^&17*=\!_P#I!A/9^J.%_M"FH2*.^2N'&VW9R:X\A_S=
M9'_%MK<='V$G^;O_`+8KT(W_`%3WT?#]4<W^FP:O/!O^I1>MNT?V0R=GV_MS
M96UGSW^WV_Y[_P!$;K2^(L?_`-@<8?\`OS_\(8VHGSKO\19.'_Y->9X]OH_V
ME%M&2`A%_P#/M?HZ:['MS_LK$@?]O=K_`-`)K>*H_P`QT`'>/[5G%H/^;0P!
M^/40O^6W_P#47_\`+%?/.<_\0Y/]2=P_IXKSGG.V7R&'I_6!\H/^B9'73'CH
M'S3_`.&37U3`XP<5;_V9W,_I(UZ76K8,:<7>T>R7Y.#Z>X?F)X%_)OKF61_&
MI8_YC'Z$]7R3A@?ULWG[>AM_^P^9KSDQN/\`KQB`0$-AY(\UNSZ__!4OV?>&
MIE_B'+?YMK\5?5.Z?]WLX/\`NKM7^$:K?+-P_P`9QY_9NXM^C?\`Z+&?/P>G
M47`Y._SJ1_#LU\V]OK]'*?ULW%_:+"UI)QL#_7/!&^V_[#_#_;?T[_,'QY^;
M4Q*(,%[^>/?H2Z^A^[!`VWN2_P#^X>YO[$SJF[G!L(\TPV[?BS+?]Y!?;4=B
MOY)$_P!$W_`BO._AZ'E[?F__`-1QG]`IJ3^+``',RX=G:'+-#?L]/['LKW?;
MVZULB?\`[G7[.A_Z=%<=WE_\`86K_L2K^TS50BUV&P\(]@#;]L;ACV]W_C+D
M7^YJ5?\`<F?S.5_DM5Z*_;[J[AC_`+A[J_@\'7[$M>)5^#XY5;)6:AH)NF[G
M):,AFJSE%DBYE7[6.;JO'`F!NT36=JHIG<KB4>A,!$QMAV`=7H0MPV;!40+\
M!?A[:W(6/GY)TL8YAZ0\E!64MH4M02GWE$)!(2/$\AXFNTL\:-P,9=TW0*1N
ML[.999-,I&C<"BNZ,)S%`K=`#AUG'U2[AN(;ZM"5'D#SM]=8$,/.D!M"E$J"
M18$W4KDGA^4;&PYFW"NDC/P3CW9Y>:B5_?::JT-X,DS5][HHD!196,Z%C>?3
M23,!C&2ZP*`[CJXMK%[I/#GPY?36PYC,BUUNK'?3Z<@.W;4.D3P`<N/(2>`"
MK$FJR$["1*"CF5F(N,;).$V:KB0D&C)!-VLD59)JHLY623(Y51.!RIB/4)1`
M0#8=42A:S9`))'@*I%QV0FN!J$P\\ZI!6$H0I9*0;%0"024@\">0/#G7Q<V:
MMLA?`\L$(T&+(T4D@<RK!`8Y.0$I6"C[Q5R>4(]$P`B*G2"@B'3OJJ6W%6TI
M4;WM8'C;G;VV\:RLXC+2.F8\60L/%0;TMK5K*/?"+).HH_*";Z?&U<T+#`.5
M6J#:<AW"[YJN_9(H2;)95XQ;*"DY>M4TUS'<-&ZH"4ZA`$A#!L(@.A;<`)*5
M``VY'G[*L<Q>390MQZ.^AMM80LEM8"5J%TI42+)4H<0DV)'$"GQ%7_=?OSWY
M#^Y/_+'O)G[J_P`X\I_I'QO)_P"=!X7M_P"4]7O[-.FYKZ>DZ_98W]O*GW9D
MO6_=OIW_`+Q_S737U/=U>Y;5[OFY>[QY5X!?-%K-GF.:^)Y&&K-CEX]OPZS(
MP7?Q,#+2;%%\YM;<[=BHZ8LW"!7JQ""8J(F\02[#ML(:[_:KK2,9I6I(/K`>
M)'+2GY?/Q]AK]-?@YS&'@?#]FHD^9$8E*WWBUA#KS;:B@1B"L)6H$H!X%5K7
M\>%1#RRJ=L>V'.QF-2MCTKK$BS9N=I6)UP1RX_9%19`W1408*)K+>>#P1*41
M$%OT>W7V:D8#S*8322M`4%FXU#_/D^WV<?HKO.RF:P<?$;<3)G0FU)S=U!4A
ME.D?K*5W(*P0-'FN>&CS<N-0KQ7I5W9<@\;/'M)N+)LGCWY8S=1PZJL^V016
MA\N5!:83756CB)H'BD"F.Z`XE\N0IC*=(%$0V\E*C+AOA*T7O+\1QNTL"W'C
M<\!]7M%=_P!YMP[??[7Y=F/D(#CIRF_R$IDLJ)#N,E!H@!9)ZJK!NU]9(";D
MB_#E-2;O(,\JD8TBY.S+YJK#E`6M4L"Q5VR7S%>3TJ9RD9..."J!8IRDZZB[
ME\LNFK["A##="DQT,ME2T?F;>\.?I(P_;!'T@^PU7L]N';L5W"JD9&`@)P$A
M)U26!97ZD;?:"3=?!752MNQX]1"T>\E0$L\7JC;V>5,]KO*A;&:+O*_S`W#9
M9U5YULDX0DL/5MK&+(*K1Y$UDY)P04VPE$0<'`03ZA[-:>1?97';LM-PF)PU
M#P7<_@'.N+[Q9W!/[+VTB//@K<1AME!03(944EO*/EP$!9(+8-U@BZ!Q585$
M2])NQLB\2U0I%T\%AF&*7?K&J=@*FS;A@F;:>.Z-[N`&R(.E`3$QNDI3CL([
MZVW9+`3(2EQ'F96+Z@>.N_M\?^2NW;W#MU.UM[)^\8!6[@G4H'J6/.K[X:5I
M3Y_,HI!4`.-N-9/PXI=TCN(%JCW]+N#!^/%?CDQ*Q>56P-W2CUGS>S$_=LTF
MZT<155VUCUR.%4RE$Z;=0JI@!,Q3#;E)$=639<#B"DR73[PX?Q-H<>/#B+<?
M'ASJ)[[Y_;\OOK"DQ<A`<C?KGG5ZTR65)"%[1Q:$K*@L@)4L%M*CP+B2@'4"
M*USS]0;\\?9R\K0KRX!SP0R'%-A1IUD4(O*..9)WR,<W,$8(+/U&/Z<$B[J>
M!^EVZ/6UNQY,=++5W$<)5_>'+TH%^?U?37JG;7<VV&(VW.MD\<G1W(A.&\M@
M:6QM;05FZ^"`OR%1\NOR7U<*W[+5K4&&46XU.T^8#E#&O`;_``U.>.#,N'4$
M!>>$5AXGE"KAX8J[>'XGJ[[]FHA#S/K;A:+>B]HY]3E7S,<QA?U^4LS8?3_4
MYQ-_4-6U_>A.G5KMJMQT\[<;6KSU4Q_D`UCL9@H-XZ%.5ORQI$AO@^Q@4[&'
MPVHWF'@&-&AU(1+@G0Z-[+<X@502B(!J<5+BA(\Z?S$P<".94FWX;_*U?4(W
M/M@8N*DY/'73LS?Z#_&F+A;V32II)^T]YU/F;'-8XIN+UZ)6:KVL:7Q$3+4[
M4=1E`6)-\0E;FSJ,3'^9#Q\E"%?$!@)F8FBFJCL`4Z!%JD=8/T1#'"!:>8+T
MWSHXJ21YAQ_B3PX<>/$V^DVYU\MX?,88;BWRHS800Y*8T'U#5E_^XF;;\AUV
M5]HI+9TW^U4EL^=0%>>>/*!?T3X3%2@WHGEG?/=5?Q*=9""W+*VB14BQ7`8S
M]":13,`H`;850'U=]3#DJ.771K1P6UXCP%CX\OGKZ?W3N;;#J=P%&3QI"D[.
MM:4P=73CH"[?:<=!X+M?3XVK>GD'4K:[M]T.TJ-L=%5P?BQLFHWK$XNF=RGP
MPRFP7;E42CSIBN@_6(@H0!$R;@Y4Q`#F`NHF"\RB&"IQ`^U=_*'^LH(_"`2/
MFO7SEVPS.$:P6/ZTZ&A0W#D20J0R"$G=6/6"05@V*`5@\B@%0\H)K5GC51;V
MQR+B`[VC71HDAQT^6^S7.XJ5A03;NH;EGCAY+MUSJ1P$06BV:9UG)#B!D4"&
M4/L0IC!)9&2PXU(TN(*2[*(XCQCO6\>9-A;G<@>(KV;NSN3;4C:V=$?)8]:E
M;JWTM(3)8)4EW;<]+2D@+XAQ9"$$7U+4$INH@&0>;5+NDC&<EBQ]*N,B9WER
MPK-"LJI8'?FD3<Y\E2!%VHMXU3S+<\:J1R!R=11;G*KOT&`PZ^,D,(CQ[K1^
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MP#E4Z>@0'6;.28[F<:<0X@H]9>]Q:WI6Q?GRN"`>1/*M/X@MQ;>E]^L9*B9"
M`[%&]BLK1)94D(_5+'-ZRH+*0C6DHU$Z=8*;ZA:HNS;0[ZYL.2CMJ+=ER*\/
M^8,>B=*H6)0JLA(\C7+J/8I=$:;Q7;UJ7Q44R[G42$#E`2B`ZM9E1M*$ZT'[
M9L\QX,)'[==?V^W'MMG%XA+V2QR2-\[96;RF!9","E*UFZQ9*%>52C8)5<$W
MX5NE5:K:R84@D%*G:R."\I>,3PZ!JS.%7*S9XY,D\>BB+#Q`9LU?556V\-(W
M880'LU&*>9,P$+0;P7O$<]?+GS^:O`,SF<*ON#(=1.A%K]3,^G4)#6DJ5.!2
MD'78J6.*4\U#B`17GQ-8^R`>5OYRT"\]*M\^4PLD8*990\1."Q6BA.'2ZHL.
ML(9<!3=[;^64]53I,(!KH3+B@MGJ(M_'?R@?>=%N1\?VKGE7T_`W/MA$+&I5
MD\==.-[C@_QIC@7LD2S?[3AU1Q;_`'8XIN.->CEIJ]K/CCC&DG5;2=1I+<E!
M=HEK4VHLT!U\P?!<FU,]3*Q$[4KN,;*NDA4`OBMDS*DW3*8P<\R\SZF6=:.*
M6;<1_J;P_8/#Z>%?*F$R^&&Z]X*5-AAMQC`Z#UVK*T[*S#:@DZ[**7%);5:^
MEQ24&RB`?/+'E"OZ%UQ(JK0;RBFCR)YDO%SJ4VS%(@TD8N6+'N5S&BRE10?F
M,`)'-L57?U1'4L_(CJ"[.('D;_*'A;Y_'P]M?4&YMS[9<V_FT(R>.4I6U]KI
M%I3!NI#C>M(^TXJ1^4!Q3XVK>;-%3MSES0/+U*UN`3X[<8F:HMZS.JE2=M>,
M&=6CQLJ9)@<$W+-VX2153-L9%50I#@4QB@,;!>92'=2T#^-2#S'+KM<>?+@?
MIM7SKL'-X-EC)AV="3JW3N!0O(9%TJW!AU)4+KXI6D*4E0X*2E2DD@$C3'CM
M0KZSM^#57=$NS9)MPMXD1CE1>H6),C:08\^Z!)/62YSQP%2=,HTAG*I#"!DV
MQ3*F`$RB8):1*C*ANH2M.HRW3Q-N!AK`/X>'TD#F:]\[I;FVR_@=QMLY+'K<
M5O[<C@`DL$E"]F3$(6!U+E*G+-I4.!<(0#J(!F;FG3+K(GYE!'4JXO\`S]JR
MN9@+*J6%V5\17D2LY149';QJI'9%VWZ0@IB8#I>N&Y>W6CC'F$1(H*T7Z3=Q
MJ%_S('M]O"N![`9_;\9.PU2,A`;Z4+&A>J2RC04X)*2%!2QI(5Y2%6LKRFQX
M5)O&*I6YES!M<@]J%L9L5N52#Y-\ZK,XV9G8AQ(E8_SGFUF!6Y6H/_T/B";H
M\40)OU"`#J9"0PYB%I"T7]/;F./VS9X>WA[/8:Y#N_G<#)[$PXT>?"<DC9A0
M4)D,J7K_`%D:7HTA=]6CS:;7T@JM8&H4:TJ\!8.&"@TFY]$;R[X=/Y`QZE82
M%8,&DGR$!Z]>=4<`-6;`':0N%3])$"J$,<2@8!&5<E1@B60X@@Q)(X*'BAJW
MCXVX>T\!7H,C<.W3C=_H3D,?K>V/NA#?\99)6M;6$T(3Y_,I>E00D<5E*@D$
M@U^NTH@(;A]/W->,5^&XY5H1RE;TUIE2F3N;ZE/7C"X8KR/!QL/$56S7-FAD
MF3?UKP$5X6L,9!RWLT]7TE$(1^J1,K15)P";A!54HFZ'$EXPW$07$-SNLV22
MH))1YO$V\H58J`O?AP(%?3'9MW<#^S)^.[=3HV.[@??4%YQUV3'B+,!M$BY2
M[(6A*H[+Q2N6RE2NJA396VXA!`C>^UZJU.R3V3+3CW,DK0I'AJO'SN/CNK//
MRI$86^TL:WCR/90+IX5M8I5HH=-Z!%E';A$#"NKT)J#K<CNO/,IBM.L)DB?<
M+\H'%"M2R5<TCF.%AX"Y%=7MK*9K.8B-M'#Y3`L;D9W\%LS0F.RV2["E]><M
M;R4E3#:@"S="6D*L&T:EI%0J,:WC*[A.7Q_6I*QYA5R"ID*#A(VAY*A:>Z9O
M[Q<I62PWCZX6%I%-L95NDS+\Q7SN4B6J<G%IH[%(B=$B>Z5)<<?;D+"(/2T7
M*T%0(0@!Q:4D]12@.`2HZ5$\;WOZ$93LS*[B@[IELQ-AIQ0A//.3(#LI*D1(
MK:,I.BL*<5/D2VD`M-QI+BH\DN7)<2M2L4<U;(*%6NKG,=7O%6LL?R3N&2XN
M/G:=(YQJ&3LCRF&:"E&U=RVK,D0]?J*SXRD;#.`2.R(3J(=1%TD<QLQ=C*=0
MF$MM31BH;)"@TI"`ZNZ@5#S*M8J'`\>%P14PUF-KN9K'M;#F8V;AG=HQ8"UL
MRD8B3CX#>5FE<E*I#9#\D(L_*;*@ZI5E(2XRM(%[IL;?VZW(%WD+%["\7=S1
M<C3U@J4ACBX^%`V<LS7WV-*Z:SFD%H/)<1+NTR':(-$>N,(B(IF33(H4UCRX
MRC'3$>+;`<;2%A:1J20H+.FP4@@7N3[U^/'C4?GY>V7&]L,;6S+F.V\G)066
M)*)\6[T?I/HGO^GT!['N-))#BW5$/E8"PI121RO.#WE!R?7\;U0MIC8ZH4ND
M4^'&&I]OG+#.5UM2'3BWY*A;^T<IPM>K2%C65;3=8$%'LPY.=PDHD(I)FK%G
MHD1%RGM"EN+6HZE)2`=0"6R@BZE:;%+G`('E(YTVYW&8W+L^5NS,F&],G9"7
M*=ZLF*TPT^J6E,6`["4GJO2%,!*XF0!2U%;2EI:%@+4.HG#W@..3N2/4ZP./
M#\AHYPUJGPOE_P#5VG0D^/LI4G\C\/?"/ZS_`'4KD%5LZZ!@M_?1-@3ZMWVJ
M%R-]Y`=17J/2GS:F]>OKA0%]73OIN/?]WC_S:S*G[;/==N(F=-_6H;66E4GU
M.+]<9IS;<E".MZK[OZHA!;?\L_DJKZK6CCVX.W04.!U443GZ3%(=1(AS%*.P
MB7K,`B!3?4'8.VN"%P.'M_9]M?GBEUU(TMJ4`3<V)L3X&U5,W0-OU((GW#8X
MBDF8#!L)1`VY1W]7L^[5+V%N(^5ZIU74VT*4/K/TW_#_`':IY5N4>HC9`I@Z
M"]144P'I3,`I%W`N_J#[.WLCJMR>9X?W:J77E)*5*40;^)MQY_A\:&;-S;]3
M=N8##N8#HICN('$X"(B4=Q!0PF#[1W[]-2ARO]/R^:@=>!X*4.'M/LM^UPJH
M-FY=S)MT"B83F,())E$PGV`_4(%`1$X!V_7MVZ743I)H775>\I5A;F3X<OP>
M%4\LV$Q1\NW'I'<H^"GN0VVP"7U>P0`=OKVU4E0',U0/N^"U<?G/$<_VZJ5N
MV(7H*@@0G2!>@J*8$Z2F$Y2[%+MTD.81`/0([ZH2KVF]5ZSQ5=2E%7MN?'A^
MUP^BN!FK0W5NU;&$Q!(.Z"0@8@FZS$,`E$1*)NT0'L$>WOTN;BQ(%52^Z`"%
MJX&_,^'"XX^`X5]!01VV\%#8!ZNGPB>J.VP&`.GVMNS0DBY)\*M#KE[ZE7M;
MG]=JX>5:"/\`FS;<3%/OX"7:9,`!,_L[B9,.P![P#2ZO:?[_`#_#XU=UW_W:
MK6MS/CS_``_LU]/+H#L'@([$'8`\,@@4!,!Q`H=/J[G`#?>&^EU#F>%6]1P<
ME*N>?$\?#]KA^Q7R!HS*(`#1L&W4)0!!(-A4'=3;8G8)_3]?IU74NU^-[57K
MOFYUKXV\3QMR\?#]BN9FZ`CZR")NKU=A2(;U0*)`*(B7N`IMOJZ>S5"JPMR/
MRX_+QJ@=<''4H'YB>=[_`(N/SUQ!JV(;<K5N40*0H"5!(!Z4QZDRAZ@#LF?M
M`.X![M5U*L>)JI>>/O+41Q\3S/`^/C51:M5.KK;(&ZNTPG03'J$3=8"(&*/4
M/6.^_P!?VZM"E``7_!0.N)(*5J!`X<2+>%<BMVY3&,1NB!A-U&,1),#&,8H%
M,)A`H#U"3;<?2'9JXDD<_"A==(LI2B+6YGE>]4\JVW*/EV_402F*/@I;E$`$
M`,3U-RB4![!^W5+J%SS_`!TZ[W$:U<1QXFJ%;-B%Z2-D"$Z0+TE23`HEZA.)
M=BE`!#K'?;NW[=#<GY^="\\57*U:K^)-_9?Z;?L4,U;'WW;-S"(&(/4@F.Y#
M#N<H[E]DQNT0[ATU*!YGZJ!]X"R5J`Y\SS'`'G\A3P$`]3RZ(%`Q3`'A)[=1
M>PIP#;8#%#L#\FJ@GGQORJA=='Y2B>(YG\%<?*-MQW:MMMR&[4$AW,B'2D/8
M3O2`/5^H.[0J5[3?Y?M^/SU=UW_\XNW'\H^//QY'Q]OC7T\%#8`\%(0+U"4/
M#)L'48#F`-R[%ZE"[C]H;ZM)5S]M6AQSP4JY^<^'#]KA7$&C0!`0;-BB!A,`
ME02W*8_MF#8NX"??M'O'5UR>)J[K/D<5KL1;F?#E]0KD+=N.VZ")O5`H;I)C
ML!2B4I0[.X"B(`'H`=4N>56!U8Y*4#?P/U_BKYE:M"F*!&K<HE*5,HE01`"I
MD,"A2!ZH"4I3%W`.X![0[M5-[<3?C?ZZO+[QN"M1N2>9YVL;_.0?Q54S9N?J
M*9L@8#;]8J($,!_6ZA$PB4=Q$W;V]X]NJ!1'`$\*H'GDV*5*!^8GY#A7(&Z`
M&$Y$$2&Z@.)BHD`1-TB7J$W3OOT;!OW[?9H3PL2?E^*J%UXI"2I7LYFWM\?V
MO;7$6K8.D?+H")#%.3^+I!L8G5TF*/3ZI@ZAV$.T`$=5!OP]O"KB\\;^=0!X
M'B>7CX\0:[1=MNS5H%N%8KWK@H4IA`#%*8`$IMC%`VPD-U%,`#N`"4P;@/H'
M5>/AP^7*@)!\IXV]O@;\/KH(`(;"4!`>T0$-^SN[0-Z0T^:@N.5<033+T]*9
M`Z.KIV*0-NOVA*`!N'7MV[=^GO"_A5Q4H@W)L?V;542E-L`E`P=11#<NX`8H
M@8IMA#8!*/:`]^^G%-6I-A_<^>A2AN80``,;8!-L`&-T@/2!AV`1Z?R:IX6/
MR^BJDDBUS;]K^_3I+U`<"@)BE,`&$H=>QA`1`#"'5ZQ@W'T#I;AI\*:CR\";
M_-5/#)X?3X9>C_J.@-O:Z@]7;;O[?]W5?&]ZIK-]5U7^N_+\/_)4&Y2Y'XFP
MU8ZQ5K[/N8Z6M'AKHE:1;^2;0D2N]-&-[!9W31)5*`@',KLT(Y7V*=P/2&^Q
MA#?AXN;.:6]'3J0DVY@$FU]*?$FW$CV5Z1LOM+OC?^)F9C;,5+L&'<'4XAM3
MSB4=13$=*R"\\EO[0MHN0CB>8O:D^5>#!O=TQ\M<2LIFA15AEY]^_CI%K6_!
MIS!A+71M&6!1O[OE)"HQLJU7?H(F.=(BY>GK$B@$N^Y\@8Z)(1J;<*0`"+^<
MD)N!QLH@@7X>WF*W7.RO<8;;Q^Z6X'4@9-YAME"'$*D7E+6W$4XR%:VVY*VW
M$LK6`%%!OI"D:L91YI8&<4)W?T)BQ*-FMH:4SX6"IS7QV[L$@D=[&LV=3,W"
M1<)2$,B>017`/`,P(943@4H@&4X/(B0(Y"?<*BK4-`2.!.KD"#P(YWX5,+^'
MWN4C<J-L+CQ.JN&J5ZCU+7HTLH(0M2Y.KII+;I#"D>^'B$`7(J_/N6V!F,[C
M:`+=2/SY4AJ]8*O+1L9)O(!&%N!ED:9(V&8(V*VKB%M<M54&/F_#,=9,Q3@3
M<N]B<-D2V\Z46Z*E!0)&JZ?>`'Y6BXO;PY5&1^R'<J1C,ME%8\MIPK[[,AMQ
MQM+Q=BZ3*0PUJU/JC)4E;W2"@$J!3JXV^3+EW@1])9(C1N)F88NBYJ;L$E(1
M$HTB9&+K#]K#VAY57ZC<$[0G7+`_0C796@*'(_731*!S'+O4X/(A+1Z=^L0E
M(!%P5"Z0H?DZD@J%[<`35[_8SN4Q$Q,H0.H<P^RRRVAQM;C;LA"G8Z9*`;QR
M^PA;[9=L"RA3A*0DU8W?-7`;2@1.0EYZ>"/E[))U4L`G5)Q6Z1\Y`H*/K&UE
M:JFV-),"5R*1.\>*B`D(V+UE$XB`#>,%DNN8^E.I*`J^H:;$V395[&YX`>WG
M4DQ\/?<U_<S^UVXL;U3$1N27O4LB(MEXA#"FY!5TUE]PAII(.HN'20.-LM-R
MFPD.1ZUBY&VE>6"WL85W"R+%@]=5=9S98<MBJ\*YLJ*1HQK/66N#Y]BU.<#K
MM-E.P#D`V'[GR'I5RRBS:";@D!0TG2HA/.R5>4GVU!?\&NX?ZIS-XN02WBX#
MKJ'4+6E,@".[T)#HCD]13,=_[%YP"R7;I_)5:YWSD;B;&]]JV-;98%V=HM9X
MTB)6\5(/HR#+/2J$!65;3*-4%&=?0M%B<IQ\>9<P>8=&V["E,<MC&*FRHJY+
M20IE%^9`)L"I02.9TI!)MR'MO6GMOM1O;=NVIF[<'%2YAX0<)U.(0X]T6E/2
M!';40I\QV$J??"`=#8OQ44@X\UY<8%<V#(]>4NI62N+8F;F[-*2$9)-(%>,J
MSDS&UNJ]+J-A:V$*S)$%N]*U%0R:OL@8OK:R*PN12VV[HN'E`)`L574+IN/#
M4.5[7\>-2CW8_N6UC,3E!C^HWF7F68[:%MJ>#DA.N.E]H*U,>H0>HT7``I/,
M@\*L3GFI@5ECYGD5W-S[>.<V)]5%:ZM4YOXYC9N*CFT[-(2M3*V&58H0U:>(
M2;E8Q?"38+I*=0^(0IL@P.05),5(25A`5JU#203865>QN1I'S@U),_#WW,?W
M0O:K$:*N2B(B2'Q):](XTXXIEI34G4&UJ=?2N.VD'4IY"T6`0HC*5.5&$29#
MJ&-4;=YR>NT=`OX5\SC7[BME&V-G3VGQTE8"(!'QLM;6S!<T<V5,51<41+V'
M$A38QAL@8[DI3=D-D@@D:K((UD#F0GAJ/A^&H5/9CN(K:\[=JH.C&X]UY#J%
MN(2_:,I*)3C;.K6XU&4ML/K2"$:PKBD**;GBKD=B7-,[9JW09]>2E*P0KQ5-
MW%O8U";@E71V"-HK#EXB1&?K"[]([<CQ`3)F53$.X2B-DS%S(*$.R$V;7PX$
M&RK7TJ\0H#C8UJ[T[3;W[?8V'EMS1DM0IA*04N(<+3P2%F-(2@W9D)04K4TO
MS!)'C<"<?%3\0R?BD\0@)&,3K*!TRK&.1$3$`>HI53$,!=^PPEV#M#4?:X_:
MKSG0O2%V.@W\#8V%S8_,""1X#CPK'I.X5B'L%<J<G-L&-DMQI(E:AEE>E]-#
M#QZ\I)BS1*4W4#-@V45.(B`=)1V'?LUE3'=<:6^E)+*+:C[+FP_9]E2D3`9B
M?BY>;AQW7,/`#?J'0/(T'5AMO4?^<M24@#C<^RLH#N#[@UCJ)JNE*:4II2L7
MNEPK>/ZM.W6WRB,+6JU&N968DW`',FU:-R@)A*FD4ZJZZIQ*1)(A3**JF*0@
M"8P`.1EEV2\F.P-3RS8#Y?LU+X'!9;<^9C;?P;*I&7F/)::;3:ZE*^<D!*0+
ME2B0E*05*(`)K7!US7P"TH$3D):>GBQ\M99*I$KQ*G.*71A.0;961L+64JJ3
M49-FG7H=`[YVH)1(1H43D$P[%&43@LB9"H^E-TH"KZAI(5P395[$J/`#Q->K
M-?#YW->W(]MAN+&,EB&W)+QDLB*MEY0;84W(*NFLONJ#+:;W+ATJ"1<C+3\I
M<)%R'6L:)V\KN<M<=$OXF39,7;FJ&4L<-\2UJ+>69%(8MG,V*M#[P9MU#E,L
MTV4[`,3JP?=&0,94O19"2;@FRK).E1">=@K@2.1X>!J$3V8[AG:TO=JX)1CH
M3KJ'&U+2F39AWH2'$QR>HIIA_P"P=6`0EWR\2%6Q^)YF<?YJ&R#.L;:[,QQP
M=D$IXT%+-74\A+SZE3@7E-:.&Q%[0RL%N2-%-%&H""C[I(/24Y#&RKP6206T
M+1Q=O;B"!I3J5JL?*0DZB#X?74G-[!=S\?/Q>-DP4"3E@OIZ7FE)9+3(DO)E
M*"B(ZV8I$AQ+G$-74+E*DCKR?-7CY#U6E7)]:Y!.(O"TH1NF2MS2LG6T(!?R
MEHD+M%IM3/:K'U-]_%Y%5R0H(K^H'4.JIP>26\MA*`5MV_*%E:O="3R5J'%-
MK\*RP_A][H3\SD<%&A-&9CDMZB7V@V^IX:HZ(CA5HDKDH\["6R2M'F)`K*S<
MG\*HY-EL2N+:5"T0L=(/Y!XJP?$K!'$/!-+3,0:=H%`8E>?B:O(MY%=J503E
M:J@8-S%4*3#]TSS&3,"+M*M;B-5BHI!(YV*@4@^W\-0B>SG<%>SV-[MP=6'D
M.H0A*5H,C2Z\J.T\8^KJ!EV2A;"'"FQ<38@`I4K$X_FG@.4I-AO;*?FU6%=G
M86NFA/AB82MDW)6I5RG3S5NMJMRR,TTMZ;)=6.73#PUD$%5!$A4SB7*O`Y%$
MA+"TIU*2I6K4-*0GWKJY)*;@'YS;QJ<E?#]W,B;AB[;D1HZ9,J,Z_P!7U#1C
M,HCA)D]=\**&E12M"7T*.I*UH2`I2D@R8XSWBAKAY/.YK6W5QDXA$)UI.(-7
MBJ[Q!V)2-63:*(C[T7FG#HX($9@D"_CCT"4!`=:R<9,5-^[NF?5@V(-O#F2>
M5@.-_9XUR#';/>KV^SVV$)2=W)D%E3*E)`04\5+4[?IAI*;K+FK1H\P-K5&\
MIS0P!#5&G75]9Y,L7<Y"<CVS-*MS#F=KYZE)MH2[.[;#(M#O:Y'TB5?H(2BZ
MQ>A`5B'`3IFZ];*<#D7'EL)0F[82;ZA96H%2=)Y**A<IMQ-O;76P_A_[G3L[
M/V_&B,F9`:9<4HOM)9?$EM3L1,9U2@A]<MI"UQT)-UZ5).E0TUE:7)[#"V3S
M8D);/]9R,5'(/S,'A*HH]1@7%L7KZ=I,E[G/86]3:*2BC4%.HC(G6(]H%'$K
M$SA$]9H^ROROYK7TA6GGIU$)O;G4(OL_O]&SQOA4*^(+@3H"TF2$%Y,8/F.#
MU>@9*DQTN:>+QTCQ(P^.YK<?I>E6F]L+/+.(JJ2D-$K1PUB;1L<XXM*8+TY6
MK0*[1-_/M+BW,!XY5$.E8NX&Z#`8`RJP&20^AA2!J6";ZA9.G@O4>0TGG?E4
M_*^'ON?!W%"VW*AL(FS677`YZAHQV4QS:4)#R5%#*HIX/I4;H-K:@03W9+F/
MQ_B4,=/'5S549Y+;IOH=TUA91RA"1ZU@"HIOKD9-L)JHU"Y&]SB+L""61*=(
M0`$E3$HC"9!PN!*.+5P1<"Y"=7E_='3YN'Y-CXBM6)V$[GSG,JRS`2'L.O0Z
ME3K:5/+#!DE$6ZOXRKTO\:`:O=@I6+ZT!6SYU4BIE5.HD5,XI`54RA2D,*QR
M)H@4XCTB*IS@!>WUA$`#M'42`;V/O#Y?57CZ4+*M"02L`\+7/#B;CV``D^P7
M]E=.4DXZ%C)&9EGB#&+BFCJ0D7S@_AMV3%BDHN[<K*=O01!),PF]/9W;ZO;2
MMQ8;;%UJX`6YD^%9(D*7D);4"$VIV8\M+:$)]Y2UD)2$_.HD`5Q@9J*LL+$6
M.!?H2D'8(N/FX:2;"8S:1BI5HD^CG[8Q@*8R#MFN10HB`")3!V!HMM;*U-.B
MSJ5$$>PC@1]7*LV1Q\S$9!_$Y%M3.1BO+:=;5[R'&U%"T*^=*@0?G!J[:MK2
MII2FE*\O>6K.;C,H9+;EJ5NL@9PX]T?&&/%8"J3UBCW-W@<EV25DZ_,2,-'O
MV5320B)Q.0(ZE5&;$Y04*5;Q"]`];AE(7#:/40GTTE;B[J"3I*$@$7(U<1IL
MFYY<+5]B=CW\?,V=B'/708GZN;HEY&<'I++"TQ'H##;;[:'5H7()=94P6HR7
M7@=)+>@ZAK;:\;9#L6/6G'.*I-V>Y&PY9N0]ZMDVM5YUG7K+7IBO3*]<2@+B
M]8(5^S.\FJ6U-DW:MW2RX*LW!7)$2I;C*-3(K,HY0N-ICR&V4)&H72=0O=`-
MQHTW)M;B+7)KUG"[LVMBMTK[K3<CCV]JY^)A(D9H2&5OQWVGV@^7HJ%J?CI@
M",IU;CC:4:76BTI9<L,]83SDN<H#E?\`".2T<-U^?J5+E'(8ROQ;,E*(8'N=
M"?60M`&NEO;J&@[9/(1BCY&-.B*:AUTS';E,IK74A(QR\1U&C-6A2P-:2DCK
M)6!KOH!*056)OX&QKFI6-8/;>5V4]=B5;]E19,MM/WA",<MJS$68B/ZT/F&E
MUV,RN0EI4@*"DI;4$ND)J.J]C_(-5QY;<13%`O+:Y\E*?@E_CE!O4YU]$5DS
M*Q)R,U7+786#%S!TAUCEDP,Z<)R+EJ4HKIE0\0YA*&P[)BNR43&W6RQ%6\%G
M4`5738%(/%6LFPT@WL;UU>5W/M?-;I@[[@93&KP&TI^81.4J2RAV1J8*&7XS
M"UI>EIGK7TVU,(<)T*+FA(!/.>IE[M-6IU*AJ)?G-AXRM<LSV3FJ].L3!*:2
M4Y0XRR3'0%2DI"-:1%\?7NE5IU+H)Q"SXISLRH+"1R9-(34B.P\M];K73E],
M(\P-OXNX@E0YH"%J";J`YDCAQJS';@VWA,U/W#D<EC48O=Z\8SCRF4PLM']7
MLA`6])0VXIV&B'+?;C+5)0T0'"X@*:"EB0$[`[BLX3G*IS1<F+8CO,Y>ZK6V
M[;&-\<V8T@3'SJ'B;$ZHJ5=4MT1'W>9*6/;.G+%$G48#+BDC^DUKZ$KQR<.E
MQD34!"CYT:;:[D:RH))2/,0"3[+FN95CF)W;J-V79R6(3OG&QX<E]1R$,,:#
M-2ZZPB87Q&=7#:N\MM#RS8%+86YY:Q#&^-[_`$N`I/'6?IUO1R++Y:XRY0:R
M:59G7M5AZ;2>/N.ZQ;WSF\L&+FJQ[NDV&F.84S)5ZF^5ZD3-T5$3@<,TN7&D
M/.9-#C?I0R^V02`HJ6\M20$$ZK+"PH&U@+W-Q4UNW=FV<_DLCW6Q<_'JVLSA
M-P8Y39D,HD.RI>:G/QDIAK6F0M,MB6W*#R6E,ILM+JT.)M4R9DD9&QWK+S&(
MI>1'I^3E<XRQ6+7PX^MZ31)_C#*=F:7CXG>'B`2HQZ>SER3:1I<S$';1(ZC4
M53@4IM&$EMF.P7'&@(BWRYYD\0XVDHT\;KU6*/+>QX*M>N$V#$B8O;>"D3LA
MBFT[0E9]S(H];&*RC(8Z.J)Z=/5O+]4IHQ"(P>Z;A2AX(221K]::%D*U8OJ6
M'87'UZ7NG&BN9V>9'!Q4IYC%64)<#QL'$U.??,&T+=W%]!,7J2<>NZ_0"!EN
M@X].I)F1&9EN37'&@S*4R$>8'3;BHJ`)*`CD=0''E7I^&W/M7"[RG;\GY3&I
MV_NZ7AT0=,EE3D?I6<==DLH6IZ&F'?I*+R&_/<-ZD\:DV1GG:.;;=RP"E9+D
ML.W*3RI2Z^5/&5\-9W<E-8+P958&><X^6KY+O%Q5DLN/9"#*[=1R*:9FJ1U1
M(W534'5"4_=R,/U&DS6TMJ/G1IX//*4-85I)"5I58$GC[017(1<:RKM[![)J
MR.(9WW`9QTI^^0A^G0AK,9>0\RF:E\Q''&(\YB86VWUJ4'%I;"G4+0,.IF.<
M@5RM_L[RM.N;?(>2<E<:LE5V=3J\\XKD%4ZS=$+M:EI2YMF"E>@WV-8V$%NH
MS<O$G1W3I%-LFKUCMFD2HZW?O-M;?I6VGVU#4-16I.A-DWN=9-P0+6!)(J=S
MV[-L9;+?\4H60QZ]KXC$9Z!(9,AE+[LF1%,2.&XJEA]Y$];H6EUMI3:6VUK>
M4C3QGSB!%3TGD3$9%*E;*O\`J(XN1N'LC'L=6GJXU0R`WL($/4HA]+1[%A:F
MK)HR!Z5[&*/(T4E"=*_B;D".S:VD1GM*T+]1,+B-*DJ.C3[Q`)*;DV(590(X
MBO,^^LW%Q-K9Q2)L&9^LF\G,I!#$AE]1A*8N)+J&UK7&4M2^D6I`:?U)5=O1
M91UB@:GD9MFC+,EDP<JR<D61Y*FR-7*7C+*R<S;L<3#TS7$44WRBK;!QTY%9
MDM`_#@UV/-(,7;5QYHA")/5!E77HBX3*809#=F-"EK;\JP+NG1IUCB'->M6D
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MS9UV'?6&3C)7'EN-!QB/FI.5BJ'DVFWB?8QK(/7D)!Q`UUR5!L0!4<*B5(@"
M8X`,KA'6VLFVIQ24((6G4>0*T*0"3X"ZA<\AS->M]C,IC<3W/Q[^5?;BPWF9
MT;JN*T-MN3,?*B,K<7R0A+S[96LV2A-UJ(2DFO/YO8'$3G.;Y7.:+DQQB*[6
M"YU:NMD,87QQ9C/TL=/XF,L3JB)UTUOBHZZS'3&MW+ABB7Q#E,N9-$?$UT9;
M"\<G#AUKUB`A1\Z-/%8)&O5I.@>:P/T<>%?3CN+:G=N(_9-K)XA.^L?&BR'U
M*R$,1P@SD..,)F%X1G%Q&KON-H>4=((;"W/+495G$V2(+'#3B[)U&W,\I7*R
MX)N4++IUN==56'KT!QDJ-'L4@\O;!BYJT2XH]JK:T.JT7>IO3@*9VZ2J!@.&
MX[-C.RCF4K;,-M#J5#4-2E*?4L#0?,0M*@NX%O`D'A799;>^T\ENI?>*).@N
M;,Q\/,Q'FB^RF2Z^_N"5,82B&M:9+@F1Y"927$-*9%EI<6AP::OCQA:K8&'[
MA&8ZR+&17%>E8QK&6F;ZA6F.D'<U$9XH<K,-JQ%K1"3R]IU&"IKJPG5B$WR)
MFZB0H'.X4*F.,.,L^H96ZT52W7%-V6D\"RL`DWLG45!'F(XWN`!>HMJ5A<(<
M]@YF6Q;TW>>0R$C&+1,C+0EES#3&VE2'`Z4PS)>E-P0F465!87U$I:0I8*)6
M*NRN9,I/,>Y(E*MR:J'(&M8HBFF/+<[E7$O:LE>_ZO'V6`)#FEZ(2^1`^:35
MFD(]NF?8CDZ1^S5+LNH8BI<92]$6PIPZT@62C2HA5[+T'A9))/A<55MS%92'
M@-FL97$LYC:$_"2,DXJ=&2TEJ/`Z,E<=_J]*88;OV:DQ%OK(\S06GC7&0Q?D
M9>C#Q60J5P<Y/K.6KCE*0LWPY.%J$I33X;E6C*287Q9DG5W[ZR2MF2@TV8/#
M/?'9K`HD5),#C5$V-ZG[V4ML1%L);"2H:M75'`H'$:0DK)L!Q!!I%WCM1O<G
M_&=<Z`C9\S!Q<>B/UV3*;E?>C:UMJA!9D(2PW'5++O2Z6AU!0LK7IJ]0[Z3=
MY+QCR-+2<D-L8X>1X_TJ](N,;7IO84)>%QQF.EVJ0CZ2O7D[988W&T_=F1'#
MN/8N4#HNU%FAUTB*'#&YH1$>Q?4:]4]UEI.M)!!6TI(*KZ4E80;!1!N`"`2*
MC\A'A,;1S':A>0Q2MX9Y6:EPBF?#4RIIV=BY<9M<M+QC,N3V8;I;:?>;6%-I
M;>2VM24G/VD;9HCC54$G=$O)9:$S3!\K)*F-Z;87$LPQ:?,[FQJ0B3-&.42<
M7&/AE`5/`IB:2*0/\AK64ME64<4EUL-J85'"RH6+G2M>]_=)X:_=^>N9>EXB
M=W=G*9R6,,*1M][;C<I4ID-+R(Q26`\5J6"F*XZ-*9B@(Y5^^5&;\L["6K+V
M9GE!R*\I7(^L\C:=C"/:8]N;Z85FK(G2*W4R6"MH0JDY3F>47,8N_1<RK9DW
M(U:^*[.B/1U;;:F7F(\$.M"1&6PI9*T@:4ZU*LJ]E%L&Q";\39-ZZZ*<9D,+
M@M@L9/%-Y_:<S!2LBM4V*AL-,&6_)Z+ZG0U*5CDN(94B,MU9<<T,)<LJUI=X
MER/(4QWQ51K%M)E,N4;+D;X@6KTXE3R5&3X]N()C-$R$#+X1.Y=6!`:\9F1\
M:03.X*)D00,*@94S(R'QF"I'H^BE`&H%6H/`D:+ZN`\_$6^>M]G>^TH^X$=Z
M5RX/ZE_<\>"&$OLF29+>;2\MGT6OU("6%":'2R&2$$!9<`361.Y&4M%ZQ;G]
MMC[)</CS!T3@"FY"8R&-;LSL"$M`R,E(6AS%TT(`UDM#/&Y)$B+A:+9O$S*]
M16IE@*(ZPI"&XS^,ZK1DOJ>4@AQ%B"``"N^E.NU[*(-K7M42S%A8?;F8[9.Y
M3$2-T[C?S4J$IN?$4R6GD-MQTN2NOT(ZYY;*T(D.M*";%X()%8HG6KI7*UF!
MG*8ZR`Y=\LZ<LSQ"S0I-CD/=TD\Y.YDMB4;:U&<:Y3H+@:GDAA9A&8,Q(4AG
M!!,#I$Z09E.QW'F.FZT!"<^T.L<0([2;IN1K&I"F_*#X>!O4XK+X#*9G!/Q,
MKBVV=D3PK)K5+80%H3M_%QBY&"G$F:/4P'L>!%#Q*@TH#HN)74Z\\*CD)<W'
MR/=.94<4PU;M49<C1M%R?DIF.04ZJDSJKB1KF()J#N?BJ@1TG'/#J'8H22B(
MJ@4>DX1FWWHUY)`3ZQ2T:`5(1Y==U6+@*>!TZAS*;VKS7X;,[M9`W1)CI8&]
MI$R,N*')F/@*]$9)7)"'\FT]%L+M*?:`#RV$N!!(NDPV;'N8)J^Q;*UQ6:K9
MB^0P1%4:^IV!I-Q#>R<MCX7B4(V^2E9AGTH*56&OM$HM\HS?J0Z%F2<B<5!.
M58\AZF`F.HM*CHE"05ITD$B-U3=`5P\UR5"X"BV1[+5WZ=T[$@;9?D85[;\'
M>#6Y')D(LJ9<4QMD95TN0VY#B$7D]92I+(=9$I>/4R$Z`DMI]1.)K6,8<9\$
M1L3$S$"UB\5TN*5@[!%V"%F8B2BX1I'S4=(1=H0;SK-=G--G"?2L4"B4H"F)
MDA(8>1S*EJRTE2U)42\HW24D$7N""DD&X(Y?7QKXX[VORY?=[<DR8^Q)>>S,
MIP/,N,.M.MN/+6RXAR.5,J"VE(5=)O<V5984!L-J-KRZFE*:4K6_,')S'V%K
M-#5>RL+=*NWD:TL5A>U>MOYV.H-1?RJ\`PM]U=M"&)#03R<0.U35-N)CIJ#M
ML01U)0<3(GM%YLH%E$)U$)*U`7*4@\R!QM]%>K[$[/;H[@8>1F<0[!98;=4P
MPB0^AER;*0VEY<6(E1'5>2RI+BDCD%)%[J%8X/,K#K>XW&KR1K3%1=.CKF[&
M_OJU(I4*RO,;Q;:9OL'5;&4AFLY,5F/?$.=!'J,L8BY4NHS=4`S?<4\LMNIT
M%Q91Y`H:TAPV25)Y@$CF>5P3P(J63V"WZ]@8.8AB$]+G/14^B1(09L=,]Q34
M)Z0Q<*9:?<00%JMI!;4NP=03:&_-7'CJJ.9=.DY7"X)VR,IK3$*E%DBY.E9*
M=BG5BA'D?6!+YA:#DJLQ6DP>?Y$C-%0YQ#H'5WW#)2\&RXST=!47-8T``A)N
MKVZB$V\216X]\/NZ6<TB"K(X4X$P7)2LF)C9Q[;;+B6'4KD>Z'42%HC]+WBZ
MM*4@W%=U7FMA@TA04([XNFH6[P51L+ZW1M6DEJUCR-R"[7CJ:.29(4RDJ#B:
ME6BC84G/2=NJ!05`H'+O08*<$N%6A+C:E`)*AJ64<5=,?E6!O<<QRK"CX?-_
M")DW)9@Q\CCI,EA$5R2V)$YR$E+DKT#=R9*6FU)<"F[A:;Z"=*K4;\U,/"\O
M99!O=(6)IL5:)F(L<G4Y)"&R6TI%CBJ5;$\:NA3$+6]B+M/,H@$$?TJ[QVD5
M,#`;?3[BG$-Z"A2W"D$!0NC6"I/4_<W2"JY\`:._#YOL,8U456/D3Y[T=IUA
MN2VIV`J6PY+C&>F_\60[$9>DZU>5#3:RLBU6USS=QLVJ<=-?!F5UK2ZLTW57
M^*FE"E7.2X!]56)YFRNY:L$(+AM%1$$B9X5Q_DW"?2"0F,8`U>G`3%/%'49Z
M(0E0<UC0=1TBRO$E7"WAXUMM?#ONY[-NXX9#")PR8C4E&25,;3`>1)6&F$M2
M"=*G''B&BCWD*OKL!>LD0YA8@?7VJ4J+-9I:.MQ:DS89$CZ\_<X[96+(%79W
MBDU.3LY2>493UGI[]&002-W(KH]0@*I0UA5A)HBK?.A*T:O(3Y]*%%"U:>=@
MH$?2#[*B7.P^^H^V9NX9HAL2X)DJ7!<?0F<IB%(5$ER&X]]2V8\I"V5J'-2'
M"+A!-7W(O)S'V,\A0^/)N/MK]XY&K&LT_!5M]*UC':%\L!:E175XF6Y#-X-&
MV60XM6HG[P354'9-,XA9&Q,J7%5);*`!JTI4H!2]"=2](//2GB?I`YFHW:G9
M_=&[MK2-U8YV"U'0)/IV7GT-R)RH;/J9B8;2CJ>,9BSC@'[I"1=2@*P]'FKA
MDDE?6LE\71$)28>USK.YR-6D4*I?F5#=FC[D7'<MT"E:W4"^+T&2;=1E4]E$
M^I/UM9S@)Y#11H4XX4^0*!4C6/+K'Y(4/$_0>-3BOA[[@.0\:]$,%_(9&1&9
M5%1(;,F$J8GJ1#.:O>,EY!N%.6"5>55E<*M[OFWCAA4B3CREY72M:=DEZS*X
MD+1)53)\`XKM=A[I89*6JQ""Y;PL/2K!'RAW0;I&0?MP*(G5*&JC`RE.]-+C
M/1TA0<UC0;J*``KE<K2I-O:">0K;8^'G=<K.'&L9#"'"&(W(:R9F-C'O)??=
MB,-MR+Z2\[+8?CI;-E!;+I-DH)K(2<Q,0NKU4Z;&_%$HRM2%.*%]95R05H5?
MF,CD7-0:W8[)T`VB9VU*LE$44%-A3<BDDITG5(&L1P<U+"WE:`I&ORW&LI01
MK*1X@7O?V7(X"HM787?36VYV?E^C9D0E2CZ);Z!,>:@Z1-D1V/>=9CA06I:>
M!;"UHNE"C5\PYR?Q[FVQ3%;J[&VQ;MK#(VZNN[/7'L''7^A.GHQ;2]TIV[(4
MDU6W,B04BJEV';I-MTF#5D[$R<:TEQXH4-6E0202E8%RA5N2@.8^FHS?G9[=
M/;S%L9;,N07F5R%1GTQWT/.0IB4]1426E)NT^E'F*3PYB]TFIZ&;A0=NV9I:
M+!\Q207D&HOFOF63=8PE05>(>+XK=)0X[$,<``1'L[]1O3=L%`*L3:]C;QKS
M48Z>6&Y(8>,9U12A6A6E9`N0@VLH@<[7-JQ:9R=28"YTW'TI-MD+=?CS2=7B
M`'QE7YH"(<SDGUF3ZB-P1CFISAUB'6.P!N(ZSMQ9#C#DE"?L6K7/^$;#Z>/.
MU34#9VXLGM_(;IAQU*P>,#1D.\@CK.)9;L#Q5=:@.%[<S4@AW?O]^M>N9Y\:
M:4II2FE*PO(=\K>,*98+];G:K.OUEB+U\=LW5>/5SJ+(M&,=&L4`,N_E9:0<
M)-6C=,!47<K$3*'48-9HT=Z7(1&8%W%FP_ND^``N2?`<:G]K;:R^\=P1=LX)
M`<RDQS0@*(2D6!4M:UG@AMM"5..+/!"$J4>`K61US<QLVJ<?-&IF6%[4ZM$O
M5'V*6M"E5\F0;^LQBD]8W4K5R)^:;Q457FYWH..U-=,`*D)CB`:E1M^47B@+
M:#(0%!S6`V0HZ4V5RN5&UO`UZ^S\.^[7\T[C_7X1.$3#:DHR2IC8@/(D.!EA
M+<B^E3CCZ@T4>\A5RNR1>K\7F/AY:[5JIQZUCDX:S-*R9+);&!>K8WBI>[U-
MO?:A7)FT])6<;,6"ENDI)),X@!6ZJ0G$!4*&K!@IP84\K2'$E7V9/VA"%:%$
M)YV"KI^D'V5%_P#`7?J-NR\U(3$:GQ%R+P%O($]QJ))5#E/M1O?<:8E)4PI0
MYK2O3<)-6:+YO8CE(BX2WNG(;`T"G".JS%RE*EF4KE6,M%N3Q]6)3&;%5+Q;
M0SG+LJE')F2#U#.$%#]*:I##>K`3DK0@%LW)U$*!#92G6H+/Y-D\3]!\14A-
M^'??$&?!A*D8MT25.ID.-RVU-XYR/%];(;GK!M'6S$"GU!7,(<0FZT*%?"4Y
MR8GC*S7;"K7LENEI`MF=W"M,J/+.[/BF*HLF$+>9K),0BF=S7(^J30@U7,<!
M$ZP@"8&'51M^<MU;84UI&D)5K`2X5BZ`V?RBH<?HK)#^'/>TK+RL4B5B$-M=
M!,5]<MI,?).3&^K$:@.DA+[DAG[1"0>">*K5E"W+W$3?(<K1'!K(A&Q))=HI
MDHT`]'&3NRUZJM[S-4]C<"E&.=V&/J;TCOP"&'Q.E5,FZB)P#$,)/,82!IUF
MQZ=QKTJ44!6CG;4+7\.%^8J';[%;YD;79W&T(:I3W24('73]X)8>DJAM2EQO
M?2PN2@ME9`TW0I5DK23C$=S>QC)U65G4JEE)&?0F:M#U_'#RC2;:_P!V+?DY
MES19>JU]0@+24'9XVO/WB;D/T:+5DNHKTE3'69>WYJ'0@K9+92HE>L:$Z+:P
MI7@4DA-O:0!4Q*^';>$/-,8Y<[#*QBF)+KT],QM4*)Z(M)F-27QP;>CN/,M%
MOFMQUM"+E8J35N2V,"82:Y[0=3;ZG2+9H,9%-8-\I<GTZ^=%C6E.0JX$]YC;
MU98WE!8"7QBN`$HAV:TQBIGW@<:0D/B]R2-%AQ*M7+3;C?E:N.;[1[P7W$7V
MT<1';SK2U=1Q3J!%0RA/45*5)OT_2AK[7K7TE%E>-1I*<WL5158K\^>N9*=O
MY!Q<B6FFQU)E7=QQHPQK)1L/D6:OL(DGX\##T]U,-3+K']55LN59+J3W$-E&
M`F./*:"VDM@)TJ*@$K+@)0$'Q*K$6]O`VKKX?P[[SFY>7C1+Q*(K2(OIY2Y;
M:8V07/0XY!9ANDV><E):<"$CW7$%M>E5@<H+RZQ(;(9J,92PHQ1?,L"Y.7@G
M:>+U;.RISG(CVGI7`2^0&?9TAF>142$0`J90)OUF*4<9PLU,42#IZG/1<:])
M4$!>C]SK\M0Y[&;W&U!N-(BJFG2O[O2\DY`1U2DPD2C%]_HJEJ#"5`$E1U6T
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M*E276.1(YUA.'0`"(FW[-0J6W5JZ:$DD>P$GYZ\18@3I3RHL1EUR0D$J2A"E
M*`3?5<`$BWC71G;57JS"35BFI9BRB*^S=OI=V=PF)6:#%F>0<`HF4PF,X!H3
MK*F`=9P$-@'<-7,L./+0TV"5J(`^?C_=YFMC&X3*9?(1\7CV'')TIQ"&DA)\
MY6H(20?W.H@%7(>)X&OI4[/"7:L5VXUMX21KUK@HFR03XI3$!Y#S;%"2CG7A
MJ`"B?CM7)3"4P`8H]@@`@.JO-.,/*8>!#J%%)'L(-B*9O#Y';V9EX#+MEK*P
M9+L=Y%[Z765EM:;C@=*DD7'`\QPK(=8ZBZ:4II2O-'E54\AER;?#5C&UMOC+
M.V#J;B:`E*ZT8O(FK6ZN7ZQSSX]U7=OF9X&O'@IE-PD[*1QU+)J$Z`$"[]5B
M'XYAM!UU#:HTA3B@3Q4E2$CRCC<W%K<.!KZX[*YG:QVAC?O?+0<;(VUN*5DG
MFWU+0[(BOPV&4^D"4+#SX>:*%-$HLE2%:K7MKQ9,%YELE*;\;XW&UJ3D<-3^
M=+^3(LBFP9TK(#.Q0<VI0H>LR_GE':\M<)&U*-'*:J)"LACUS*&,44^J1:R,
M%N2K*N.HT/I91TQ<J18C45"WY`1<<>.H`?-ZEB.Y&P,1N)7=F3EX1AYZ-B(7
MH4:U2X2V'F1,=D-:`E+49N.'6U(6HO=9L)`5JTYJR8Y)#*\/RR/A3+*-0K%F
MJM6=X_&!C4\G/8MEA6XXSFKBSJGOL6SF)B;38$03$7@*K,"JK$*`@!1Q*5$,
M$X;KL^H<0I6O4=`)=2X$E5K@E*3]"K5STF3M/]2I'9(;@PJLY,AR9")O7<./
M0XO+1<@U%5(Z6I+KL=E5_LBE+Q0@GCJ&!0F$\SUFFVS$DEBRV+S/)^#Q5+LY
MV,1CGU6Q5)MK3[ZNE?R!*!(IK1"E/BFB:B1VR+I-VNN":8@)3#K9<R,!V0B<
MEY'3B*<!2;A3@TV24"W'42;W(L!?V5T^2[A[`S.X(.^(>9@I@[.DY)I;+A6B
M1D6U1PU%>A-Z"'1*<4H$+6V6T(*E<"!7TF,.9EM->K-(CL575K*\8T<FSDH]
ME6L:RB<GNW7(S'65:G`XZDPDUC3ZMKI5;?*JBLFU3;2!$4#B(J=9:-3H++JW
MEO-E$PMI%B;M@,.-J4OAPTJ4`+7NFYJR!OS8.&RLS<4O-8]R#O!6/9;0VI:W
M<>E.#G8Z2].;Z8Z(C2WV4ITJ<4XR7'$@!-CFA&>4(K+LORR#!>5I"L7V9ME6
M88[:PD6;(L2P<4I>`K-JFZX>:*U91]EG%"HJ"#DZC9`Y55`Z1$`P%41R"G#^
MH92\VE*BLDZ#YKJ2#;B4CCRX^%<^7]H3=C,=D#N3"M9;&QXTE<Y3S@@N+$H/
M2(S3X9U+7'9!6/LP'%@H2;CCCF/<%9AH\;3N.LKCNS.GLMDKCUEI_DE@DR=X
M]KU>Q[@['U0N\8ZFQ>I.T[%#V^H+,FC0K80=-7"*I3E`QBDRR\C!DJ7DDNH"
M0R^V&S?6HK=6I)M;D4K!)OP((M>I;='<;8FXI<_NK"RL-$=G$9O&MP%E2)SS
M\W+S9,1Q+6@H+#L64AUQPK'3<0X@I)`)E?+T7D:U7C)C2%Q!DE9GRC@>/,'7
M)=W$QB#3'Z^)\D64MY4R.89E0:Z#6LRX2\6*(.P?$3,F`IJ"`:T8+D5IAHNO
MM?Q13RB`3=?4;3IT</-YAI-[6X'C7$;&F;4PVW,0_D,[B1(V=*S;S[2''"N:
MG)0&##$'[(=>\AHQ9&KI%DJ"O,@$U!UAPGFJV8]K6&8[%EN;3/&:!S*[=V"3
M1CFM8RH]GDS1M-AZ%*`^65E5;0Q)YM?S"+8K8H@F?<^I!K(0&92IRGDE$I37
M"Y*FP.*BL?,>'"_MKT;%=Q.WV#W5,W_,S,%>.W?)Q24L-E:I&.0SYY3DQO0`
MV(ZCTD=-3A<-U)LFL_>M,EI97LO+=G@_+#^J7:1R/3XS'00<8EDUHVLN'<+U
M"O6J9JIYLS5E%R-TQ[(,5S^:.JBT,U<&*)5#%)K!44P489<AI+R$H45W.CRN
MNJ*0JW$A+B5#A:]QX<>9CR-HKV3$['R-Q85O,X]J!*<G=9PP%*8RF5E/QV9'
M2U+<1$G,.H'3"5NAYH&Z`I6,53!>8*O"$X[R..K8JZR9?L`Y0/DIBBQ<4>FQ
M--N+:[7Z(FY;SY';2>K"<6FS9H$0.1XY=IB0Q2`<2YG\C!=<.22ZC[)IYO0;
MZEE2=""!;BDWU&YX`&IC,]QMAY;(GNI%RT(1\1C,UC_0.%:9DIV5%5$A.--:
M"E;,@N%UU96"TAI>I)58&<>)5,R*.0,:*6O'%KH+;`/'5AA.PR-E:LFT?:KT
MA,(J.1I;EH^='G*FE&H@Y2?'(B!A4*7PP-OMH9J1'].\&G4.&3*+H"2;I01^
M5?DJ_`CYCQKSGO?N#:@VOETX/*P<F[N;=2\LPAA2RN-#+1"?5)6A/1DEPEM3
M(*[!).HBU]7(#`N2XC,649F^XTRA>Y`DGR3D;,TA*'CZ)K^4J5D9ZNVQM3W6
M7>L]YN[1XQ=Q*31DX,W"NJPJRJ1P!LD"LHYD8CD5I$=UEM-F`DE2R6U(`UJ#
M?N(((62>/4"P#S-O8\GW*VC.V%AH&VLOAL;%+.!1'6],FNOXZ7!2%3Y2<9_(
MXBDK3)4Z\@+,U,M"%I)>642'Q_P/DC'5JXOJ9:Q),VR_XZRID]ED++16$;:@
MEC7S'3\*1D+W[)OC2T?7H--NV@ERI`(LG;4AR$$%S&#6R4Z))CRD1'DIC.,M
ME#?ND:%C4C2!IU&Y4+\P>?"N7[G=R=I[JPN\1L?.1X6V<KAL>N%C=;D;I"'.
M1ZN%T6T!I;[Q4N8@J_/-.*2I5VT@^S.N('*O@:FE*:4II2M=N5M0LEWP3;X6
MH12L]8F4E0[?'P3=5-%Y.%Q[D:I7Y["1YUA*@,G+L*TJW:E.8I#N%"%,8H")
M@E,,^U'R*''E:6R%I)]FM"D`GY@5`GYKUZGV6SN(V[W(@9#.O"-BW&9D9;R@
M2EGUL&3"0ZNW'IM+D)6X0"0A*B`2`*T'20R?$Y?E.6X8+RO(5F\3MEJ[+'3:
M$BAR1%1YZ.[@:W:YFN'F@:M&%CL"I&Q]G)E&R)P64#I$0#H5*AJ@##B0R'FT
MI7K)/3)U74G5:YLGCR^:OI=Q[9\W8K/9`[DPK>7QL:/(7.+SGH75B8EY^,T^
M&BI2X[`+@^S`6M)0GS<:CZO\>,RP%&:\6G^/[.K*72;PU=5<GL463O'M:BZO
MQWJ6/;@TE)P'B+Q":@[I7U&K=L1L87315)4I@`3%+L.96"Y)^^$N(TH2XC1R
M6HEY2TD"W(I-[D\""*ZG)]T]@Y/<2^\T;)Q$PL?'RL08Y94F=(<D9N3-BJ;9
MT%!:>B/I<<<+@Z;J5MD$@*-Z=4',-M_5A;3X7O\``EXHU#'E3L<&_9119?(T
MC#9FH\Y9U<<()2QD;)'P](IBDLW464:>;6=(MR@503&+8F5"8ZS/7:5ZQQ:D
MGC9`+2PG6;>6ZEA)L#P!)X"H]G<^Q<%]\X-.?Q<D[UG3I##R%.=."V[BI;,<
M3E%O4PMV7*3&<"0YTTMN.J)2`#P-3<N5Z0RCE5'">29A+D]6,WUBIU)M&1/Q
M!296Z9!"S44V2V"\NFWJT;/Q`B9VN15WY)QL0Q3>T#KP7$LPS(:'I5M*4KB0
ML)1I7H-O-I/(<+CC5PS^Q<I%PVRW-PXAAS9TW$2),E3CG0EM1870F"`L-%4A
M;+O!I"DM=5'F21RJKW`67UJB;BFWH=G4?5C)EIRP3+:J+-+'LY75\52L?!Q[
M":%\>1"Q3-KLIXT[0[8/!(Q56,IT"0#4&2A^H.84XBRVDHZ?$K"NH"HVM:P2
MG5>_-0'C5D;N7L1K-_\`&EW)PQ'F8>/C3C05&:U(&2;6ZM;.CI]!J-'$@.!S
MS*>0V$Z@JURB('*3B]T+DFMA/*3"#PLGA>F6"A.86+3OT^-6H>6J+>[!5H(D
MRHA+PU6DKJP7;JBX2.]:>8.F0HI`4Y:X8CN8L2&2X_U5)7<Z!J6VM`*K<"H(
M(/`V-A?CPU)V2V8UMO)]I4;APSF2W`<K*8FI=<]$R)$S&3(;,A[I!33LA$1Y
M"TZ%!IWI)4HA9*9"0H^4HGCM5XQ;%5T<7""RY#<K9.H,V<:JK[F_6ZXMSS%S
M!W[S*V<9*8PZG6+(>EL.VP.!'LUJ&1#7DUJZS8CJ9,<*N>?2TARUCY+^//YJ
MY=W<FS9O=29+;S6/3@I.#=VVW)4MP#J_=B8R<@M/3U""MT6#O%SQ+=JC1]4<
MKQ%AR=F@F&,D2K'DI7\\TVL4YA$Q:]HIK^VHT^MX[D;]%J3*24#$6UG%.9!Z
MLFJY-'H)$*H0QS@`;;<B&ZRQ!,A"3$4RI2B3903J4L(-N)1<)`X:B>'*NPCY
M[9.0Q>'V`K<&)8D;1DX:5(E+=<$>4B,93\U$)P,DO.QE.-LM)4EOK+4HH4E*
M2:M[OCOEU_5W7%0M*LR$F.0[!DP<M.4&@XV&M2F#%:TR10L)7WGU;&-Y;)QB
MK+R@"1HL"_B"4!+J].3A)>&9+B-'3".F+]34'M1NG]SH\U[\Q;G6TUW4V/&S
M*.])R$14/[J9Q_W:E2O7]=O+A]:E,%&@,>C4J0EWJ^9Q!;TA1!J\O(/*]FMF
M/N09\%Y2A8S`T7A6H3]"=Q,2:[VA:J/Y*2ODK3XAO,G:3L7557P(ME#+H&>F
M(<R90*`;XT/1&67L6)#2E25.J"[G0G58("C:X*K7/`@<*CF<CLG$X/)]KT;D
MP\B7N5_+2F9B77?21TR$-MPVI3A:"F7)`05N)T+#0*0LDDVQLF+,TUJ!R;'#
MAR[R[SEQ5%8NOI,FL8JAC&3=\A,N7<&F2E#R1`KA$L>Y%:RAS)>:*#YJ[;[B
M<A#'RKF0''&B'FPF&Y=7/[0!EM/DX>:ZT%/&W`I/MJ7.].W^7RF(DG/8UB/L
M::''BM3@.1;3A,9$U0+-W?)FP78Z0KIW:<9=/E4H)F/G1AO(-D=8`6;PECNV
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MU:;(X^=0.-*I`2--E8EC"2$#+PD2UBIELZC(U9PQ0.K*LUE@,F<P+%4!01W,
M.N2RZ@O)OK2M+B5.J(4"2"";BQ/'D0/JKX^[R2TY#NMN+(HR#649DY>2\B4T
MZMY#S3SJG&E)<<"5JLVI*2%`%)24V\M3YJ.KS6FE*:4K5O,_*"%PU:6M96I%
MPN16%=C[OD&6K1H$C/'-#EI]>K1EFET9J9BGTP5W.-54P:1:3QZ5-(ZID@3`
M##*P,2Y.9ZP6VWJ64(!OYU`:B`0"!86-U6'&UZ]B[?\`9W(;]PJ\PC(P(!=E
MN1(33_6USIC;(DN1VRTTXAK0RI)ZLA3314I*`LJX5B;KFO08VSVEC,52XQM`
M@27]M!Y7,G!.JC=;'BZNI6FYUJNM6<RXL8OD(E10&*KAD@VD%V;E)%0QDR@?
M8&WY"VT%"T&4K02WQU)2XK2DJN-/.U[&X"@2+5-L?#WN>9AX<C'S8#VYI)A*
M=QMWDR8C&0D&-%D/K4R&-"G0GJI0ZIQA#K*UI"5DIM[;FBFXC58S]2F1T\OK
M6F"KD+A@TC0C66;:6:N/KI#6=M8$K:I2FT`-/C'#YR9>137:@B9%1,%]DQN.
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M6T*A#K6.>GG4LK;DZF]AC0"!EF)F[Y55^H((I$%4>D`P)4LK#[0AE"2ETA>D
ME9TA-M.H$*X&X%N9K*W\/CKD]3R]PXA&R51&'V,J4S/3/JDNAAEE+8C&2AWK
M$(>"V4I92"XM6CC5Z8\TJ%,W"IQ,%5K;+X]M+R@P"F7D?<3:H0=RRA2V&0Z1
M5I)@^F&UI%Q(U.3;+KN46"C1DLZ2064(J(E+8<!*0PM;BT)E("ST_-J*6U:%
MD$#2;*!L+W(!(X5I2?A\W)`P,Z=DIL%C<\-N:\,82\J2]%QTM<&7(;6AI4?2
MW);<2AM3R774MK<;0I`!.49-Y00>-<A)4=6E7"R1\2G17.2;K"#`%@,8LLG6
MCX-H+J?0E)F.F),DY.E5%0(UL\,S9MUG"P$(0.K6BXAZ7%,@.(2XK7H0=5U]
M-.M5B!86'M(N2$BH3:'9S(;MVJ=QMY&#$EOF8F!%=ZQ>R"\?']5-2R6VG&FR
MTR4Z>NMH.NK0VW=1-L!/SHQ^S6N+Z:IEZAZ7#PEWFJ%>5T8)Q$9=3QTY.SM3
M*E,F4VO,H/D52>(T+(MV17C8053$0[-;?ZO25=-+:T*?*D!:?,"WU!=.LD`6
M]MB=)X'VUT__`,N&YWT08V/R&-?W`](AM38@+P<QGKTA<9<M:V4M*00=+I8<
M>+3GD6`:H^YJ(1T.LR6PIDI7+\;9+'`V+";5]0W-K@V=/J-=R!8[&K.)VX:4
M^@VE-ML8Y1.VDE573AZ1LF0RQ5"$H,"I2]27VO1%"5!VR])*U%`3;3J!*DJ'
M$6`%[VM2-\/KLJ<)3>X<2-B.Q&'F,LI$P1GERI+\)A@,F+ZM#JI4:0A06PE+
M:&5.K4&R@JNK7FG1)*W5B)B*E<).B3BN/8J;RJE[@1J=-MF53N$*)5IUFXFT
M[&9\_D6ODG:S9FNVCW:Z!%U"`?J+:<#(0PM;BT!](60V;ZE);L5*386L`;BY
M!4`;5IO?#]N2+@YDR=-@-;DCB:ZSCCUC)E1L<$F7(94&BP$(0KJM)<=0M]M#
MBFT$IL<GPERC@,TV5>NMZ5;:<63J3?(V.Y2S'@#-,D8V=R:D.VMT,C$3,F^B
M2JOTMQ8R23-^5$Q%#(@0V^L.0PZX#`=ZB'`E>A83?R+`N4&X%^'BFX)'.H;N
M'V;R?;[$)RKN0@SRS-5!G-1P]K@3TMAU49XNM-H<L@VZT=3K)6%("R1:ID5R
MOBY"=L576R10D;+3X].7MM?6N-?2FZQ%K&;`C)6*+/(@]A6"GGD-EG*::8^.
MGV^N3?1$29TTO!IPM+-DG2;*/'@#R)X'E[#[*X-.RMY+QL3,HQ.35AY[I:C/
MB*^6I#@U70PYHT.K&A?E;*CY%_N56Q>=S_BJO9)H>)7UNACW;(KN98P$6VEH
ME4Y'4)!K6%PW?I@_!PV7=1Z0>73!,QUC*$V#8V^LS>-F.1')@0H,-@$FQ\3:
MXX<>//V6-3&-[8[UR>TLGOB/!D#;V*0TMYQ33H!0Z\&`I!T:5)2L^=6H)2`J
MYN+5-0=VM*N`II2FE*:4J/\`*618+$]"L60;(F^<1=<:H+"QBT`<RDK(OWS2
M(A(2,0.=))22G)N0;LVX*'32\9<HG.0G48-F)%<FR$Q6K!2_$\``!<D_,`"3
MX\.`-=-L[:N2WON:)M?%%M$R4M0UN'2VVA"%.NO.$`D-LLH6ZO2%*TH(2E2K
M`ZMK\UFR42V9(X2R<]RV2SV&NS^%VSRB?%=>1JD(O:)R>=2RMN2J;R%/7FQE
MF1V[]51\L)4$R"J/3J53@%%967VQ"*4D.65I45'2$@:=0-^=P`.=Z]D:^'MQ
M<U<AS<.';V.8;#[.54F9Z9\R74QV64M)C&2EWKJ"7@ME(:1=Q9".-7)#FUCU
MY9:ZA%5NU2.-)DM,92.8B^Y&M/K5DR%1&N2ZG7I>/>R[>U"J[ICU!RX<HL%6
MC)5<B*RA%1$@6G;\I+2]2T"6DK/3XE2DH7H400"GWK@"]R!<"W&M1SX>MTQ\
M1+=G2X3.[HYEJ;Q9ZRI4AB#,5`DOM+0TJ.`F4A;:&UO)<=2A3C:"CS&U1O.*
ML/8N>>/L89'A9%1K793%,%*?"Q9#,T-;[RWQM7).J'0LBS2(3<VQ\U!PG+*L
M%&;%VBZ5`J0G$ERMOO(*4H=;6@%0<(U?9E*"XH*N+GR@VTWN00.//=E_#GF6
M)<9B/F,3)B)6^WDGF_4%&*>C0U3WVY-XZ5NE,5#A0J,EY+KS:V4$K"0?C*<Y
MH".@8]^CB7)4I8HQ"Z2.6*5'J4]2>P_!XXF@KMUE;(NI:$H>>+'S1O`:HPSF
M06?CZR!3$];5R-O.N.%/6:#2B@-K.H!TN"Z`D:;IN.)*@`/&LD+X<<G*R3L9
MW-XAG%O*B-XV6L2@SE'9[77B-L`1RZSK:\[BI3;*6>3A2KA62K\SZ"UNLE#K
MUJUEQPR<3D$US20(1:BRUVKE.0OTK48YLG+FLZCH:ZN;R[HS`C1P\:N&Y%1.
MF'7B&!D*9"@M'JR`2UQUA)7H"N6FVKF+W`(-K&H=OL!N9[`,SFYD([L=0T\K
M%'K"8U$?E&&W*<):].$]<#6V'BZVTXTXI&E1TV&,YLQ\C#.$S8=R,SR4_DZ(
MSHN*'+ZCFL=\C,FL9^8I%CBY9"UJU>-BG4#5Y%Z^!^];.(U%J8KA,BIDR'O5
M@5H7P?:,5*5E;EE!*"V0%)(*=1.I20-(()/`VO:2E_#S)BSTK^_L4YM%IF8J
M9DDHF="&YCULM2V'&C&$AQQ+TAAIHLM.(?4X"TI2`I29+4Y1TH<#L,Z,H.T/
MF\NNR@XJ@$:L$KN[OC^4"!;X^%!:0)#(6,)[=H<RCLK0IRB;QNC8VM7[HDC(
M&`I2`4@DK_)T`7UWYE)''@+VX6KDD]F]P#N2[VWD283;K`6\Y-*EF(F&AOK&
M:%)075,='[4:6BZ00.GJX5&4IS?@X^#8N6V)\BRMPCS9!<9.Q\R7IP6#%<'B
MF0B6%_GK`[<6E&%EF;%*;:O&"<8Y>.)1D<5&Z9A(8@;:=ONE[27F@RK0&UG5
MI<+@)0!Y;@G20=0`2>?.NOA?#ID9.3=:>S>)9P+OH4X^<H2BQD7LDVZN$RRD
M1RZTI?1<:>,AMI$=X!+JDA04<A#F=02W4\2K7;.WQH5Z]KY,V*F@PHQ[I'4)
MQDY_5A8!+C;4E&M0;"H+PT<#(SHY&Q53*FZ0Q?<,HL:@M!E:0KI<=6DKZ8-[
M:?>\`JX'$BPJ+_X`;F5M[US4J(O=_30^<2`]ZL1')J<>W)"^EZ905*4!T@_U
M0T%.J0$"]8Y'\WXM]"/5%\-9-B;Z]=T4F/<92J]):63(\5DT%#4F<AWP6M2N
M1#%V*1TWP2;QHI'+)F(N4O8(Y3M]Q*Q]NR6$A>MP!12@M^\"-.H_-I!O?A4K
M)^'6:QDD):S^(>VRVB89V0;3,4Q`<Q]O5LNH]*'W5I!"F>@TXE]"@ILGB!5]
MSKIC>.KDHPQUD*99>[`F\KG9%K)%<)Q@9#E<3K*7!%W86RLLNWOL!(MS)PX2
M!_*1Z[L-T/#.H3MU\*4E3K25:B$7U?:G0'/*0+`:"GBK3Q('`WJD?X;\^[*E
MPY65Q;#_`%BSC0LR",LYZ)O)`12EA0;283S"PJ3T1U7VV/SA4$[86O(^/J)#
M,;'>+U4:5`2;AHUCYJVV2(K44^=OT_&9-6SZ:>,FRSEPD`F*F4PG,4!';8!V
MAF8LJ2X6H[:UN)!N$I*C]=J\2PFT]T;DR#F*V[C9V0RC*5*<:C,.R'$)1P4I
M2&DK4$I/`D@`&P)KHVS*^.J57[+9;!<JTSCJD"Q)OJGHE-PU?I0WO]&$.DJ\
M2$DW(1!BN&[4W2LLDH0Y0$I@,-68<I]Q++:%:U\N!Y7L3]`/`J\/V*VL'LK=
M6X<I#Q&+@2URIQ26OL7"E2"[T2[<(/V*'+H6X+I2I*DDA0(JZ8\O=<R?1JAD
M6H/TI.KW>N1-G@GJ*S=<%8Z89(O4"JJ-%W#<'2)5O#6(4YO#6(8HCN`ZI)CN
MQ)"XKXL\A1!'SCA^#V?-QK4W1MO+;.W)/VKG6BSF,=+<CO((4FRVEE*B`H)5
MI41J22!J20H<#69ZPU`TTI32E>=')_&.793)-N>X\H*MUB<XX>J6(74NG,1L
M>TQY+UJ[V"QN)^RMWZA'"U?=PDR!4Q;`=0'2(E$/TA1UTN'EP414"4YTW([Z
MG+6)*PI*4A*;<+@BYOX'A7U3V>W?L:'M*#'W1DTX^=MS.R<FEHM.+5.:D1&&
M$LL%`(#Z76O,%V26U`@^4U!=AXO9OLM;=<<V]-+'U3&UBS)D.I9:?SD:,3>E
M+G3)Z.H5=3CTE323"25L-N=)2HJE`C9K'E.`CYA/4FUE\>T\,HMR[KJ6D*:L
M;ITJ!6J_(@!`T^W5;P->D8SO'V[Q&73W6=R!=S>6B8N#)QJ&7.K#$64RN:^5
MD!M;89C-*CA)NXX^4\.DNL@88_SV7(L1RK<8/GB2=0G*U6"8:"R5[XQEJJQQ
M7:<8V"ULWA5S0YS(S,\D\:-C&\9=@B?8`,8H:PJDXTQ58D/ILXE2NKI5I"BX
MEQ*3X\0FQ/(*(J+D[G[9G:DCLLWN&*8D^/(D?>O0?]*U)7D(^08C*21U0%-,
MJ:=6!I0\I-R0":Q6)XQYZJ]9G<3*T)*50Y)0N,WUVNL;88GW)ANQ0UB/.7Z)
ME6YE?-S+./CVZ"<:LR`0=N53`7L((ZSKRV-=?3,2Y;TJG`E!2;N@IL@CV7).
MJ_("IJ;W?[9YG,1MZIR2F%[2D3T1(CC#O6RK#K`9A.MD#2RMQ:EJD)=MTT)%
M^*@*27&W/=IA8>CACPT./&]OD*9J$[(6.'-%YDFY;/%"R[28F`.BL9>*;NZQ
M5G;.16>]!6TDLB`AT`<=&\KC6752`[<22@*&DW;`96TLGVV4H%('-(JD3NSV
MTPV0?W&,J'QNQ<%J2RAAT.8MEK#3<9+<?!`#A1(D-.L(:N7&$.$>8@5E9:'R
M"C<D/^5C;"$O(35YFK17G.'2V.O(VFMUA[45ZW4['(O%7(11EG<R8AWZ)3"=
MHS-UCOTB&L'J<8Y$&(5("4-I2H.:564K5J4D#GP'(^*N%0IW+VOF;3:[+.[B
M8;QV-CQWTY3H/F._(1)2_)8;0$]2R6KAE1%G71IX7%6:B\8LUT5&H8"5J(2E
M2>W[!66K#EUE,,`@85+&>&Z-1[A5BQ:R@2QYQU;Z;U1O204E(]V!C"`I'#62
M3E<?(*\D'-+W3>;2U8W/4=6M*K\M(0KS?\X?/6_N3O#V]W*N?W,1.Z.:;Q>8
MQL?&*:7UG3/RDN7%D=0#I!E,659^YU)>:(%PM-27E''^;[E=;T2,Q))(0_)N
M$P=!3<JZLE?,3$`X=R#875I6M":;E09`D]29D7D49D)@,\3!N?8YPUJ1)..9
MCMZWAKB+>4!I5]IU4)"=/LLH65?P-^5<GLW<_;K`[>QQF9UI4[:$C+O--I8?
MOE/O2"PF.(]TCI]&6UTI(=M9I753Y4FH=F^,6?+92HG#1*$G$M^.<)EA6DW9
M_8HCW+F*8M8&8T=A&H)JB[A$58@H+21W?JMUQ\$>W6^UE\:R^J:723*+86@)
M-VTIXK-^1X\!;B>==WC>\7;/![B?W\K)*?=W7)QHEQ$,.=7%M1O-,6X2-#Q#
MGDCAOBM`Z@X5F+VB9_+D.=Y71^#II>;NLC?JL3##FR5U&W05<M.*<1T>!LTL
M]\Q[F'PKECATH\1(<RJ46]04#<4U`UK>IQHC)PZY`Z;:4*Z@2HI)2XXLI`Y^
MZL6/+4"/94$QN7MDK:L;LC*W%&3C\>S#D?>J6'S%>?C9+)S'H[2=/5XQ9[:6
MED!*I#+B>`6DU8ZUQBS95F"&`7%-]X5#(5SPAD^R9793D6$32S4.U-[ID"KK
MQQU?>3B3%W&MV40=(HIN/-&5$2E1/K,]F(#RSD0NSS;3K8;*3=06G0A0/*UB
M2H'E:WC6_E>\/;[,2E=S6LATL[BL?EL>QC5LN=24)D946%("P.FEO0XMV2%&
MZ.F$6)<34R\5L4Y<B;Y0W>1J(I1XS`F!V.#&<DI+1DDAD.Q-Y5)=W:*XFQ4.
MX0J:D4B0Z7F`(MXZ@IB&Y##K0S$V"Y&6F*YU%R9)>M8C0DC@E5^:K\[<+5P7
M>C>NQINV<DQM/))R,O<VY5YA;8:<0J"PILA,=\K`2J2'"0K1=&A(4#YA6NE>
MXR9LK63[RZG\>WC)C6&G^2-JB4I.W4^,Q7?&6;';U*NUDR:2A;7((O8Z9;MI
M9O("*,>G!"HF`=;7>2<RT%V*TEMQ#(4EA)\JBXDM<U7]T6L2DCGKX_E5ZKE>
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M^B4PG:,C"H._28-=")&,7$&',@`-@'JV.DJU:E)`YV`]T^)KZ/5N/M;,VDWV
M3>W&PW`Q\9A].5+#YC//IE)?DL(0$]6R600RHBSCH"!:XK#(7B9FJ`JS'C(K
M5@?56VR>);K8,R,YAA[@K1*;@>K8TMT`:+65++K3)K;7O&C@(44UX]P`B(&3
M/K8=S>/=?.6U:7D)<0&B#<ZGE+2;\O=597L4/G%3^0[W=OLGF7>[[<WI9J"S
MDHK.*6TOK2#*S,C(1GNH`6TM>F?TODG4EY!`!"DU<W&$N0MI1H=IE<3+04MQ
M9K-&J<#7?B:%=+YD6KF6Z=:;1(U=R@J9NP9J42F$5C_-](JR;T$/^*4U8G(8
MUGJL(>*VYBUJ*M)^RNVI*0KV^==C;\D7\16FCN%VLPZ\GA86;3(@[SF3)+S_
M`*=Y*<4'\9*C1T2$D:EK]9**7NE<)CM%S\M%<%,-<AX)S?<F16'7<O/<F:]E
M^KR%*-98!N\Q&[R!=AM5*D;D[.N9D]C48X12E19F4,W<?9VZ&?C'`W$4_I;B
M*:5KL3U-"-*@CQ!O[M^8J]&_NU>29QFT)N=0QC-H2L9)1+$=Y2,FF%$]-+;B
MI`UH<*_-&ZH2'&_GKL/>+.9G,"?C`A4Q+1J[?;-EJ'S8M,QH0\VU>8TDH*OU
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M2E1J0$L09NB\"5VN%QUYZ^5_(L3RE=PK>Q0I8MY:4\J.+K(X78R)W`%)-H1B
MP@F_,7R)S;%`VXZP>MQR\DISJVC%HQP=)N$]/0'2/9?PYUS#F^^WD[N7*RIR
MH;VY*Q+FW4.J8=+B(YQR8C>56@)_-%P7+(/6`XD6J.'^(.049,7S,<;B![+3
MG(Z&S13I#'Y+'!(RF+27LE4@L<3EH<KKD8NF'N2'<O9HK<PJ,SF31`!/N&MA
M,[&J;:@J>`;BJ:6%Z3YRC45I2.8-R`F_.NKC;[[7S(&-V)+SK3&.VF_BI2)A
M8>4WD3#]2].9CI2"M*^LZVU$*QI<2%+N$V-=5QQ/R^_AW/&(]9.UI)KO.9.'
M-II2.4@%&$OAM:FMJXC$%5&;^(V]\10!0@D!/W8<5"B.P@%YS4,+&7"[O]-+
M?2L=5P[JO?EIT^/[JL[7>W8<;(([PIF:]Q#'-8_[HZ:P\%MY02E/ETCH]!4,
MKTV)5Z@!!`!O5P<XQY$6&>IF>I3"<A"V+!3+$51:XO3M->>S606=)>OY*_SM
M=?HN`C0;E<O_``H@BYBF=D2$X"`&+K&F7C&FG,<F1J;D%Q17I4`@J`"`H<SP
M%U'PK5;WAVJQ6,G]LX6X6I&*W([DY2L@8[Z&8*I:$(A,OME/4*M*-4DH!#14
M$GD:L?[/O(6OPEZC(_&(R[KE;6E8BRF3L<,FVPK(.LZY.R&?XH.LH4))JACW
M))2BHRZP&7CE$@_RZ0ZR?>>-<4VIQZR8:P4^4W<'1;1Y?9YT>/Y)OX&I#_BC
MVNRF0QLN5F.@QLJ8'8X+#I.60G#P(7\7`!Z:E3H!.EVQ$5]"_P![6*F;F-@;
M*-BE\%6:C-KK:X#'M4N%&L5<Q^]JC2R+.+/6T(./G$V]V$81:/<)HJ1[HX`*
M[5!\9;<"$.(:.#R,-IN0S(*$.N.)6%*"BGRFY'EXWY*'@2+5P78;N3LS%P-R
M8C<2\?!RF4FQ9;#\U$E3`3'D%Y;)5$^V"TDI?;!\CBV0CWE)%0[$<1LP1V2:
MQ</@1FI6Z]@"/XV+P<K:6TU,2-C/BJ-BB\@Y!ZY,+27E(*0;A53G7ZGZ\6S1
M<)CT#V;QS4(Q5,]4]=4DOW"2`$]0GHCQ`4/M.'`*)!KNI_?+8DK:4S!?>*QE
MY6YEYX/-1E,LML#)..?<B$)\S3;R%'(I2BS*)#KC2AJ%>E/'"-GX3`N'X"U5
M5:DV2MXZJM8FZNX<L7BD5)5J);03LA7<88S!R@Y6CQ62.D/2=-0H]^^N5R:F
MEY%YQE86RIQ2@KB+A1N.!X_3\]?)7=>9B\CW+SN3PLQ.0Q,O*R9#,A*5H#C;
M[BGDG2YYTE(6$*"N(4DCE4UZT:\_II2FE*^8]P]_\'[^[^#]NJCF>55/A5`]
MHOM=P?=W?N:M\/K_`+G[%6_E>/(_MBJCWF^X?O\`^#I^5\OE>B>1Y\_&N)N_
M\/H[_P#@_7]NGMJOM^7R^:@=QO8_!W^SJOY/U4/O?5X\_E[/GJH]P=W>'=W?
MXWV:'\543[Q^CY7_`!4+[/X1[N_VO1]GYM6GE^#E\OP4'U?B^OY_;53?G]/=
MW!^3\^J'E]8^G^_^*JGD>7*N(=_\+N]/=W_P?S_9J_P'+Y?BJT_5\AX?CKG_
M`-CW^C\/?JP\OE[?E^S5?P5\R^T3O]G\/MAW_9J[P/T_+Y?151[GAS\.7U5S
M_%_B_=]/P:K^'ZZ>SG^+Y?CI]?M=_H_![/\`@_GU:/#ER^7U4\/'G\O^2N'U
M]W>'L^U^'[?J^W5QY>//Y6^7*K?`?3X_2.?SU]P[@_-W?@U0<JN%-5I32E-*
M5P/W>GN'[O1W_3NWU8J@YUQ_%Z?:^_T?9]>K5<CRYU4>[X_+VU0>XW?W_3;_
M``?J^W5_Y?A\OQU0>'R%<_0/?Z/H&J)][\'X^7XZM_)-<"]P]WX/9_WM#[_A
MX_(_/5YY_*_U_BIZ/3^'_MOM_P!S5QY'ES\?E^#YJ>WZ^7XOE[:J/</?^?O)
MW_G^S5I_&/IY_M?BJB.7U_+Y>V@_PN[\'L]_\+_"U7\K\%#]7U_+\%5#V1[_
M`&A_='N^S3\G\/X^?R]E4/+Q_'S^7U53^!^`?8]GN-W?3OT/,<^?CSJY7CSY
M?7]7XJH'=^/O]KV0[M6)Y^'R]E6GWARKG]7M]_X>[TZN]O\`A>%/#QJGU_>'
MW>GV?MU=^317+Z_K^7LKB'>'_6C^Y_Q7T[M4'(_353S\>7U?WZY$[_\`%#O[
;^\?H/VZ#G]7R_P"6@]WQ^5J^FKJ4TI32E?_9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g672020pc_pg001c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g672020pc_pg001c.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`,0`R`P$1``(1`0,1`?_$`*0```("`@,`````````
M``````<)"`H$!0(#!@$``P$!`````````````````0(#``00```&`@$``P@+
M#@<```````,$!08'"`$""0`3-A$2%!4W&#A8(3,T9#46%U<9.3JQ8G*BLF-S
M)'2T565F=J3$176U1D@1``$#`04&!P`"`P````````$`$0(A,4%1<1+P89&A
M(@.!L<'1X3(3(S/Q\D/_V@`,`P$``A$#$0`_`#GR0VQ7*_RMR36+FNU')V6C
MR)+_`,#U-BF%*>6M0H2:C629#IJW9J-K(B6[6.\2&=/'R(?P)H6V!SN*>UV[
MSV!-\\O=+'5*4@-Q;'<<%?MN1I`!.666*U,`VZ6R+:3K)HEK.4%V5LG;ALY$
MK-N.,9FMBA/>9F&YJ\STRHF3G)#[](,1':;-D()+)*)A)5!TT[X$(<USMI[&
M^F6[=`9/(C>7L)'HM,$D18`O<,O?%1"K/=#E4Y*6W.`Z_P`DGT=B)*5H*DPI
M!"8ZV7/8\G+KN<[77V)%K.B52:;B[U#2I-%3P#;^4!26Z2I.070\(.GEQ-0M
MEA(N\STEK\Q=C;<C.(`:(Z@[T\?B]2TFV[<U5MA:86[0SDMF6RZ0D1E+$97(
MG>WJ!/TS.Z*;4M9M'V9%<=4K;Z.WXO>R"HRJ^]'2$*XB!!XMYKGTA*'6CI,/
M`.3C`2B-());W+@[7(%BTB``_JU0@W7^PE_5.N=E6E(EB[^QH?=$S<%S.;;N
MDVRB1(LKM=/M/([K;\_K,62@QR@K<:1%^DS@`N4`4,980-0BY-9!\(#V"RO;
MUDR!)8@<P33"YOA-W-`8Q`ONWA=2#<5F2;<NT5"F#</G-;,K00E76)),I.J_
MK#66"I.2I#,DQ?V4C;73(?)KPB*Z#T?8QH!@QH,&&9UQMMC.-MM4H7$9S</?
MN.[<BQ`!,8Z2UWRCMY]UR/65F#[(GYXG;17]*3Y^/;_*9_-?=/WW3:YXG^I_
M'%;3'`?VMX8+.Y`79$<7W/OS&C^LMQRNYC3)8J,9\=D`W/X^+W61-1S)C2KF
MQHS0U%,<\.D$F.SQK+-ZT4,4F*>V"#4Q0MA-=\B!:VE.(GI/V.>_=OQ21C(Q
MU5;P]]R/S:KPJQ)(+F5YTG+BX+LB,^)BZ#5B6N%>:E68WKHCP\_I"C*0I#>4
MPL9.=+^%<+,+NOO=U1KIRBGN17T5!LE"HNVHP@;Q%;MGW9I)67[-\);G(?8N
MO+)Y,'ZZK*S:LE3L*/?CIAZNR>2:[\'CBI]9K$5RC!W6@MC5Q,#9ZZ8AVP,2
M.!"3'"Q#!PX9/)Y[;&^Z*JB!;:A\TIG6>WC*('`.V5H5Q$:1+`2?Y05M6JNJ
M+;+D7?&TZ6:940U69"@T'E;ZI4D);5KY!*MR'H[:D.O,XDXC&07+-6"3R2FZ
M9=5C-$XL:/O%S$C!E/#1]A`"VS'J(C$FF^E@VXU#A`=(>0%??;DF#UYJ.[@Z
MZYKF%R#(""_[>3;7ZZ%*VA:MTGI@2%Q^U#DXS8*SUB#`\:^*4QFQ_;ARO1`=
MJ6@+1I'=8">9P44>^4@3'4M"C/)R11\LJ)9N:B+`6MFO)MX^G218JQC8BB<.
M"E$MLI(MMDB;)?C+C8O@C2`FC@M%_@6F<`$U"O,RPSS@T0-UT8V8!.G-5(3;
M;`&AK(NN@A,HR>-*9X'=@ZVDAI5Y>^2*_FU5A]?^(?LGGR"^2:</1[]<_LKY
M-?Z;[6^\^B?F,?\`FUAV\+4=>[_H]HV]$]+D9Y:(GIU%SODQE2?&ZTHURLNQ
M8:L5%;A9<G++X>"HZXA<4MI\$0T<02J8@ILWO9M!IZBD*RF(<;!8H$9"-[:C
M[:8TZ)29F(J648QU/2XJEQQ:P':Z/9QDF$GG9&V/&B/+%[8+0G:OQ]*L>:1T
M^@9W0#3V:T#):.S422UY0LV_F6Y"YUNN;&1&.A%$XX46<Z'A``>G,`7J2'86
M^3<GWN+%T%JL`14V>;^BT$!0ZQK-.!\M7E*LM?%X&;]WWC2&:Z)D;2W%VIV;
MV]"<@O*KRK92<]W!'CT+$TVL!TDGI@NYWQ`:$)F]]R!4T#CK`\(#4)DD@Z7P
MJX+N]&\UB9$&(`#/PMHG#P(ZXC;\HMB)Z!U$1J[1Q);&M94=T01+*G'P;+Y"
MC+/4$^`#UKIH2V@Z$(LJQ#4L_P"-%)V$5$P@N1R)#T'PV"YW?8?J;$487AJW
MT-#M>I.7<VN],PHA9XZ>&A\<@6'S:)TM&`8,>+JK5"M2FO6-NJ+:K9:2W$+J
MXC#O/&)=D+3`DEZ$V0WIJ--]'WW53",$=(+FV2ZB<Q@0T"C/W7G<*-D'R`NS
M3:C'MM&PV^GB;\DP:PK7DBG[DE2#9M-L^@7%Q&*N\'1#,VT`6T:/J\+2U*J@
MKIA:'>0B%5]<F"<I9+N1026XWE/5CH*$!D995-]AP2P@8I-CJJ),Q<4RM.."
M4:6&FVEN=V"E'\9:T_QKBF^SY>/?1QL]Y!_XI\-_5R_T+Y0??'0:]\?H]_'+
MFMHW'[M=PSY+P-]A769GF?";,.T7PQS5X(=1223#D?STW>34[=<W6;PN+MH@
MD]]J@E7B%K,Q1A3T:BXID!6D12=]`5#/A&!,9:3Z@[:7&+N_L_BA'ZT=V+V,
MVS)6;&:*$Y(<HO?@<6#H[4:J;S3R0NRG^S8D$.7HKAND]@78U)6BVHQ\#)N/
MF.WIV7P072^2;O5CII6D-6W/IA@FD9R6#G``]L%V`(Y$^=J>3B;6DAN("*'%
MU5VJ:LUYXN"UY\H;([<BTK,"+<H8*/["D!W+0NV;C<DSV;;UEDUPH2*IN^=F
M)&Z5A"8Q]N!AMDDF%S0:B74=Q`!NC1D-`E$C2`'MLJ"A(=9!%7(HUM&^5!.I
M3CJ'>.Q[91'?"40W[LLYU*UK!KDA)J>?2F9%\)MR0"S'@V1N1OY35ADC/Z,8
M<C(JVQH])QF>+K:<Q2JH5/ES"IN3UT`8CIMNM%68^0X(R<!B[7V6._JF-2CQ
M3Q!*K@;50&#-2G69,X;6-,5UG_+K:.`8:NL_70;1>?6`/6@%,:;H72\$UFDJ
M!#>5%.4R8[E#0!"``!HT=ZP?.D'E:QB*\!RIG:M&6F-CB1;GYUR0`G^NE5I`
M:U0*>GJVUGN+RQ6]?$,V,>EA*S,E\LT!U5KU>48S4_9VF=5GA7;BFMO:Q\-Y
M=!YPZI>H>13HYKND"/6`@Y8@$`!SA4W!QXW^"4."94#'=CL%=/\`H_:6>K;%
M_HP^9=\!?^5/F)]O\GWO/\;I3\X8"QO!3URQO?Q23KOS[K::U\U1*S:B\F$X
M&:1JJ1'B:YJU+]2D:+H@LVXF6V9/8=HHUUF!XI#J#L/'3"D`PC)9L\&:1`TU
M6.:"IXHFP8VBR8ROIGBF#@4O0<="::NA:I\5Z1*]74H/8N?:T/B:G]'%D%:O
MQRI?($4B$E'$*E4ZX).&U^2)166^:2'`G(:IAJG6X8$11#.`=@S&0Q,$5+5>
MG(Y(6!Z-5`*!7OQ;I$(3%*][);C2%G1=V([#U'B*P3E).D[=E:BECGW'6"QB
M$^U!LMYT1$&T(_=+6)(\88*I.AH%AIJ1HL8-*6AP7>1,!VS^A`C(#.QJJK3,
MQH!,A6[%U7Q^A%4GBG$;[4.UQ,/'FPVO8^:-_.XP9,K"T0H^H[9>$>R\1BA(
M:.3K<M"H-94^*(:+J$9\0YSHI#$#?<SF'X1!_:))A;;N?#/DK?L?I*D[.:;S
M2&%UNU\[+[NCAI7AX\TJHT8TL/UWJ[4!P5Z;!F-M.1AJ*YBT\^(A>8QI-(8A
MIT;,!.<@H(BF(OZ(P6V-RN#?<!UM$:^Y4_4"Q[Q\4S49'1%L3>UQ\<4)H3+<
MWBC;&>KUM67RULXCXO[)64K]`IZXBF"I)CR:3E>;H@&<I&3"L/ZL55,"0U'C
M;*.1U[?J6!BP.GBPL;$[I;(_D)U]/23C8Q\Z&A1_C`$:]0&&U%:,^D>?7K(<
M?GU3?GU]F[0]K/GU]Q>A;[Q\H/YOI7]#C'ZO?QR4]`PE]FNX9\E6/Y:BL!3K
M(?*Y4%]73K[426%#E$K58E"%G\W)B<E.2/&A09NQZI[))B.6.\CHIL5Q.\'4
M/40/0+.I4;OMM=L!]]+O&)Z20#_L,"J=D2'4`2/\;PM'7*9&=`$6MIE53MY&
ML\S51+@6Y4C2I-5?=W:H(#0DQ?LPQI@C\ZBF)&9[=4!U,DE+0.=-3!#.O7EA
M,=YD/&F=F[<A6,"#+W)/JAW`?M,$1?V]E)YMU)FRF3EARQ$>0O``-[[$12HH
M2+%7'1F1U"9WA5&:`66H6EMP:)V;.`L<*T<(+IE",-+JS@34PKK@V%$@;+Y#
MP"8QD`"&U%GMN!].:$B*BND.W+UY)C/((^+L1Q7^D;@F^Z<B\?H^KF/EY[L+
M'I=GX@LA$YYZ,H)#;,][.1@R`]`+H.J-1!-4K1O)GQ'V>.BQ@<8-.\"VS0D@
M`G:FY(`Y(CM55NY?M)QEWHY9F_)@S<F2Q1HO7>78%4B5MRK;3HEM38&(8N(Q
MO2]9COY%5)"<XRQ8*22.Q@]XRV1P,CJQ;)8$EKD0,+EE+MS+!I7UOZ?BN]=`
MC.$=1Z7Y!_FFY$@[Q?5LK#8,C,YAB2L@2#%<8URDBRM:GH,ABQI!5E^2L,TQ
MJD(%8@T$UNXC3<I[97KC3DR[54^;#0T@GDJ(L&^OT%:/:$0X#28OPL''DA+N
MZNDV./&M_!6RO-*Y=_7I8WU2GFV?ZM]9EZWODM[(?XG^4=.EI[N/*SG:N;IY
MX;<+$Q=^]KEK],7_`'(MT8HQL7%I_P#9O[16?\MTP6E8C@'VC:W]LJ'W4SH4
MIM6)*'947]N)?E[=,L$`$3X:2/\`=$_][!Z!,;$;''\*N+\-B_\`+B]"EN16
%Z9!?_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g672020pc_pg001d.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g672020pc_pg001d.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`)P+&`P$1``(1`0,1`?_$`+8``0`"`@(#`0``````
M```````'"`8)!`H!`P4"`0$``00#`0```````````````0(%!@<#!`@)$```
M!0,"!`0$`P4`#PD!```"`P0&!P$%"``)$I4961'5UPI1D1,4(146,2(C%QA!
M88$R0J+"0V,DU(5&6)A2,[,T="4U)L<W$0`!`P,"!0,#`P0!`P4````!``(#
M$1($!08A45(3!S%!%"(5"&%Q,D(C%A>!D:%#L3-3)"7_V@`,`P$``A$#$0`_
M`.SUNE9X9JX87*%DF(^`3OS;2R$C?9[[5M=<ZT88Y.;1K6`WDZVC:9[I"95S
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MGI'I<>11.N9O/=A67.<RIZ1Z7'D47BN^=O.4_"NPM+=*_"M[E.G_`.2:7'D4
M7CKG[S?87EKG<I^DFEQY%$ZY^\WV%Y:YW*?I)I<>11.N?O-]A>6N=RGZ2:7'
MD43KG[S?87EKG<I^DFEQY%$ZY^\WV%Y:YW*?I)I<>11.N?O-]A>6N=RGZ2:7
M'D43KG[S?87EKG<I^DFEQY%%N^_JWRBZ9G]8/]'SD_JK_DY^OOZ-/NW%^I?U
MO^:?9_R^^[_37ZC^\^T_C\7Y9];P_P`WX?CJJII7W17:?U!B.M(`4%40PJ@A
M"'Q\1"$--0(:4I^VM:UU**H<+Y/X_P"1=VEBQP;+35DZ[P4^U$92Z@;1UP,.
M8C[2C7%GMV[57(419Y]#;8I`$]*)0E&-.8$)HJ@K2@.KZ%%.W%7XU^==34HG
M%7XU^==*E$XJ_&OSKI4HG%7XU^==*E%%EKF^*;U,SOQYM3YM:V;&"Q6Q)CRC
MLHFZ!O3?83S7*+8UG.L4&H"[.8AO2]*844$E4:>$0?WRP4K2M8JBP9T9=XU,
MG(EAXENR8VO8<D)0L5'+'T1KRKZ%QNNQ"*<1P+A;%15H-L%`&%M*Y5"6:L*.
M%]H.E`5K4%!+N-*\47Y8.7V-$I3O*>,,>3*UW;/T(I#5TL1?:RK[^?,9*G6V
MJVGFW=4JM":Q&5(7WQ(2,*96>,)AU*5I3P%PKJFE>**QW%7XU^==34HN!=;O
M;+%:[E?+[=;?9+)9D"NZWB\WA>FM=IM-KMY!BI?<KI<EQI"*WV]"E*$8<<:,
M!918:B%6E*5KJ*E%$J?(Z#5DEQK#J&3VVODN8HON<UQ8U4!EP6GOJ)K,)&&X
MOZP7-*A-L2BP$_F!(@C&J`8<`R@R@##XUHJBFGBK\:_.NIJ43BK\:_.NE2B@
M7(W*/'_$2/297R6E5OP_')[CMC1)=KF)O:BVC<EY37!9:[10%AM5Y7!4+$MI
M4C"*I-"Z4)%Q"I^'C!=05*+$,8LY,1,T$;G6XK9"QW.`&4-`%W)6=<%X;LW0
M701X+8JNMCO=OL]Z3V^X&)3`$JOMZIC#"Q`H/CI4.H#J^A16IXJ_&OSKJJI1
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M"2GX\V[$L$PTW%B:WN*8)E>HE1;49B&Y+`F([#9R$Z%5<[Y=SPB3V:QV]6L,
MH+Z5`#@DA%7*SX;Y%2LE+=&7&<,_$.^Z`"J41'AD]1XU0%'@C?XE&XW;O9;0
MMF.2Q6KQ^B9>[_>P#7C!4T")*`5"@Q0^Z+X=,+8%%)'\G@YK;@HY2_1O\PZL
M0&>DUC<(&16[EV$+F-2`4B`3;#+P<%."HQA&,=?$(:A_'78^%D_$^?8_X?<L
MO_IOI=;^].*R0[/W2-G?[".!D#8_W'X'SBT#'.;VC/\`&#B:F00@R$`$`#B0
M>"P5IX^8>OR2KU#C*W$\V'3*C=%<`7EAV3<1EU<X4AMH'4N[D%IBU_TK@IM`
MPUHK*3&'&)JA%]4(>$7AS3:3J./C#-GAE9BFE'$$#ZOXD^X!]B:5]ED^O>&?
M+6UMFXWD/<FV]7P=C9@C,.=-CO9`X2BL3BX\8VR@@Q.D:QLE1875%>0SL<L1
M9"D%RQ.Q=PS-QVR6SJ+:N9D6'</EQ>X+52V*`I+KQI2U_`KK:58Z%*_MQG52
MF5X3>"OX:B?2M0QL=N7D0RLQGTHX@@<14?M4<16E1Z+BW#X@\J;2VGA;\W1M
M[5L#9FHV?&S)\=[()>XV^*CCQ9W6@NB[@9W6\8[@LO788P#;9#L$2KLV=P--
M)CI;MU=S?8X\]9KJX+HV+&:(BZWTA(6I&$NW(SBQAJ,P0.,18Z`H+@%X<+</
M(=C.S&L<<5K@TN]@33A^_$>GI45]58,;9F[,S:.5OW%T_)?LO!S(L6?-#1V(
MLF8!T4#G$@F1P(-&AUH<TNMN;7..G,P?^:O<=_Z[9I_V[77M_=8PJ_+X4PHM
M<E4AJY;D6:**6*N%$TJ1VHW$9@`ZZNBY&)R;?8/RS[RH_P`U6'*R@`*\>*HA
MTI^W5S;HNJOQ?FL@F.):77T^FT"I=^P`)KRXK;&+X(\TYVS/]BX>UM:EV'\1
M^5\]N.XXOQHPXR3]RM.TP-<7.I0!I/HOO5QMQ*I+H("KN$YO?SK,+XP1AU#I
M=J[JC^RK<OL_L*+^"ETK;J?<41U'174C^)]+A_'7%]KU#X?W#LR_"ZZ&VE:5
MYTKPNI2O"JM8\1^43L`^5?\`']5_UN#0ZE\=_P`6E_;OO]>UW/[?>M[5_P!-
M]W!1Y9F-M^.)S6QF6'=#R\N[MO5[2-JT-Q!N-2^?=KDX5ZX%L169&EHJH(ZX
M*[B8$DLNE?$1@J4I^W7:?MW6XXG3OQ9Q"UI<33@`!4D_H`#59;J/XS?D-I&B
MS;CU39>X<?0,;&=D2Y#\5S8HX&,,CYGNKPC;&"]SO9H)6=VG'?$&_2M<H,LN
MXAFU=)BLXEA5RCA%N(2X>YTRFVE#/N:#[0*_Z1]TM9!8AJ4A1@U*<(!5,+#0
M(O#K/TK48\09SX91AD`WD&E#Z'F`:BA(H:BAXA8OG^'/*^E[%A\G:EMS5X/'
MF0&&/4'X[VXSFR$-C??ZMCE<0(Y7-;'(2`QSKA6:^G,P?^:O<=_Z[9I_V[70
MM_=:V4-5QNQ(I+=(%KN%9NTFFI7U:1EU#Y=_5G%]E^9?:?8??\'YI^7?ZQ]E
MQ_>?0_B?2X?QUWOM6H?#^X=F7X773Z:5I7G2O"ZE*\*K8G^HO*1V#_M/_'M6
M_P!<74^X_'?\6E_;OO\`7M=S^WWK>U?]-]W!>Q5C3B:BEI)`RS<&S@330O3E
MJ4<9';ALN@=J@!R*MR((!;ZK^&EP46VGW):00Z*C"/`P)=05I6H:7J#L,Y[8
M93A#^NAMI6E?VKPKZ5X55,'B;R?D["D\I8^@:J_QQ$\M?J(@<<5I:_MN<9/_
M`(VR?VW2@&)K_H<\.!"RR\860*WGLS(VO>:VX+;'](B1PKV,T5.>DV4O3G0M
M-(%<Y%EL3`4CH)+9T@Z#-,,$6&OA6@:B$$5*<,>'D2X\F5&QQQHBT/=[-N-&
MU_<\OTKZJPZ=L_=.K;:U'>6F8&1-M72),=F;E-:.SC/RG68[)'$CZI7<&M:'
M'T+J`@G!1X^8>%RV&!3-Q/-@$SC-"F#&HMQ&7*.FJX:7[X%J^TJO^C2]C1U^
MK1#4S[RH/QH5KL?:=2^']P[,OPJ5OH:4K2[G;7A=2GZK)V^&?+3]A'RFW;>L
M'QR&W'4?CO\`C6!UAEN_EV0_Z3/;V0>%ZF_IS,'_`)J]QW_KMFG_`&[5OM_=
M:T4,.#''$9J2A9(4<VX9FY89;<@40K''ETW#Y<2N:X"N=/&U$`1CN'TTZR[4
M_P#*$'#+/5>-/I`'Q!\>_'I6H38IS8H978C:U>`:</4\R![D5`]_0K8VD^(?
M*FN[)R?).B[>U;*V#AE_>SXL=[L:/M_^ZXO'%S(O_*]@<R+CW'-H:98^\-<?
MHO"U1R'FWN!,^CY>-FCYG!O6>LUD&N5[.$9A=E;-H)+4G'*KFO$4+AI0-``I
M3Q&(-/QUQ8V#E9E_Q6/?VXR]U/Z6-]7']`K#M?9.[M[.SF[1T[)U#[9ITV?E
M]EH(Q\.``S9,I)`;&RHJ:U-:-#BHZD2%,*(C=]6!*.Y#FBP7Q1/;E56HY]Q&
M8+;>Z)KN&@K6>)&-8(02[@"M!%5K6G$&M*_LKKL8NBZKFP_(Q()9(*TN:*BH
MX?\`KP67[1\$^:-_[?\`\KV1M;6M5VS?(WY6-CNDANBX2MO!XF,\'<CP]5,M
MZP]R3B),8ZL0\V)UNSKM(1*P0MFJ]!9%P1)'T:5,&V;NZKK9D<SQ0JNM`_2)
MOMEO*D*`P5##4"HL(BZVZA'H5JBH/%64Q:R.M.3D6B>Y35O<;/IJ.URQ9-4/
M.A2F5.J&YG8:HI`^(]OBQ%0*.[$HSCR5EKN9%*)KQ9EJ1:32@#Z!#(-45C>*
MOQK\ZZFI1.*OQK\ZZ5*)Q5^-?G72I1.*OQK\ZZ5*)Q5^-?G72I1.*OQK\ZZ5
M**6/&OZ$\?&OC^5_M\?Q_O\`XZA%4_<3R*MV).)L[9)W$9010_$;X=5C)-&$
M%%[RJB(M3#M0.*M*"-NKUN2!/0/[:_4U!-!5%TY=A^?8&A#/7'J(8Z?;I<YV
M;F'J&SY0&.UG/AFHR<[6*ZWA+*A5:%3RM=K3.4B^M"^7"TEJ[>(X@PXNE>+^
M*&HJ&D`_NI4^1QE=N))XLQTS:<>;+Q=#5NV[G=L'KMC:N8$=)V`Z(3OTYNEC
M'W)VN%'84[HNCUM)*6B:V'E&$%(+>G3\%*J`FG'*G@?U1?2R)RAW$+`T]S3*
M]FYMO)KLS`7<U+A>-8`3L".ES1?D;WB08S;=V:,CN!;8!.*XMRT6AXE%6A*0
M:6,@7W9IQIIIQ(TTU/$U]"BM[.^9V2K8M7N+UC<EZ^64[#F.82<.,(243=,_
MDPO>$!%.R[*+`-593:7$5S=`ZGU_,_O:5-IPAI0->'0DB[]%"JWN*YIY0MII
MG.R#LVLDK=)D'X`0/D&XX.QFQO:SK:#1>SJ8R)Y7Z5<XYJ?"<UJ6MAOM)41E
MOLEKH4N)3!$:!(;QTH8)/MZT4J\N%CSNTC[P$_R+?P)"[](&T9M[O>]@0$_;
MH07AV76ZWZZ!1)ZB']!)1<O,^F#QKP`\*>/X:D?R_P"%"UV;OR^L9[N3%RU*
M"?QX2XXX29"WLY.$8S28Y-S=OD62F&H"Z5&,DUF2(=4RE*5\0@\/#5+OY5Y*
M51[%S(E_XNOS<5W%&P@2W"69RVX97S#:0K^F&MMI%RFO<+N<?Q5>+PA-KX*K
M0W&LEM2\1`_`LTHF@!_N"KJ`:5/NBOFUMP;<)Q4A+,9]NVY9?S^QVY@[8YOC
M>9LU,52H,!&^55X?378=P:S<-M=M06AXPO<[:^RW!9DZGB%2EJ&0&HBJ'#,J
M!(!_9%&$AREGD]\-=Q&')3D_.!^0?>]NM9/])WRKQ0M,(7VRRTU;S;%,J8_M
M567:T5GOD)S>Q5Q@;8>+B7VY.`W[00A%C&9'U4-:^B*W$<O[(&`I`V_8H4SE
M>)#`HV/,IYX`[G"P(ZM;J2.6RMNRNB)T""ZHV^IN]OM,462XI;.C)(5EIKFG
MMY1ZX@X\0ZZD>P_1%BN(.3^>K3=VSM.4WY?O#(-E;B$&SHME."+TQ6"W&>TU
M$20LLD5EWQEW%MV1&X#WQ>#+<6*\+SS?!6L-."`H"<99)0$\*^ZA1S%N4NXC
M=8?VQ,X7)G6XKPVMQ3<!8D>/W&8AA1Q;V1'$9KY#?5I0Q_%]Z*LAKJ3(2+"U
M#$CE*4&F&GC/3&A,*/)&8HBIX&OJ5*V*^X,5WJW8N8MKFRSDLB.-!N18B+&[
M'JY>@M2)^7U)>W8=9V4LNEU)46NV)'5<"RT!BA468G(`HJ,T(@!%2M3O3_D*
M%25[QIG9$ZG='W87MCO&FV^Z6YMTW^)X>BN'GPP)%<MR?+7<:-Z&3"[%C2L_
MZ('=;,"V`2)A*$=##J"*#4H02!&&10\7>G!2I&4NK<2HHVX\25^X"^$TH[F@
M7GD?(F1B&,8]1..!(T8$"LE]J\=L>[&:E5V*AUYOUW.-_-5P1+*A\*@`6$1E
M#''@*^J+"79FEG/&>&693VN^3]N<<P[/N>B".7H_;W9VJU6IG?!-%+6-%%<C
MVU/:%:2URDO0..B4!]DJE5"7$T+K41AHC:JFA_0HLP9F6>8K4POV_MR:0<IU
M#ZCZ:\XV_>LI(_;J9I&Q9'&+>13IN45M*)T*@EN)[L@+QW<Q*`RXK#%`%]+J
MJ4%J#C"R@4J!-+OU4+9WM9S1,&3L=Y%9*26]KJXHWEC+V;4&+K95I;6EM3%Q
MPBUR&QJTZ6(=OMZ14N3N^]V"Y7$Q0J-4FF>(*A'0'A350-0BHQMQ1Q"DPR!O
MK/#*!EL5X/!7G#,4=32ND.S6N\+VOC<TH^3%,2U56W9(H7MAF)FF0O4I3$HB
M0\20)I=?J)RZ@@>]>:*,,HY>8C$B##F#-LS,V?V)"Z/%J2Y+A*%\&(=4Y#37
M)34:EW46YK2*])<F)6KL\>X],]P)5R"Z%W@Y&M/6!.*+'X$@*)@^E`BCF(\E
M]P?.]X;3,3-#,UP8UJ\IMNV1YXGZ0(]CUC7ZX7QWQ7+!-A*<K=LM[MZ=%97`
M["[<E1JC"#"DA*)8KJ6FXA`H$"33]D56,YI!R]RPP3W`,LG=E3?K3!S)S[MN
M)S?PS,9C*K'R6.8>G^-&Y97.H<U;80]DTS+W2-+=C%1:GZ"E*!20,FI1Q5$\
M&I!/ZJ5W5RO^Y3_^F3?^`7JL>BA?O4HFB)HB:(FB)HB:(FB)HB:(FB)HB:(F
MB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB+7;/M"#=R+
M;A*<G#^G"8XSJ7,D*GP^S%-1+%B=-;A%<?\`#K?"HE5NJJ3P_BT)JIX/PX]1
M[A%L5+%0!@!B`$P(1A$(L7]Z.@:TK4`O#\>$5*>%=2?14N!<TM!H2/7E^JTS
M0/"9$+[L#[M9C[?4E.20<*;Q(3R>SYNM5E]N=^O\ZV^VD)+86G\"+%8V]8+6
MC06Y(16M""4P:T%Q5_#/M1SOG[(CD$<<4<>HAC6M'`-;"3QYDDDDGUK_`,GZ
M+^4?),OD?\#M+SF:7I>C:-I/DF+`Q,/"BL@B@@T621SI"[C/-//++/D2OXO?
M(12@XXS'4-P\YLQH/B_$M@)[+$.W\Z9(>4Y3Q4PZXK;[)C[0+B/Y,)I`5<5X
M>ER0+E8S;N:H4G@1)P#)X@4(!]:O+SL^/0Y\S6I2[,U%K&Q0\``QO_D+!P:"
M.+>`JZAXEQI>=W^1/(>B_CQN;>WGO5GY/D#RO@Z?B:+HE!&R#3L)[#]W=@-_
MM8<<C&AN(UD;#-(6R4<97=OAN]AQ+C/F;A<\K0T&,R\4[!;I]01`^XANQ;P>
M#QE!S,I;?WX7,-_6+UUVOS/1TI<2K1]LKN)@%180'"++K4`*H,K.U70L_'E>
M]^LR.A[C)!:UK`[Z>TT`!KB`TN)`K6HX@$]G;^Z=_>:/QS\C[=U#4-3U+SKE
MS:&_5<+58CB8F)IN-F,@PCI,#&,B@RW_`/UW97<B@:8W%T8>\!SJLXK901=+
M6Y-#F1CJEFVJ'S/37F=H?H0-+R<CB6W+UMF:&/,-`-K;/LSG+=;,0<N7'D&#
M2#N-P,XQ@%2M1775]*RL7:LVFXT5<3',;KP160BKY9"*U`]:`BMK>2WCYS\)
M;WV%^&^XO$&AZ#,S;&U<W2,OYW]D/U21C)LO7M7([EXQXIG,AA8]HE$$#+6N
M!`'9Q!2G&"@O'AXPT%0-.(7AXT\>&G]FOA^RFM3E?%5U;26^M%U_DK%E7%.?
M4^1<KLC$>8XTR#W!3K%^9V^QD/B<V`HDV^U0L.^MN25*0M)91LRME`(VRI^(
MU,>$RHJT&=0PG9C\K#UG3?M>%)FX^3BZ8"6U+(GV#Z@Y@/U7UI<1Z'UHVA^K
MTVZ-B^=?%3_$&Q-3W]MW>>TO$PG[;YG86BYS=-@OSH<C3FO+IAF=YP;F24;(
MPL`^F,LD@?&^^NIL'L^<9?AJ$'S&KEW/'8S;F\E7ZJ)R5;TZNEQJ4C>D1&XT
M2]#:A,]F'U*2AL9]%`3^`PZI=*B+&#OZG'!.U^GX.1D1YC-*N#?I[!A:""RT
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M)+H$OBR;/J_`RL-CG'6&:8TRQ5/::P4+RP$#Z@T_3QI4\":NIZ^\E2,S-@;T
MV;C9V3)YZQ_#VD_=M'=)(=!Q-.Q6X\N1/IU8P#J+,9\;PPVQ-DE?VY'DOIV>
M05H`T%1AXJ`&&H@?]J@14K4/]WP\-:D/HOB@X7,(::$C@5U@L@65(\&J+Q8+
MYC_>U#Z/W1FQ.C-R\0U;*BPWEKO]T)JMAFI7(6NJ\#GA49M$ZJP4*J0E)),.
M'0/"&HMN:=D8NH,;+'D@8XTGLNQR'5#F\'.MI;;2H#_4^GH5]LO$^Y-G^3HL
M?5M,W9C,VNWPADZ+E[4?\EL\.3@XSODY;L<L^(,2@[D>==?*][(VDU(;RWHA
M3'L#(F83[2@'-%CWPK+;+&ZA)4]79;TUE<*&VV)NHKK].ES*M`+4<.@$83/H
MB#7BX?PI6ACG1SXN"PD8#]O@N;_22Z@<XCTJ?0GU7!MS*FBW5M#Q]%D2CQSE
M?C-+)/BW.^*]TT#Y)\A\5>V93*T$REMX/"[BKTON%$L:[N.+<C*'R]GTYYDM
M66%X6U=MQ`HL[+:S;9R0AEQVQ[.2"B:SMAL)[LJK2OB(U6>H&:9X5K2E,=QM
M0.7LK-Q6Q1Q0P?'`M'%SG/\`K>X^[G$#]J`+S!M?R3/O/\`]\;0ATS3=+T3;
ML^UXF?%C+9<S)R,MSLS/S93]4N3DNBB'LV)D;6,J*DX++\(P^^\G&'BMC''Y
M2A]MC)QOYJY;3FHJ=?[G%0R%5;V%I5>RVAUW+=,@'"!5+92U/T$(*@%0K]X\
M2?GP=1S\?2)-7U:4_&?B'%QXOXB3VNM'"UOH74XMJ*CZ0[)O'WDOR#M?PKJG
MG3S5JSF;7S=E3[/VMHK:01ZF'-[/ROALI$<;``(ES'1WS$.%_"(2[PS!_4,,
M,\*!XQB'PT_8'B%47A3^U3QUK[TX+YFL;8P,]:`#_HM(VY7$\=-=MW6:FRR6
M`I8W\_HF?^:LGV"^%W_(-L'M1Q-.P,Q#'22Y7!0B;2@:>X5!<4M#D0RDU2Q$
MIA_4-%38.T\S+R)!IDDDOR#`]N+&1;"ZH<YQ>:5<.`IZUX\:@+Z6?AIOS=^N
M:Q!XVUG4M69N?_%-4P=GZ;/"8-!R6Y./E3YC]0?'&U^0T.CKCRV3!TEXDF;8
MQII=G%EO$DOY=LQWN*6D;>;N*.7<+,)DQX85?*'*[):7:%Q9%STX4Y%H/(_+
MD-PL]NLUK*H<-6)(C-,H300OWK_MW1LK3]%E@9$'39>GS2/?5O`EE(8A]72Y
MSG$@`$^I'IZ._&7P'OWQ]X`U+;^D:#)EZQOOQ_K&=F9X,-&32XIQ]`T3'<Z4
M.[CXY9\O)>6-B$LS&&0@?387*QDR?$LNY2[@-P:.(D\P2!RP&<>R7_8R9"DX
MF.+;:6VTBPM5>L1T018XCC[\!?4@[C4*O$HP01`)H49;-&R,7-P<+;+),W&U
M$-F^IA+&%Y+GU=0U>!0CT(]@1=4:E\%;EV3OW8&Q_P`4,34/(&UO*)PM<#<S
M!F.!IIU"27(RB<IC'WZGCAL!@O92..CV`M=)>S?VE5$KTJ1>G^I5.O2)5Z?Z
MP>`[[=:G+5$?6!_@&_2-IQ4_L"\::UFYI:XM/J"1_P!."^4T\$F+/)BS6]Z*
M1S'4XBYCBUU#[BH-#[A:]<;_`+<O<(W."6W6GZ6&GPC6.@*;P^Q#-JB%784[
M1"X/X=+V=&R9HB6_YRH?MZC_`!X=4CU*XEL1U*)HB:(FB)HB:(I8_P"!/]U_
MY>B*JV>6*$4YI1/:(.FPQWF1P:]V@_KQ9F>X`-LUS+H\OR)QV*P.)6.W7(2]
MI*;PG*-6H@A*$I^B"GU`\/XP15%'&1>)D1Y/7G'URR&6YK0Y<7YN;D_PXX&#
M>B&M=6^^6V08E)0JCJVVXEW!GW=$()%PMM0``J)*`'C#PZ$5]44#(]K_`!=0
M0BS,?DP9,#'K"R[#FXWPB>Q-;]2;@OVY2/2BZZTL(0*V31R74W_VSZ(!U3\)
M=3_&G'5:/^Z+DO+;)QB?<4Y:PU?J27^C,U,@R\FIK^Q>Q*2\5DTIP-%RA_1E
MQK8C0MIM?F;)0_ZD(I57Z?U`_5_?\0J#B.911IDALZ8@922M+LLR'<Y^L*V?
MH_;S!FYC1G-5^8<92K^B[/2QL-WOAG6Y&<E<#M9"(LH=O$I&9;J*DY1YJ0TP
M(JC@M!-47!F+9EP^FUS7YP.2^9%-JWOJ"(^QYEMDQQ.-_8S'FQD1(V26I%B^
M6+%:$-*.IQL:VI2!IC*F%(CU"<H2E*<&@P&+0BM1"^%$,01+ZZ<F6H?:R0+E
MC;#&*JY8YW,FN]N4Q;`Q?TF(:9;R+-;O_MP@_P#R"^AE`*Z_C0DNM:^,THBQ
M.?MO#'')9ZS2_922/A9?)[Q8*P]?I5F=9=KM88B3/P4DHE3?1"M"NMH?*!VU
M">3=*F'4`$L`?HU\/&H@'U18FW]K3#RPUN"0UG.1Q-R\82-G;[O3,<KG%<&I
M=L=&K=:WNW)%B%-;D"P+[.NM?N#KT4H*-J?X&%EECH$5%H_[(L1A3:)Q$AYO
M3.V[T?-F0:6=8:18XNY=DM+U^E:[6C'RTT,K9(>9"P]/:*-1J64\8#TPR`57
M%J$Y!@3Z5*#346A%Z(?VA<3XE:$[-%;?,@IG_J#@ZF,KM<\]35?9(=[:Q\3)
M%22T1-'5W4HK>2T6W8ZJ:')A`(-4T.()J(P0`<%5H1?;C#:JQOC`J)Q%.Z?G
MU=H:QOFW%)GN&2)3HZKV*'I[7GK'=:;HL,;J:JA=82#0H[`,JA*>T("2B`$#
M`6'4@`(I#9NW=CNQ4>":)O5?H`;=5G=MDQO%=744O*`E>C-$Q;O62R@64G]:
MTI91?N4+HBX#/$7A7^]TH.'Z(NNU#VUYD/=\L\<*+MOMS8O(8;SA*R5DJ7D>
M6E)1Q!M<>->\7MR*F[B7#-X<=P=;)N<S.`5M47`@])4]+5*64(XM,`115%IK
M^RE=G_)K%B*\M6]&S8EJCI_*XIG*-,A6G^E+Z"P*J2'$]R579I?FIXT%PHO;
M]%:P?W:2@2ZJ`>%/J`\/'7)ZJ%F>0D*,G)N$I<Q_D[\YK'TV,B_Q\]Z-JY`L
MM^_3SE)^WN7Y+=3$B\NVK_IU_AFU)-H"O^#71%7+(S;OQYR<B"$8D>YTFM4_
M&O\`3)T!2[%D@7!@S?%5R:S70,Y-=6S(%K3"-+4W=OVPDFY`,3#(5B+"9],!
M@"Q`@@%%&=@VC\.&]%D'0NGM$DW..83R"IE0LL3AD%2X!SS/H#0*B9!R4N-U
MMJI?+:I*M!0XI(<8D1`%0(?I5`$(:1:$52,WL$;["^"&3.(N!>,K]G]'G9)C
MUN%T9%_EMI62+,5'9(*JWN5=*C=0N=/9UMECI`Y[42K!9[>J4#37$@HP-*%B
M-H,104"+;=BI`UDQ;QG@3')O#3GVR%HI9D?B6I05+(NMWLMH("Y;X`(@`'7\
M^<QJQ;6HJ4%6JC][\?'4@4%$5(,KMFC#?+V7G)-CV5SK&SRD>R6=L3>G@:8K
MW%K9GYN6$HI-:[7+[>MR-:B<HR$!!:42DO[=0:G+"$P0AA".@M!19E+VT]B1
M+5]A>^(BY=A,,(PJHQHL]GQWEAPQ%:WCC@J-HH40A(0[&$Z[7YC*57&8=0E4
MD7'U/.^JH'4SQ#%H19?`.VSC;C8[<<'I&YDE#O.*D#R)C?$5'*\T]Y1)(NDQ
MZFOR_(7`G+L*`=[NZ"\&T*MZOC)JG1@"6(!M:<>I`HBKW,VQ[@_.3_F)\NM1
MD#9+;.;VMDKOF*&--U^:\+"FBWK$*HZ9[9&I2%78B9%NI2,9*A2H"J3A`K4C
M)))-,H8"+0BV_!I0(0!I^P``%T^/"`-`!\?[?@'52+SHB:(FB)HB:(FB)HB:
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MI:@2@1-`!I2I-:_CJY#5<@:4-'+6'$&3WN(-Q=;;0FM+2/:E?U6SHO*^XH_$
M\7AE\&#)L^+<HUNKHWF=^4,;XIB>\2!IQG1<'1B,/))/<`X*H4%6[`_'I\-M
M[L6];NZD+=<QSM.9=^Q6RN5,!SWA62(E>8[FO;X!MB6^@N8*T^Y^H*@S^`-!
MBK2GAJ]:CO#-U2!T.1CX@);:'-C<'-''^)+B!2I(X<"O0'D_\X/(OEK;.9MK
M=&WME,=F80Q1F0:8YN=C1--6#%R9,F1T)C->W:*,J;0"5ET27/;RAR4[-)=@
M9NY;?K8R%SMND21&\<.,N[_$$-7)]T4!=BR/FB9"Y-48[H6K,#0*D]0`OCXJ
MT&8$!@>'-W7J6?AG$D;"U[PT22M9264-_C>ZI]/T`X<!0$A6#?WYD>6?(FQL
MC9FJP:'BYNIQ8L>JZKB8?8U;5X\*WXK,_*$AO$9:TDQLC+J4!:PN:;`7#)[!
MI;.$>3Z3"^:%H>4:--V-"P6VR;=N2UK;"A([STBA;=KI;4T&!4GWZVF(P_9*
M2SRJD>(OP%6OCJV-U?-;@2:<7%T$C@227$\/8<:4/O4%:HQ/-._L7QGJ_BJ3
M+DR-NZUGXN7/)-+D2Y+78@<UD44CIK6P2!Y[T;F.OH.(HK!AW.\=P"",$<YN
MA$`5!!%3`3+FE0B#7QI6E?Y3_MI6FK9P6IG-#@6NXM(5`+%>-O=O32FEY&T=
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M'=L#\KE2-&N:#="V+*B;Y1$,I3T=L)MP?&I9YB@7U*UK05`_NZM&5J$^7BX^
M'*`(<9KFLI7T<037CZU'M1::W?Y+U_>NS]L['U:/%9H>U,')Q<,1->U[V9>1
M\F9\Y<]S7R&3@',;&+10@GBJP-&Z[?+,F6U2U;&MN:JK(V)$O4OLB#+IAYEX
MM@UC2JX*B'<GTVF<*%PJ4US">.IJ<H:H9*8R@>&E0!""EXFW7J,^`<%S(!(^
M,1OF#*3/C']+G5X@^_#CQ/KQ6[=?_,;RKN+QU/L+-Q=!CU/-TB'2LS6HL(,U
MK-TR#A'A9&6)+71EOTR.$0?(VM2'$N6P'J<X[>/C_+C-WQ\?'Q_H$RY\?'X_
M_P`GUC*\H4X4]E0T#FV_Z3^=/1S2W*U1)LG5G$$*J<-,N#(.(FX2<)%95`S/
MY+4/&YPC#]8'&J$2`[]@?I4H53)/\IU'[:-.#8@1%VN[:>]VO3MW5I;3A2GZ
M_P`N*]2N_+OR@?%#?%D>-HC)&Z)]E.L-Q*:T=&NN^V',[EHQJ?0:1!Y9ZF\F
M0\B\.[`"^9$_U$K69N2T5'R%:)BND1$X8Y<`A6]3/8$-4%GE6YLRL+B--=B,
MO^+405(2C#ZU$(-0B&`41[HU&+2_M;&Q4[9C$MO]T1'UC#J_Q/I0C@*>X!7#
MI_Y:^4-,\1?ZBQH-&[#=)ETF/53BUUB'2)WWS:9'E]P`8KS]-#&7-91H-S6N
M%A'9F+B(\YPAN?KNPL^0O6#[3(5F:"-)@AE<6WEJ22K<DMC@$X$)L,G+%IQ*
M=&&J:I2@@(!5K4=!_A2EK@U&?'T_(TU@;V,@L+C0U%AJ+>-!Q]:@_I1:FT'R
M?N';GC/<7BG3X\4[;W-D8$V6]S'&=CM.D=)!V'AX8P%SSW+HWEPH&EOO2VT6
M;!.Q2I?9>L[GW@[6Y75(])1=2&UXN966IO.=R?GQK@$4X+9;<?DE;K;!*#S"
M/I'&"%1*8(N@Z4K6NK])O'-EPVX,F/B&)D=C28W%S10#@;Z`T`]J<!P7H_/_
M`#E\AZIL;%\?ZAMG8T^C8.C_`&W%?+I;Y9\;'[`@K!))DN[4EK6ON:T#N-#R
MTTHMG0]SO'88Q#K&^;8:C$(5:!P#RYH&E15K6M`T_E/^`:>/X:Q)>*6MM:&B
MI`%./JM?TGW;;VEB7[W*[B:&YC;[:]G&V'G*D.-[#S+ZU0U+;P9H2PMUQOUH
MAADTU>M3?2#4X)*DD"@?$.M`C&8(62X>ZM1P<$8<+82]C2UDI966-KO4,=7A
MRX@\`!Q``7J_9/YC>5]A>/L;8>D8^A2YFFX>3B:9JV1A"75]*Q,NOR,?!RKP
M&,=4AA?&]T8HT$M:QK9XFG)?!:=BF06[H5S.MIS%EEG3&A6MG;JR1MB^].5E
M*U2U!;'*J/@E:9=VU<SE8OOTHN$2FE*?OAK3QUT-/UK.TTR=AY(E@?$0XN(#
M7T!+144<*<#[<EJSQOYM\@^+Y-3?H&9+-'JF@Y>DO9DS9,C(<?,8UCY,=HG8
M(LB,,'8E%1&:_2:J"9)O&WO*,O7^4[VT-R^U6=]N-JO"586;>'.7=HA2678R
M:%4;-]?+.+A<PU6<CJ0`1I1"D@H\=*BJ$(AC$+OXFZM1PL)N)$V$R,:YL<I9
M6:,.]0Q]??TJ030`>@`6T=F_F)Y6V1L#$V-IF/H<^H:7AY6)IFL9&'W=8TO%
MS*_)APLLR`,#ZD-<^-[F"C02UK0+SWG.26972FM?#'#O()WOJZ@JD0R=E#%;
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MD3I&>X*[XZ7ESR\ITM?U(O87M&>X.XOX.^.3Q?Z.W/3B_P`6T^.IM?U(N1TC
M/<,]\<7+GSY3J+7]2)TC/<,]\<7+GSY3I:_J1.D9[AGOCBY<^?*=+7]2)TC/
M<,]\<7+GSY3I:_J1.D9[AGOCBY<^?*=+7]2)TC/<,]\<7+GSY3I:_J1.D9[A
MGOCBY<^?*=+7]2)TC/<,]\<7+GSY3I:_J1.D9[AGOCBY<^?*=+7]2)TC/<,]
M\<7+GSY3I:_J1.D9[AGOCBY<^?*=+7]2)TC/<,]\<7+GSY3I:_J1.D9[AGOC
MBY<^?*=+7]2)TC/<,]\<7+GSY3I:_J1.D9[AGOCBY<^?*=+7]2)TC/<,]\<7
M+GSY3I:_J1.D9[AGOCBY<^?*=+7]2)TC/<,]\<7+GSY3I:_J1<<S:,]P=Q?Q
M=\<GB_TEN>G%_C6GQTM?U(O7TC/<%=\=+RYY>4Z6OZD3I&>X*[XZ7ESR\ITM
M?U(G2,]P5WQTO+GEY3I:_J1.D9[@KOCI>7/+RG2U_4B=(SW!7?'2\N>7E.EK
M^I$Z1GN"N^.EY<\O*=+7]2)TC/<%=\=+RYY>4Z6OZD6\7^FW,[ID_P!,O]6A
J?];/\F_T;_5[]O=/I_S&_-/NOU[]O]M^:^'V/\'P^EQ_VM5T-*>ZA?_9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g672020pc_pg001e.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g672020pc_pg001e.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`20+&`P$1``(1`0,1`?_$`.\``0`!!`,!`0$`````
M```````)!`8'"`(#!0$*"P$!``$$`P$!``````````````8!`P0%`@<("0H0
M```&`0,"`P('"@@(!Q$```$"`P0%!@<`$0@A$A,4"2(5<;46=W@Y"D%1([2V
M%S<X&7DQD;&S)"6W&&&!,D*R="@Z-74V=E<I&M%2HM)#-%1DE%5EE=769Y=8
M$0`"`0,#`@($!0T-!`@#"0`!`@,`$002!08A$S$'02(4"%&RLQ4V87&Q,B,S
M<W1U%G9W.(&10E)RPL.T-1<W"3EBM1@9H8)3)#2$)4=%A5?!\9-E)D96)RG_
MV@`,`P$``A$#$0`_`/W\:4II2FE*:4II2L157D%@6]64U,I&;L17&X$!\8]4
MJN2:98;*4L6!ADQ-!1$T\E"A'`0?'W2_`[#W[;:S)MNW#'B[\\$R0_QF1@O[
MY`%3G>O+#S*XYM(W_D/'M\P-B.BV3DX&5!!]T^]_=I8EC]>XT>MZU_5O5V4[
M(F/\BPKBR8^O5.O5=:/7<:ZGZ=9H2SPK:18$25?,'$K"/GS%%ZR37(99(R@*
M)E.43``"&K,V-D8S]K(C>.4B]F4J;?#8@&M)OW%N3\6W!=IY/MN?MNZO&LBP
MY6/+CRLCDA'6.5$<HY!"L!9B"`38U:A>0&!S51C?"YLQ&:C2D^%4C;F7)%-&
MJ2-H,50X5MC8@F?<[N?$B)Q!FFL9QL01[.@ZO?-VX=XX_8F[X745T-J`O:Y%
MK@7Z7M:];H^6/F2N]2<;;CV^#D4.-[3)B^P97M*8]P.^\':[JPW('=90ER/6
MZU\LG('`U.M84.W9MQ%5;R9:.;EIEDR338.UBO,$04B$`KLG--9<5I0CE,S8
MO@]RX*%$@&[@W1;=N$T/M$,$SX_7UE1BO3Q]8"W3T]:KM/ECYE;]LOYR;'Q[
M?,WCNEV]J@P,J;&M$2)3WXXFBM&58.=5D*G5:QH[Y`X&878N-7V;<1,LC&E6
M<$6@.\DTUM=C3<AX'D(<M56FB3HRK[S*?@M_`\97Q"]I1[@WJNV[@T'M2P3'
M&L3K"-IL/$ZK6L/2;T@\L/,K)X\>6XW'M\DXH(6F]M7`RFQ.RE]<OM(B,/;3
M2VI]>E=)N18U=\%D"AVF=L]7K-VJ-CLU)<MF=SKL%9(:7G:B[>@N+-K9XB/>
MN)"`<NP:J"D1VFD93PS=H#VCM8DQ\B*-994=8G^U)4@-:WVI(L?$>'PBM%N7
M&.2[-MN'O.[[=G8NT;@C-BSS02Q0Y*I;4V/*Z*DRKJ748V8#4+VN*\13,N'T
MD+TY5RMC9-MBYPFTR8X4O-7(ACMTLHLBBVO2II0$ZBX55;J%*20%N8QB&``W
M*.W/V+,N@[4MY1ZGJMZ_2_J]/6Z$'I?H:V*\!YT\FVQ)LN[&7>%+8"C#R"<Y
M0`2V&.W?)4!E),.L`$'P(KQ[-R&P#2V5;DKCG+#U3CKE$IS]0?V;)E+@65J@
ME2(J)35;=2DVU0G(E5-RF8KEJ95$P*%$#;&#>Y%MNXSLZ0X\SO&;,%1B5(\0
MP`Z'ZAK.VCRM\S>09&7B;#QS?<W*P)S#E)CX&7,^-,"08IUCB8PR@JP,<@5@
M0>G0UTV?D=QYI!X5.Z9YPQ45+)`L+37B6?*-'@#SU8E?$]UV.%+*SC092!DO
M!/Y=XAXC=;L'L..PZK%MFY3AC!CSN%8JVF-S9AXJ;#H1Z0>HJYL_E1YI<A7(
M;8.-;_G+B9+X\YQ]ORYA#D1V[D$O;A;MS1W&N)[.MQJ47J]"9'QXK;F>/TKY
M3%+Y(P)+5'TDEH@SVY]6%#J)DL;.ME?#,NH$YTC%!X1$S<1*(=_0=6#C9(A.
M08W]G#:2VDZ0WP%K6O\`4O>H^W%.4IL<G)WVW<!QN+)..^6<>88R9``)@:?1
MVEF`()B+A[$>KUKBIDG'2-O=8^6OU*2OK&"/:'M(4M,&G;V=93$H*6)U6C/P
MF6\$F)P`SLZ(-P$0W/UT&+DF$9`C?V<MI#:3IO\`!JM:_P!2]ZJG$^52;&G)
MX]LW!N-29(QTRQCS'&;(/A`L^CM-,;&T0<O_`+-6DYY$<?V=.C\B.\Z8=:X_
MEY9:!BKTYR;2D*=)SC<CA1Q"Q]G5FRPCV6039JF.V37,L4$CB)0`H[7EVW<6
MF.,N/.<A1<H$;4!\)6UP/JVM6\B\K/,Z??I>+0<<WY^3P0":3#7;\LY4<+%0
MLKXXA[J1DLH#L@4EEL>HKI?\D./$56(&[2F>L+QM,M3F29UBW/\`*-'9UBQN
MX986\NU@9YQ.IQ4PYBG`"FY(W54,@?V3@4>FJKM>Y/,V.N/.9UMJ41OJ%^HN
M+7%QU%QUKGC>4_FEF[QD\>P^-<@EW_"2-LC&3;LMLB!91JB::%83)$LB]8RZ
MJ''5;BO?3S+A]5"BN4LK8V4;90<*-,9N$[S5SH9$=(J(HJMJ*J64%.W.$EG"
M9#$CQ<&*8Y0$-S!O:]BS`7':EO%]OZK>ITOZW3U>@)ZVZ"M:W`>=))N43[+N
MPEV=0V>IP\@'!4@D-F#MWQE(5B#-H!`)\`:]N=R!0ZM.UBKV:[5&N6:[.7+.
MF5V=LD-$3MN>,@0%XUK$1(/6\A/N6@.DA5(T35,GXA>X`[@WX1X^1+&TL4;M
M$GVS!20M[_;$"P\#X_`:UVV\8Y+O.VYF\[1MV=E;1MZ*V5/#!++#C*]]+9$J
M(R0JVEM)D90=)M>QKP5,U8;197B25RUC-*.QD_)%9)?J7RK$98^E%')F2<;>
M'1I4$*F_.\(9$$7YFZ@J@)=NX-M7!@YI9$$,NJ470:&NXM>Z]/6%NO2_3K6R
M3R_YY)D;=B)LF[ME;O$9,!!AY!?-C"AS)B+V[Y*!"&+0AUTD->W6O$9\C^/$
MC5IF\Q^>L,/Z377S&,L%Q9Y1H[JK04E*&*2,CIFPH3IXF,?2)S@""*ZQ%%A$
M`(`[ZN-MFY+,,=L><9#"X4QMJ('B0MKFWU!6QR/*CS2Q=Y@XYE<:W^/D.5&\
MD&*^WY:Y$T<?61XH#")9$0`ZV12JV]8BN]'D+@)S3'61V^<</N,>,9A.O/;X
MCDNEJTQG/JD052@W5H)-&@V\PHFZ2,5L=<%Q*H40+L8-Z';=Q6<8K8\PR2+A
M-#:B/"X6U[7]-JM2>5WF9#OZ<4EX[OJ\HD@,Z89P,L930@L#,N.8N\T0*L#(
M$*`JPOT-7?<<B8_QW"M[+D"]4ZBUQV]:1K6?N-GA*Q"N9%^155BP;RLV^8L5
MGKU-`YD4BJ"=0I#"4!`!U8AQLC)?M8\;R2`7LJEC;X;`$UH]AXMR?E.X-M/&
M-MS]RW5(V=H<7'ER)51"`[M'$CN$0D!F(LI(!(N*Z#Y-QLG:I6B*9!HZ=W@H
M`]KFZ:>V0)+5#U=,$#'LDK7C/PEX^`(5TD(O%D2-P!0OM^T&]1BY1B$XCD[#
M-I#:3I+=?5!M8GH>GCT-7%XARQ]EAY(FU[B>/9.2,:+*&-,<:7(-[01SZ.T\
MQTM:)6+^J?5Z&K0K7([CS<TYY6GYYPQ:TJK!/+1:%*UE&CSJ=;K,=V>\+%/'
MBYQT6'@F/B%\9VX%-NEW!W'#<-7Y=LW*'2)L>="[!5U1L-1/@%N.I/H`ZFMY
MNWE1YI;`V,F^\:W_``GS<E,?'$^WY<)GR'OH@A$D*]V9['1$FIVL;*:[J[R'
MP!<(RSS=2SEAZT0U)C`FKG+UW)E*FXRHPYBN3A+6=_&3;EI`1@D9K""[LZ26
MR1Q[O9-M27;-QA=(YL>=))#90R,"Q^!01U/U!7#=?*WS-V+,P]OWOCF_8>?N
M$W:Q8I\#+BDR9?5';QTDB5II+LHT1AF]9>G45>`9%Q\-)_.6%ZIPXX]TC/\`
MYP`L\)\B?<0!W#-?*OSWN+W2!>OF?'\';_.U8]FR._[-VW]IO;1I.J_P:;7O
M]2U:+\U>3_G#^:/S;G_G7W^S[%[/+[7WO^R]FT=[N?[&C5]2O,3R_B99S1F2
M64<=JO,GM%'^-&B=VK1W.0V*2"3I5[1D"R8JVUHFV7(H91@#@@$.4PCL(#KF
M<+,`D)BEM$;/ZK>H?@;IZI^O:LQN"\V2'<<A]FW40;.X3/8XF0%P7)*A,P]N
MV,Q8%0LQ0D@BUP:\6-Y!8$F;H.-X?-V(97(A9.1A34*-R53'UT+,1`.C2T2-
M6:S2LX$G%E9+"X0\#Q4`1/WE+V&VN/MNXQP>U/CSKC6!UE&"V/@=5K6-Q8WZ
MWK/R_+#S+P./_G9G<=WV'BQA27VR3`RDQ.U+I[<GM#1"'MR:TT/KTOJ723J%
M_M6Y`X%O-F-2J3F[$5QN1?/]U2JV2:;8;,7W6!QD^Z!B9IW*A[N!,WC_`(+\
M#VCW[;#JDNW;ACQ=^>"9(/XS(P7]\@"F\^6'F5QS:/S@Y#Q[?,#83H_[SD8&
M5!C_`'2W;^[2Q+'Z]QH];UKC3>KNI^0J#D.(=6"@7BH7F!8R#R)>S=/LL+9H
MAG*QY$E'\8ZDH5Z]9MY!BFN0RR)S@HD!RB8``0U9FQ\C'<1Y$;QR$7`92I(\
M+V(!M<&M'OO%^3<6SDVSDVW9VW;E)$LB196/+CRM&Y(218Y41V1R"%8`JQ!L
M38U6U2WU.^0$?:Z/:*[<ZM+%7-%66J34;8H"3*U=+L7)H^8B'+R.>%;/6RB*
M@IJ&[%4S$'8Q1`*3038\AAR$:.8>*L"I'IZ@V(Z=:Q]ZV+>^-;G+LO(L/*P-
MY@T]R#)BD@FCU*'77%*JNFI&5EU*+JP8="#5Q:M5JJIW3IJQ:N'KYRW9LF:"
MKIV[=+)MVK5L@F95=PX<+&(D@@BD03'.80*4H"(CMJH!8A5!+'P%7889LF9,
M?'1I,B1@JJH+,S$V"JHN22>@`%R>@JUZ=D*@Y#9NY"@7BGWE@P<^2?/J=986
MS,V3S83>4=N85Z]1;N>T-_#.8#;?<U>GQLG&8+DQO&Q%P&4J2/W0*W&_<7Y-
MQ:=,7D^W9VW9,J:T3*QY<=G7^,JRHA9?J@$?5J\-6*T54+.4C)!NL\CY%B^:
M-W+]FX=,W;=RW0>1;I=C)M5ET5#I).8YZV417(80,BJF8AP`Q1`.3(ZG2P()
M`/4>@]1^^.H^&LF?#R\658,F*2.=D1E5E96*R*'C8`@$JZ,K(1T96#+<$&O*
MK5PJ5S:N7U/M-<M;)F[58.WE:FXR=:M7Z&WC,G+B+=.D4':._M)F$#E^Z&N<
ML,T!"S(R,1<:@1T^'K69NVQ;YL$R8V^X>7A9$B!U6>&2%F0^#JLBJ2I]#`6/
MH-<H6W5.QO)F.KUGKT](5UV$?8&,+-1LH\@GX]VS*9:L7*Z\8['L-^#7*0_0
M>G322&:)5:5&56%P2"`1\(OX_N53<-CWO:8(,K=,/*QL7*37`\L4D:S)_'B9
MU`D7J/60D=?&O37DXUJ]81KJ08MI&5\U[K8+NVZ+V2\BB#A[Y!JHH5=YY-`P
M'5\,IO#(.YM@ZZX!'*EP"5'B;=!?PO\`!>L.+#RYL>7+ABD?%AT]QU5BD>LZ
M4UL!9=1Z+J(U'H+FO%D[O2X5_P"ZYBWU>)D]DA]W2<_%,'^S@`%`?)NG:3C9
M8#!V>S[6_37-8)W76B.5^$`D5L,3CO(-PQO;,#!S)\/K]TCAD=.GCZRJ5Z>G
MKT]-=T];ZG53Q:=HM%=K:DX^+&0I)Z:C8<\O)'[>R/BRR#EN:0?'[@V22[U!
MW#II'#--?M(S:1<V!-A\)MX"N&V;%O>]+,VSX>5EKCQ]R4PQ22B*,>+R:%;0
M@_C-9?JUQF;C4*XX2:6&U5N!=+H^81;3,Y&1;A9N)SI`NDB^=(**(BHF8O<`
M"7N*(;[AHD$THU1HS#Z@)^Q5=OV'?=VB,VUX67DPJVDM%#)(H:P-B44@&Q!L
M>MB#1>YT]M7G-M<VNMMZHS(=5Y9EYV+2KS5-)4&ZBCF:4=%C4")KB!#"94``
M_0>O3003F00A',Q\%L;_`+WC2/8-]FW1-CBPLMMZD("XXAD,[$C4`L07N$D=
M0`O4=?"J]&=@W$,6QH3,4O7CL!E23R,BS4ACQ8(BX&2+*$6,Q,P!N`G\8#^'
MV>UOMUUQ,<@?M%3W;VM8WO\`!;QO6,^V[C%GG:I<>9=T$O;,)1A*)+Z>WVR-
M>O5TTVU7Z6O7"!L,!:HIK.U><A[)"/BG,RF8&393$4\*F<R9S-9"/7<-'!2*
M$$HB0X[&`0_ATDBDA<QS*RR#Q!!!'[AZURW/:]SV7-?;=XQI\3<8[:XIHWBD
M6XN-2.%9;@@BX'3K5/7K95;:@\<U2RU^SMHY\O%R#BO3,=-(,9-ML#F.>*QK
MERFV?-Q,'>B<2J$WZ@&JR0S0D"9&0D7%P1<?"+^BKFZ;)O.QR1P[UB96'++&
M)$6>*2(O&WVKJ)%4LC>AA=3Z#5P:MUK*:4II2FE*:4II2FE*H).5C(5BO)S,
MBPB8UKX?F9"3>-V#%OXRJ:"7CNW2B2"7BKJE(7N,'<<P`'40UR1'D8)&"SGT
M`7/[U9.'A9FX9"X>!%+/EO?2D:L[M8%C95!8V`)-AT`)\!7&6F(F!CW$M.RD
M="Q30$Q=R<L];1T>U!99-ND+AZ\51;(@JNJ0A>XP=QS``=1`-$1Y&"1@LY]`
M%S^\*KA8.=N>4F#ML,N1FR7TQQHTCM8%CI106-E!)L.@!/@*Y/Y2,B@:&DY%
MA'%?OVL6Q%^\;LP>R;XXILHYH+A1,'+]XH':DB3N44'H4!'14=[Z`387-A>P
M'B?K#X:IC8>9FEQAQ22F*-I'T*S:(T%WD;2#I11U9C95'B17DV:YT^E-6[ZY
M6NM5)D[<>4:/+-.Q<"U=.@3.L+9NXE735)9QX*9C]A1$W:41VV`=<XH)YR5@
M1W8>A03]BLW:-@WWD$S8^PX67G9"+J9<>&29E6X&IEC5B%N0+D6N0*\NO9/Q
MI;9(T/5,AT:S2Y6ZCLT57K;`34D5JB*957)F,;(.7(-TC+$`Q^WM*)@W'J&N
M<N)E0KKFBD1+^+*0/WR*S=TX?R[8\3V_>MKW'#P2P7N3XTT4>HWLNN1%74;&
MPO<V/P5?.L>HY7P1``$1$```$1$1V``#J(B(]```TH`2;#QJPI+*N+X:/92\
MODB@Q45(L&$K'R<E<*\QCW\7*F6)%R3)ZZD4FSIA)';*`W6(8R:PIF`@CVCM
MDKAY;L42*0N"00%8D$>((MXCTCT5)L3A?,<_*DP<':=SFS8I7C>./%G=TDCL
M9(W14+*\892ZD!EU#4!<5=/OV$\2'2]\17BV$BBD`G[P:>).)HLQD%5(<GC=
MTF1)@`KF%$#@5$.\?9ZZL]N2S'2;+X]#TZVZ_!UZ=?36F^;=QTSOV)M&*0)C
MH:T)+:`)3;[F2_J`/:[>KX]*\8V0*$1Y8HXUWJ)9"H`R-;&)K+#`\JY9+M".
M&Q-1>@O"`_$X>#YDJ7B[AV[ZN>S9.E6[;Z7OI.DV:WCIZ=;>FU9XXQR5H,7*
M7;LXXN=K]F?L2Z<CM_;]AM%I=%CK[9;3Z;4D<@4.':OWTO=JC%LHN0?Q,F\D
M;)#,6L=*Q44K.RD8_<.7J2+20C81$[QPBH)5$6I#*G`$P$VJ+C9#L%2-RQ`(
M`4DD$V!'3J">@/I/3QIB<8Y+GS1XV#MV=-D31)+&L<$KL\<D@ACD150EDDF(
MB1U!5I"$4EC:NA/)..E:\ZMJ5^I2M48,$)5]9D[5!'KS.+=.7+-M).IHK\8U
MNP<.V2R1%CJ`F=1(Y0$3%,`5.+E"00F.3O$V"Z3<GQL!:][$&KC\2Y5'NB;(
M^V;@N]22&-,<X\PG:155F18M'<9U5U8J%+!64D6(KFID7'R550O2M[IJ5)=$
M.JVN*EGA"55PDF9<BBB%A,^"(5(0S54!$JP@`IF_[T=@QLDS''$;]\?P=)U?
MO6O_`-%<5XKRA]Y;CB;;GGD*$!L48\IR%)L0#!H[H)U+8%?X0^$5PB\E8ZG(
M;Y10M^I4O7^\Z?OV+M4%(0WB)M7#Y0GO-H_59=Z;)HJL8._<$DCG'V2B('Q<
MJ-^U)'(LOP%2#\'A:_B0*Y9G$N5;=G_-6X;9N$&YV![,F/,DMBRH#VV0/8NR
MJ.GVS*OB0*]&,N50FE+`E#VJMRRM3=JL+2E&3D8_4K3Y`AU%V5@(U=*FAG:*
M:1C'3<@F<I2B(AL`ZXM!,FDNC`.+K<$:A\(^']RL7+V'?<!<5\_"RX$S4#XY
MDAD09"$@!X2RCNJ20`R:@218]:\=QE/&+5\A&.LC4-M).H+Y4MH]Q;Z^B^<5
MGR#F5^4:#120*X6@O=;)9SYPI1;^71.IW]A3"',8F65U"*0J&TWTFVJ]M/AX
MW(%O&YM6?%PSF$V,V9#M6Y/B)D^SLZXLY1<C6L?8+!-(F[CI'VB=>ME73J8`
MUM?R%0;8WC7=6O%0LK6:6D6T.YK]EA9EO+.(@A%99"-6CGKE-\M%IJ%,X*D)
MS(%,`G`H#KC)C9$)(EC=2MKW4BU_"]QTOZ/AK'W/B_)MDDFAWG;L[$FQU1I5
MFQY8C&LI(C,@=%*"0@A"U@Y!"WKO^7%+]^L:O\KZO\I90),8RN^_XGW[(A"+
MKMID6,3YOS[L(ARV43=>&F;RYTS%/VB40"GL\_;,NA^T+7-C87\+FUNMQ;X:
MM?F[R#YNDWCV',^:(>WW)^S)V4[H#1:Y=.A>ZK*T>IAK#`K<$5XDMEW$\`::
M).Y/QY"GK3]A%V,LM=:W&F@).4277C(Z:*\DD1BG\B@U5.@BOX:BQ$S"0!`H
M[7$PLR33VXI6U`D65C<#Q(L.H%Q<CPO6QPN#<VW,8[;;L^Z9"Y<;R0&/$GD[
MT<94221:8SW$0LH=DNJEE#$$BNV)RMBZ>>34=!9)H,U(5I@K*V)C$W&NR+R`
MBT2D,M)335G(K+Q3!(JA1,LN5-,H&#<>NCX>7&JM)%(JL;*2K`$_`+CJ?J"N
M&=POF.V8^/E;EM.YX^+ERB.!Y<6>-)I#>T<3,@$CFQLJ$L;'I5?(9"H,3.1E
M8E;Q4(RRS3D64-7I"RPK.<EG@),EA:1D2Y>IOW[D$9)N?PTDSF[7"8[;'+OP
M7&R'C,J1N8E%R0I(`Z^)M8>!_>-8V+Q?DV;MTV\86W9TVTXZ:Y9TQY7AC6[C
M5)(J%$6\;B[,!='%_5-O(=9AQ&R?V**>92QRTE*@B+FV1KF[UE!_5VX.FK$5
M[$S5DR.(1$'KY!'N<E2+XJQ";]QR@-P868RJZPRE'^U.EK-TOT-NO0$]/0*S
MH>"<XR,;%S<?9MU?#SFTXTBXF04R&TL]H&$964Z$=K1ECI5F\%)%X%GH,R4*
MN69B3(64Z2=<6+(LQ2GU%XYS,(IPJ@+=DJ=:(9K.B@@*@F;)'5#V"F,%CMR7
M8:6NGVW0].MNOP=2!U]/2M"=MW$/D1G'G$F("9QH:\(#K$3*+7C`E98SKM9V
M5#ZQ`JUU<K8N09/Y);)-!1CHJ>"JRC]6XUU-E&V<W=VUM^Z/(@@SGC=@[,U#
M%<#L/L=-7?8\O4%[4FIEU`:6N5_C#IU'U?"MRG"N929$6(FT[FV5/C>TQH,6
M<O)C_P#;HO;NT/4?=5!3_:JO'(-"+*RD$:[U`LW!NX6/FH<;+#!*Q#^R.VS"
MNLI2/%[YN/=SS]ZB@R35(0[I94A$@,8Q0'C[-D:!)VW[;`D'2;$*+L0;=0`"
M3\`'6L8<7Y*<*'<AMV=\W9"2O%+V)>W*D"L\[QOHTNL*(SRLI(C569R`"1V?
M+RC]\HG\LZIXD&HBE-I_**([X=5Q,.Z\W3E"^<[H]1>?8+L2`MV"9X@HB&ZA
M#%![/D=#VWLWAZIZ]`W3IUZ$'IZ"#X5P_-OD6F%O8,W3D@F(]B6TH6)9V,?J
M^N!"Z3$K>T3K(?48$^,^R]B:,0D74EE#'<>UAY\M5EG+ZZUIHA%V@Z;I4E;D
M5G$FFFQGS),5S`S5$K@2HG'LV(;;FN%F.0$BE)9=0LK&Z]/6'3J.HZ^'45GX
M_!N;9DD4.)L^ZRS3XWM,2IB3L9,<%1WT"QDO#=T'=6Z791J]87K;)DS'%-1<
M.+?D"D51NT7C6KI>R6N!@D6SF90>NH=NX5E'[4B*\LVC7"C8AA`RY&ZAB`8"
M&$*18N5.;0QR.2#]JI/A:_@/1<7^"XK'VGB/+-_D6+8MKW'-E=9&408TTQ98
MBBRLHC1B1&TB+(1T0N@:Q87[:UD7'US?2<73[W3;7)0H)FF8ZM6>$G7T258Y
MTTADVD6^=.&`*J)&*7Q2D[C%$`Z@.J2XV3`H:>-T5O`LI`/UKCK7#=N*\HV#
M&AS-]VW/PL3(OVGGQY84DL`3VVD15>P()TDV!%7EJQ6AII2FE*:4II2FE*:4
MII2FE*:4K\.WHT%*'JRR>Q0#9GR*VV`.GX&6#I][IKO?FP`X@I`ZW3XZU^B;
MW]R?^">'ZLFQ_&BJ:[T("E+P"R6!2@4/S_9KZ```'2O5``Z!]X``/@U!N??2
M*/\``I\H]?/G_,B)/O-;03X_FSM7R^54+T<0G[%KCN7L+L'J5--@[0V#^J;4
M7H&VW^3T^#4V?Z;97Y/_`*537OW+9O\`C_Y4;F_]TS?+8Y^SUJG]5@I?VT33
MV0ZW;BMOT#K_`%-CT.OW^@:Y\3`/!B2.NB7X[U>]RXG_`(`7^IM_(?ELVOF:
MBE'[0/';@`_[9>#1_@#^$#8^$!^$!ZZY;>!_=TQMU]CE^*]/+\G_`)8DOZ!;
MO]C-J<7TXRE#U&_5[$``!'*>)]Q```1_H^0AZC]WJ(_QZZ_Y']&]H_D2?%BK
MYV>]82?=4\C0?#YFW+[.#4?5D*7\W_VC/V2]<EU7?H'7:TWLP;_?V,(C\.I`
MOWWCWX)_DHJ]/;63^<ONJ]?_`(1D_P!6PJT=]6TI0P!Z48`4``.$U9``````
M`(*A;`'W@#4CXB`VY[Q<7_[Y)\8UZ+]R(D^9OG5?_P"H.1\MF58GJ^%*$SP'
MV*4/^K@XU%Z``>R5.U=I?@#?H&LOAH!CW&XO_P"IY'\RI)[C))V_S,O_`/5?
M?OLX]3X5X`_;>8)Z!T]-V&VZ?P?UQ9`Z?XM=<S`?F/.?3\Y/_,KYH[J?_P#/
M'DGZV)?DH*H[6`?MQ,Q]`Z^G5.[]/_68H/Y-5@`_,>$^GYQ7[+5?V0G_`)=N
MP_K4A^+)4(N4RE_82<8?9#IS2O8AT#H/N+*`;A]X=AVU/=N`_/[*%A;V)?CI
M7T-X63_S(.8#T?W?X?RVWU9G),I?V1/IN>R'Z5>5GW`^[>G`C_&(==9.V@'F
MNY`CIV\?Y(UO_*8G_CD\V!_^2\<_J8J2:N%+^;[[.;[)>F3;3MT#IO:Z*8=O
MO;F`!^'41D^_\A_!)\E)7DO=2?SG]ZKK_P#",?\`JV94@OJ.E*/J,^D((@`B
M&5<L;"(`(A_1\>#T'[G4`_BU'^-_1K=_Y$?Q9:\P^ZD2/=5\\P/#YFVW[.=4
M;MG(7\P'VAOV2]>24,(]`ZB&7)@P"/3J(&'?X=26+^T>/_BS?()7K#9R?[S/
M=<Z__M.7_=D-1\8(`/V-_._H'ZQ/'3[@?<E(C_NZDVXJOY\8`L+=F7[`KU!Y
MD_MZ>6X]'YK;Y\G)62*"0@^@EF(!*40-SJKPB':'4?D[C8NX].H]O3X-8V8!
M_>%CCT>Q?TCU$^3$C_,LV'K_`.W,W]8SZG&]=XI3>G_C4#%`P?G[PIT$`$.M
M>MP#T'[X#MJ`\!^D,GX!_E$KYV?Y;Q(]YO=R/'\VMU^7Q:Q_8"E_;,\R![2[
MCZ:LR`CL&^PL,>`(;_>'M#^+63#]#,+\II\:6I-MA/\`P$<#%^G][4/Q\ZH.
M/2<*4:UZD^Y2COZ<F=BCN`#N43P>X?`.W74^Y8`LFTZ>G_J./_.KZ*^^P2-V
M\I;?_5;9_P"FJ]O2T`/[HGJ\]`_5+:?<_P#A&5-6N5JHWK9;`?\`BQ]E*C_O
MD_XY^1GZ;M\KMU3F(@'_`&?(0V#;^Y4MTVZ?^8J#_+KKJP_/\#T>UC[%?.9R
M?^9\/U@#XPK4BL@'YV?LZW0/T*V+[G_X\J(_RZWDX'LO(_J9`^,]=X;N?_T5
M[U'Z00?UW*K0KB<4H>OL\V*`?[6O*$>@`'46>7A$?A$1WU)]Y`_N[OZ?8X/Z
M*O2WG62?\LV,GQ_,CCWQMLKN]&XI0]7)[L`!L/(W;H'3^CSH=/O=-8_-0!P]
M2`+^I\=:M^_H3_P/1_5^8_C0U-WZ%92EX0Y@`I0*']YG.70```Z0=-`/X/\`
M`&VH)SO^W8?Q=/E)*^>'^8X2?>'V*_\`_$=H^6RZV$]%T`#TT>,X```'N_(X
M[`&P;CE^_B(]/NB(ZPN=?2K*^NGR:5UA[_Y)][CEU_\`M<#_`'9A5*/J(UXX
MJ.;G!'M+]F+@S@N]I@ZP7EO-%\-E*#=**)05ZE,>8AM5YQICRTD*<B$M79^U
MQGG%XQ?O;R1XPB2B:A-RC)MA;V?!W#<(#;<(8$[9]*AY%5W7X"JGHPZK>]Z]
M5^[ME3\9X'YC>8_&SH\Q]CX_AC;IE`,V''G;GCXF?FXYL6CGAQI.TF0EG@&0
MSHRGJ,OM<&<6\4\AL9W*ILZEAG+ELJ%[I%?I="&!H4;F2N1+:)L,PA8:9#L&
MC>Z.,<)-R/&3D"E7C"NE-SBFH!`PCG;MF;=+%,7GQ$=&+OJ<Q$D@68GU=?@?
MAMTMUJ"S>8WG)S7RNW?8=[DSM_X/@YV'ESY>9WLQ]KGE:2")H,J5V.(,XL8I
M4)*9!C6RAU+'/F3Z5)9$I$S38N^W'&:\YY%LXN-`<1C&Y1T8G(-7$LV@)26C
M)=M#/I>-159@]30,Z9E7%9N9-<B:A-?B3IBY"SO&DH6_JO<J3;H2`1<`];7L
M;6-Q<5UIP_D&)Q7D./O^;MF!N\>-K9<7-61\5Y"C+&TT<4D32I%(5E[)<1RE
M!'*'B9T:-7AAA_'5V]..PX;NDW/5O%1LE\I(&S2S:X.(652H]7Y0Y/<23><N
MDBJLZ]VRL+#F;33IRJ)W;%=SXJ@"H8X2G?<W)Q^3KFXZJ^7V<<J"NH:F@C`L
MOP@FZ@>!M;PKUKY_<ZY5Q[WK<7GG'\?&R^9C:./38\38JRQG+R./;>L;0XL8
M"]R.6428L<:VCF2+0AT!:^\>J'CK(N9,K\BL/4R-X]<1'G'62P?$V.JQS?#J
M6<G(3P3SO.\-&QC>#2@*=C>OMUX^LV1TBB\?)OW3E`P,4VQU..XY.3CX,.VY
MKG)WD9(E(8]SM"UNT2;W9S8N@)`L`1>]/-#DO*N*\"V7RKYWGR\H\\4Y5'N\
MD&2[;H=H7L]E=GEDD:8S96?,R3Y^#&[10F&&*0')>54M*(QQ3>,W-7BX6"Q=
M2L,8+_-/EW%.+[[BN0;6&?SI+MJ%!Y$4;<@CMH>!D2MHJL8^EYB(=]UE<2,N
M"BRSMNHX%-:\^5/NFQY8DE>?/[T<CK)=1$-;)]QZD=2ZJP]0!>@4@7K=YW*]
M_P#-WW?>9'<MYW#?_,;Y[VS<=PP]Q1H(=GB;,FP0VRAI9DU29&;C8N3';`2#
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M(Q\+8\;(SL7(:'2"ATQ%W=G#.H.IP2P74"```1?K:'>7?.-CY1L7!/=^XOR7
MS"XKR;+V?V2-\-_9-I?<MRS,S)2;*QTD7)S<?(;(AQSE1O&(X$5D24!P.&3*
MY?N1/*3G$YB\&X&SI`8UQM@^N0[/D;*SS--IC2Z8<_./)T7$;6(@916BW"Z6
M&8?N)"S*J(@W6;QZ0$5%J8[;EC28^V;1@!I\C'EEEE)[('5TET!I+D:E4!0$
M`-P6/2]CRXCNO&?*SR;\NHLSD?)>.;GN^[;O/*VQQPN6S\3=/88\S<VEFC&9
MBXD$4*08"JVM'RG+)W@LN6<Z*<?<B\(./N6:U@'&^2,H9HH>"\(\7%<_TJN9
M6ME;GLMMF#&IIV:S7*-GI69;8\8OG\_***+*$?>[7"IS&%8R@X>W_.6-O^3B
M29,L6+!)++/V6:-2L?5M*J5`UD*@`M:X`\+5"?+E?,_BOO$<HX3NW)MVVGA_
M']RWC=N0C9<N?;L:>';&=\DX^/BR0QQ-G.D.'CA54P]^)%`[86O)SUQVIF$J
MSZ>G$S"%!K^2Y*IY(M=L@\-9&!K&8GRO'4O'<\&3\@9AERLI9"*EH.;OB$_&
MG1B9<!L"Z"23#P`[VW+;]RGSY=RWG.=HE>-5,B??(R[C0L8Z7!"E6NR^K<EK
M^.;Y:^:>_P#F%N_FCYV^8>Y96T8F;M.-C3;I@ZI-RVU\O.A^;\+:XM<9DCFA
MPWPYPV3C?]R21WR>X=,N%X3&UOF>-&3L7?FV4E9+$OJ*QN0N1W#^D.8?Y(*8
MJDG$!DD^%<(%?R,1!7RC2E>G8BUMXMPG#EF7HOF)F#45"-QSI,N%-TBRS)99
MML*0Y#7U=P73NR]"58$-&6&K2-+:CU-=@;CRS8]O\W-GYE\["#$WORKDP=BY
M/EK+[2-QC6;`&[;MH26;#RXYX<G;GR$.4<6+V;)&3,$:461E:^R-<C?4BCL2
MXPN'&;&%EP#Q4F#TQW#1^/I6)>9&RG;L29&R2G1J\\53QE+6C'C-=!4ARM)!
MTA!HOU2$$Y#CD86,LLFUMFRQY62N1D#6"7OHC61$UD>N%>Q!Z@%RH\#4AX5Q
MK%W7,\ILKF^\8'+N7XG)N1Q#*65\V.5<';L;<\'`.9.H.?%CYK(ZD&2&-\N3
M&1F"LHD0BL<4#`WJ"80J6$J96L<UG(O$W,[3(-3I$.PKL#)-\37O#9,:6.7B
M(I!LT=34(-WEH]!^J0SHS=X=(RABE*!8T^3D;AQO(FSW:66+,B*,Q)([B2ZU
M!/@#I4E1TN`;5Y9S>5\F\RO=@Y%O?F%N&7NN[[5S;:FPLG+E>>:-MRP]T.?!
M%+(698I?9,:9X5(C#Q*X4$DF2S46KR132E-*4TI32E-*4TI4=?J9SU>FN#O(
MYA&3,-+.:\^QM"6)FQD6+]>#F5,G8TDTHF:;MUE5(R3/'2;9P5NN!%11<)*`
M7M4((R?BD<L?(,5F5E#!RI((N.W(+CX1<$7'I!KU1[H>V[IM_O%<3R<S'R((
M<J//E@=T=!-$-OSXS+$S`"2,/'(A="5UHZWNK`5GJHQ;"<X(YL@Y5`7,5-O\
M00TFW*H9$Z\=*YSQHP?))KD_"(**-7!P*H7VB&$#!U`-<.(DCD$!'B%E/[T,
ME8_N99F3MWO(\>W#"8)F8\6YRQL1<!X]HSW0D'H0&47!Z$=#T-:,Y`NELH4E
MQVX59EEW4WD#"?.7B98<.WF=<)+2>;N-CN^/HVF6]5P<$CR5ZQPX*%<M/80#
M^:;MGQA,5^!M;_%@BR5RM]PE"X\^WY`E500(IM%V7TV5_MTZ^!(L+6KT;QC8
M-EY+B<J]X+@4"8_&.0^7/)(-TPX5(CVG?EPTDRL4*+B/#SEOG;=<V[;RXX`.
M,5J;*_XKQAE>/8Q.4L<4/)45&/1DHV,OU0KUQCX^1%!5J+]BRL4=(MFCT6RY
MT_%3*4_AG,7?81#4$QLS+PV+XDLD3D6)1BI(^`E2.E?/?C/,^8<*RI,[AN[;
MEM.;-'VY),+*GQ7=+AM#O`Z,R:@&TDD7`-KBH[_28P]B.O\`#_"F1X'%F.83
M(<E'Y+C9&^1%(K,;<Y"._.W=6WD'MH9QB,XZ9>7CFZ?A*+F3[$$R[;$*`2?F
M>;F2;YD8LDTK8P*$(68J#VTZA2;`]3Z/2:]3>^WSOG&Y^>O(>*;EO.ZY'%H9
M<"2/#ER\B3%1_FW$;6F.\AA5]3NVH(#=V-[L;RF:B%>-*IW21UVKE%,P$46;
MK))G-OL4ZB9B%,.VX[%,.^JJ;$$^%ZNPNL<R2.+JK`D?4!N:C&I?`FZP`4MH
MYR6SKZ-+@8ZG0,Y1/'8V:M5*$J]Q+`L(-69A9"-6-&7?(,JOX:Z((JQHI)"!
M3`.TLR.102]PB(L9&+$/U5F++<FQ!ZHBCIUU7->O^0>\MQ[<SN$\6T294FX9
M,F5-#F:7QY\F;(Q>\\PBE20=S$PL=-2-J6<.XN/'.#CCE?5WG'R98V:K5IQQ
M\JE%B("N0[1T]@GTD#QC#Y22++S<<]L<;#RV/HLD?%F24\T)W*P.S'(&ZFO&
MZ8X&2C*[C)=RS&P(%B8^@(4D.;MZ.@TUUW%YK<:CQ^48&1AYF7%RC-S)9IY6
M5)DCTO+MQ[43I!)+%FR&;(#+V[1H8`K'U;-N?$N]WRTWZ-<SU4J6,;].2KZQ
M)Q*SBUS,JR?V%.XH*Q%=N55>,:+(NYZ,9!.-V\M(1,RL!GZ;5BY(5,U^#><?
M'AC95=\N-0%OZH!`T]2K`N-).DE0R_:DL.M;[C_G=QOC6S;9EPXV;G<PVS&C
M2`RA<:*-T@.*PEGQ<A7S$6&27V1WQH<G%0C&:;)B8N,:RW!?*]F0GE+#?Z7[
MQL=ADKY(.(Q"6(9/)%BH;K&5FN;0[N(<($?/ZC'Q94B*-U")J^9`P'()0/EI
MR'#B*B*-]*J$%[?:*_<538^`8MZ?@J787O'<*VB3&7:]LW#V7$Q8\-%D,1O@
M09B[ACXK!95)1,E\@L5=2R]H@JP)7*EFXK7..8Y/JV/',$_K^3&&/9:2LUNN
MLQ#7D;Q3<BS]^F7[@(''TK#)DLJDN1)%TU!N6-4)W$9*`4"FPHMW@8PRY(82
MQ%P%505T,@0#JX/JVZ@WO_&J%[1YS[!EY&S[SRE,F+=-HDSHH\?&Q(I<3V3*
MP8<*)%[V;'*3CB,LT<FLS@V;(4DE<ORF.+@_88C82K1-U[G99$@[$V6LCFZ-
MH]]9JE,Q\%9'L])5^KO)U-H`&:*'&-14(,F(`0Q""H.$F5"K3,AMJ*$>KIN%
M8$J`"P'P_;?P?W*@V%RO8L;*WS*PG*=^3!F@80+B,Z8^3$\T"0QS9"PENDJC
MOLI]G!+!F"U@:6X66A_`.F36ZMF3X];JT`WB&TO.-:.H>%X]2F(7TD^KB,>+
M5Q**3\@#I!R*8J%9D`!`%"@0=BF^PK*&:,E=3&]@6ZS"4`&_A86(^'ZE=DX7
MO`;-C;FF1-M[R8PR\B9I6BA;+`EWN/<TC2<OJ6,0H8W2X4RDVNI+"]8'CKDR
M/A<XUQ*<I]6C,FM6]=A30SF3LGNB'E[A:I.ZS48E9(`LI60?5RVKF9UM21FH
MAI,F6606;H.#IZL2;GBM)!*5D=XCJ-[+<A%"`Z39K,HN]E8K8$$BH_N?FKQ#
M*W#CN[/C9^9F;0[3R]U8X.[+%BX\>)%(8)NWD:)\9!+G"#$R9,41I(DLD2O6
M(9G@QD)[!S<6GD*%?IM8M2FU"'>J/(FLN:>PIN3J;3)*PQL-7B^[;C165V8`
MQ%D"D<9"-%(R&RA#)9L?(<99%<QL"3J8BQ;46C9@I+=5<H;W]:[7O\,YP/>-
MXOC[CC9C[7D1L\PRLJ5`LF0N4^5M^5E1P/+/]TQ<Q\2;O"73.'G#K)ZC!\NL
M^/.5GUJQ=>)*UQL+)8A?,E*Y"+V5SD<TNUL4\LCE(TQ=IC']2FF1IFB"BRCD
M6;1,J:Z6S@ZB0AMA'<\-89<=4+).#J.G1:P^YV4.P-GN6)/@>EC4&G\TN%8^
MR[QQW$PI<C$WV-Q/,,=<#M-!"#MW:Q(LW)B?M9FJ6=I9&+(WW)5>]^<1QQOT
M+FB-OK)_34H4]\M%LG'J;^8/)O8:4MN2;#&U^0J$E`RE=F)9DE>B^0FFKR%D
M8<ZCQ/O?-UBI"?=,:3!.,P?N=M5`L+`A8U+!@0P!T=5(96]7[4B]<<[S7XSN
M'`)>-9$6>VX#;<?&A0I$(TECQL""2=,J.:.>*-SAGO8DD67!E!<=M.-*A>K)
MMG%K+$E?9"TP3VI1\,WR)*76.AXW(5HKSZ3/-JWI5X_C)M?'5MEL8O%QN'B2
MD:S<3$1-/_&>)I1IS>&:_#N^&N,(9`Y<Q!22BD"VBP(UJ''J^JQ"LHL"7J0[
M+YR\*Q.-1;-N4>=+GOM4>(\LF%CSI&(AAA4DB&=C1;@H]ETX\\J8N3BP]N!G
MRU&H9_<81DY.)S^T=.8..=YJH\=6&Z[?S$HM$/"8X/3GZTH^4CXE:81+)JBL
M4X$2.NF7N,1,YNT-<-P5'QF`8B"0M\%QKU"PN;=.GU/JUUE'YAX>)F\8GA3)
ME@X_N,F0RMIC$JG.&4@C0/((CVQI()8(QL&=1<XQB^+MFN&3%LF9=E8F+*_4
MC9"1H>.YQY(03N2K3O'"];;RL_/5"(G)6,0=8Y0?F\L6*4*NN+<_CHD$Y\I]
MWB@Q1BX08VN`[@`V8/JL`Q`/KD==707Z&IAF^<>T;%Q%>(\'AGF,0D2/,SH5
M298\A<X3F.&')EACD*YSPCN'(4HG=7MR-I6][W@ZR2>0)C)=:0H\G))V/%UF
MB*Y91>QT=.JTF%R!`RK"PR[&%F%XXQB7<C^-<IM'W@R,>B91+8`,6QC[A$F,
M,67N!=$BEEL2-90@@$B_VEF%Q=6/6H[QOS%VG#XQ!Q'=FW&'$.)N./+/CZ'>
M$9<N%-&\$3RQ!^N(89XS)#J@GD"O<V-@3'%S(;^`PPQC+W7J^_PR,I;X=O&Q
M)E(A7(,[=&,^[C6(OH]R\@*;!U7WA7X]9IX;_P!VR:Q#$*3=,V2F[XRR3L\;
M,L]E-SUT!2+FQL6+:7(/34H^O4GP?.3BV-N>_P"3E[;E96-O_;QI6DDM*,*'
M$>%9'T.JS94V3V,V9)=4/?QT8,6]84[#CWE6(8T@S:L\?)-WCBG*XPBXN73G
MU(NZ5YQ5W-<->;F\+5#K$F6VR?A0)&SI`C1_*H>]1%Z!TZMN>&[27?)"RR=P
MD6NIU!M*C5X?[=P;A#H]7K<RO-'A>=D[B)<SE$,&[9XW"22(PB3$G7(6?V/%
M7VD`Q-ZVK,,D;F2'"D]C`QRKVK=.'5^N3"*KJDICN*84BV6&X5>TL"3*<]:9
M2R9;K&6FJEGARQ!6\`2FS%;1,U30D)0'SENU6$S0$13->@WS&@9I0LI:1%5E
M-K*%C:,Z3?UM08WN%L"1UO>MUQ_SXXSL&3-NB0[K-D[C@P8N1CN8C#CQP;;D
M;:PQY>[JF.5%.PD9X<?LQO-&!/W-0M!/@9?32LQ).+I304N)XQS?3H-I@J\^
M^8Y)MF;P=)F.R$J!T,NS*#]$3]^R!W)1]HQ>Z\>18VA5$;V2^CPZ`HL5O'_L
MP0?JVK>M[RO&AA08D6WY^G`$BX8+16A1\#&VG2;/U!VR)X7M:[B$CH#;(!.,
MN5X^8Q_/LHG"4HXQ;!-J%&0DI(6)I"9"KJ-3R;71N=W,E29-1G8_'NR"_NHB
M3Y$3*R0^\=W1.W&^=L-DEC9L@"9M9("W0ZHVTIZP]7U"-5QX)ZO2HPWF]PK*
MP-TVS(GY##%O.2V9)-&D#2X4YR=OG]EQ+Y<8>"V(Z>TEH6LN)_W7[BU^%>X;
MW>`.N=Q?X"Q)S<;CJ"L+&3A4F[3W=AFW8W<8S>,7"48XDWKU"FU*52<I/%U$
MT'TR<$#BD!S*5DWS'DZ"-ETERI!],JOW`>M@-3*18=0O7K:J[IY]\>W-56+;
M,G%;'ESIH'CE);7NN-GKGJZF01HARLG&:-HD4O#BKW%UE0NP6#L87#&LOD).
M=49N(2P7*[V6`797>6F4$VEJR#:[>U9HTQ[2H-E4#M6-A32<`WDY(BRZ0B':
M78=:S<,N#*2(QW$BQHINH'VJ*I.H,2W5>EU6PKK#S%YAL7+<':WVT2)N&+@8
MD$P?$CB);&PL;%9CE)ES/E!G@+)KQX"B,`;F];%ZUE=54TI32E-*4TI32E-*
M4TI32E-*5^'?T:?K993_`%/D5_-2VN^.;_0]?KI\9:_1-[^_[$T/X38_LQ5-
M?Z$7Z@62_G^S7^3]1U!>??2*/\"GQWKY\_YD/[3.T?HSM7R^54+T=]2WQW_>
M5-/BNTZFS_3;*_)_]*M>_,O]O[E7ZIF^5QZIO58^NB9_\]>*WQ-C[5SB?T%/
M\B7X[U>]R[]@&3\G\A^6S:^9I_W@>.^F7@[^7'VN6W_X<M^)R_%>J^7_`/IA
MR_H%N_V,VIQ?3D^L:]7KYU,3_BV0==?<C^C>T?R)/BQ5\Z_>L_95\C?R-N7V
M<&H^[)^C_P"T9?.55ORHO6I`OWWCWX)_DHZ]/;7])?=5_)&1_5L.M'/5N_0#
MZ4?T)ZU\14+4DXA_:>\?CDGQFKT7[D7^)OG5^L'(^6S*L7U?/^&>!'[N'C7_
M`#=IUE\,^][C^4\C^94D]QC^S_,S]:^_?9QZGOKWUWF"?W;L-\<V377,WT'G
M_*3_`,ROFENO^GCR/];$OR4%4=K^O#S%^[JG/QF*U6#Z#0_E%?YU7]D_T[=B
M_6I#\62H1LI_42<8?IHWOXCRAJ>[?]/\K\27XZ5]#.%_ZD/,/U?X?RVWU9?)
M3ZHCTW/G5Y5_ETXUD[9]-MR_!X_R9J0>4O[<OFQ^1>._U,5)/7/T??9SOG-M
M'Y54;40D^_\`(?P2?)25Y+W;Z3^]5^2,?^K9E2"^HY]8QZ0OSJY8_%L>ZC_&
M_HUN_P#(C^++7F#W4OV5?//\C;;]G.J-VT?H`^T-?21AO[6IC4EA_M'C_P"+
M'Y!*]8;/_B;[KGZ)R_[LBJ/?!'U-_._Z1/'7XTB-2?<OIS@?@9?L"O4/F3^W
MIY;_`*+;Y\G)62:#]0EF'Z=-=_)[&VL;,_Q#@_$OZ1ZB7)O]2S8?U<S_`"^?
M4XOKN_J`8U^?S"GY/VW4`X#](9?P#_'2OG9_EO\`[3>[_HUNOR^+5@3_`-<Q
MS(_=K3'XACW63#]"\+\II\:6I-MG[!'`_P!;47Q\ZH./2;_Y-^I-^[ESK_IP
MFI]RW[YM/Y1@_G5]%??9_M;RE_6KL_\`35>OI:?JB>KS]$MI\495U;Y9_;>R
M?C8^RE:#WRO\<_(S]-V^5VZIS$?]WS'Z%*WXBIKKK_W`'XV/L5\Y7_U/1^L`
M?&%:D5G]+/V=;YE;%_9Y4-;R?_PG(_Q@?&>N\=W^A/O4?I!!_7<JM"N)_P!?
ML\^EIRA_$LO:D^\_X=?^3@_HJ]+>=?\`IFQ_H1Q[X^V5W>C?];D^^'D;^+SF
ML?FOT.7_`*GQUJW[^?[#T?\`\C^-#4WGH6_J0Y@^DSG/XDIVH'SO^W8?Q=/E
M)*^>'^8W^T/L7Z([1\ME5L'Z+WU:7&?_`(OR-_:]?]87.OI5E?73Y-*ZP]__
M`/:XY=^%P?\`=F%4HVHC7CBL49GPGCC/U)5H.3H1:7A0E(NPQ+R.E92O62K6
MJ!<>;K]NI]I@7D?/U>TP3O\`"-7S)PBNGN8@B*9SD-EX6=D[?/[1BMI>Q!!`
M*LI\593<,I]((M^[4UX!YA<K\LN0KR;B&0L&X&&2"17CCG@R,>9=,V-E8\RO
M#D8\R])(949#8-8,JL,98AXC8SQ'>7>41G\IY4R@M7U*C'Y"S=DBQ9-LU;J*
M[I%\[K-25FU_=U9BY)ZW35>"S;).'ITR"X55[2@&7F[QE9L`Q=,,.*&U%(D5
M%9OXS6ZL?@N;#T`5+^<^>/+N<<=3AWLNS;+P]<H9+X6TX$&WX\^2%*+D9(B&
MO(D1&98NZ[)$&/:1+FMI-:FNFZU3L'#3"EDX[6OBX[;6YGB6[3]HL5C81%QF
MHR=?.[ED60RC9&@V)JL23)%2EIDU_%;`;PCLSBV,`I")1V\>]YT>Y)NP*',1
M54$J"`%01CH>EPHZ'T'J.M=T[9Y^>8.U>:>%YQP/@R<WV_&QX('EQ8I(47%P
M4VZ!NPP[9DCQXTTR6U"4"4$.`1\QOQ!H..59]);(&?,FU^STR5H,Q1\TYMO6
M5*"XK4T1JW?M"4^V23Z$1548-1:`H5(#%:+*HAL10P#7*WO)RM)$>-%*D@</
M%$D;ZA>QU*`?$W\?$`^BJ\L\].3<J3%>/;.-;1NF'N$>;%E[5M.'MV:N1$69
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M#,U))$AD6<NHU3,_1<F`PFV4/(=P@A2->V98DT1R%`98UZ^JC^(`N=/I6_JD
M5VELGO*>9>P['@[7B?-<F[[5@OA;?NDV#!+NVWX;B0>SX><RF2-(Q+*L#$/+
MC+(RXTD0L!<F8.'6)LS6N1NDK)Y,I,_9JDUQ_D)QBK(]EQVCE"A,%GZL?4<@
MMZ^Z02FV$<67>I-G*8-Y)NV>KHIN2)*"35K"WO,P81`@BDC1]:=Q%?MN;79+
M^!-A<=02`2+BM1P3SXYMP'98N/X4.T;CMF'G-FX2[C@X^<=OS'"!\G":928G
M?M1-)&=<#R11R/"74-619?`&+9@N#FYJ\$;%<=+`QLF)H&%<K1<#77\31Y['
M<.D,4V$K9XQAZM8W*+5%0!*B<2'+[10UC)N.6G?.J[Y*D2$]2P+!SU^JP!/P
MU%<'S-YE@'D4HRN[F\JQ7@W*:51)-.DF7#G2GN-ZRO+D01M(PZL-2GH35/FK
MC_0\ZMZFK:%[37K3CZ;<V+'N0\?V:2IE_H\N_CEX:66K]CBS@H1G.0KI1H_9
M.4W#%ZW-VK(G[2"6N#N.1MY<1:&AD6SHZAD<`W&I3\!Z@BQ!\#5WR_\`,[DO
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MSNY[O'(=FY%@RXVT2<<8-M4&W01XF+@,)O:&>"!`5,DL_P!UGDE,LD[6$K.B
MJHY87XKXYPE992ZQ4UDF^7>1JT90FURRU?YW(EC@,>PSU22C:)79";5,,574
MY-3S*X%*+I^X*15VLN=),Q&=N^5GQ"!UBCQPY?3&@12Y%BY`\6MT'H`Z`"YK
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M=>23:-DG40]47JUGAK?$"E(,CIN42I34"W.<"B`*)E,0?9,.M?@YL^W92Y>,
M0)E#`7%QZRE3T/U":ZSX)SCD'EQRG'YCQ=XX]\Q4G2-I(UE0#(QY<:6Z."IO
M%,X%_M20PZ@5:N7^-N(<YVC#5VR)6ADK9@/(+#)>,;`S?.HR3@K"Q,B<[=1R
MT.F=]`R2K1N=VQ5[F[@[5$QB[IE$+F'N>9@130X[6BGC*.#U!!!%[?"`2`?1
M<UN>"^;/.?+G9]^X_P`6R^SLG)MK?`W"%T62.:!P0&"L"$FC#.(IELZ"20`V
M8UG?6!76]8NPQAZD8#QI6L2XY:/V-,J82X0S63DW<P^2"<GI2R2'CR3XZCIS
MWRDPN8O<(]A!`H="AK+S\[(W++?-RB#.]KV``Z`*.@^H!4QY_P`[Y#YF<NR^
M;\K>*3?\[M=UHXUB0]F&.!+1H`JVCB0&PZD$GJ364=8E0ZFE*C;OTWRXAB56
M+K[/(UCC&EBY%$L5UCXNHH/9(%$<PDQ^1[7R$;2S&%K,5&Q;B%,P8KIRCQPQ
M3,=14G:YE.-'LKEWD,2L4ATJ2UA]ZUV;P)8E@]R-(#&P'AZRXSM_D?GMFYFZ
M2;5B9CXFQF#$>3)*1V.UG-*3$M&\N1))D)EB:5&QXDR'"HC7AO23F+P6M8J-
M.36?&U1.EEU2+EJ57IMUDF<G8V\Q[?`+:[-#5Y9^BE.X[,Y76).MV<:Z?`G[
MX,0P]AK"1X_=F$:XQF^YW#L-`!0][2;VZ/8>H2P%]%_&M!AX''3NV]#;L?C+
M[X#M@DCRYX5P(89,-VWIL1N^$)ASNVBG#>6>.'5[`&'K#%LG.\UG->:PL=%3
MJUFGX<CFM/8P'44K%FK%]N%H=_+R4LL06NQ4K8H:!BH04$C&*X82:@HB!O#4
M#+2/81*9&*]I6]8&QOJ15&@*;D*2SW]!47](J98>V^[[#NC[AES8R[/C9!7(
M233()/:,/%QU]CC@E[\D<$LV3EZV`*38Z=P$:TJ@4E>54FK;WD(QRK$#F9&_
M1>/"J/)U=]43265HM-E(3\9;*ZA6<+RF.<4I.UH8Q3NF5B4<;*B#AL0BM1'M
M":!(86[!0OX6:T9N`5;5('DL&\"ENG0],E<+R7PTP8-PDV6<;`V%)FD+"$R>
MWMLA=(9,:<Y&ZQYVXF-<H$1RX(2Z7BF9DO)I-Y3R%'W=:UGY&T3*$K3)96'I
M]/83<-2(&,C,6PTBW73G"Q!8@)Q3+;%\V059NU)QXJ<$#(GB3`(6FCP\9HQ#
M[+)B"079B"Y)D(\+WMVR";C2/&^NM#-MW#.+Y6W1[*.*;EPZ'/C$N5E/%+ES
M22;C+&P,/=,O9&V/"[K+&,2)09`ZYRV-CN(_.C"3O58C+%F9[-#'8FC*8,Y8
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MD.7$0!<R-?4O2J2C&Y1QN&<A5F6+D0<F6Z)PY$4IS[TE[(O`FO<`@C><A-+O
M=(1DG7I^#.$DH\@W3<[*!D(IL)!.G))`-<CYH;.CE3M>R(TI;H%OH;U$**3=
M3ZMG!NX8_P`0U?Y&/)O+Y]M>[X7S4.(X,^Z2Y:]N*`3>QS$X>$V)BRN9X9AV
M%BRXW$N9#D2ZM+XCV]ZX9'S*A(X&NCROY;2DD*='+WK%=8KML11>VYE+&8WL
M&\K"URQU.P>418+]T?8"Q:3B)42>PCWSAC$U;@Q<$KD0*T.CN'1(S+T4BZ="
MRL/$=4U6:ZR+IK6;%Q3@,F+R78,?*V-L1L^08>XY$^,2F,\6O#U1RSP9,&HN
MEI\(Y#)DJ^/N./[.`:P\]G^;D>T4K;QAE%.R$QMDVCR<M'L&=AC&UJR(\@KO
M1\F1DW%1'N=X_P`:,$9.OMR)=X)?@BKD.H8IQSECV!SW08>UW8W`)(.E`4>,
M@FX$ATN?W;=*GF/MGN\Y4XW;'DV8[2=VV_+CC=V@D;&P5FQ,O`DBDE[JIGN<
M?-<M8MZYC94!49,QJYY"4:<I.0LHSF0#T2T9+N$9/5--"]Y'FV[+R>:QKD_.
M5YG1B/\`'M?,H6!:HL&(O8XRA6[A1P0P@"F)E#;)XY,;$6/VA(E(;U$%[Q:@
M#KLY^W))L;7%O@B'+HO*[D6W;AQ?AV-M8Y)A[1BR0Y).'@PL^O:>_##.^84S
M9[>V2---VIP#+$L3`77YCJ7S>O@/(C%LODZ1S+:I"OU-HYDU,E)S%3=VJ6>Q
M<I98\<GTV$J5;6J<,NY?=T5Y^'(NT0*8YBF1!2F2FWC<8V/:&"@9NFBS:0"%
M.ABS:C8>M9K$_5M7E.#Y=Q^9FU9$R[/%P'"BFR66,8!BR5QXDDCQW^;\J7)G
M&3*(X;9'9RBDLA"@B33CVP7;E\\B9IY)Q&6HF'M,M&,Y!"M5YX-@QG*T?!\+
M'Y%;PZT-$+RLK3;U<W;Q["OVB3@0EHTX(&-YM`@94<&R*RJK0ET4D:CT</*2
ME[FP=$`#`V]5A?P)J4;9Q[R+@S<>##GV2?/PX)&0Y$Z=G/CR]WE?!:42RB./
M*P\58HLJ&5D'LTZF0#L2,<KRUEY`0-2Q;9*8VRK;8>O9KR`Y]T3<#(FN=[PU
M\F+7#5=E>6,E%,YUOX4[+(OF*SQ%K(+HQS0[CN544[\-(MMDFFBG,*.V.G4$
M:4EU*6*$&W@""`2`6:W0"H5A;1Y8[GO>\[3O[[+@Y^5Q["7NQ31^RX>Z^T8T
MN0^&\<C0M>&-X9EB:2%'GG6*R*NFW<#%Y-U^[5.7RL^R5,UEF25@;')O%;%+
M.;`]KV$:K()MGF.203.`@8R>MR<J^:V)DL=PM+-0BCIAYQ/:[N/S3+`Z88B6
M4V*@6%@TK#[>Y)(72"AZ!3KOZM;3S*/E!NG'\W!X7'M&/N[F.:"-1!&L*3[M
MD(67.,S3320XIQX9,&50B8TAS5<]AKU8V7D8M@VTLLAH9&J%U2R1!VE&0CHV
MR3!G%"O;=2VC4%9[%$/)7*NQ55L:CR`%Q$Q\E)135JP%Z@JV6<'&G:VL;@C8
MO:?'[16Q*CUT]75:0A6++9[,55B6TD$`59&T>54?F-AY'%FVK/X^VTS8Y1Y(
M(M.9AL,;VD0[E+'BSR9,`BS`F3-!!DR29(QY$ECB6K0L%\Y>J+(3L94<Q1\-
M+.L0NX.,<,8V3F4S8<?5B9RC!6&,AZ^P4BS9G0>SL>JZ60:MWA&#4S,C<50*
M-Z/'V0`QN\!<"0$W('W4,(R"6-^U9#8$D7.HFU;W:^->1B1MMN9G;#+GP)N:
MS2*\D<1^=$R(MNF@DEG<2?-13#F6-7D>(S3"=I=!(\P([F9,HY+N/R@R'`GK
M%8LUKCFKMW8$GCDLQ8,V3J%!J&-&=/=0MNE6<*X@HUN^4>I/XTC1L9%)P<^R
MG/5L2&&#3$VMU4GI;H(AK9RUU%];$6LUS<@>&6<KR"P)-HV'V7:\E<S,Q\:1
ME6`JO:AVF$YN5GOE++C1M*N9.\(B:&<R2B1XE7U-B*O<['8>3<[.J/,EEQP>
MNQCFF1<C!YOKD,X3;5"4-/'+5W%$9TARY-,(J[>]GK>2%P0@((FW;^)JY8(H
M]J5`(O:M1U$&(G[86];7J'3^*"+>)\;=6;QL&U;7Y0XVW)'M!Y6,J1<J1)MI
MGE4ME1]D>T+F-EJO:*_^&B>#06[CBTNC`#FX<UFS)Y**UW)*3Z,@<N9"=U9O
M&Q\N:>JF3F%)^2%4@9%G&$29W_#%A?RZ\7%'4\^K'QH-E@4.Y(H&S$&PDA`T
M6DM&@:Y%FC+ZF()ZI*H4,W@&:XL!79T.P^[Y+D1X:96TMC39.V82Y#2/%V<G
M;WR_:LF9'D);"W6!,5,C("]E9LCNH46%EK8KC&^R4XM=A2L<CE63BQBK$K<0
MR7%3S"+B,@$R-/(04?CUS8H>)4=0RU*+WN21QG,4DD1B9,Y5%5!4U>[+B"%3
M$(0^I=.@@DIH%R]B>NOPO9B=5^@%NJO-_&XE%LN*^TQ;+#F=^`8OL$D+R2X1
MP83,^:L$L@649?2,SB/(9CD*ZE$0+NOK0UY\II2FE*:4II2M6>5/-CBOPCK-
M6N7*O,U9PO6+M85JI59BSMYQPVF;"WBW4TM%MBP<3++%<)Q;)5814*0G:0>N
M^P:H2!XTK2/]OSZ/'_\`=^)?_EN0?_LS5-2_#2K]Q7ZU'I;9MR31\08JYDXS
MNF2LDV-A4:-4HMA=DY&QV.4,8C")9*/JHT9D<.C$$"BJJF3IU,&JZA2I1=5I
M32E?AW]&GZV64_U/D5_-2VN^.;_0]?KI\9:_1-[^_P"Q-#^$V/[,537^A%^H
M%DOY_LU_D_4=07GWTBC_``*?'>OGS_F0_M,[1^C.U?+Y50O1WU+?'?\`>5-/
MBNTZFS_3;*_)_P#2K7OS+_;^Y5^J9OE<>J;U6/KHF?\`SUXK?$V/M7.)_04_
MR)?CO5[W+OV`9/R?R'Y;-KYFG_>!X[Z9>#OY<?:Y;?\`X<M^)R_%>J^7_P#I
MAR_H%N_V,VIQ?3D^L:]7KYU,3_BV0==?<C^C>T?R)/BQ5\Z_>L_95\C?R-N7
MV<&H^[)^C_[1E\Y56_*B]:D"_?>/?@G^2CKT]M?TE]U7\D9']6PZT<]6[]`/
MI1_0GK7Q%0M23B']I[Q^.2?&:O1?N1?XF^=7ZP<CY;,JQ?5\_P"&>!'[N'C7
M_-VG67PS[WN/Y3R/YE23W&/[/\S/UK[]]G'J>^O?7>8)_=NPWQS9-=<S?0>?
M\I/_`#*^:6Z_Z>/(_P!;$OR4%4=K^O#S%^[JG/QF*U6#Z#0_E%?YU7]D_P!.
MW8OUJ0_%DJ$;*?U$G&'Z:-[^(\H:GNW_`$_ROQ)?CI7T,X7_`*D/,/U?X?RV
MWU9?)3ZHCTW/G5Y5_ETXUD[9]-MR_!X_R9J0>4O[<OFQ^1>._P!3%23US]'W
MV<[YS;1^55&U$)/O_(?P2?)25Y+W;Z3^]5^2,?\`JV94@OJ.?6,>D+\ZN6/Q
M;'NH_P`;^C6[_P`B/XLM>8/=2_95\\_R-MOV<ZHW;1^@#[0U])&&_M:F-26'
M^T>/_BQ^02O6&S_XF^ZY^B<O^[(JCWP1]3?SO^D3QU^-(C4GW+Z<X'X&7[`K
MU#YD_MZ>6_Z+;Y\G)62:#]0EF'Z=-=_)[&VL;,_Q#@_$OZ1ZB7)O]2S8?U<S
M_+Y]3B^N[^H!C7Y_,*?D_;=0#@/TAE_`/\=*^=G^6_\`M-[O^C6Z_+XM6!/_
M`%S',C]VM,?B&/=9,/T+PORFGQI:DVV?L$<#_6U%\?.J#CTF_P#DWZDW[N7.
MO^G":GW+?OFT_E&#^=7T5]]G^UO*7]:NS_TU7KZ6GZHGJ\_1+:?%&5=6^6?V
MWLGXV/LI6@]\K_'/R,_3=OE=NJ<Q'_=\Q^A2M^(J:ZZ_]P!^-C[%?.5_]3T?
MK`'QA6I%9_2S]G6^96Q?V>5#6\G_`/"<C_&!\9Z[QW?Z$^]1^D$']=RJT*XG
M_7[//I:<H?Q++VI/O/\`AU_Y.#^BKTMYU_Z9L?Z$<>^/ME=WHW_6Y/OAY&_B
M\YK'YK]#E_ZGQUJW[^?[#T?_`,C^-#4WGH6_J0Y@^DSG/XDIVH'SO^W8?Q=/
ME)*^>'^8W^T/L7Z([1\ME5L'Z+WU:7&?_B_(W]KU_P!87.OI5E?73Y-*ZP]_
M_P#:XY=^%P?]V852C:B->.*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2
MFE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*Z7*P-VZ[@0W!!%580^^"1#'$/
M_!U4"Y`^&KD,?=E6(>+,!^^;5%\SY]W&9@J2]:4&#AWDM2J],7=8K2]Y!"HV
MY1A?INX5UK6:-"K6B=9P<#4V+TCA%/O!K+IK*)@1,>Z6MQR&.213(S!9"$^T
M34MT"DLYT@DL18^E2+U[$G]V;8<#<=QQY]SR9\>#<)XL0:L/"]IQ@^%%BSMD
M9DHQX7FFR9HBC-;N8S1JQ9A;9)/D^BA>N.](FX6)AW^9J.SLMD3&>!^I4)BR
M0QWM)B(YRR:J1\\SGI6&E60N?%1*"B"`D`_C;%U7S23CY.1&S,L$A5>EM04V
M<FYN"`5-NOB?@KJ5_)YY..<JY#M^1//C;!N+P0'LZ!E102A,N5U=@\+0QRXT
MO;TL=+R!BO;ZXJM/->5H#:ZN;E6*VQ<Q-WB&59A2OK`V>2>/23EM4L]M0F#Q
M#NM6Y!"A4=Y(,7$,Z61&563BGB;18GBK9D.PIDE!`[$&,EC86#V72MKAE]=P
M"&`]4%U+#H)ILWN^87)I=OBV',RY(I]NE?(ET0,L>:8<88^,T0E6?&)S,N*"
M9,J-&]F1LV!YXVT1V_8>=-G;.W<+!4BNJ2K3).3*8Z>J.K/8VC.OPN5*[1,7
MVU"!JD,\L5@^7L%+/'XLF)#K^/%KH(>+T-J['QZ$KW))&T=I'M90;F-GD6[$
M`:"`+GT,";5M-K]W'9Y8$W#<=QRAA/M.!EJ@7'@9II=NGS-PQC-DRK!!['-'
M%#W9B$T9$<DFCJ*R,KR;R87&%HL3C'3.'NT#D/&5`;PKN*O$F#DM]=59/Y0J
M5!G#M;XD*T980?MXD[9.211432<E35*J`8OS5B^UI&)2V.T4CWN@^TU>KJ)T
M>*V+7TD]1TM453R@XB>88>U1;K)/Q[)VK<,UI5DQ(]/L2Y![`R6E;#-I(#"^
M2)&@=E9X2R%+^YDOE$YQ8MB*%G8Z!<3UZJ$_8+/YKY0U<D"Z;P8)U--""F(]
M:::)6>].$8TR+X47#5+Q3&`QTQ(-O$V@9@F>,L(XW"K:S7Z^MU!MZJ7:XZ'I
M\-:WB7DY#S*/?-PVZ7)7;=MSH8,?3V,@S*9KY),T3B)CCX:O.&AUI(VA00KA
MJQ.SYE72W,'SACCRDLT*3C:9O^8JG:YV3-+Q;BI0.-)6XT&'<-HQ2-/.IJWI
M0T:Y=)"TD6I6BH%(F[!0F:VQ00L`TLA,DH2)E`L=1D"N>M[>IZP'53J'BMJF
MT_D'Q_8\F.+)W3<9)=PW:+"VO)QH8^U(N3-GQXN;*K2"00D8:B>.-A)!(9T)
M9H"K77EKF+/8VON2J(VHL3*/*C-XR2K:SF<=M#3U:M%<";O<R\0)'JBS6I+I
MRQ;`F0QRK'E6G<)!..K&%L<>5CQ9!D8*ZR:N@Z,K60#KUU@$_4TM6EX1Y#;;
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MQ]6U9A]C"6F6\<WM#\Z!<L1&17-55H*JZD,DKY!6G-%K"5UX8*BR:K#X8@`&
MUL3QR+61W6[8E`OI'WLIJU^/CJLEOA(KLQ_=DVU,]XCNF6,"/>(XFD;'0'YM
MEP5R!F@"4C6,IEPC'?3W9(_6N2*RMA?D_D#(MOK<)/8_91]<MSZRDB+0T876
M#;)C!-+:[4@4$[?"1R5J?LT(!HJO*Q2B\.H60`B9_$3$#8>=M.-C0/)'(3(@
M6ZG2?$J+^J3I!N;*UFZ?!4+Y_P"3W&.*[%E[AMNYR2[K@QXYEQV?$F8]YL91
M,QQI7..CF:14Q\E4RE,)9UTM<=4+R@O*7&R=SC:JU7VTZ[:54:%5EH>^TB,D
MIB[IP[>O13Z9M\8*TO'#)S:0*RL8W5:"U345(40*(:J^TXYW1=OA=C&"VMKH
MQ`2^H@*>AL.BL;WL*Y;AY.\<?S:QO+K9<O*?;4DR?;,@2X>7)'%B&5IY$BQ9
M+1/VX6TX^0ZR=QD1B+U:3SG&_E7SR&IM4@3/+!.55/%,O/2D@:(M]3L]*QY,
MNY]TVCFP/D).E6B^H,9:.3,90C==FL4^[@2IWUX^J*))W:RJW<``NK*S@#KT
MLRH2K?"&%NG7>8_NZ8V%C1Y^_P";DB#%QLD[C%#&G=QLG'R\Z)85:1M!CR\?
M#>;&G8!2Z3H5M$&:_IKE9*T]EC!U;JM"II3>3<KXQR1)1,N\6C()WC6-MK9G
M.U<SIBDM),;-<8:.CP0<^$HS/(F3,911`>_&CV=)VE$+M=8HY$!`N=96X;KT
M*J6-QXZ;]`>D9V_R6PM^R-XAV/-R"^/L^V[A@1R1*))ESY,9GAR-+D1OCXLL
M\VM-2RB`,`JR#3:V`.75YRM=XBNVRD0579/ZP^FI<K8MJ2+6E(*AXYL\^[);
MYN-9U"W-64_?"QJK*/4"19$\)RN0$C*=E[<MEQ\/':6&1G8.`/M?6N[J!I!+
M*2$U7/JGJ!UM6Y\SO([CG"N/3[KLFXY.9D19B11:O9C[0)LS.QX5.+%(^5C,
M\.&9UEF7L2G7%&VL+J]B`Y9V&_X5=9#Q]4(R2M".2E::K!(FG+/[OK[QG\L:
M_8DJW`,DKG;)!?'$A'O'T9$MEWC1=5V9,JZ3%3NMR[-%C9XQLER(>UJOT6Y!
MTLNHG2HUA@&8@$:?`L*P-S\DMKXQY@IQ;D^=-%LS;0,H3'LX^N=6]EF@,\SG
M%QD7.2>*'(R9$BD18`S1OD):TYGG@S92TLSC(.JS#"*?8-4,_CK-(.4'=<N<
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MA00!I]`9M&U,5E:[2W(2V8S3A8]M1:@UB2NIL:U=WKQZ_E*DWLFQK:V:A0X0
M6RKU)/RCE87:J8=Q0#Q"!K3OAP)MR918G(>]A=0``VG[7[<^'B.G[QKIC,X7
MQ["\K\+ESY$K\CSGDTP^T8B*B1Y)@_\`#,WMDNH(S=V->VK="?5:M9R^H"@H
MS4FD*?$.:XW?9>1DYI&PN?"K\1!,*7)84L<TBI&$,C$9(&],(Z0.4W9%22X%
M`ZJ2:IR[;\VS?0782D1V&GQ)+B51U\4T%E_C*/02!7;Q]V*5,@8$N=.FZM'M
MACB,"WFEF?+CW:"(B0WEP/8YIX`1?(@2Y5'9%.P>#\VW/(-A6A;C`5>-1FJ]
M8+G4'%8D91TY;0,#?9&CK1ML9RC9+R\JN9!NX0<-SF0<[N"`0GEP,KK=PV^#
M&B[D#.2K*K:@/%D#W4CT>((/4=/AZ=7>8GEYL'%]K7<-AR<R:3'RH,7*7(2-
M5::;"CRQ)C-&QU1@%T='`>.T3%F[MDVBUJ*Z<II2FE*U:XO\UN+?-".R!+<8
M,P0.78[%EO/0[^Z@HVR1Q*U;DVXNCPCLMCA851=P5`HF[D`52V_SM]4!!\*5
MM+JM*_'O]L6_5-X>_29GO[([=JV_A517\_75NE20^CO]:MZ?/TI,;_C3K55^
MV%*_KXZOU2FE*_#OZ-/ULLI_J?(K^:EM=\<W^AZ_73XRU^B;W]_V)H?PFQ_9
MBJ:_T(OU`LE_/]FO\GZCJ"\^^D4?X%/CO7SY_P`R']IG:/T9VKY?*J%Z.^I;
MX[_O*FGQ7:=39_IME?D_^E6O?F7^W]RK]4S?*X]4WJL?71,_^>O%;XFQ]JYQ
M/Z"G^1+\=ZO>Y=^P#)^3^0_+9M?,T_[P/'?3+P=_+C[7+;_\.6_$Y?BO5?+_
M`/TPY?T"W?[&;4XOIR?6->KU\ZF)_P`6R#KK[D?T;VC^1)\6*OG7[UG[*OD;
M^1MR^S@U'W9/T?\`VC+YRJM^5%ZU(%^^\>_!/\E'7I[:_I+[JOY(R/ZMAUHY
MZMWZ`?2C^A/6OB*A:DG$/[3WC\<D^,U>B_<B_P`3?.K]8.1\MF58OJ^?\,\"
M/W</&O\`F[3K+X9][W'\IY'\RI)[C']G^9GZU]^^SCU/?7OKO,$_NW8;XYLF
MNN9OH//^4G_F5\TMU_T\>1_K8E^2@JCM?UX>8OW=4Y^,Q6JP?0:'\HK_`#JO
M[)_IV[%^M2'XLE0C93^HDXP_31O?Q'E#4]V_Z?Y7XDOQTKZ&<+_U(>8?J_P_
MEMOJR^2GU1'IN?.KRK_+IQK)VSZ;;E^#Q_DS4@\I?VY?-C\B\=_J8J2>N?H^
M^SG?.;:/RJHVHA)]_P"0_@D^2DKR7NWTG]ZK\D8_]6S*D%]1SZQCTA?G5RQ^
M+8]U'^-_1K=_Y$?Q9:\P>ZE^RKYY_D;;?LYU1NVC]`'VAKZ2,-_:U,:DL/\`
M:/'_`,6/R"5ZPV?_`!-]US]$Y?\`=D51[X(^IOYW_2)XZ_&D1J3[E].<#\#+
M]@5ZA\R?V]/+?]%M\^3DK)-!^H2S#].FN_D]C;6-F?XAP?B7](]1+DW^I9L/
MZN9_E\^IQ?7=_4`QK\_F%/R?MNH!P'Z0R_@'^.E?.S_+?_:;W?\`1K=?E\6K
M`G_KF.9'[M:8_$,>ZR8?H7A?E-/C2U)ML_8(X'^MJ+X^=4''I-_\F_4F_=RY
MU_TX34^Y;]\VG\HP?SJ^BOOL_P!K>4OZU=G_`*:KU]+3]43U>?HEM/BC*NK?
M+/[;V3\;'V4K0>^5_CGY&?INWRNW5.8C_N^8_0I6_$5-==?^X`_&Q]BOG*_^
MIZ/U@#XPK4BL_I9^SK?,K8O[/*AK>3_^$Y'^,#XSUWCN_P!"?>H_2"#^NY5:
M%<3_`*_9Y]+3E#^)9>U)]Y_PZ_\`)P?T5>EO.O\`TS8_T(X]\?;*[O1O^MR?
M?#R-_%YS6/S7Z'+_`-3XZU;]_/\`8>C_`/D?QH:F\]"W]2','TF<Y_$E.U`^
M=_V[#^+I\I)7SP_S&_VA]B_1':/ELJM@_1>^K2XS_P#%^1O[7K_K"YU]*LKZ
MZ?)I76'O_P#[7'+OPN#_`+LPJE&U$:\<5KQRAD>1K#$THEQ:98O#*DFZ+&I6
MO+\A.)TG&U?4CY)S,9#<5NN1KV7R%*U_RJ16-?(O&)2+I<@+OFR!%##0W]%*
MPQZ8.3+[F7T\N&^5LI6F1N^1L@\?L=VNZV^639HR5CLDQ!MW<I+O$(YNT8(+
MO7*ACB1%)-(F^Q2@`!H/"E6OQMRSDBW^H'ZEF++-;Y.9QYA]#AF;&-3=)L"Q
MM,-D'#=FL%U&*.W9HOE!L<TS2<+^866V.0/#["[@(>)I7/T]LL9'RJ^YYIY%
MMTG;4\8^HGR$Q/0"R1&)`JV.*K7L8NJ[48[R+-H)XR)<S+HZ1EO%7$5S=RA@
MVV#T_7I48.=.2&/OVB'.;&')CU7LM\'*=B=GQE-@W&],R?@['D9,1MTPHVLU
M_F4&&2<27V;L;@;2)!,*"X%(=84^P>XH!Q)Z]32I*?3#RGFGD)PY-8\UVFUV
MMRXR3G2C8JSA+4TF)[YFO`==R!8ZWAC.\G34(B%;56R7BD-VSTBB,<S0="5-
M\FW3(X*77(7(ZTJ/^H<D.9]ESDOZ-LEEA5OR1QO-IY*R3SA9N:$A;K%Z?23^
M)E:;<*]5"H*,&7+N^.I1&C3"`PPQ\.1NZM":9DW,>D;C<WT^FE?HD13!%))(
M#J*`DF1,#K',JJ<"%`H'54-N910VVYC#U$>NN=*[-*4TI32E1S9(R3R6A^>?
M%ZDR4C4ZCQZO,MFZ'C*O7W;F:N&2'%1PH[M"=IOS]Y&-&-;B(F=6\*,AV!EU
M3J("Z=.3`9)LC)L7$VN3CV7D('?<8UB)9A94U2A=*6-R2+ZF/P@`"Q)]5\3X
MEY29_NU\QY#B19N=YH[;!M,LF1.JQ8N`N3NRXYQ\)%D9YY9(1JR,J8(H5Q##
M"-+RR2,ZC->5*@PS7RLM5ARSRB5)G?/^%H3C=>8_']3=8DPF.1L/8[/$TZLV
M2:RWRMD#4V>=3=.LMFG'++W6R>M3QL!$JO!(D=7S99[A;3#'A8H$&-/+DQEV
M[DNB1KL0(X!K6S*H5KD'4S`7]%?1GR^\EMEVOA/#D/&^,<@W'EFW/FY*[ENW
ML.Z9W=RLB"+;..)[5"L65CX\,<OM$L4@GS<E(`SJG8,WD(\&0AHA^9['21GT
M8P>&D8<1-$/Q<M$EA>Q1C+.3&CG0G\1`144$4C%]HW\(P61=,C+8BQ(L?$=?
M`_5^&OGEN,`Q=PGQA'+$(YG71+]]32Q&B3HOW1;6?U1ZP/0>%1[\XWF1:'"W
M/,TIR'RSBG&%(Q[X6.:;Q^QXE<;C.YB\&RRZ\]D@'E'O"<I26S*-8MV[)3W7
M#I%%TI(.R=Z!B2/85QLB1,)<:&;)>3UVF?2HCNHLEG6S7))(U-X:0>M>H/=U
M@XKR7<-OX#A\6V3>N8;CNE\[*WK..+BP[7>"(0X&G+Q#'EL\DSO*OM&4Q[*8
ML#:9`VX&`K5:+S@S#ETN[BL.[I:\7T2Q6YS2I)G,5!>SS%8C'\\K696.<O8^
M0@SRJZHM54%ED3H]HD4.78PZ;<88<?<)X,?4($F=5U`AM(8@:@;$&WC<`_4K
MHOS,V79^.>8V_<?XZN8G'\+>,R#&7+C:+*&/%D2)",B-U1TF$87N*Z(P:X95
M-P-(^=62,NQ>6<!XTQO)\G(*LR]5R[>LBR?%W&]8O-Z?&KAJ/"TBOB^O=<G:
M9!,G3V?D':YW)D%5@9$22$5%4RCO>/XV$^)D964,5IE>-4$[LB==1<^H0Q/1
M0`/AOX`UZ&]W'B?!LSA/)N6\LAXAD[O!F[9AX,?(<_(P\-._[7+ES:,.>'*F
M=4A@C01AU4RL[@(C$;6<4+K6;_@BF6*JY1O>8&"BEA8/;GE&)BZ_DKW[&626
M8SU:O==B*Q3&D!9J;*HJQ3AI[L:J)>4+W>((^*II]WADQ]P>.6*.%NEEC)9+
M%19D8LQ(8>M?4?'T>`Z6\Z^/[OQGS(S]JWK9MMV+)`@=,7;I))L#LR01O#/A
MSRY&4TV/E1E<A)?:)`W=-M(&A=<N>>>K!CBR<<,/0%IO]'3SM:;^:Q6+$51"
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M>^/L>#LGMVS09+?-V8,W:,YG>9/G#:9=<C1X<ZHH;'>61H,F.>.Z`"-*?G[E
M&ZXAX\N+;2K4M1Q7R+BRM7&VP[6$E+W`XZM%YAH2\OL5UZP-WT=:,GE@':I8
M>/!J]<KKF$6[9PX*DD:O'<3'S-Q[60G<`BD95-PI=4)02%;%4O\`;&XMZ2!>
MKONR\.X_SGS179.082[B%VK<<C%QI6ECPYL['PY9<--QG@9),?;S,JG*F[D2
M(@M++'$7<8^X$Y9L^1)ODI6AR-><GXMQED"H5_%]CS/#-:KG9#WK1V,W=8>^
MU96MTFS-X!A8'(#`2$Q"L'D@V46`IG"""2QLGD.'#C1XLHBCBS)8V,BQG5%T
M<A2C:F4DC[<*Q`-O`FU2?WEN$[1Q;;N);L-JV[9^9;OMF5-N$&U2MD;.>WEO
M%B2X>0)\O':9X5(S8<7+FBAD6,D122O&-^+4\L,?6;`^J,*QL=J9PTDYK=?D
MY@:_&S4ZBS64BHN0G082IH9B^?%(FJZ!JY%!,PG!)02]@QV%8FE59F*PEAJ(
M&H@7ZD"XN0/1<7^$5YIV6#:\K=\7&WS(DQ-FDR(UGFCB[\D4)8"21(=<?==$
MNRQ]R,.0%+K?4-)>"U]SI<W_`"TB>0-LKUINF/.3CZF-$::Q<Q]'JT(;#^(K
M0VJ=.2DDDYIS"P[RRKE\V^W>/ES*.%`3\4$B;[D&-@0)A/MR,D$N)K];JS'N
MR+J:W2Y"CH.@\!7H3WCN->7&P8W",WRPPLK#X_NG$$RF.4ZOEY$WSIN>.V3E
M&,F)995QT/;A^Y1(%B4MHUMOQJ.UYHII2NI;PP15%8`,B"2GBE,'<44^T>\#
M%'<#`)=]P^[JHO?IXUSCU]Q>WTDN+?7OT_Z:TEKV=>*"08^EL?4SWO+W&M5O
M(-'8TK%CGY1*15GC;)7(UZ1N6,8JQTJE#4"0:.$%3IND&S'PC%V["COI=OWD
M]U,E[(CLCEI/5NI5B/$W%W4@^!)O7H;=/+CSK<[I@\HS^Q@X&7/A9;Y>XKV!
M)CR03R(6[CAXS+FP2HZ@QO)-K!OJ(RW!V;`"B^)ZU`15?*3+=3A[/C9HSJIV
M[%]6L9H1EOJ8FWCDDH,*R25(\B&SGP%$5$UA;D`Z*O;A21;D!-+(6O"Y5[MU
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MMXE(X.(B]W1`T8J)RI+FD/,-SB0YCZYC#WJ:Y>0A.VKDM)TTRH6!/7THIU#T
M6L:SH^%>>6\B63.W&9,%MNQ<R6;(W$+",3=L%\F.1V:0C3+AXKC(4`L@A[4J
MAE"U46&U<5+S"VW*,SC8EQD??]/Q[:FJV-WKF\/;6[EH)E7ZL]AGC1N_<34#
M.%:H'[^K%9H(=Y02WU2*'>,>1,2.70NEG4ZQH"@$E@0;6(N?J@_5JUM>R^=/
M'-PP>&X&['`Q?9<K-QV&>BXB8RQS//D)*C,BQ30]QQ;[\D@.DE[5D"P3^!*Y
M7J;6K=2V\3'Y*IKII%4^;I"KETK6,7PLC??<$_'%:/DV):RBY<*M6SD^P/E_
M#1W64`#8T4>XRR/+!(6:)P2P?^%(0EP;B^KH"1Z!<]!48VO;/,S==TS]WV/<
M'GRMHSU:3*BRPJC(W"6/#[T+ZD+^T%4621!]Y35):-"1B:3R?PTGI"G6T]!B
MK;[R@XC)K"Y1F)G4RTKU7+7<='87FSR",,9>(BH:"<UY%5=R03QY&*152I%8
MB*.8N)OL:O#W&32QC*F2UVN]T47ZDG78#[:YM?5UFV'P_P`_-MQL_8UW.?![
M.3+M[XLFY+$T^1W\X/AXZ&6TLDLRYK*B$"<S.4+G('<OG(F4>+<)9[^WOT-!
M.[549BBU:X+/:$M+R*KW*45&3-702>A%.#RK&2C:(U4743.=)`(=,%A*+<G;
M8Q</=Y(8SC,PA=79;/86C)#=+]""YMZ3JZ>-1WBO#O.7<-GVR7C.1DILN=!F
M9&*$S!$@3;I)(L@E.XHC>.3,D"*P#/[4V@'NM>OC,OX!0IENR\M6W%6:8]?U
MM[9PEJ`\CK;$R#JHQT54)!.(;,5Y!^Y=4BWH-&2S;QC^1<BW`2@4R9>#86Y&
M=,(-K:4,%LX*D:B6%[V%G4D@VZB_U:Q<O@OF;+O^#P:/+3,GW2*=,?MYJOC2
M(N2\F4AE9U1%7+Q7DE632.]&);$D,>RQL>-@9'IU%E\9UZ:LK*G-BPT@UQ\C
M,5^HTR:/8V\$UE9ANP6CX2#EEHN528BI_14%/%+W(BY)XU(FW3V9\A)66(N;
MC78LPTWL+W)%U)])Z>-NG':LGS:/%,_DF#N^5C[3)GMW4;-,4V3E1=AIFCB9
MP\LT8DQVFT_='70;2")NW9+_`#CP^F?.WJ6B81^\E<<FS&\F)/&SY:9DJM&3
M+W"IGIQ=P@R"\ZT>RRL+Y,0\X#9WX8$\%0=\A=OWM+8Z%@HE[0`<6#$"6WC:
MQ`U7\+B_B*D.-Y=>>V!V^.84^1%CP[K\UK%'GH(H\B2)-VT#3+H6%DC7+[OW
MHR1:M6M*]N!OW&C+LG4,<JTD/-P[][/X[A+3CU]"M$VS)*RD&XU!5RR39IPS
MX(.122<I'(*HD$IB@"A.ZW)C[KA(^5W/5(`<JX/7U?5;KXBZ]#_]E:[<N,^;
MG!L//Y4FX_<)XTASIL?.25BSF`^RY(5RQE3O0,T;`Z;@@W5M/&AW#CE7,33V
M7*_C-[C[&]7%C?$7;_'#J'/)?U,HG#6*GP*"#J0D'"\9+"V9@V0*N87()$)N
M;MU7(@W27-7"DE$F4]TL'O;KU#'P'47-S;I>J\DV+S6W;FV-P?<]WCW3EF9K
MPRJ9RRB/[J#+!E3$JB*)(M<O<<H.WK9K"]>39[IP^;L+=7'E)JUC^2%N+`2U
M8@\<I2[\]IR'3ZS;FIH-FWC2B^^6U=D(_P`)XV/X#M5OX(J>(U.5/G%C[V62
M42.NM+AB]AI1F4WZ]-+!NAZB][6/7.V?C_GM-DX.ZP;AF8OMV#WH\B;.,2#'
MP<K(QF[S-)ZGLDZ3:HI!KC5^X$T3*6NYM<^,ZD!A^MN*Q`QD':;!<:CCZL35
M!-'-ZS:*%%V&V7*#E8A]%D3J$I$%I3U187!4@7>-R]AU#J)&/9,&["2>4.QD
M159V#WU*Y55((/K`ZQ:W@#Z+&M'+L'FZFY[[NT69DS;CAXN+DYN1%FAVR,?,
MD@QL6:.5)"<J.7VN)5T%M$3G4J*CA?#QCE3C)E5[`5^FTH@,+&WD)6JR4GC1
M>$KTT]F\:0<A/Q\<]>1R0)3BV,[&V3?(+$1.=H!T![Q1,0O/+P]VPU:2>3UE
ML&`>[`!R`38^&M38B_6Q]-;'E_#/-_AF/E;IOVX'VG$9(\F.//66>)(L^9(7
M=%<WA&?!(T+H7`ETR#3K#&NM-VXRVS&KJV250CKU5[%>6V/DH:/H:LG.62Z4
MB3EX&&CXZ%,R0>N'$:A%N5HQP`D*K&B51L<R2R0*4AQ]VARA"KF.98]=R]@J
MN`22;VZW`8?QNAZ@VQMFX]YO;+RU-DQ,Z7;MYQ-N;-,KY@CA@Q,N.*:5WEUE
M%60R1KD)U*SW695>-RO5.W_BDS,UJLW6JX#>K3.-8AE%/,;.$F$#)<EI8D55
MTD&3J#12C"V20=I^]@[$_(`LF9\"0&+I'C;PUYHW:[K(20_4B`7;K?KI'VOP
MV.F]<]MXQYU9`?>=OR\ON9F/GRO(N>I>:/8(C)D$NLQ,G816]F-SWBCC'+D&
MK:4Y!\3XU&]5XE9.G57B-@J%_E66+I$:1(J0<ID*KKU.;?MHKRC\TH[J<VBQ
M2.0[=VF<!3-LY2\2Z-MWES'+K^["S(#(-0N$;4!?I8,A/I'[AMMU\K_.S+DV
MW=&S`=Z1H,K"C?<(_:XQ-'A9`R8D:34G;7)Q&F8$/&P(9;POIOFM0/'Z)S"]
MI%2P]Y6XUJ'2CI>W15&,E6X=E,UYS((0DE:=R(J+O8*1,0J0@KL5P5/<-]@Q
MY9-R?"$\TUX&-PI?J;-:X7ZA'_1>HYNVY>9V;P2/D.][[KV'+G,D6-)F7GE>
M*=4,T>/U("31@EO5ZH7L;7KQ'V5N)+QT9A)1E5<+RD%ES%I$'M#.JE+5K!39
MM(7RBI"M$&;/(-I$N"/6#,1%M),B^,T!4A=]7%P]Z`U(7`5HY.C^#2]$?QZ$
MGH3XJ>AM6QQ^%>=^/",G$FS4CAR=LW$E,P`Q3[PS)AYAM+J69I%,4TOV\$I[
M<Q1C:KKP3:,#RTY<VN)Z46E3<DY>SDVNO0G%-6N[-I9)N'<V:*D%V3<EFAD;
M*1X43IJ&\!9SXAB$\T0RMG<8=Q2-#F2=Q!8#U]6@Z0=)%_5.FWU[6]!MI/,C
M9_,G"V[;YN;;@=PVZ)$AB`S%RAB,T$4JX\B!V./*<<Q&S*-:II5F[+!-E]:J
MNHZ:4J`S)OVEOTG\19)R'B>[98R8RNF+[Q;,=V]DSPED21:,[12IU_6Y]JUD
M&D0HU?MF\K&JD(LD84U2@!BB("&N.L"E?G&]`SUBN"_IZ4OF1!\F[W<JS(YJ
MY*.\FT%*O8VMEP3?U!2'.R2>/E8%D[)%O#.#;"W6[5"AUZ_<X*P'C5:_6M4?
M6<X'7C@]E+U$*]>[HXXP8<OL;C6]6=?&EN:V)C:Y:R8\JC)JRIRS`L_)-3S.
M48@@KI)&3*18YQ'M2.(<]0M?T52H2?MC:R*/$SAX*RJ:0&Y-3P%%0Y2`(_FB
MMX[`)A#<=M<7\*J*_GW^>9?^F-?_`&A+_P`?5NE21>CJ\:']5CT]R$=-C&-R
MEQN!2E72,8PBZ=;`4`,(B(ZJOVPI7]?K5^J4TI7X=?1H,4?5EDMC%'N9\BNW
M80]K\#+CT^_T#?7>_-F4\04`BX*?'6OT3^_N#_P3P_4DV/XT537^A`<IN`.2
MQ*8I@_/]FOJ40$.M>J!@Z@.W4H@/P#J#<^^D4?X%/E'KY\_YD0(]YK:`00?S
M9VKY?*J%V/43_8M<=S>(3M'U*FFP]Q=A_JBU'_AWV_R`W^#KJ;,1^>V4?1\W
M_P!*H^S7OS+5O^/_`)4+&_\`=,WRV./L]*Z/59,7]M$T]HOLW;BMW=0]G^I<
M>CU^]T'?X-<^*,HX,02+E)?CO5[W+@?^`%_J[?R'Y;-KYFHQ0^T#1VYBA_MF
M8-+U$/\`*$V/2@'PB8=OAURV]E_N[9;C5['+T_ZKT\O@?^6)*/3^8.[_`&,V
MIQ/3C,4?4;]7LH&*(AE/$PB`"`B']'R&'4`ZAU*(?"&NO^1_1O:/Y$GQ8J^=
MGO6`CW5/(PD=/F;<OLX-1]V,Y/D!]HS]LO3)=5W]H.F]IO90WZ]-S%$/A#4@
M4CN\>^I$_P`E%7I[:U;\Y?=5Z'^R,G^K81^Q6CGJVG*.`/2C$#%$!X35DP"`
M@("48*A;"`@/4!U(^(L%W/>-1`_[Y)X_RC7HOW(P1YF^=0(L?[PLCY;,JQ/5
M\.09G@/L<H_]6_QJ-T,`^R9.U=IN@_Y)MAV'[NVLOAS!8]QU$#_U/(_F5)?<
M9!&W^9EP?\5]^^SCU/C7A#]MY@CJ'7TW8;;J'7^N+(/3_%KKF8C\R)QZ?G)_
MYE?-#=0?^7CR3];$OR4%4=K,'[<3,?4.GIU3N_4.G])BAZ_XM5@(_,>$>GYQ
M7[+5?V0'_EV[#^M2'XLE0BY3,7]A)QA]HO7FE>P#J'4?<64#;!_A[>OP:GFW
MLOY^Y37&GV)>O_72OH;PL'_F0<P/H_N_P_EMOJS.29B_LB?3<#N+N.5.5FP;
MA_FWI<#?Q"/763MK*.:[DQ(T]O'^3-;_`,I@?^.3S8/H^9N.?U,5)+7#D_-_
M]G-]LO7)MI`/:#J(6RBD$`Z]=C&`/A'42D^_\A^K$GR4E>3-U5OSF]ZKH?[(
MQOZKF'[%2#>HZ8H>HSZ0A1,4!'*N6!`!$`$?Z/CL.@#U'J8`^$=1_C?T:W?^
M1'\66O,'NI`GW5//,@=/F;;?LY]1N6<Y/S`?:&_;+TY)0P#[0=!'+DR0`'KT
M$3@(?"&VI+$?_4>/_4QF_JZ5ZPV=6_O,]USH?HG+_NR$_8ZU'S@@Q?V-_.\.
MX-_[Q/'3IN'W92)V_CV'^+4EW%E_/C`:XT]F7[`KU#YD@_\`'GY;GT?FMOGR
M<E9(H)R!Z"68A$Y0`O.JO`/M!T'Y.XV/L/7H/;U^#6/F$?WA8YOT]B_I'J)\
MF5C_`)EFP]#_`(<S?UC/'V>E3B^N\<I?3_QJ)C%*'Y^\*=3"`!TKUN,/4>G0
MH"/P!J`\!^D,GX%_E$KYU_Y;P)]YS=P`2?S:W7Y?%JP)\Y?VS/,@.XNX>FK,
MB(=P;@`,,>"(B&^X``&#^/63#]#,(>GYR3XTM2;;%/\`P$<#-C;^]J'X^=4&
M_I.'(6M>I/N<H;>G)G<P[F`-BE/!]QAW'_)+N&X_<U/>5L&DVG20?_4<?P_Z
MU?17WV`3N_E+8$__`-K;/_35>_I:"']T3U>>H?JEM/NA_P"Z,J:M<K93O6RD
M$6&6/LI4?]\G_'/R,_3=OE=NJ<Q$0_[/D([AM_<J6#?<-M_(J!MO\.NN[C\_
MP?1[6/L5\YG!_P"9\/U@#XPK4BLF+^=G[.MU#]"MB^Z'_1[40_EUO)R/9>1]
M?'(%OWWKO'=P?S)]ZC]((/Z[E5H5Q.,4?7V>;&*/^UKRB#H(#U!GE\HAT^Z!
M@V^'4GWEE_N\TW&KV.#I_P#A5Z5\[`1_EFQ@^/YD<>^-ME=OHW&*/JY/=C%'
MN'D;V["'M?T:='I]_H&^L?FK*>'J`1<:/CK5OW]`?^!Z/ZGS'\:&IO/0K,4W
M"#,`E,4P?WF<Y=2B`AU@Z:8.H??*(#\`Z@G._P"W(?Q=/E)*^>/^8X"/>'V(
M$6/YH[3\MEUL)Z+@@;TT>,XE$!#W?D<-P$!#<,OW\!#</N@(;#K"YU]*<KZZ
M?)I76'O_`((][CEU_P#M<#_=>%4H^HC7C>O-F&)Y.(E8U-0J2DA&OF)%3@)B
M)G=M54"J&*40,8I#*;B`=1`-*5K3P?X_37%+B#QQXV6.QQ=NGL(XCIV.):SP
MC)W'1$Z^K,4C'N)..8OU5GC1HZ.GW$(J<QR@/4=4'06I6M&4^+?+G'_*?*W*
M;A-D?CZU=<C*-B^IYSQ3R8J.0).M*67##:PQ%"R50+AC&=C9^*DU*K9%(R4B
M7C5PS=D:-UTUT%"F`RQO<4K//"+B].<6<6W&'O5_:Y2R_F;,^2^16<+W$UT:
MA6)G*N5Y1N_FVE*J:DG-NJ]2:S%1S&)BF[AZ\="S8$575,LH?8!:E4V'^*[S
M'G+'FCR*GYBM6*(Y.O\`CR\JU?+"J^^:87#&*AQ]*DE)!Z*S9X:<D-G3?RY4
MP23#M/N;KI;K>E;6V\+:-4LH4(U>)>!@98M//;BR1ZJG9Q8+A!*61.'$LLI!
M)R8I"[(U,5P9`#`F8IA`0K2H?UO2=E(/!U#LE&S(V;>I%1,RNN4SGFI/UYRL
M;(N?[:V:P^5JU?*U'OT9)?C?D#'J7R+3J3=V5&'K3.-\L(NX]-4_'3T^K2IE
MV`OQ8,AE"M"28M&PR)&!UE6!'XHD\V5DHX31<*-"N.X$S*$*<2;"8`'<-<J5
M5Z4II2FE*UQRAA*6ON?.,&8&<['1\9@21R^^F85TT<K/["3)..5Z2P3C'*2A
M6[,T6[6!=852F!1,.TNQNNMIB9Z8VW9>$RDODB,`^A=#ZS?X;CH*[6X=YAX7
M&?+/F/!<C&EES.2Q;8D4JLH2`X&<N6YD4C4W<4:%TD6;J;BMCM:NNJ:C:R9Q
M&SJ>7Y.US".1L75C$_,==:2RFG>*E89F[XWL=AH,/BW(%CQJ:(E&<'9CVJG0
M399!G,>72CI8AU_$704%L$HQ=YV\)B2YT4K9F#TCT,`KA7,B![@E=+$BZWNO
M3H1>O67$?/'RX7!X?NOF'M6\YG-N!*(]N.)DP18F?!!F2[CA09_=C:;'&/E3
M2*\N+K:?&(CTQR*)3O\`TJIQ-"IM2HL`5<L%2ZS`U.%*Z6%PZ+$UR*:0\<5R
MN(%%=<&;,G>?8.XVX_=U')YGR9WR)+=R1RQM\+&Y_P"DUYDY!O>=R7?L[D>Y
ME3N6X9DV3+I&E>[/(TLFD>@:F-AZ!TK6[*]#Y9)9#FK=@+*N-ODS<:;%5F4Q
M]FR`L<O!4&QPSB5%OD3'ZU1=L74@XEF,OX<I"R`IMWBC%NH1XA^$(;9X>1M!
MQUAW&*7NHY(>(J"X-O4?4.EB.C#P!/J^FNV>%<E\DGXMC['YF;+N_P`[X&?)
MD1YNTS0139L$JQZL'-&2KJBQ/%JQ\N'4\2RRJT$GJL,E\<,(PW&_!6+L&0$N
M_GXO&E385M.=DTDF[R9<HBHYDI11F@8[>/3?R3E95-JF8R;5(Q4B")2`(XVY
MY\FZ;A+N$H"O*Y-AZ/0!]6PMU]/C41\V/,//\V/,?>?,;<X(L;,W?-><PQDL
ML2FRQQAB`SE(U56D8!I&!=@"Q%6AF:E\E%KU5,A<?LD4EHC'5F<J=MQ%ER/G
M%\<V,))\QDX>\1LO4.VS0-UK;AF=ML)'3)_'NE$C$05(FOJ]@S[6,=\;<8I"
M2P99(R-8L+%2&]4J?'T$$7ZCI6\X#O\`Y2IQS-XOYG;3N#R2Y<.3C;GMCPKG
M0=M'CEQ)(LF^/-B3JPDN#'+#-&KAI$9HZ]+B_@MU@#&;NL3=F2NEXN%]R#EO
M)EL:10P,5.Y'RG:Y*X6QQ`P`O)`82O-'TEY5@V,NLH1JW(*ASJF.8>.[;@-R
MRA*BZ($C2-%)N0D:A5N;"YL+DV\36+YP^8\/F=RY-XV_#;;^.X&V86V8&,TG
M>DAP=NQH\7&6:;2G>G9(^Y-($53([!%5`H%O<CL%7'(UEPIE[$]@JU>S+Q^L
MUHF:<%\C).5HUFKU_JKFFWRFV0L(Y:S<2G+QBJ#EK(M/&59O6*0B@LD=1,;F
MV;A#BPY&%EJ[8.2BAM!`92C:D9;]#8W!!M<$]0:VGE1YC[#Q3:.0\&YMBYN5
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MPED>MS+M%TWC!P=)V@)E$`(>FT[A'M\LHG0OC3P-$X4V8*Q!NI((N"H-B+$7
M!Z&K?DYYC[9Y>;MNL/(<2?,XIO\`L63M.<N/*L.6F/DM#)WL65T>,31301.$
ME1HID#PR660LO@8"P;DNKY6S#R`S78J-(9-RY`XXI/R:Q=&33&BU.EXN&V.(
M%$LE8U1G[79963NK]=V_<HM2)(@@V11*1(3J7-QW#%FPX-NP%D&+"SMJD(+L
MTFF_1>BJ`H``OZ23UK9^9GF+Q'>.%;#Y8^7V+N,7$-CR<[+[^X21/F9.7N/L
MRS'MP#LXV/''B0I%#&TA9NY+)(6<*NW.M-71U:YX)PE*XCMW):R24Y'S"&=,
M[N<NQ+9BU<MU8&-7QKCBBEAY$ZYS$=/BNJ0JN*B6R?AKD+MN`ZV>X9ZYL.+$
MJE3CX_;-_2=;O<?4]>W[E=J^9'F%A<XV/B.TXF-+!)QSC:[9(SLK":09^=F=
MU`HNJ:<M4TM<ZD8^!%;&:UE=54TI72X1*X;KMS"8I5T543&+MW%*J0Q!$NX"
M'<`&Z:J#8@_!5R*0Q2K*.I5@?WC>M*8K@5A5H@RC9L9BYP#813<5RU$A9&&>
ML?DL]K2<:=N6*1.U:-7,J]DT!1,15O)/%%4SE]D"[Y^19[$M'I20_P`);@@Z
M@U_'J>@4WZ%0`:]!9OO+>8$\DF7MW8P-S?JL^,94E1_:$G,@8R$,S+'%COK!
M5X(D1U/4G)7]V:JKS="M4G9K?)VW&L1C>%JD^I)),5&K3'[N64>'=Q,4@Q@9
M!Q>8V<=,98RK4P>74_HH-SE*8,3YUF$<D*(@AE9RPM>Y<#TFY&@@%>OCXWJ)
M?WO;S'M^Y[+AX>##LF[SY\N3"$+AFS5C"A9)"\R+AR0QRXP60>NOW8R@D&PI
M7A+CZT3ULE[G:+=865K<R;EY#M#0]0(Y6>QEIB&$A8)2F1L#+VZ?@(RYOVC2
M0D5EG)F0I(KBMX8G/DIOV3#&B0(BLEK'JUK%20H8D*"4!(``O<BU^DEPO>%Y
M/L^VX6#L&'@XN1A)&JRMW<HJ$DQY72"/*DFBQH9I,6&22"!4C$NMXQ'J"K2D
MX+8Q<NE7=AL-LM9G\RRG9UM/>X'$;//PMRUQL)Y"/3A4F_9<GQ6B4F4@%!9%
M@@!>TQ1,:IY!EZ=,:(@"E1:]P-.E;&_\$7T_`6-7S[Q_,(85@VO%P<(18[PP
MM#WE>%/9ABP!',I:^*G<;')OI>:2]P0!<EKXFP$\E986&LP56AV&3H$\GCIG
M1:#*5&)G,<C6"0:K2-EH)PBO#K-JLB1>/6*=N8RAU"]AQ`0M0[S)&4DD37D*
M'&O6X8A]5[D'Q]8V(Z^`K4;)YV[GMCXFX9^'[;R3%AS83G-F9D>3)#G>T&8-
M)',I$H;(8I.I#@*JFZW!]"Y\4Z??H^#)8+#8&\W5:;`5"J3%9!C5F=8"(EU)
M21E(>JQ#=&KE4L:1&S-RV7:KM$F;1,B":0B<QN,&\3XS-VU4QO(S,&NVJXL`
M6/K>KU(((-R;WK%V#SIWWC.3DMMF+BOMV;GS9.3%D:\ALCNQ"-(Y<B5CD$0$
MR2QR)(DC2R,TK.`H%K!PLJ+"5GW5;OMWK<-<8^:@;A6V9*V[CI.K6B%H$5;*
MY$+2$&Y=5=G97-"!ZX49F*LF[E7QT#)"HEX-[Y^G9%$L<;NA#*QU7#*7*L;'
MUBNNPOZ%6][&^Z/O`[YDX6-#NVV;=EY^!+%-BSN9U>/(QY<V3&GE"3*N0V.N
M9VD$H*F/'QED#Z'[EPY"XBT+(UVL=ZE9ZU,)2RH-$GK.-7BTXPBD:PJ<7$.R
M-W$8NH=W#L*Z[2;'.<?#)-O@V'O3\.UC;UDXN.N.BH42]B;WZEB?3Z2PO_(7
MZM]7Q;SRY+Q3CV)QO"QL*3#Q&8HTBR&0B1\F252RR`!97GB:0`#4<3&_BMJK
M&'$G%L=5W-`:)R++'+ZZPE]>T6&.UK4*O-1%60@%4B*UIO$2;:-E99@TFW"*
M2Y-Y1N)BB"*JB(\6WG+:49!L<D1E`Y]8V+:OX5Q<`E0;?:GX1>K&3YW\RRMX
M3DTYBDY7'M\N&F9*&GE$4N09@2)VEC:2.)Y<1&9#_P!W>Q!D19!XMGXBP=I;
M4%@[R'<46>/Z*WHD6Y(QJ*UE(R9PLE7B/XZX.*^I8X%U,0\EX$RFT7(VER-D
M/&3`2J"K<BWJ2%I'6)-4DFL]6TW)#6*WTFQ%UN+K<V/A;8;/YY;CLTVYY4&U
M8#3[GN39DBE\D8Y=I8YRCXJSB"98I8]>*TB&3&,DFAC=`GC/N"^*7$HJ\83=
MTB(HBKCW776\NE(1\4R?LIA22B4G<XVE9EY%/K=*DL`HN'*H$E6:!B"5$HI#
M<7D&8J:66-G]+6L2018]"`"%&CH/M2?3UK/QO>.YK%A+!DX^WSYA"]R=HBCR
M.CQ".4K"T<2R)C1G"#)&M\:60,"YUB[X;BK3Z6WI"F-)0U!GJC89>P2=EC*S
M4WDI>59YE*L)5*W&=Q(E?K*(2ZHI+E[%4#"(E'VS@;'?=YIS(,H=R-U`"EF`
M6Q!&FQZ>'AZ:T6?YT;[R"7<5Y="-SVW.Q8H8X),C)6/#$+QO&<;3+Z@!B74A
MNK@"_P!JMJ2I\2ZC7L;M<3OYMQ)4IK8:E.+,H2O5G'[V:2I:2!H=G996BQT&
M_FW!Y..9/'#XQR/5UF90,IV&.4W*;>9I,HYBJ!.587+,X&OQ*AR0.A(`\`#X
M>%7M[\[M\W3EC\UQL=8N0/BY,(>:?(S4B.66[KX\>8\R1+VWEB2$`Q(LI(74
MJD6@'!>B-6\&I$7J]QL[63+$AITZD#(JFCVK&F,*I%SC-]#JMK`UI*5&:^[S
MN>Y<OF7@'.8'2N]_\X,@E@\<9C?Q'4=;L6(L>FK6;VZ=%^`5O?\`B-Y)-+DK
MG;;MLNW9@!EA`F0!V?*?)DA9)0T#99RY.^([(>W!I4=E*ONP<4ZC:JS6(&=M
M=O=2%?M5GO#RT(*PK&:G;5<Y(TE9)%T1K$)QS!!X1=9FFW:((IHL%A1#?8#:
MQX]XFAE>2-$"LBH%ZD!5%E'C<VZ&Y)N1>HYM?G3OFR[OF;EMN%@)BY6%CXBX
MY$KQ0XV+'VX$4M*9'*D+*SR.S/,HD/P52TCB)C_',N-GIDK,0=O5C;)!.K6U
M8UL)I]7[!4JQ66\,\=#""==K6WE,C9*-$1[V[E%1/<6ZZJ1N61O63E)VIU5H
M;J=-VL&5F:XZ_P`(,RM\(-_$`U=Y#YY<GY5@_,^_PP9&Q":"9<9GG[230Y.1
MD-*J]VP:=<J>"?T.C*UA+&CC@GQ&I</CZPXUIU@FX*K6"6K$VO#3K."R1!*/
M:]6(ZH.4)2$R'&V)G-14Y$0[-15LN/8V?,T7+445"=:'>9Y,E<J=5:5587!*
M&S,6Z%"+$$FQ'B"0;BN3>>/(,_D^+RW?L7'R=YQ8,B(2PM-@3!)\A\I3'+@R
M0-%)#++*JR)UDAEDBF[BMTMA]P7QF]:MDQMF1@DS(N&TY/.;&$E*61N@,`%7
M-($D6SJ,:/J86J1P,'+-NW6$6W<L*ICF$;R\ARE8G1%I]`TV"_;:K6ZV;4UP
M2?'I:MQC^\=R_'G=A@[3[(&5H85@[<<#'O>T:.VRR,F6<F?O1RNZ@26C"!0*
M]>.X3X@CF%Y("+B0G[C3']*8W&7C*[)6>F,Y)M;D'LA59!Q#B+*0>*7)THL8
M0,54W0P=IC@;@V_9KO&>@CC<,5!8*Q&FP87ZCU!;_P"ZL'*]X3G67D[<VI8M
MLP-P3+?%BDGCQ\IHVQBB9"++ZZ*,6-4`L5'@;A2+LK''IS`Y+DLK/[[\H+;.
M124?,RS['>/$)E19I`*UY@XB;"U@R3D&T;M014.R17\JLJF83$V54`;$NY"3
M%&(L>F%3T`=[?;:C<7L>M^I%Q^X*TF\>:,6Y<1BX7C;9[+L>/,7BC3.SFB`:
M83NLD#3&&9F;4!*R=Q58`-=%(QTOP/Q(:'DH%I.7MA'2%0)`D%.?\[(1=J!*
MI-U<E1$E+-Y!W'6UTUH\8BLFF(1JB")TQ;>&JJ4V6.19HD$A6,L'OX6!7UON
M9`M=1K8C^%<WOT%2N/WD^;C/BW*?&VV7+BSC,;PZ$DQ[Y+#`ECB9%?&5LO(9
M2P[ZNZOW=2(1F+%6"F.,9A[,FMU@M:I(^7@:NTEVL&Q95&M3EJ>7"2B6!(:-
M8K2*[V8<I^*Z>'76,DT0*7L$%!4P<S<&RT":%07!:UR68*%!-R;6'@!;J3]2
MT"YIYD9',,"/`&#BX2&6*;(:)IG?)R(<9,6.1S+(X0)$K:8X@BAI9"=5U"9X
MUKJZVII2M6YG@YPIL<Q+6*P\/N+<]8)Z3?34Y.S/'[$TI,3,Q*.E7TG+2TF^
MJ2[V1DY%ZN=9==8YU5E3F.<PF$1U2P^"E?E-^RY\<.-V:L=^H*ZRU@7"&67-
M4Y?/("MN<BXMHE[7K<*6`55+"P:UF@I52'BBJ!W`W;BFEW=>W?7!`".M5K]<
MS#C'QLBL:S>&8OCW@^-P]9I1&<L>*&&)Z$SQK8)IN\B9!O,3=%;P"=7E91"0
M@6*Y'"[514JS)`X&`R*8EYV%4K)EDIU0N3=LTM]5K=K:,UQ=,VMD@XR=;M')
MDS(F<-D91JZ307,B<2"<H`82B(;[#JM*M#\QF$O^AW%G_P"OJE_](U2PI5;&
MX>Q)#2#.6B,6XYBI6.<$=Q\E&TBLL9!BZ2W%-RS>-8Q)RU<)B/LG(8I@^X.J
MVI61M*4TI5JQE%I$+(C+PU.JL3+""X#)QE>B&$B(.=_,@+UJS2<B#C<>_P!K
MV]^N^KSY$\BZ'=V3X"21^]>MUE\CY#N&+[#GY^;/A=/N<D\KIZOVOJ,Q7U?1
MTZ>BO4B8""@&9X^"A8F%8*K*N%6,3',XUFHX7`I5USMF:**)UEBD`#F$O<8`
M#<>FN#R22-JD8LWPDDG_`*:PL[<]RW.<96Y9$^1DA0H>61I&"CP`9B2`+FPO
M8>BO,"C4D(M&$"G58(5L^"4;Q`5Z)"+0DP[@"118>4\HD^#O'\,4@*=1Z]=<
M_:)]?<UOK(M>YO;X+W\*S/SCY"<QMP.?F^WO'VVE[\O<:/\`B%]6HIT'JDZ?
MJ5\D*+29:3";E:=59.9`S<X2\A7HA[)@=H!`:'!^Y:*.NYJ"9?#'OW)VAMML
M&BY$Z)VT=PGP`D#]Z],7D?(<'#^;\+/S8<"S#M)/*D=FOJ&A6"^M<ZNG6YO1
M6BTE>8"PK4ZJK6`'23T)Q6O1"DP#U#L\!V$F=H+T'2/AE[%._O+VAL/0-!D3
MA.T'?MVM:YM;ZU[43D?(8\#YKCS\U=LT%.R)Y1%I-[KVPVC2;FXM8W-Q7JLH
M*$C7LE)1T/%1\C,J)K2[]E'M&KV551`X(JR3I!%-=\HD"ANTRIC"7N';^$=<
M&DD90K,2J^`)Z#ZWP5AY&X[AEX\6)ESS2XL`(B1W9DC!M<1J20@-A<*!>PJC
M-4:H8DTF:L5XR=E.56QIFA8T23ZA1,8JDT46W;*G*8YA`5_$$!$?OZKWIO5]
M=O5\.IZ?6^#]RKXWS>@V.XS,H-B"T![LEX1\$7K?<QT'1+>%4LC0Z-,(Q[>6
MIE4E&\2U!C%(2-=AWJ,8R*!"E9QZ3EFJ1DU*5,H`FF!2`!0Z=`UR7(R$)*2.
M"QN;,1<_">O6KV+R7D6#)++@[AFPRSOKD*3RH9'Z^LY5@7;J?6:YZGK7"2Q_
M0YD6AI>DU&5-'LD(Q@,E6X9\+*.;=WEH]H+IDJ+9DW[Q[$B=J9-QV`-%R<A+
MZ)'%S<V8BY^$]?&N6)R?DN`'&#N&=")9#(_;GE37(WVSMI<:G;TL;D^DUZX5
M^!+*I3I82(+-MV01B$P$:S"51C0$3!'I2`(^;39`8PCX0'!/<?X-<.Y)H[>I
MNW>]KFU_AM\-8)W3<CA-MQR)SM[2=PQ=Q^V9/XY2^DO_`+1%_JU\-7H`\JK.
MF@X<TXLR&-6F31C(956.,("9@K(B@+M1D(@&Z0G$G^#3N2:.WJ;MWO:YM?X;
M>%Z#=-S7"&VKDSC;ED[@B[C]L/\`QPE](?\`VK7^K7EJ4*BJQ*$`K2ZFI!-7
M1WS6%4KD.>);/5`4!1XA'&9BS1='!4P"H4@'$##UZCKF,C(#F02/W"+7U&]O
M@O>]9J\EY&F:VYIN&:-R=`C2B>42,@M93)JU%1864FW0=.E<5\?T)U',8=S2
M:BXB8Q1PM&Q:];AE8Z/5=G$[I5BR49&;-%')QW4,F4HG'J.^@R<@,7$CASXG
M4;FWPF]5CY/R6'+DSXMQSESI@HDD$\HD<*+*'</J8*.B@DV'A5:6HU0I(5,M
M8KQ4ZTH96NIEA8T"0"IC%,92%*#;MBE#&(41%#PQ$0#[VN/>F];UV];QZGK]
M?X?W:QSOF]%LASF91;+%ISW9+S`>B7UON@ZGH]_&JQ[!0DF]C9*1AXJ0D891
M1:(?O8]HZ>Q2RP$!56-=+HJ+L5%03+W&2,43=H;_`,`:HLDBJ55B%;Q`/0_7
M^&K&/N.X8F/+B8D\T6+.`)41V5)`+V$B@@.!<V#`VN:HC4^I'1F6YJO73-[&
MN#FPH&A(P49YR"@J@XF4A;"247!41,!UP.;N'???7+O374ZVNOAU/3ZWP?N5
MD#?=[$F/*,S*$N(NF`]V2\*VMIB.J\8MTLEA;I5&EC^A(1KN%0I%11AWZZ#E
M_$I5N&3C7KEL("V<.V)&0-7*[<2@)#G(8Q-N@AJIR<@L',CZQX'4;C]V]7WY
M/R67+3<)-QSFSXE*I(9Y3(BM]LJN7U*&](!`/IKF2AT=.(4KZ=-JA(%9V5^M
M"$KL06(5?E!,I7JD:#,&9W902*`*"03@!0Z]`T]HR"_<+OW+6OJ-[?!>]ZXM
MR3D39PW-L_-.Y*F@2F>7NA#?U!)JUA>I]6]NIZ=:]66@(*?9DCYV%B9I@DLD
MX28RT<SDF:;A`#%07(V>(K(D61*<0(8"]Q0$=AZZX)))&VJ-BK?""0?^BL+!
MW/<MLG.5MN1/CY)4J7BD:-BI\064@D&PN+V/IK@-<KQI-S-F@H8TR]8C&/)<
M8MB,F[C1`@#'N7XH>:78B"9?P1SBG[(=.FG=DT"/4V@&X%S:_P`-OAKD-UW0
M8:;>,G(]@CD[BQ=Q^VLG7UU2^D/U/K`!NIZUY4=C^AQ!7Q8FDU&++)LE8V2+
M'5N&9%D(Y?;QX]\#9DD#MDML'>DIW)FVZAKFV3D/;7(YL;B[$V/PCKT-9N5R
M?DF<8SF[AG3&&021ZYY7T./!TU.=+CT,+$>@US84.C13:19Q=,JD:TF&X,Y=
MJPKL.S;2C0`4`&LB@W9II/FX`J<.Q4#%]H>G4=&R,AR&=W)4W%V)M];KTJF3
MR7D>;+%/F;AFS3P/JB9YY6:-NGK1EF)1N@ZK8]!\%>K[@@@AODZ$+$A7_*^1
M]Q>[6?N;R6VWD_=G@^2\KM_Y/L[/\&N'<DU]S4>Y>][F]_K^-87SGN7M_P`Z
M^T3_`#IKU][N-W=?\;N7UZO]J]_JU3%JE7*I"K%K<`5:MI&0KJI8>.!2!1,0
MJ1D84X-^Z+2,F0"B5`4P$H`'\`:KWIK,-36;[;J>OU_A_=JZ=ZWEDR(SEY)3
M+:\X[KVF-[WE&K[H;DF[W-S>J1O1:0TEQL#2G55M/"X7>#-MZ]$(RXNW0*`Z
M=#))LRO1<.06/XA^_N/WCN([CKD<C(9.VSN8[6MJ-K?6O:K\O(^0SX/S7-GY
MK[9H"]EIY3%I6VE>V6T:5L+"UA86\*1E%I$+(C,0].JL3+#X^\I&5Z(82(^:
MW\SN^:LTG/\`2.X>_P!KV]^N^C9$[KH=W*?`22/WKU3+Y'R'<,3V#/S\V?!Z
M?<Y)Y7C]7[7U&8KZOHZ=/17JQ,#!P+51C!PT5"LEEUG2S.)CF<<U5=.`*"[E
M1NS111477`@`<X@)C;!N([:X/))(=4C%F^$DG[-8>;N6X[E,,G<<B;(R%4*&
MD=G8*O@H9B2`+FPO87Z5W1D5%PC%",AHUA$1K4#@VCXQFW8,6X*J'64!!HU3
M2;H@HLH8YNTH;F,(CU$=4=WD;7(2SGTDW/[]6\S-S-PR6S,^66?+>VIY&9W:
MP`%V8EC8``7/0`"J_7&L:FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II
M2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*
M:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4KPX2LUNM$=IUROP<`F
M_<>;?$A(EA%$>NA#M%R[*Q;H`X<"7IWGW-M]W2E>YI2FE*:4II2FE*:4II2F
ME*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4
MII2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2F
ME*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4
MII2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2F
ME*:4II2M"^;F(<H942I?YOJR^MONVI9<AH9%C;(^KCCW,MK8U!'#>='(R<S"
MD=-,4NXJ6.=1F+R5;>\0,T:+B93MH1>E8LR#Q3SK,9&EIJ@VZTUTS3F0KR)I
M5RF\D3$TV9MVW#$N/V,=88->:7?O<5RN7C+0;^J($3;IP[E1PT10,1%R1;[-
M*Q/A3CEGJ`CJ@OF/CNZN.77L-B1]4,B-\X0A(7C.C%U\C;(M!+96U@;W21)%
MVPTI)D]R1+YA=R3*3.5.U;HJ>7I:E8,?<)<ZOL?8EA*UQ[G,;5:IQ_&QEEK&
MGOC`E\<9)R#0*EE!A?LLM:%.Y6/B&823?V".:J+2DNUE9T52NEFO?%LQ46I4
MQW%"GY`Q]QOPU1\I$.G?:E18BOV`BTX:QNP5BB'9L1DICSDBW<2YHM)`7A&S
MERR0="HDU65;D24-4>%*V$U6E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4
MTI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32
ME-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4
MTI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32
ME-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4
MTI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32
ME-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4
>TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E?_9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
